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Abstract 
The thesis explores chronic leg ulceration experienced by young people who inject 
drugs (PWID).  
The applied health research study, in two phases, used a sequential explanatory mixed 
methods design. Phase 1 involved a survey of 200 people who injected drugs to 
investigate the prevalence of skin problems and leg ulceration, together with the 
identification of risk factors for ulceration. 
Phase 2 involved a series of fifteen qualitative semi-structured interviews that explored 
the results relating to risk factors with a sample of PWID who had experienced leg 
ulceration, and investigated participants’ perceptions of appropriate harm reduction 
methods. 
 
Main findings 
There were three research questions in this study: 
1) What is the extent of skin problems and chronic leg ulceration in young 
people who inject drugs? 
The study identified a high prevalence of leg ulceration as 15%.  60% of the sample had 
experienced a skin problem. Each reported skin complication is clearly defined.  
 
2) What causes chronic leg ulceration in young people who inject drugs?  
Leg ulceration experienced by PWID in this study was directly linked to deep vein 
thrombosis (DVT), as well as injecting in the groin and the leg. DVT was strongly 
associated with groin and leg injecting. The acceptance amongst injectors of the groin 
and leg as a site of choice has occurred with a lack of awareness of the long-term 
consequences of damage to the limb.  
 
3) What are appropriate harm reduction measures in young people who inject 
drugs?  
Harm reduction methods related to the development of leg ulceration have been absent 
across schools and drug services.  Training for healthcare workers which enables them 
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to identify risk factors should be developed, and harm reduction information related to 
leg ulceration should be included in drug education within schools, and instigated 
within drugs services. 
 
This applied health research has led to a number of practice-focused recommendations 
surrounding clinical care including early detection of venous insufficiency and 
accessible services to prevent, assess, and treat venous disease in PWID. 
 
The original contribution to knowledge is three-fold: 
1. Leg ulcers have been found to be highly prevalent in young people who inject 
drugs. 
2. Ulceration is predominantly caused by venous thrombosis due to injecting in the 
legs or groin.  
3. Harm reduction related to the development of venous disease has lacked impact 
and effect. 
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Chapter 1 
Introduction 
This chapter provides the foundation for the thesis on leg ulceration in young people 
who inject drugs. It demonstrates the personal and professional motivation for the study 
together with an introduction to drug use and leg ulceration. The chapter finishes with 
an overview of the structure and content of the thesis.  
 
1.1 Personal interest 
I have worked as a nurse for almost thirty years, latterly as a ‘tissue viability nurse 
specialist’ concerned with preventing and managing wounds, with a specific interest in 
leg ulceration. My interest began when I was running a leg ulcer course and a student 
submitted an assignment, involving a case study of a drug injector. At that time (1998) 
there was very little published literature relating to leg ulceration in people who inject 
drugs (PWID), and I wondered what the aetiological picture was.  
 
Later, when I moved from a full-time practice role to academia, I sought a sessional 
nursing role to maintain clinical expertise. I was approached to help with the Glasgow 
‘Big Issue Foundation’ project (an organisation which works with homeless people), as 
they had set up a physical health service and had been encountering increasing numbers 
of  drug injectors with large, malodourous, and chronic wounds which they lacked 
expertise to deal with. I helped set up a wound clinic and found that PWID reported 
difficulty in accessing suitable care, and they seemed to be provided with simple 
dressings rather than a more appropriate assessment and management strategy which 
could achieve quicker healing. My curiosity developed, and it seemed that 
recommended clinical guidelines for the management of leg ulceration were based on 
available evidence relating to elderly people and did not necessarily apply to the needs 
of this ‘new’ younger population of leg ulcer sufferers (Male et al, 2007).   
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The service that I set up with the Big Issue won the British Journal of Nursing 
Compression Award in 2002 (Bartlett, 2002; Finnie
1
 and Nicolson, 2002a; May, 2002). 
Subsequently a physical health team was set up by NHS Glasgow and the Big Issue 
service was absorbed into the NHS service. I continued to work within the NHS team, 
and also set up a new service within the Harm Reduction Team in NHS Lothian, but 
my questions surrounding leg ulceration in drug injectors persisted. 
 
Personal observation and anecdotal evidence from colleagues suggested that chronic 
leg ulceration had become a significant problem in drug injectors (Finnie and Nicolson, 
2002b; Goodall, 2010), but the specific causes were unclear. Leg ulceration is 
traditionally thought to be a disease of old age (Beynon et al, 2010) and where it 
occurred in younger people (aged under 50) it tended to be in men who were 
overweight, with a history of DVT and with long bone fracture (MacKenzie et al, 
2003). This was not the case for the drug injectors I saw clinically. Most were 
underweight, and had sustained no fractures, but some had a history of thrombosis.  I 
was puzzled about these chronic painful ulcers and the drug injectors themselves were 
also unable to explain what caused their ulceration.  
 
1.2 Context  
It is estimated that in Scotland alone there are almost 60,000 problem drug users 
(Information Services Division (ISD), 2011), and of these around 50% may be 
injecting, and mainly using heroin (ISD, 2012).  Problem drug use is defined as ‘the 
problematic use of opiates (including illicit and prescribed methadone use) and/or the 
illicit use of benzodiazepines and implies routine and prolonged use as opposed to 
recreational and occasional drug use’ (ISD, 2014).  
 
PWID are at increased risk from systemic disease, both acute and chronic, including 
dermatological, cardiac and respiratory diseases, diabetes, and blood-borne viruses as 
                                                 
1
 Alison Coull was formerly known as Alison Finnie 
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well as localised problems at injecting sites (Cortimiglia-Bish and Brazinsky, 1998; 
Saunders et al, 2004; McClelland, 2006; Keaney et al, 2011; Nambiar et al, 2014). In 
one of the earliest retrieved reports, in the period 1938 – 1947, Hussey and Katz cite 
many medical and surgical complications from injecting including abscesses of the 
skin, thrombophlebitis, septicaemia, endocarditis, tetanus and malaria (Hussey and 
Katz, 1950).  Subsequently other authors have listed additional conditions of 
pulmonary embolism, cellulitis, bacteraemia and osteomyelitis (Louria et al, 1967; 
Holzman and Bishko, 1971; Levine et al, 1986; Thomson and Lynn, 2003). 
 
Health of PWID is regarded as poor. Self-perceived health in a sample of 990 
individual Scottish problem drug users was compared with a sample from the UK 
general population and was found to be consistently worse. Those who injected had 
worse health than those who did not, and men had significantly better health than 
women (Neale, 2004a). 
 
Marks et al (2013) investigated the reasons for admission and costs associated with 
injecting drug use in a London hospital, and found that bacterial and viral infections 
were largely responsible for the mortality and morbidity of injectors presenting to 
hospital. They estimated the cost to be £77 million per annum to the NHS.   
Health care professionals are increasingly encountering injection-induced skin 
problems in PWID  such as wounds, infections, cellulitis, burns, abscesses and leg 
ulcers in their practice (Finnie and Nicolson, 2002b; Guild, 2008). Traditionally, skin 
and wound care is a nursing role and these rising numbers impact directly on the 
workload of many community, acute and specialist nurses.   
 
1.3 Prevalence of skin problems 
Before this study, the incidence and prevalence of skin problems in drug injectors was 
not known; however, skin disease was known to be a frequent cause of morbidity in the 
homeless population (Stratigos et al, 1999), many of whom were injectors 
(Hammersley and Pearl, 1996; Galea and Vlahov, 2002). Identification of the incidence 
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and prevalence of these problems is challenging, due to the often chaotic nature of a 
drug injector’s life which can be compounded by unemployment, homelessness, and 
criminal behaviour which may inhibit appropriate access to health care (Taylor and 
Kearney, 2005). 
 
1.4 Skin breakdown 
Skin breakdown may indicate underlying disease processes such as malnutrition, 
vascular disease, or infective processes (Bellis et al, 2001).  Drug injectors have to 
breach the skin surface in order to achieve drug entry.  Numerous skin changes may 
then occur, such as skin tracks, urticaria, pruritis, abscesses, necrotic changes, burns 
and other changes associated with venous disease (Pieper, 1996a). 
 
Skin problems may be a result of injecting behaviour, the quality, solvency, and 
cleanliness of the drug, the equipment, and the environment (Finnie and Nicolson, 
2002b). Long-term drug-injecting can result in sclerosis and thrombosis of most 
superficial veins and if venous access is no longer possible users may resort to skin or 
muscle 'popping', where injecting occurs directly through the skin surface and the drug 
is absorbed subcutaneously or from muscle. This approach can be more risky, and may 
lead to abscess formation and infection (Binswanger et al, 2000; Finnie and Nicolson, 
2002b).  
 
It was unclear if there were factors contributing to infective processes such as abscesses 
becoming chronic ulcers especially in the lower legs as numerous micro-organisms 
have been identified in wounds of PWID (Tuazon et al, 1974; McGuigan et al, 2002). 
The physical preparation of heroin by injectors involves heating or boiling with water 
to dissolve it (Ponton and Scott, 2004). The duration of heating may not eliminate 
spores or other micro-organisms and it is possible that the heating process may activate 
spores, enhancing the infective process. In the outbreak of clostridia novyi in Glasgow 
in 2000, 23 drug users died and skin or muscle popping was strongly associated with 
disease (McGuigan et al, 2002; Taylor et al, 2005). All cases had soft tissue 
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inflammation at or near an injection site. It is apparent from the subsequent report that 
there still is a considerable amount that is unknown about the causative factors, and that 
skin changes were the initial indicator of fatal disease. Since then there have been other 
cases of serious systemic disease in PWID – of botulism and anthrax (Powell et al, 
2011; Powell, 2011a). All of these initially presented with lesions of the skin which 
emphasised the importance of wounds to systemic health.  The opportunistic factors 
that lead to skin breakdown in one drug injector and not another but with similar 
injecting practices are unclear. There are a number of other factors, such as lack of 
sterility, skin cleansing, injecting technique and adulterants to consider in skin 
breakdown in this population (Hughes, 2001). 
 
A preliminary search and initial literature review conducted in 2006 and repeated in 
2015 revealed a considerable number of publications about drug injecting, infections 
relating to drug use, and harm reduction methods with PWID. However, there were no 
empirical studies relating to identification of incidence and prevalence of skin problems 
and leg ulceration, causal or risk factors, prevention of skin problems, appropriate 
treatment methods for wounds in PWID or studies relating to improving outcomes for 
drug injectors with skin problems. There was also a dearth of literature about the short 
and long-term implications of skin problems for PWID. 
 
1.5 Leg ulceration 
Possibly the most significant skin problem in relatively young individuals who are, or 
have been, drug injectors, is chronic leg ulceration, which impacts on patients’ health-
related quality of life. Major issues include pain, exudate, social isolation, sleep 
deficits, depression, and mobility. Costs of treatment are high and there is a 
considerable burden on both sufferers and society (Franks et al, 2006; Palfreyman, 
2008; Shiman et al, 2009). Ulcers can be large open wounds which are associated with 
greater illness-induced difficulties within the home environment, such as odour and 
exudate, poorer quality of life and greater psychological distress (Pieper et al, 2000). 
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Injecting affects the veins causing phlebitis, and clots occur frequently as well as signs 
of chronic venous insufficiency (CVI) (Pieper and Templin, 2001; Pieper and Templin, 
2003).    
 
Many injectors report periods of hospitalisation due to deep vein thrombosis but the 
causative factors remain unclear, and lasting damage such as post-thrombotic syndrome 
may result (Pieper and Templin, 2001).  It is known that venous disease can lead to 
ulceration which, in the elderly population, tends to become chronic and recur. The 
progression of venous disease in young people is unknown, but it is also likely to be 
long-lasting and costly in terms of managing a long-term condition, pain and suffering 
(Pieper et al, 1998). It is possible that current young drug injectors may become 
middle-aged or elderly patients in leg ulcer clinics of the future. 
 
Whilst a number of possibilities contributing to the development of chronic wounds 
have been outlined, the mechanisms or opportunistic factors that contribute to these 
skin problems remained unclear. It is puzzling that some wounds become chronic, 
especially on the legs, and remain long after any drug injecting has ceased (Pieper, 
1996a; Finnie and Nicolson, 2002b; Beynon et al, 2010). It is clear that injecting 
practices vary, and that these could be linked to the development of skin complications. 
By exploring the current and past history of drug use with drug injectors themselves, 
patterns may be identified that provide a greater understanding of the causative factors 
for skin breakdown.  If appropriate prevention and treatment methods are to be 
established, then an understanding of these factors is absolutely crucial.  
 
As drug injecting increases, these problems are only likely to become more common, 
and investigation before the problem becomes any greater is imperative. 
 
1.6 Objectives  
The objectives for this study were therefore: 
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 To define the range and the extent of skin problems within a representative 
sample of young drug injectors. 
 To determine the extent of chronic leg ulceration in young PWID linked to the 
above. 
 To detail potential causal / risk factors in the development of chronic leg 
ulceration in young PWID.   
 To analyse potential causal / risk factors in the development of chronic leg 
ulceration in young PWID.  
 To identify appropriate harm reduction measures relevant to service delivery 
and treatment in Scotland and beyond. 
 
1.7 Overview of thesis 
The thesis comprises seven chapters. Following on from the introductory chapter, 
Chapter 2 contains a review of the literature relating to leg ulceration in PWID, 
aetiology and related risk factors. It highlights the need for better definition of skin 
problems, and identifies a significant gap in the literature related to cause and to harm 
reduction, concluding with three research questions. 
Chapter 3 explores the philosophical approach and the potential methods that could be 
used to answer the research questions. It identifies a sequential explanatory mixed 
methods study and justifies this as the best approach for this applied health research. A 
quantitative survey of 200 current and past injectors to identify the extent of the 
problem and the potential risk factors is outlined (Phase 1), followed by a qualitative 
approach of interviews conducted with people who have injected drugs and have 
experienced leg ulceration (Phase 2). The statistical analysis is described together with 
framework analysis for the second phase. 
The results of the survey are presented in Chapter 4 with the identification of the 
prevalence of skin problems and leg ulceration in the sample as well as the potential 
risk and aetiological factors which were further explored in Phase 2. 
The Phase 2 findings in Chapter 5 detail the analysis and emergent themes from 
interviews with drug injectors who have had leg ulceration.  
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The synthesis of the two phases is presented in Chapter 6 together with a discussion of 
the results, including limitations and reflections on the study.  The penultimate chapter 
identifies the answers to each research question and links this to literature that emerged 
during the course of the study.  
Finally, Chapter 7 presents the conclusion to the thesis with recommendations for 
future research and practice. 
 
1.8 Terminology  
The term commonly used for drug injectors at the beginning of the study was 
‘intravenous drug user’ (IVDU) however, the current nomenclature is now ‘people who 
inject drugs’ (PWID). Where appropriate, the new term has been applied within the 
thesis. A glossary of terms and abbreviations is provided in Appendix 1. 
 
1.9 Early dissemination of results – publications from this 
study. 
The work presented in this thesis has led to two publications: 
Coull, A.F. Atherton, I. Taylor, A. and Watterson, A.E. (2014) Prevalence of skin 
problems and leg ulceration in a sample of young injecting drug users. Harm Reduction 
Journal 11:22    DOI: 10.1186/1477-7517-11-22 
 
Coull, A. (2015) The role of intravenous drug use in venous leg ulceration. British 
Journal of Nursing 24: S17 
 
Chapter summary 
The purpose of this study is to identify the prevalence of leg ulceration in a sample of 
young PWID, and then explore the risk factors that might lead to leg ulceration. 
Following that, harm reduction methods which may prevent leg ulceration in the first 
place will be identified which also inform practice and policy.  
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Chapter 2 
Literature Review 
Introduction 
This chapter informs the study by exploring the literature related to the research 
objectives outlined in Chapter 1. It seeks to find evidence relating to the prevalence of 
leg ulceration in people who inject drugs (PWID); to discover potential aetiology and 
risk factors, as well as key contextual factors of substances and the environment which 
may contribute to ulceration together with any specific harm reduction literature related 
to reducing or preventing skin breakdown. The review identifies gaps in knowledge that 
led to the development of research questions.   
 
2.1 Literature search  
The literature was searched widely at the commencement of the study in March 2006, 
with the intention of undertaking a systematic review. Initial searching around the topic 
produced frustratingly little relevant literature, and no specific empirical work, so a gap 
in the evidence was quickly confirmed. 
 
The initial searches were then widened using broader subject headings (Table 1). No 
papers were found that provided a prevalence of leg ulceration in PWID. There was 
literature on injecting risk and potential causative factors and some related to injecting 
harms however, this did not link directly to leg ulceration or venous disease, and no 
empirical studies were found. This made a meaningful systematic review impossible 
(Bambra, 2011). 
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Databases searched: 
Pubmed / Medline;  Cinahl; Health Source 
Hand searching of non-indexed sources: 
Phlebology journal; Wounds UK journal; Leg Ulcer Forum journal; EWMA conferences; Exchange 
Supplies resources; Lifeline resources; ISD sources 
Authors searched: 
Butcher, Darke, Del Giudice, Frischer, Goldberg, Hay, Hope, Hunt, McKeganey,  Neale, Pieper, 
Rhodes, Robertson, Scott, Strang, Taylor, Whittaker 
Terms searched:  words and  categories within titles, abstracts, key words and phrases:  
leg ulcer*, inject*, ‘skin’, ‘skin disease*’, ‘substance use and related disorders’, ‘substance abuse’, 
‘intravenous drug use’ , ‘drug injecting’, ‘arterial occlusion’, ‘infection’, ‘bacterial infection*, 
‘vascular complications’, ‘varicose veins’, ‘vasculitis’, ‘vein insufficiency’, ‘phlebitis’, ‘embolism and 
thrombosis’, ‘wound care’, ‘wounds and injuries’, ‘harm reduction’ 
Years searched 1953 – 2015; all available languages  
Results: empirical studies  
Prevalence of leg ulceration in PWID : 0 
Risk factors for leg ulceration in PWID  : 0 
Harm reduction for leg ulceration : 0 
Table 1 Literature search strategy 
 
More tangential literature was reviewed which provided small amounts of information 
around drug use and injecting. Many of the publications were overviews or case 
studies. Some paper titles were misleading; for example the paper title ‘Extremity 
complications of drug abuse’ (Ritland and Butterfield, 1973) was expected to provide 
good information relating to ulcers on the extremities, but these were only listed as 
‘skin ulcers’ and as a vascular complication but with no further detail. Although useful 
in understanding patterns of drug misuse and developing ideas behind risk and harm 
reduction, the papers lacked scientific detail. 
Throughout the study various electronic sources, were searched, monitored and 
followed up for topical evidence and a focussed search, using terms directly related to 
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emerging results, was repeated in 2012 and 2015. More recently, from the 1990’s 
onwards, there were more robust empirical studies mostly related to blood-borne 
viruses and not related to skin breakdown and leg ulceration.  
 
The lack of empirical studies meant systematic literature reviews including rapid 
review, realist, meta-analysis or meta-synthesis methodologies were impossible 
(Pawson et al, 2005; Cronin et al, 2008). Instead a narrative review of the literature was 
conducted drawing widely on the published literature to provide background to 
injecting practices and to link these to potential causes of skin breakdown. 
 
2.2 Context of drug injecting 
A global problem 
Illicit drug use reached a peak over the last five years and has remained stable at 
between 3.5 – 7% of the adult population using an illicit drug in the last year. Around 
27 million people worldwide are classed as problem drug users with dependence and 
drug–use disorders (UNODC, 2014). Problem drug use is defined as ‘problematic use of 
opiates (including illicit and prescribed methadone use) and/or the illicit use of 
benzodiazepines and implies routine and prolonged use as opposed to recreational and 
occasional drug use’ (ISD, 2014). 
The predominant substances used are opiates, but other psychoactive drugs are also 
misused (UNODC, 2014). Drug use exists in both developed and under-developed 
countries, is a significant cause of death across the world, and many countries spend 
vast amounts of government money attempting to reduce drug problems (Reuter, 2006; 
UNODC, 2014). In Europe it appears that supply reduction dominates spending, 
prevention activities receive a small share, and law enforcement accounts for more than 
50% of budget totals (Ballotta and Bergeron, 2006). Large numbers of drug users are 
imprisoned worldwide,  some may continue to use drugs whilst incarcerated and there 
is an increased risk of mortality from overdose after release (Strang et al, 2006; Farrell 
and Marsden, 2007; Hecht et al, 2014).   
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Scotland 
In Scotland alone it is estimated that there are almost 60,000 problem drug users (ISD, 
2011), and of these around 50% may be injecting (ISD, 2012).  Edinburgh and Glasgow 
are Scotland’s largest cities and contain the majority of the country’s drug injectors.  
 
Glasgow 
In Glasgow, the drug injecting epidemic began in the early 1980’s (Frischer et al, 
1997), and in 1983 the prevalence in Glasgow of problem drug users was thought to be 
around 5000 (Haw, 1985). By 1989, the number of PWID was estimated to have risen 
to 9424 (Frischer et al, 1991).   
 
From 1990 onwards heroin became more widely available in Glasgow, and injectors 
started using heroin in preference to previous drugs such as buprenorphine and 
benzodiazepines (Hammersley et al, 1995).   
 
In 1992, Makower et al reported that PWID attending Accident and Emergency (A & 
E) at Glasgow Royal Infirmary were becoming a significant part of workload and 
described the characteristics of attendees (Makower et al, 1992). The average age of the 
drug injector admitted to A & E was 24.2 years.  Mean age at first injection was 18.3 
years, with a mean duration of habit of 5.7 years.  The three most commonly used drugs 
were buprenorphine, heroin and temazepam, although there was widespread mixing of 
drugs.  Sites of the most recent injection were upper limb, and lower limb - groin and 
feet. The drug-related reasons for presentation included abscesses, some of which were 
in the lower limb, cellulitis, deep venous thrombosis, phlebitis, and ‘vascular’. Only 
65% were known ‘registered addicts’, which suggested there were many more drug 
injectors who were unknown to authorities.  
Glasgow now  has the highest rate of problematic drug use in Scotland, with prevalence 
rates remaining consistent in the last five years, and thought to be around 13,900 
individuals (ISD, 2011) including the largest number of injectors in Scotland (ISD, 
2012) with proportionately three times as many males as females (King et al, 2013). 
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Many believe this estimate to be conservative, citing the additional hidden presence of 
heroin users throughout the UK (Shewan et al, 1998; Taylor and Kearney, 2005). 
 
2.3 Social and physical factors associated with drug injecting 
Injection drug use is most common in disadvantaged communities (Macleod et al, 
2013) and is strongly associated with social and material deprivation (Baumann et al, 
2007; Macleod et al, 2010). Drug users are more likely to have fewer educational 
qualifications, lower rates of employment, poorer physical health, and housing 
difficulties as well as more behavioural, psychological and psychiatric problems than 
non-users (Pieper, 1996b; Strang et al, 2006). Problematic drug use is also associated 
with psychological ill-health, and social factors such as unemployment, criminal 
activity, and relationship difficulties (McClelland, 2006; Nambiar et al, 2014).  
The health of a drug user is bound to their social environment (Galea and Vlahov, 
2002) and social networks with friends and partners are influential in drug using 
behaviour (Lakon et al, 2006). Many PWID have been imprisoned (Gill et al, 1995; 
Taylor et al, 2013) where injecting equipment is not readily available and sharing of 
equipment is more likely to occur resulting in increasingly risky behaviour (Long et al, 
2004). 
 
Homelessness 
The extent of homelessness amongst drug users is extremely high. For some, drug use 
precipitates homelessness and for others drug use is an escape from the harsh reality of 
being without a home (Neale, 2001). 
 
 In 2000, Fountain et al (2003) surveyed 389 homeless people in London, and 63% of 
respondents reported that their drug or alcohol use was one of the reasons they became 
homeless. Substance use increased with the length of time the person was homeless. 
Kemp et al (2006) identified that the risk factors for homelessness are similar to the risk 
factors for problematic drug use. It is likely that trauma precedes homelessness, and 
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that the use of both drugs and alcohol and criminal activity increases following 
homelessness (Martijn and Sharpe, 2006).  
Homeless people tend to be involved in riskier injecting practices and homelessness 
may have a direct impact on health outcomes (Lowry, 1990; Keaney et al, 2011). 
However, it may be difficult to distinguish between ill-health caused by homelessness, 
or caused by drug use in homeless drug users.  There is evidence that homeless drug 
users exhibit higher levels of life-threatening behaviours such as high-risk injecting 
practices and suicide attempts (Greene and Ringwalt, 1996; Reid and Klee, 1999; Galea 
and Vlahov, 2002; Davidson et al, 2002; Rowe, 2005). A study conducted in Ottawa, 
Canada found that homelessness is the strongest predictor of public injecting which 
obviously reduces privacy, but also impacts on safety (Navarro and Leonard, 2004). It 
is more difficult to maintain cleanliness, injecting would require to be swift and 
undetected, and there may be less opportunity to collect and store clean injecting 
equipment. All of these factors may contribute to skin breakdown.  
 
Initiation into drug use 
In Scotland, early and damaging drug using behaviour tends to occur in the late teenage 
and early twenty years, followed by attempts to quit drug use in the late twenties and 
early thirties. In the late thirties or early forties there may be some success in stopping 
using; however it is not unusual to find drug users in their 50’s or 60’s who have 
remained intermittently dependent for decades (Robertson et al, 1994; Mustasa, 2001).  
 
A number of international studies report earlier initiation with some commencing 
injecting as young as 12 years of age.  Drug injecting can be evident from a young age 
and is not a problem restricted to a particular age group (Chiang et al, 1990; Fuller et al, 
2002; Dolan and Niven, 2005; Day et al, 2005; Abelson et al, 2006). 
 
Although drug use may start early for some individuals there is also evidence that drug 
users are becoming older and a substantial number of drug users are now aged over 40 
years (Beynon et al, 2010). It would appear that drug users are living longer, and using 
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for longer, thus increasing opportunities to acquire drug-related problems such as skin 
disease which may be exacerbated by age-related changes. Long-term users of illegal 
drugs may be biologically much older than their chronological age therefore diseases 
more common in old age such as leg ulceration may appear much earlier (Beynon et al, 
2010; Roe et al, 2010; Palfreyman and Fenwick 2011). 
 
2.4 The Injecting Process 
2.5 Substances 
This sub-section describes the many substances that may be injected and might affect 
ulceration. The extent of their use within Scotland is described although no evidence 
directly links causation to ulceration. 
 
Heroin  
The most commonly injected illicit substance in Scotland is thought to be heroin 
(diamorphine), a potent opioid that acts on receptors throughout the body.  Heroin in 
the UK tends to be brown and is usually sourced from Afghanistan, the world’s biggest 
producer of opium (Brett et al, 2004; Zerell et al, 2005; Robertson and Richardson, 
2007; UNODC, 2014). Heroin can be highly impure and is commonly manufactured 
and prepared on the ground and contamination during production can have major 
implications for health (Tuazon et al, 1974; Zerell et al, 2005).  
 
Heroin has high lipid solubility and enters the brain rapidly. It is a depressant that 
produces a euphoric effect, ‘a high’ of relaxation, calm, freedom from worry and 
freedom from pain. After the euphoric period, the person enters a rebound phase 
marked by irritability, despair, anxiety, decreased sedation, and increased pain. 
Tolerance to the euphoria develops rapidly, which tends to result in the user steadily 
increasing the amount of drug used to achieve the same effect (Pieper, 1996b). Users 
may start by snorting or smoking heroin but the increased tolerance also escalates use 
and subsequent cost, and individuals will often start injecting smaller and cheaper 
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amounts once their smoking threshold becomes financially unsustainable (Devey, 
2010). Once injecting commences the protective layer of the skin is breached and 
damage occurs. 
 
Adulteration and dilution 
Illicitly prepared and supplied drugs, especially heroin, may be adulterated with 
chemicals such as quinine, paracetamol and caffeine which may have a similar, 
complementary or potentiating effect, and diluted with a variety of generally inert 
materials such as dextrose or lactose or talc substances which are added to create bulk 
and maximise profit (Kirchenbaum and Midenberg, 1982; Coomber, 1997a; Coomber, 
1997b; Passaro et al, 1998; Buttner et al, 2000; Brett et al, 2004). It is unclear at any 
time what exactly illicit drugs comprise (Matzner, 1973). Much rumour and 
controversy surrounds the topic of adulteration and the lay perception is that illicit 
drugs are adulterated with dangerous substances such as brick dust and rat poison 
though this appears to be a myth (Coomber, 1997c). However, the adulterants and the 
lack of purity within heroin is a cause for concern and may be implicated in infection, 
venous damage and skin breakdown. Unusual skin lesions may also occur due to the 
variations in additives (Dunne and Johnson, 1972). 
 
Some small scale studies have shown that foreign body elements of the inoculum were 
responsible for soft tissue infection with crushed tablets and cocoa powder cited as 
problematic (Fullarton, 1983). Talcum powder and starch have been known to embolise 
distally (Al Zahrani, 1997), and dextrose solutions have caused thrombophlebitis 
(Kirchenbaum and Midenberg, 1982; Fellner and Ledesma, 1990).  
 
Quinine was initially added to heroin in the 1930’s because of its anti-malarial 
properties as malaria was common in injectors who often shared needles. Quinine 
became widely used in the 1940’s as its bitter taste was similar to that of the taste of 
heroin, preventing the purchaser from tasting the apparent strength of the drug 
(Kirchenbaum and Midenberg, 1982). Quinine may be used for its ‘rush’ – a feeling of 
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accelerated and enhanced euphoria (Dunne and Johnson, 1972; Gursel et al, 1978), 
which may result from peripheral vasodilation (Kirchenbaum and Midenberg, 1982) but 
it is a known sclerosing agent used in the treatment of varicose veins, which works by 
irritating the vascular endothelium leading to thrombosis (Kirchenbaum and 
Midenberg, 1982).   When injected into the skin it can cause cellulitis, often followed 
by bacterial abscesses and leading to ulceration (Fellner and Ledesma, 1990 
Anonymous, 1997).  Quinine also possesses acidic bactericidal properties which may 
render a wound transiently aseptic, and presumably would also damage the skin cells 
essential for healing. 
 
Knowledge of the cutting agents is important because they may contribute significantly 
to the disease process. However, injectors may be unaware what their injection truly 
comprises which creates a difficulty in the identification of these as causative factors in 
skin breakdown. 
 
Use of acidifier 
A laboratory study undertaken by Scott et al (2000) demonstrated that the addition of 
an acidifier to impure brown heroin is necessary to create an injectable solution, and 
this is common practice in Scotland.  Scott’s study found that the diamorphine content 
of the heroin she studied was only 56%. Different purities will require different 
amounts of acidifier. Acidifier (citric acid or vitamin C) is commercially available in 
single-use 100mg sachets distributed free by injecting equipment providers (IEP) in 
Scotland. Injectors also report using unsterile traditional options such as lemon juice or 
vinegar which can cause problems such as fungal infection in the eye (Albini et al, 
2007).   
 
Adding acidifier to injections may cause tissue and muscle damage, scarring, and 
reduced blood flow which would favour the growth of anaerobic bacteria such as 
clostridia at, or in, the injection site especially if injected intramuscularly or 
subcutaneously (Brett et al 2004; Taylor et al, 2005). It is possible that injectors may 
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use too much, causing acidic damage, such as burns, or sclerosis of the veins (Williams 
and Southern, 2005).  
 
Acidifiers are not used in countries such as the US and Australia where the street heroin 
is in a soluble form (Maliphant and Scott, 2005; Coull and Pieper, 2006) and this makes 
international comparisons around injecting harm difficult, as different solutions are 
injected.  
 
Cocaine  
The use of cocaine has become progressively more widespread. It acts as a stimulant 
and produces an intense high, or euphoria, largely due to enhanced stimulation of the 
dopaminergic system, which lasts only a few minutes and the after-effects are 
depression and a craving for more (Pieper, 1996b; van Beek et al, 2001). Due to its 
short half-life it is typically injected more frequently and frenetically than heroin and 
higher doses can cause severe behavioural alterations (van Beek et al, 2001).  
 
Cocaine has a potent vaso-constrictive and local anaesthetic effect (Buttner et al, 2003; 
Ducasse et al, 2004). All routes of administration of cocaine are associated with 
ischaemia, atherosclerosis and infarction of various organs including the heart and the 
brain, and although intravenous use is most commonly implicated, the causative 
mechanism is unclear (Myers et al, 1991; Tolat et al, 2000; Erwin et al, 2004). 
 
Vascular damage in cocaine users has been reported, in single case studies, with users 
suffering from arteritis, thrombophlebitis, atherosclerosis, vasculitis and occlusions, 
although adulterants may be implicated. In cocaine these tend to be more water-soluble, 
and less toxic than those in heroin, and therefore less problematic for vein walls (Karch 
and Billingham, 1995; Chen et al, 1996; Hofbauer et al, 1999; Mockel et al, 1999; 
Gertner and Hamlar, 2002).  
Alkalinisation and extraction produces a heat-stable pure form of cocaine called 
‘crack’. When heated the crystals make a popping sound, and crack is usually smoked 
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but may also be injected when mixed with acid and may be more harmful than injecting 
cocaine (Pieper, 1996b; Lankenau et al, 2004; McKee, 2005).  
 
In a large study of 212 cocaine users in Sydney, Australia, both injectors and non-
injectors and infrequent and irregular users identified serious physical and 
psychological symptoms. Amongst non-injectors the most common physical problems 
were nasal bleeding and ulceration, chronic sinus / nasal congestion, and heart 
palpitations. Amongst injectors the most common symptoms were worse - severe 
weight loss, palpitations and chronic insomnia. Of eighteen physical symptoms 
recorded (for both injectors and non-injectors), two related to skin, ‘facial sores’ and 
‘abscesses at injecting sites’. There were no reports of chronic ulceration; however, the 
skin symptoms may not have been explored in enough detail (Kaye and Darke, 2004).  
 
Van Beek et al (2001) also report thrombosed veins, abscesses, and skin picking and 
‘coke sores’ caused by compulsive scratching and picking. These areas can become 
infected leading to sepsis. Whilst they report a number of physical and psychological 
issues with cocaine injecting, these authors do not discuss the issues associated with 
cocaine’s anaesthetic effect. If a missed hit (injecting into the subcutaneous tissues 
usually in error) occurs it would normally cause pain, but not with cocaine which 
numbs the injecting area. Because of this effect, injecting cocaine tends to cause more 
problems because of the absent natural warning of the pain response. 
 
Benzodiazepines  
Oral benzodiazepines (such as diazepam and temazepam) are often prescribed to drug 
users but intravenous use also occurs.  A study of 208 drug users in Britain identified 
186 participants who had used benzodiazepines, and of these, 103 had injected them 
(Strang et al, 1994). Different preparations of capsules, tablets, and syrup, all designed 
for oral consumption, had been injected and were commonly mixed with other drugs 
such as heroin or buprenorphine because of the additional  pleasurable sensations and 
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emotional feelings produced (Forsyth et al, 1993; Strang et al, 1994; Dwyer et al, 
2009).  
 
Gel-filled (rather than liquid) capsules of temazepam caused particular vascular 
problems, as it was toxic to vessels and appeared to cause endothelial damage and 
swelling (Wilce, 2004) probably due to the wax content that solidified once injected 
(Forsyth et al, 1993). These were painful to inject and known to cause thrombosis of 
the vein (Halliday et al, 1986; Dwyer et al, 2009). Manufacturers changed to producing 
solid–fill capsules. However, these were also used for injecting and caused even greater 
morbidity (Strang et al, 1994).   
 
It is unknown whether injecting temazepam causes any long-term effects on the skin or 
venous system, but it is likely to be of importance, particularly in long-term injectors.  
 
Buprenorphine  
Buprenorphine is a synthetic opiate, usually taken sublingually as an analgesic. In the 
early 1990’s there was a change in trend in Glasgow from injecting heroin to injecting 
buprenorphine (Anonymous, 1993). As a controlled drug, its availability was reduced 
and subsequently Glasgow doctors entered a voluntary prescription ban in 1993 in 
order to attempt to reduce supply (Forsyth et al, 1993). It continued to be used illicitly 
with tablets being crushed and injected, which caused significant harm to the skin (Del 
Giudice et al, 2005; Jenkinson et al, 2005). It was reintroduced in 2006 as an alternative 
substitute prescription to methadone.  
 
Amphetamines 
Amphetamines can be snorted, injected or smoked, and using results in an intense 
euphoria. Synthetic amphetamine is a known potent vasoconstrictor (Ducasse et al, 
2004) and injecting can result in severe infections and abscesses at injection sites 
(Rawson and Condon, 2007).  Amphetamine users sometimes experience a feeling as if 
something is crawling under their skin; this can lead to scratching and skin picking, and 
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the vaso-constrictive effects can reduce subsequent healing (Sim et al, 2004; Rawson 
and Condon, 2007). Amphetamines are thought to have only a limited presence in 
Scotland. 
 
Methadone 
Oral methadone, in syrup form, is prescribed as a substitute for heroin and commonly 
with other medications such as antidepressants like benzodiazepines (Holt, 2007), but it 
is not unusual for both prescribed methadone and illicit heroin to be taken concurrently 
(Seymour et al, 2003; Bloor et al, 2008). Whilst injecting methadone is unreported in 
the Scottish literature, methadone injecting has been reported in Australia (Darke et al, 
1996) where it was found that long-term injecting of methadone ‘for injection’ caused 
the tissues in the arms and upper thighs to become ‘woody’, with loss of contours, fat 
and muscle atrophy, and numerous deep punched out ulcers (Farrant et al, 2005). 
Whilst opiate substitute prescribing is controversial (McKeganey et al, 2006; Bloor et 
al, 2008) studies have indicated that the receipt of prescribed oral methadone is 
associated with a significantly lower risk of illness and this may be due to the reduced 
likelihood of injecting (Taylor et al, 2005). 
 
Cannabis 
Cannabis is usually smoked to produce a ‘high’. It is a known vasoconstrictor which 
can lead to distal arterial lesions or occlusions with venous thrombosis and therefore its 
role in skin disease is worth exploring (Ducasse et al, 2004; Hall, 2015).  
 
In summary, different substances are injected in Scotland and it is unclear which if any 
drug, or what combinations, may contribute most significantly to tissue damage.  
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2.6 Injecting technique and preparation of injections 
This section describes the techniques and preparation of injections that may contribute 
to skin breakdown although no empirical studies were found directly linking techniques 
to ulceration.  
 
Preparation of heroin 
Heroin needs to be prepared before injecting and the materials required are usually a 
spoon or cooker (a container used for mixing and heating), needle and syringe, 
tourniquet, acidifier, water, a filter, and a heat source such as a lighter or matches. The 
process is rarely sterile, and equipment may be reused many times (Scott, 2008). 
 
Brown heroin is mixed with the acidifier that will dissolve the heroin. The combination 
is diluted with water or another liquid and heated, often in a spoon or foil, until it 
dissolves. The water may be tap water, sterile water, bottled water, saliva, from a sink 
or even a toilet (Joseph et al, 1973; Ponton and Scott, 2004). The resulting fluid is then 
drawn up in a syringe, usually filtered to eliminate impurities in the solution, and 
injected (Taylor et al, 2004a). Filters are available as part of Injecting Equipment 
Provision (IEP). This is a recent development (Scott 2005; Scottish Government, 2010), 
but filters may also be home-made using cotton wool, cigarette filters or other fabrics. 
Fibres may be drawn into the syringe and injected causing multiple microscopic foreign 
bodies (Joseph et al, 1973; Khanna and Drehmer, 2001).  
 
In 1988, 50% of Edinburgh’s drug injectors had Human Immunodeficiency Virus 
(HIV) infection  (Robertson et al, 1994) and common practice  involved initially 
washing out the heroin from the syringe by repeatedly drawing back and injecting the 
users own blood and secondly, washing the heavily bloodied equipment in a communal 
receptacle (Brettle and Nelles,1988). Early papers such as the overview of injecting and 
infection-related behaviour written by Hughes (2001) describe risky practice related to 
lack of sterile (new) equipment, including cleaning of equipment, hiding of tools, and 
different methods of sharing. Sharing equipment is known to be heavily implicated in 
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the spread of blood-borne viruses and has been actively discouraged following a 
number of good quality studies (Hughes, 2001; Taylor et al 2001; Scottish Government, 
2010). Many of these practices are now less common in Scotland but they may have 
been part of a drug using career for those that have been injecting for a long time, 
possibly as paraphernalia were not freely available (Thiede et al, 2007; Scott, 2008; 
Strike et al 2010; University of the West of Scotland, Health Protection Scotland, 
University of Strathclyde and the West of Scotland Specialist Virology Centre, 2012). 
 
Injecting equipment 
Reusing blunt and dirty equipment may have implications for skin breakdown and 
infection. Current recommendations are that IEPs should provide as many needles as an 
individual client requires, and supply, free of charge, acidifiers, cookers, filters, water 
for injections and pre-injection swabs in order that injectors may use a sterile needle 
and injecting paraphernalia for every injection (Scottish Government, 2010; Preston 
and Derricott, 2013). Using the shortest needle reduces the assault on the vascular 
system, but it is also important to use the right needle for the size of vein (Maliphant 
and Scott, 2005).  
 
Filters 
Filtering the injection is important as particulate matter including oral drug suspensions 
or tablets crushed, dissolved, and injected may contain micro-particles which act as 
emboli and cause phlebitis and soft tissue infection which can create blockages in 
peripheral veins leading to occlusion, necrosis, vasculitis and skin breakdown (Al 
Zahrani, 1997; Brust, 1997; Khanna and Drehmer, 2001; Ponton and Scott, 2004; Del 
Giudice et al, 2005; Darke et al, 2015). 
 
Learning to inject 
Most PWID are taught to inject by another injector which can perpetuate unsafe 
practices. In a study examining initiation into injecting heroin in Sydney, Australia, 
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Day et al (2005) found that the majority of study participants (63%) were taught to 
inject by a friend, family member, or partner. Only a few study participants (10%) were 
self-taught. Initiating others into injecting was also associated with sharing of 
equipment. Women appear to be more vulnerable to initiation by male partners 
(Simmons et al, 2012). Injecting others can be relatively common practice, and may be 
done because of problems with technique, or an awkward site such as the neck, and 
might be performed for a fee of money or drugs (Cherry et al, 2009).  
 
Injecting sites 
The forearms are often the first site for injecting into due to easy visibility and access. 
In a detailed Australian survey on injecting sites, Darke et al (2001) reported that 94% 
of injectors start in the cubital fossa. Other sites used in order of popularity were: 
forearm (71%), hand (53%), upper arm (20%), foot (19%), leg (18%), neck (10%), 
groin (6%), fingers (6%), and toes (3%). A smaller percentage had injected in the 
clavicle, breast, shoulder and penis. The mean number of injection sites used in the 
preceding six months was two. There was marked progression in the use of different 
sites and whilst the starting point was the cubital fossa, the forearm was next used for a 
median of two years after commencing injecting, the upper arm after 3.5 years, and the 
hand after 4 years. Injections in the neck, foot, and leg occurred after six years of 
injecting. Injection in the groin, toes and fingers occurred, on average, after a decade of 
injecting. The unusual longevity of use of certain sites may be due to the purity of 
heroin used in Australia (Maliphant and Scott, 2005).  
Women have more difficulty accessing superficial veins as they are smaller and less 
visible and it is more likely for the vein to be missed (Spijkerman et al, 1996; Derricott 
et al, 1999; Andresz et al, 2006). It is unclear whether women have more skin problems 
than men. 
 
As injectors become older and veins collapse, riskier sites may be selected such as 
breast, tongue, feet, femoral, axillary, jugular and penile veins. These are areas where 
veins may be smaller and more easily damaged, and also may be in more bacteria-laden 
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sites such as the groin and feet, or close to vital structures such as in the neck, where 
complications such as an abscess could cause compression (Bennett et al, 1973; Finelli 
and Taylor, 1977; Barg et al, 1986; Cunningham and Persky, 1989; Cooper, 1990; 
Haverkos and Lange, 1990; Maggi et al, 1995; Bergstein and Baker, 1995; Butcher, 
2000; Biller and Murr, 2004). 
It is unclear whether the injecting site is important in the development of skin 
breakdown.  
 
Skin and muscle popping 
As veins become more difficult to locate, drugs may be injected subcutaneously or 
intramuscularly known as ‘popping’ (Binswanger et al, 2000). Once venous access 
fails, popping may occur typically in the legs and buttocks (Formica and Perazella, 
1998; Forshaw and Power, 2001) but also in the foot and ankle (Pirozzi et al, 2014). 
The proximity to deeper structures such as bones and tendons can make popping in 
such areas very risky. With popping there is usually erythema, swelling and induration 
at the injection site. This may be transient, form abscesses, spread via lymphatics or 
tissue planes, or heal, producing hyper-pigmented macules or circumscribed retracted 
scars (Hirsch, 1972).  
 
Popping is a major risk for serious infection (Pieper, 1996b; Forshaw and Power, 2001; 
Murphy et al, 2001; Taylor et al, 2005). It is likely that deposition of unsterile and 
foreign material in extravascular spaces, such as muscle, provides a focus for infection, 
as it creates more favourable conditions for the growth of anaerobes, causing deeper 
wounds and potential for systemic illness not seen when injecting into the venous 
system (Graham et al, 1999; Brett et al, 2005).  
 
Injecting into wounds 
Wounds may also be used as injecting sites which may contribute to non-healing (Reed 
and Jefferson, 2003; Williams and Southern, 2005; Thakor and Wijenaike, 2009). One 
single case report of an unusual non-healing ulcer of the forearm in a 32 year old drug 
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user was attributed to injecting heroin in the wound. This was described as a ‘shooter’s 
patch’ and was painful, with vascular edges. Microbial cultures were positive for 
staphylococcus aureus, pseudomonas aeruginosa and other skin bacteria, and 
radiography revealed bony changes consistent with osteomyelitis. Unfortunately this 
case was lost to follow-up, so it is unclear how and if healing took place (Tice, 2002).   
 
Other authors have also described ‘shooter’s patches’ following skin popping, and the 
ulcerated tissue is used as a portal for continued injecting (Lyer et al, 2011; Phillips et 
al, 2013). It would be interesting to investigate how common wound injecting is, as this 
would affect a desire for healing. 
 
Femoral  
Femoral or groin injecting is becoming more common (Rhodes et al, 2006a). Drug 
injectors may choose to use the femoral site as it is easily hidden and a reliable site for 
speedy and convenient injecting especially for those that inject in public (Ti et al, 
2014). Sinuses may develop from repeated injections at the same site creating a 
permanent and readily accessible route from the skin to the underlying vein, on one or 
both sides, that can be used for many years (Chiang et al, 1990; Jensen and Gregersen, 
1991; Devey 2010). 
However, it is a risky site with many reported problems. Thickened scar tissue at the 
groin site causes difficulty with injecting such as needle breakage and a requirement to 
use longer thicker needles. Swellings or aneurysms can occur in the groin area, and 
there is a risk of inadvertent arterial injection, DVT, venous insufficiency, infection and 
pain (Gan et al, 2000).  
 
MacKenzie et al (2000) identified femoral injecting as a risk for iliofemoral thrombosis 
and severe groin infection in a retrospective study of patients admitted to hospital in 
Aberdeen. Maliphant and Scott (2005) investigated femoral vein injecting using short 
semi-structured interviews amongst 47 IEP clients who were groin injecting in Bristol, 
UK. Their small study reported a wide age range, varied length of injecting time in the 
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groin, and differing times to start groin injecting from time of first injection. One 
person had used no other site other than the groin, nine people had used one other, and 
another nine had used two sites. The study was too small to be conclusive, but they 
noted a possible increased risk of vascular complications, such as DVT, leg ulcers and 
vascular insufficiency. Ingram and Baxter (1994) describe three PWID who presented 
with a swollen leg. All were assumed to have DVT, but following Doppler sonography 
DVT was not confirmed; instead, each case had femoral stenosis thought to be due to 
the peri-venous fibrosis secondary to repeated injection.  
Injectors can find it difficult to use the non-dominant hand (Maliphant and Scott, 2005) 
and dominance may be significant when choosing which femoral vein to use, rotation 
between sites, and skill in technique (Aitken et al, 2009).   
Groin injecting is viewed as becoming normalised within the UK but harm reduction 
strategies are piecemeal and provision of information is patchy (Zador, 2007). Miller et 
al (2008) consider that groin injectors who use this site as a last resort should be taught 
to inject safely there, whereas others choosing it for convenience should be encouraged 
to use other sites.  Concern has been expressed that in attempting to reduce harm 
amongst those who femorally inject, service workers are crossing ethical boundaries 
(Rhodes et al, 2006a) as in fact, this site is never ‘safe’ to inject in (Zador 2007).  
Of all the papers sourced, none laid out clearly the risk that a stenosis of the femoral 
vein creates and the full ramification of groin injecting requires exploration, 
particularly of the impact on the venous system lower in the leg.  
 
Pseudo (or false) aneurysm 
Pseudoaneurysm is a collection of blood contained by a clot that has formed outside a 
blood vessel following an injury. The collection is attached by a channel to the blood 
vessel so blood flows within it (NICE, 2004).  It is a serious complication of groin 
injecting and occurs as a result of intra-arterial injection and repeated trauma to the 
vessel wall with or without infection. It usually presents as a pulsatile mass in the groin 
and can rupture and bleed easily (Kirchenbaum and Midenberg, 1982; Cheng et al, 
1992; Ting and Cheng, 1997; Al Zahrani 1997; Heis et al, 2008).  
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Johnson et al (1984) state that pseudoaneurysm should be considered in any patient 
presenting with groin infection after injection and may require surgical repair (Reddy et 
al, 1986; Millburn and Brittenden, 2006). Lo et al (1990) report amputations in drug 
injectors caused by femoral pseudoaneurysms resulting in distal embolus, sepsis and 
thrombosis. The mean age of limb loss was 26 years compared to 57 years in the 
general population.  
 
Ischaemia caused by damage and surgical repairs could lead to arterial ulceration lower 
in the leg, and surgical repairs could also damage both the arterial and venous systems, 
impacting on the limb and precipitating skin breakdown (Welch et al, 1990; Gan et al, 
2000; Georgiadis et al, 2005).  
 
Arterial injection 
An artery may be hit with a needle accidentally, particularly in the groin, producing 
what is known as a ‘flash’, a burning pain or paraesthesia and red flush along the 
arterial line. Spasm and ischaemia may follow, with swelling and a cold cyanosis. 
Gangrene may develop later if an injection into the artery occurs (Pieper, 1996b; Del 
Giudice et al, 2005).   
 
The literature describes, in small case reports, examples of complications following 
intra-arterial injection such as amputation, vasculitis, penile infection, digital ischaemia 
and distal micro-emboli. Surgical intervention was often required (Daniel, 1973; 
Bickley et al, 1988; Cunningham and Persky, 1989; Charney and Stern, 1991; Dodd et 
al, 1994; Forshaw and Power, 2001; Del Guidence et al, 2005).  
 
This is important as the damage caused to arteries by injection or surgical repair can 
affect blood supply and impact on healing.  
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2.7 Drug use and skin problems 
Injecting breaches the body’s outer protective layer and this section examines the 
disease processes affecting the skin.  
 
Since Hussey and Katz (1950) initially raised awareness of skin problems in ‘narcotic 
addicts’, numerous publications have reported injecting injuries to the skin, as well as 
soft-tissue infection, but the majority tend to be superficial case reports and may be 
dated or focus on treatments rather than discussing causative or risk factors (e.g. 
Biderman and Hiatt, 1987; Butcher, 2000; Acton, 2008; Powell, 2011a; Acquaro, 
2012).  
 
In an early study by Weidman and Fellner (1971) 86% of subjects attending a medical 
clinic for drug injectors had cutaneous adverse effects. Kirchenbaum and Midenberg 
(1982) reported that abscesses and ulcers (which are not defined) were the most 
common cutaneous complications at the site of injection. They postulated that they 
were the result of the use of unsterile needles and syringes as well as the uncontrolled 
inclusion of adulterants within the drugs.  
 
Darke et al (2001) interviewed injectors about their physical injection sites in Australia, 
and the majority reported experiencing problems, with females reporting significantly 
more problems than males.  Prominent bruising or scarring, lumps or swelling, were the 
most common, with difficulty injecting due to vascular scarring. However, the authors 
make no mention of open wounds nor of chronicity of these problems. This may be due 
to purer heroin which may cause fewer skin problems.  
Roxburgh et al (2005) also found women reporting more skin problems than men, 
which may indicate a higher likelihood of vascular damage in females. 
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Skin and soft–tissue infection 
Skin and soft-tissue infections are significant problems in drug injectors.  Hope et al 
(2008) estimated that over 30,000 PWID seek health care for injection site infections in 
England each year with at least 18,500 requiring admission to hospital.  
 
Many papers and reports about drug injectors refer to ‘soft tissue infection’.  
 
Fullarton (1983) described soft-tissue infections in PWID in Glasgow as types of 
abscess or cellulitis, none of which are defined, but microbiology and treatment is 
described in detail.  Dunlop and Steedman (1985) in Edinburgh also reported PWID 
presenting with an open wound, cellulitis or abscess but these were not defined. 
Takahashi et al (2003) estimated that the prevalence of soft tissue infections (by case 
note review), abscesses, cellulitis and infected ulceration in PWID is between 21% and 
32%, but again definition of infection was missing. Stone et al (1990) reviewed all case 
records of attendees in the A & E Department in Glasgow Royal Infirmary during 1986. 
Of these 0.6% (n = 488) had documentary evidence of intravenous drug use.  Clinical 
examination revealed signs of soft tissue sepsis in 31% of these (n = 150) in varying 
sites of the body, and this was defined as ‘either abscess or cellulitis’ but these were not 
explained. 
 
Marks et al (2013) agreed that skin and soft tissue infections were the commonest 
reason for admission however, they lumped together ‘skin and soft tissue infection’ 
without definition, and included in the categorisation were cellulitis, infected chronic 
leg ulcers, soft-tissue abscesses, and necrotising fasciitis, which are all different.  The 
categories are therefore unclear, as cellulitis can be present in isolation, but would most 
likely be present with any infected wound, with necrotising fasciitis, and possibly with 
an abscess (EWMA, 2013), but in this case it is listed as a separate diagnosis. 
 
Orangio et al (1984) reviewed 34 PWID admitted with soft tissue infections to a 
Jamaican hospital between October 1981 and June 1982. They compared the microbial 
results to that of other drug injectors without infections admitted for detoxification.  In 
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the infected group, a variety of soft tissue infections were noted; enteric and 
oropharyngeal organisms predominated, with a high incidence of poly-microbial 
infection. However, demographics for each, together with definitions, for example of 
‘ulcer’, are missing.  
 
Henriksen et al (1994) reviewed 145 hospitalizations in 89 PWID with acute soft tissue 
infections in an orthopaedic unit in Copenhagen, Denmark. ‘Soft tissue infection’ was 
not defined but included superficial abscesses, deep abscesses, cellulitis, purulent 
arthritis, and tensosynovitis. Most infections were in the groin, and a few also suffered 
serious complications such as DVT, pneumonia, septicaemia, or thrombosis of the 
femoral artery resulting in amputation. Most of the infections were poly-microbial 
which was unusual in the non-injector. The authors state that this was not entirely due 
to the nature of the substance injected, nor to the use of tap water to dissolve 
substances, but more likely due to the use of contaminated syringes and needles. In 
particular, they identified the presence of oro-pharyngeal bacteria, due to putting the 
needle in the user’s mouth, and cleaning the skin with saliva.  
 
Similar results from a study of corresponding size were found by Summanen et al 
(1995) when they compared specimens from cutaneous or subcutaneous abscesses in 
IVDUs to non-IVDUs. 67% of the IVDUs organisms were of oral origin.   The 
identification of oral bacteria suggest that there are aspects of injecting process such as 
licking and use of saliva that could be explored further (Binswanger et al 2000; 
Deutscher and Perlman, 2008), together with aspects of hygiene such as clean 
equipment, skin cleansing and hand-washing and their role in skin breakdown (Phillips 
et al, 2013).  
 
Defining infection 
The European Wound Management Association provides this definition of infection: 
‘invasion and multiplication of micro-organisms in body tissues, evoking an 
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inflammatory response (systemic and/ or local) and causing local signs of 
inflammation, tissue destruction, and fever’ (EWMA, 2013).  
 
The traditional criteria for wound infection may be 1) abscess 2) cellulitis 3) discharge 
(serous exudate with inflammation; seropurulent; haemopurulent or pus) (Cutting and 
Harding, 1994). A more modern approach includes other factors such as delayed 
healing, discolouration, friable granulation tissue that bleeds easily, unexpected pain or 
tenderness, pocketing and bridging of the wound tissue, abnormal smell and wound 
breakdown. Not all of these criteria would be present at one time, but clinical 
assessment is important to diagnose infection (Cutting and Harding, 1994; EWMA, 
2005; EWMA, 2013). 
 
Wounds are breaks in the skin and are not sterile. If investigated, bacteria and other 
micro-organisms will be cultured from them (EWMA, 2005). Once there is a break in 
the integumentary layer then the body’s protective surface is breached and a portal for 
entry of organisms is established. However, it may take some time for these to become 
pathogens and cause disease or infection.  
 
A break in the skin does not mean that the wound is infected – other signs and 
symptoms such as redness, swelling, heat, pain and a spreading cellulitic response 
would be more likely to indicate infection. This is an important difference.  
 
If a wound was clinically infected then treatment would be focussed on anti-microbial 
therapy such as antibiotics. If it was contaminated or colonised, then topical treatment 
would be more appropriate (Leaper, 1998; EWMA, 2006). This is commonly 
understood by specialised wound practitioners, but may be misunderstood by others 
who are less expert and who may see an open wound and assume it is infected by 
appearance alone.  
 
Hope et al (2008), in a survey of PWID self-reporting injecting practices and symptoms 
of injecting site infections, considered the symptoms of injection site infections to be 
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‘abscess (pus-filled swelling) or open wound/ sore at an injection site as these are most 
likely to be due to bacterial infection’. An abscess is usually a closed wound unless it 
has been drained or burst, and is indeed a sign of infection.  However, the assumption 
that an open wound at an injection site is likely to be infected is incorrect, and suggests 
that open wounds at injecting sites on the leg which have been present four weeks or 
more, and are therefore ‘ulcers’ (SIGN, 2010), are being misclassified. It is also 
possible that other open wounds in other sites without the signs of infections such as 
redness, swelling, pain, malodour etc. have also been classified incorrectly. Hope et al 
(2008) found that infection was associated with injecting in particular sites but it is 
unclear whether this included the leg, but did include the groin.  
 
In the ‘Shooting Up Report - 2013’ 28% of PWID reported a recent injecting site 
infection (Public Health Groups, 2014) and despite being described as a ‘major’ 
problem the authors do not define what is meant by a site infection; instead they state 
that an experience of an abscess, sore or open wound would be ‘possible symptoms of 
an injecting site infection’. In a later study, Hope et al (2014) discuss injecting site 
infections and state ‘a sore / open wound will most probably be infected’. This is a 
misunderstanding, and the authors go on to say that the sore may have been caused by 
excessive use of acidifier. However, excess acidifier may result in a chemical burn and 
again this does not mean the wound is infected (EWMA, 2005; EWMA, 2006). This 
message that open wounds are infected could give license to incorrectly, and potentially 
dangerously, prescription of antibiotics without truly identifying an infection leading to 
the occurrence of resistant strains (Leaper, 1998; Kearns et al, 2004).  It is of concern 
that wounds and infections may be misreported, leading to over- or under-estimation of 
problems and potentially inappropriate treatment. 
It would appear that abscesses can present without cellulitis, and cellulitis may be 
present without an open wound or abscess. Clinical examination would appear the best 
way to identify wound infection, but it should be possible to define cellulitis or abscess 
for reporting purposes.  
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Abscesses 
In 1950, Hussey and Katz reported that they were unable to find any published 
reference to skin abscesses in drug injectors but they commented that it is likely that 
such abscesses were considered a matter of course, and were not worth reporting.  
Since then, abscesses were commonly reported but not defined (Biller and Murr, 2004; 
Lloyd-Smith et al, 2005). 
 
A report from the early 1980’s (Horn et al, 1987) identified that after inadvertent over-
dosage, DVT (typically ileo-femoral thromboses) followed by abscess were the 
commonest reasons for the admission of drug injectors to a Glasgow hospital. The 
abscesses were mostly in the groin and almost exclusively caused by staphylococcal 
infection possibly originating from the skin.  
 
Under-reporting may also have occurred in the literature due to failure to recognise or 
report the true nature of skin damage. For example, Makower et al (1992) studied drug 
injectors attending A & E in Glasgow and noted abscess of the lower limb but no leg 
ulcers. It is possible that these ‘abscesses’ were chronic ulcers and not assessed or 
recognised as such. There is apparent confusion of definition with terms such as 
abscess and ulcers being used interchangeably (Reese and Sullivan, 1997). 
 
Spijkerman et al (1996) undertook a  prospective study of 758 PWID over 8 years to 
investigate  incidence rates and risk factors for skin abscesses and  reported that more 
frequent injectors, and especially females as they  have less visible veins than men,  
have a higher incidence of skin abscesses. However ‘abscess’ was undefined and it is 
unclear whether these were infected, sterile or not abscesses but ulcers. 
 
Gonzalez et al (1993) undertook a four-year retrospective review of 57 patients with 
upper extremity abscesses associated with drug injection admitted to a hospital in 
Chicago, US. All of the abscesses were due to intravenous injection or skin popping. 
Three patients with abscesses present for more than six months had osteomyelitis.  
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Murphy et al (2001) performed a case control study with 151 IDUs with abscesses 
requiring incision and drainage and 267 IDUs who did not have abscesses nor skin 
infection. They found that skin popping, use of a dirty needle and speed-balling 
increased the tendency to form an abscess. Skin cleansing with alcohol was also 
identified as potentially preventing abscess. However, the definition of abscesses was 
not provided within the paper.  
 
It is difficult to compare papers and draw conclusions when the meaning of the words 
related to skin breakdown and potential infection are not defined and can be 
misunderstood. 
 
Scars / track marks 
Track marks are early and visible scars of injecting usually seen overlying veins on the 
forearms resulting from repeated unsterile injections, irritants, crushed tablets, foreign 
body reaction and infection causing thrombophlebitis and sclerosing of the veins 
(Kirchenbaum and Midenberg, 1982; Maliphant and Scott, 2005; Darke et al, 2015). 
Damage to the veins may be a precursor to more widespread venous disease. 
 
Lumps 
Foreign body granulomas are seen in injectors (Fellner and Ledesma, 1990) and 
injecting crushed tablets as well adulterants of starch and talc are implicated as 
causative factors (Stuck and Doyle, 1987; Darke et al, 2015). Missed hits may also 
create lumps which could be sterile abscesses, or blocked veins (Derricott et al, 1999). 
Although common, it is unclear what the implications of such lumps are on skin 
breakdown.  
 
2.8 Impact of injecting on health 
This section explores the role that injecting may have on systemic health.  
 50 
Blood-borne viruses (BBV) 
A predominant issue for harm reduction services is the incidence of blood-borne 
viruses, commonly HIV and Hepatitis B and C (Cullen et al, 2005; Cooper and Mills, 
2006).  Hepatitis C (Hep C) is highly prevalent amongst Scotland’s PWID (Prevost et 
al, 2015), and can lead to cirrhosis and liver failure, but it is unclear whether BBV have 
a role in skin breakdown (Hutchinson et al, 2006).  
Redondo et al (2002) report a single case of chronic leg ulceration in an HIV positive 
patient who had been skin popping. The ulcer was deep, with healthy granulation 
tissue.  Arterial pulses were present but Ankle Brachial Pressure Index (ABPI) was not 
reported. Dramatic improvement was noted with antiretroviral drugs, steroid therapy 
and a hydrocolloid dressing with almost complete healing within two weeks. This was 
without compression, suggesting that it was unlikely that the ulcer was venous in origin 
but instead was a more acute wound, but it is unclear if this was linked to HIV.   
 
Arterial disease  
Many PWID may have arterial damage from previous infection, surgery or arterial 
misadventure (Ting and Cheng, 1997). Pieper et al (2009a) identified peripheral arterial 
disease in 16.7% of a sample of people in methadone clinics but it was impossible to 
identify in the study what the reasons for this were.  
 
Fellner and Ledesma (1990) report a single case of a woman with ulceration overlying 
the medial malleolus, with pain and swelling of the foot following injection of heroin.  
The ulcer was punched out, necrotic and draining fluid. The authors consider that ‘drug 
ulcers of the addict’ are often painful and found over bony prominences, with pressure 
as a factor, and what they describe is symptomatic of arterial disease (Moffatt et al, 
2007, p108).  Many drug injectors are also tobacco smokers which impacts on coronary 
health (SIGN, 2006; Shin et al, 2013). Arterial and vascular disease may contribute to 
skin breakdown and poor healing (Moffatt et al, 2007, p99). 
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Lymphatic disease 
Along with impaired venous return, lymphatic blockages due to injecting can cause 
oedema, puffy hand or foot syndrome, and if persistent, lead to brawny, non-pitting and 
persistent oedema which can increase the risk of ulceration (Kirchenbaum and 
Midenberg, 1982; Pieper, 1996a).  
 
Neurological disease 
Drug injecting is associated with a variety of neurological complications including 
haemorrhagic and ischaemic strokes, seizures, movement disorders and cerebral 
atrophy (Neiman et al, 2000). Traumatic injection neuropathy can also occur in the foot 
due to repeated injury from injections, and allergic reactions, vasculitis, and ischaemia 
and extravasation can damage perineural structures (Finelli and Taylor, 1977; 
Kirchenbaum and Midenberg, 1982). Neurological damage to the leg can create limb 
dependency, leading to venous stasis and risk of ulceration (Moffatt et al, 2007, p139). 
 
Systemic infections attributed to injecting 
Serious disease can manifest itself initially in the skin, and apparently trivial wound 
infections in PWID can present with systemic effects which might otherwise be 
dismissed as direct results of drug intoxication such as collapse, paralysis or odd 
neurological symptoms. A number of organisms have been responsible for illness and 
death in drug injectors such as clostridia novyi, botulinum and tetani (McGuigan et al, 
2002; Beeching and Crowcroft, 2005; ECDC, 2015). Heroin can be contaminated with 
soil where clostridia spores can lie dormant; dissolving heroin in acid and heating may 
stimulate germination of spores and is likely to destroy the bacteria that could compete 
with it (Zerell et al, 2005; Baumgardner, 2012). 
 
Anthrax infections have occurred in drug injectors in Scotland, and can be initially 
difficult to differentiate from other injecting site infections.  It can be challenging to 
treat and has a high mortality rate (Grunow et al, 2013). 
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Necrotising fasciitis is a severe infection that spreads rapidly along soft tissue planes; 
the disease is insidious and often the true severity is not initially apparent (Gonzalez et 
al, 1996). A number of bacteria may be implicated, including group A streptococcus 
and there is also a high mortality rate (Bernaldo de Quiros et al, 1997; Neal, 1999).   
 
Other systemic infections 
Other infections including endocarditis, epidural abscesses, and renal lesions are not 
uncommon with a number of case reports of PWID published (Arbulu et al, 1993; Fred 
and Hariharan, 1997; Prendergast et al, 1997; Formica and Perazella, 1998).  
Systemic infections may affect the vascular system and may lead to skin breakdown 
and possibly death in PWID.  
 
2.9 Leg ulceration 
This section examines the existing literature surrounding the prevalence, aetiology and 
risk factors of leg ulceration and relates this to PWID. 
 
Ulceration of the lower leg is a common problem in Western countries (Callam, 1992; 
Scottish Leg Ulcer Trial Participants, 2002; Hall et al, 2014) affecting approximately 
1% of the population. Leg ulceration is a common source of morbidity in the elderly 
(Franks et al, 2004) and there are a number of concomitant factors such as peripheral 
vascular disease, trauma, haematological factors, diabetes, and vasculitis, but most 
ulcers are multi-factorial (Burton, 1993). The majority of sufferers with leg ulceration 
have a chronic condition which causes pain, embarrassment, and social isolation and 
once healed, the ulcers can readily recur (Dale et al, 1983; Lees and Lambert, 1992; 
Jawien et al, 2003).  Venous ulcers alone have been estimated to cost between £300 and 
£600 million per year in health expenditure in the UK (Hall et al, 2014).  
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Definition of leg ulceration 
Graham et al (2003) undertook a systematic review of prevalence studies of lower limb 
ulceration and found that the definition of ‘ulcer’ was inconsistent, the population was 
ill-defined, and there were differences within study designs that meant data could not 
be pooled effectively.  More recently, Hall et al (2014) undertook a point prevalence 
study of complex wounds in one city in the UK and also identified problems with 
comparisons due to the inability to identify an internationally agreed definition of a leg 
ulcer. The absence of consistent definition appears to be a constant theme within the 
wound care literature. 
 
The definition of chronic leg ulcer for the purposes of this study is ‘a break in the skin 
between the ankle and the knee of 4 weeks or more duration’ (SIGN, 1998; SIGN, 
2010). This is a definition commonly used and understood as it enables the 
differentiation between an acute healing wound and an ulcer that requires altogether 
different treatment. 
 
Prevalence of leg ulceration 
Leg ulceration has been increasingly reported amongst PWID (Pieper et al, 1998; 
Godley, 2007; Guild, 2008; Beynon et al, 2010; Devey, 2010; Goodall, 2010; Greene, 
2010; Powell, 2011b) although the precise prevalence was unknown, and no recent 
prevalence studies have been found to update this. 
 
Risk factors for leg ulceration  
In older people, venous ulcers are primarily caused by a failure of the calf muscle pump 
to work efficiently, which can lead to valvular incompetence within the deep, 
superficial or perforating veins of the lower leg (Nelson, 1996). Venous stasis may then 
occur which is exaggerated in patients with mobility problems or those whose 
occupation necessitates long periods of standing or sitting with little active movement 
(O'Hare, 1995).  The valve damage may cause influx of blood at high pressure from the 
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larger veins into smaller fragile capillaries causing damage which results in cell death 
and subsequent ulceration (Dormandy, 1997).  
 
Assessment of leg ulceration 
Within the UK typical care of venous ulceration comprises objective assessment, 
including a Doppler test and calculation of ABPI, high-compression bandaging and 
appropriate referral (Franks et al, 2004; SIGN, 2010).  
The assessment comprises careful history taking of known risk factors for vascular 
disease: tobacco smoking, alcohol intake, BMI (Body Mass Index), nutritional intake, 
medication, cardiac history including claudication, diabetes, joint and mobility 
problems, DVT, cellulitis, leg fractures and occupations that involved standing for long 
periods, parity (for females), as well as clinical signs of venous disease: varicose veins, 
ankle flare, and skin changes such as lipodermatosclerosis or skin staining (SIGN, 
2010). The assessment should identify causative factors to enable treatment planning 
tailored to the likely cause of the ulceration (Moffatt et al, 2007, p47). 
 
Studies related to causation in injecting drugs users who are younger are limited 
however, some insight about presentation, risk and impact of ulceration can be gleaned 
from case reports and overviews.  
 
Butcher (2000) describes a client with a twenty-year history of injecting and a three-
year history of chronic leg ulceration, who had marked pitting oedema, ankle flare, and 
heavy brown staining of the skin to the lower two-thirds of the calf. He had an 
irregularly shaped ulcer 6.5 x 5cm and several satellite ulcers. 
 
Devey (2010) describes a client who had been femoral injecting for 12 years and had 
ulceration with venous changes – ankle flare, oedema, varicose veins, hypertrophic skin 
changes, and varicose eczema.  
 
 55 
Forshaw and Power (2001) report a 41 year old injector with multiple lower limb 
ulceration distributed along the line of the long saphenous vein, who had injected a 
mixture of drugs including amphetamine, crack, heroin and methadone both 
intravenously, and subcutaneously, in the lower limb. The ulcers were deep, linear with 
irregular necrotic borders, an offensive smell, and surrounding cellulitis. The authors 
hypothesise that ulceration in a drug injector  is caused by possible acute 
thrombophlebitis from repeated injection into a vein, whilst surrounding peri-venous 
and subcutaneous injections may cause tissue destruction, cellulitis and abscess 
formation. They consider this may have been compounded by venous insufficiency, 
lymphatic destruction and lymphoedema secondary to the sclerosing effects of multiple 
injections. 
 
Mittal and Pahuja (2000) describe four cases of multiple leg ulcers in Indian males with 
a history of drug injecting. Specific demographic and wound data is not provided for 
each case, but the patients had a history of injecting buprenorphine, diazepam, 
pentazocine, and norphin. All four showed sclerosis, pigmentation, and non-pitting 
oedema of the lower legs with dermal fibrosis, proliferation of dermal capillaries and 
pseudoepitheliomatous hyperplasia. It is unclear whether this pathology might relate to 
all injectors or to these specific drugs, which are not in common use in Scotland. 
Pardes et al (1993) describe four patients with leg ulceration following popping – one 
had multiple ulcerations though the specific sites are not stated, one had an ulcer 
overlying the left medial malleolus, one had ulceration that extended from ankle to 
middle of calf, with a smaller ulceration over the right medial malleolus, and the fourth 
had an ulcer on his right leg with site unspecified. In two patients there was evidence of 
venous insufficiency. There is a lack of detail in the reporting of each case with 
investigations described as ‘normal’, but no specific investigation named. In each case 
the ulcers appeared years after injecting in the area had ceased. The authors surmise 
that skin popping led to lymphatic damage or some degree of microvascular 
compromise that took a long time to ulcerate, but also state that the reason why the 
ulcers developed is unclear.  
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Beynon et al (2010) note the premature aging effect of drug use, and in particular the 
effect on the lower legs. Damage that occurs in the active period of injecting persists 
and advances long after injecting has ceased, and legs in particular can prematurely age 
by around 20 – 30 years. Venous ulceration can occur during drug injecting or years 
after injecting has ceased (Pieper, 1996b; Lawson, 2010). In a retrospective study of 
venous ulcer healing in injecting drug users (Pieper, 1996a), the average age of 
participants was 42 years. She cites the main risk factors for venous insufficiency in 
PWID as deep vein thrombosis, vein injury from multiple injections, and pathological 
changes from the sclerosants and adulterants contained in the injected drug. According 
to Pieper (1996a) leg ulcers of PWID tend to be larger in area and more numerous than 
those reported in other venous ulcer studies. 
 
These case reports together show young PWID have ulceration of longevity, with 
marked signs of venous disease or chronic venous insufficiency. Ulceration may appear 
long after injecting has ceased, and may be multiple and in various sites on the lower 
limbs. 
 
Chronic venous insufficiency  
In an American study of 204 PWID, chronic venous insufficiency (CVI) was found to 
be a common occurrence amongst 87% of participants (Pieper and Templin, 2001).  
 
CVI manifests itself below the knee with oedema, heaviness and fatigue, together with 
burning sensations near potential varicosities. The skin may become dry, fibrotic and 
darker in colour, and eventually ulcers may develop. The most common causes of CVI 
are deep vein obstruction, such as thrombosis, and superficial vein regurgitation due to 
dysfunctional valves (Pieper and Templin, 2001). 
 
CVI commonly occurs in the third or fourth decade of life for PWID  (Pieper, 1996a) 
and in the sixth or seventh decade for other persons, often with a history of leg injury or 
phlebitis (Burton, 1994; Scott et al, 1995). Chronic venous disorders (CVD) are 
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classified in a staging system that ranges from no visible or palpable signs of venous 
disease through the signs of CVI, varicose veins, oedema, skin changes to ulceration as 
end-stage venous disease (Eklof et al, 2004).  
Pieper et al (1998) administered a questionnaire to 32 drug injectors about their drug 
history and experiences of pain with venous ulcers. Greater pain was associated with 
larger wound areas. The study also revealed that 14 participants (44%) had a history of 
DVT, and 21 (66%) had a history of lower leg cellulitis. 31 participants had used 
heroin. 29 persons had been groin injectors.  
 
Chiang et al (1990) report on eight cases (6 men, 2 women) who had been injecting into 
the veins of their lower extremities; 4 participants had also injected in their groins; 7 
patients (12 limbs) had experienced ulceration, and there was recurrence in 10 limbs. 
The age range of the patients was 28 to 40 years. Venography revealed obstructive 
venous disease in 7 limbs, 3 showed venous collaterals and one had valvular 
incompetence. The authors consider that chronic venous stasis is seen in younger 
patients but that a strong muscle pump may moderate the effects of venous obstruction. 
 
Chronic venous insufficiency characterised by swelling, pain, ulceration, preceded by 
injecting in the legs and groin, appears to be prevalent in PWID. Venous ulceration is 
treatable by reversing venous hypertension with the use of graduated compression 
therapy (The Alexander House Group, 1992). 
 
Thrombosis 
Scott et al (1995), in a case control study investigating risk factors for chronic venous 
insufficiency in an elderly population, found that DVT was a pre-disposing factor. 
Injecting is also associated with a higher risk of clotting, thrombosis and embolism 
particularly if the femoral vein is targeted (Fah et al, 2002; Glenesk, 2008).   
 
Vascular damage often begins with thrombophlebitis (Maliphant and Scott, 2005) 
which has been reported as a complication of injecting in the lower limb (Stuck and 
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Doyle, 1987). The thrombophlebitis appears as swelling, induration, erythema and 
tenderness along the course of the vein and can precede deep venous thrombosis. After 
larger or more prominent veins are used, obliterated, or ‘burnt out’, smaller and more 
peripheral vessels are used. These have less adventitial support, and extravasation can 
occur easily with resulting adjacent infections. With continued abuse the superficial 
veins of the legs and feet become thrombosed and cordlike. The most common area for 
this is the greater saphenous vein at the medial malleolus with proximal extension 
(Kirchenbaum and Midenberg, 1982; Mottahedeh and Da Silva, 2003). 
 
Formation of DVT in the lower limb is thought to be due to trauma caused by injecting 
and the natural coagulation response of the body to injury (Baldeweg, 2000; Syed and 
Beeching, 2005). Formica and Perazella (1998) report a female drug user who after 
losing intravenous access began subcutaneous injecting into her legs and buttocks. She 
had experienced several bouts of cellulitis in the lower leg, complicated by chronic 
non-healing ulcers as well as superficial and deep venous thrombosis (DVT). She had 
an inferior vena cava filter installed due to the frequent episodes of DVT.  
 
McColl et al (2001) reviewed 322 women aged 16 – 70 years who presented between 
1993 and 1997 with venous thromboembolism in Glasgow. Injecting drugs using the 
femoral vein was a common risk factor in 13.7% (n = 44). All women with drug related 
thrombosis presented with DVT. The mechanism of thrombosis was also thought to be 
due to the trauma of repeated femoral vein puncture leading to endothelial damage and 
the injection of irritant materials.  
In 1999, Syed and Beeching reviewed all DVT patients (n = 232) admitted to a large 
district hospital. Intravenous drug use was the causative factor in 48% of those of 40 
years of age or younger (Syed and Beeching, 2005). 
 
Three cases of chronic leg ulceration are reported by Sudhindran (1997) in a journal 
letter. No detail about the ulceration, or the patients, is provided but the author states 
that all three patients were injectors with a history of groin injecting. All had suffered 
femoral vein thrombosis, and the ulcers were considered to be post-thrombotic.   
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Woodburn and Murie (1997) state that PWID can develop post-thrombotic ulceration, 
but they would also expect to see symptoms of underlying venous disease. They 
consider that ulceration may occur after intra-arterial injection, and skin necrosis may 
follow vasculitis and capillary thrombosis, and therefore compression therapy would be 
of little use.   
MacKenzie et al (2000) identified increasing use of the femoral vein for access in a 
retrospective study of patients admitted to the Infection Unit in Aberdeen with DVT. 
Twenty patients were identified with injection-related iliofemoral venous thrombosis. 
Concurrent with the clot, 9 patients also had groin abscesses. Following treatment, 
seven patients were left with a chronically swollen post-phlebitic leg.  
 
Gorman et al (2000) state that post-thrombotic syndrome complicates 50 – 75% of 
DVT. Clinical features include pain, swelling, dermatitis and ulceration. McColl et al 
(2001) considers that there is clinical uncertainty about the best method of treating 
intravenous drug users with DVT. Erratic compliance issues with oral anti-coagulants 
can lead to under and over-coagulation. 
 
Importantly, deep vein thrombosis is common in drug users, but there may also be 
sequelae in the form of post-thrombotic syndrome particularly if the clot is proximal to 
the calf as reported in many femoral injectors (Nicolaides et al, 1980). 
 
Summary of risk factors 
Within the existing literature a number of signs and symptoms have been reported in 
injectors who have experienced ulceration including cellulitis, abscesses and infection, 
thrombosis and DVT. Some authors suggested causative factors which include groin 
injecting, arterial hits, repeated injecting in the same area, injecting cocaine, poor 
hygiene and adulterants in the drugs injected. All of these factors need to be explored in 
more depth to identify risks for skin breakdown in PWID. 
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2.10 Harm reduction  
Harm reduction seeks to reduce the damaging effects of drugs by teaching skills and 
offering individualised health information and resources (Schmidt and Williams, 1999).  
It is wider than individual behaviours and needs to address public health needs also 
(Kippax and Race, 2003).  
 
No specific harm reduction studies were found that related to reducing the development 
of leg ulceration. Many commercial materials such as ‘The Safer Injecting Handbook’ 
(Preston and Derricott, 2013) describe ways to make the injecting process safer, and 
state that problems that can occur such as infection and ulceration however, these form 
part of a list of complications and are not sufficiently focussed to demonstrate a clear 
link. No materials could be found that discussed what sequence of events might lead to 
ulceration.  
 
2.11 Challenges and the need for this study 
Whilst there is literature about leg ulceration, literature about injecting drug use, and 
literature about PWID, there is little truly known about ulceration in young PWID. 
However, clinical experience, observation, and case reports reveal there is a growing 
leg ulcer problem in young PWID (Godley, 2007; Guild 2008; Powell, 2011b), and the 
extent of this is unknown, risk factors are not clear and prevention methods are 
unidentified.  
 
Other authors have already called for more work to be done in this field:  
 McColl et al (2001) recommended that the long-term sequelae of venous 
thromboembolism in PWID should be investigated.  
 Maliphant and Scott (2005) investigated femoral injecting and recommended a 
longitudinal study to examine the relationship between groin injecting and loss 
of vein patency. They also suggested that work was required to determine the 
prevalence of groin injecting and the incidence of associated problems.  
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 Taylor et al (2005) recommended the development of surveillance systems 
nationally and internationally to monitor the incidence of serious soft-tissue 
infections among PWID.   
 
Finally, in 2006, Rhodes et al noted an absence of published data on physical 
injecting sites and the need for such data in future work (Rhodes et al, 2006).  
 
2.12 Research questions  
Whilst it is clear that leg ulceration is a problem for PWID, it is not known what the 
extent of the problem is, and therefore the first research question was:  
1) What is the extent of skin problems and chronic leg ulceration in young 
people who inject drugs? 
There are a number of issues identified in the literature that may contribute to leg 
ulceration such as injecting in the legs and groin, hygiene, and homelessness, but 
direct risk factors for leg ulceration are unknown. This led to the second research 
question: 
2) What causes chronic leg ulceration in young PWID?  
Once it is known what causes the ulceration, how can the risk be reduced and leg 
ulceration prevented? 
This leads to the third research question: 
3) What are appropriate harm reduction measures in young PWID?  
Identifying the aetiology will allow the exploration of targeted harm reduction 
methods. 
 
Chapter summary 
The initial literature search revealed no empirical studies that identified the prevalence 
of skin problems and leg ulceration in PWID, nor were there any empirical research 
papers that identified causation of leg ulceration in PWID. Consequently there was no 
literature recommending harm reduction methods to prevent leg ulceration. There was 
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clearly a gap within the evidence base relating to leg ulceration in PWID, and a 
difficulty as there was poor definition of terms throughout.  The narrative review 
therefore looked more widely at potential contributing factors within the published 
literature related to aspects of drug use that might contribute to skin breakdown and leg 
ulceration.  
Having identified these research questions, Chapter 3 will discuss how these questions 
may be answered. 
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Chapter 3  
Methodology, Related Methods and Plan for Analysis 
Introduction 
This chapter begins by examining the underpinning philosophies and various clinical 
and health research methods which were considered in order to generate knowledge to 
inform practice (Gerrish and Lacey, 2006, p5). 
 
The chapter then outlines the sequential explanatory mixed methods approach to this 
applied health research study that was chosen to answer the research questions: 
1. What is the extent of skin problems and chronic leg ulceration in young 
PWID? 
2. What causes chronic leg ulceration in young PWID? 
3. What are appropriate harm reduction measures for leg ulceration in young 
PWID? 
The chapter concludes with a description of the ethical considerations. 
 
3.1 The underpinning philosophies 
All research has a philosophical foundation, and there are assumptions upon which this 
study is based. In the following section different philosophical ideas are considered 
with relevance to the research questions. 
 
Positivism 
Positivism is a theoretical position strongly associated with quantitative, or empirical, 
research that believes that scientific truth can only be derived from that which is 
observable by the human senses (Gerrish and Lacey, 2006, p538) and that which can be 
counted such as in numerical form. Positivism seeks to derive theory from evidence but 
it can be argued that there is no single definitive positivist view (Paley, 2001). 
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Positivism also explains the world in terms of ‘universal laws’.  Some laws may be 
universal (such as the law of gravity) but the circumstances within which laws are 
applied may differ. Sometimes this may produce the same effects and sometimes this 
may differ.  It is unlikely that the exploration of leg ulceration in young PWID within a 
specific population in a specific city would be the same in a completely different group 
in a different country, as it is known that drug injecting practices differ across the 
world. For example, heroin is the most commonly injected drug, but it is derived in 
different ways in various countries, and therefore its purity, appearance, and ultimately 
its effects may differ.  The development of ulceration is therefore likely to be a 
complex and potentially multi-causal problem that may be influenced by many different 
things.  
 
Foucaldian and post-structuralist traditions (Dyson and Brown, 2006, p55) challenge 
traditional positivist research on the basis that positivists may not make clear the 
conditions under which the research was undertaken – thus hiding certain aspects of the 
research process (Dyson and Brown, 2006, p66). Post-structuralists consider that the 
reality that we think we know may just be one of several possibilities (Dyson and 
Brown, 2006, p54). The activities of the researcher can create rather than reflect the 
social world for example, who is to know what reality is, since it may be what is 
perceived by the human researcher and may be dependent on a number of different 
relationships. For example, questionnaires may be devised in such a way as to 
encourage responses that may not be the preferred answer of participants but may 
demonstrate the restricted views of the researcher, thus creating bias and false 
outcomes. 
 
Adopting a positivist stance means that it may not be possible to find a cause for leg 
ulceration in PWID as this may not be regarded as something observable. The ulcer 
itself is observable on the skin, but what has caused it may not be clearly seen and may 
be affected by different physical and social circumstances. PWID often have very 
complex lifestyles that are challenging to observe and understand. Positivism assumes 
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that phenomena are measureable using the deductive principles of the scientific method 
(Bowling, 1997, p110). However, in this proposed study there is so little known about 
the phenomena under investigation that knowledge needs to be developed from data 
collected. Positivists also believe in cause and effect which is determinism (Parahoo, 
2006, p40), but cause in a rather weak sense because the cause may not be observable 
or measureable (Paley, 2001). However, postpositivism believes that this is not absolute 
and so it is more realistic to identify ‘probable causes’, and therefore postpositivism is 
more suited to underpinning contemporary empirical research (Clark, 1998; Routledge, 
2007). Science is still deemed to require precision, logical reasoning and attention to 
evidence but is not confined only to what can be observed (Clark, 1998). Data are 
acceptable in inferable forms such as self-reports inherent in interviews or 
questionnaires (Clark, 1998).  From data such as these, theories of causal and risk 
factors may be proposed, and tested using an in-depth study.  
 
Scientific Realism 
Scientific realism is potentially insightful – ‘it is able to probe what is ultimately 
generating the way things are. It doesn’t stop short; it asks why things are happening’ 
(Dyson and Brown, 2006, p43). For example, are leg ulcers occurring because of a 
particular social environment, or a combination of social and physical environments – 
are they linked to homelessness, for example?  ‘Scientific realists take the view that, 
just because you cannot directly apprehend a concept or a process does not mean that it 
does not have real consequences’ (Dyson and Brown, 2006, p85). Therefore it is 
important to observe but also to take into account the context and other factors that may 
occur that are potentially hidden, and which positivism would ignore. It would be 
realistic to identify probable causes of ulceration based on data accumulated, even if 
these cannot be observed or directly proven.   
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Critical Realism 
Generating evidence that may be as close as possible to the truth is a critical realist 
approach which combines the search for a high level of objectivity within data 
collection, whilst appreciating that the ‘absolute truth’ might not be attained (Parahoo, 
2006, p41; Burns and Grove, 2005, p23). Asking PWID to recall and explain illegal 
activities may mean that information given is not necessarily the truth, either because 
they do not wish to tell the truth, or because they do not remember as a result of time-
delays in recall, or possibly a drug-related memory loss. Similarly participants may 
under-estimate or over-estimate drug use. In addition, the Hawthorne effect of 
participants telling the researcher what they think the researcher might want to hear 
may affect the absolute truth within the data (Gerrish and Lacey, 2006, p250). 
 
Controlling bias in any study design is a major challenge. The construction of a 
questionnaire and the phraseology of individual questions might include bias from the 
researcher’s own natural view point (Porter, 1993). Adopting a systematic and rigorous 
approach, with intent to reduce potential variables and bias, will enhance the accuracy 
of the research (Bowling, 1997); however, realism is essential because much of the data 
will be based on the recall of participants.  
 
The combined use of differing methods within this study, such as the triangulation of 
qualitative and quantitative work, embraces the ethos of postpositivism recognizing the 
value of different approaches to developing nursing knowledge (Clark, 1998).  
 
However, scientific realism accepts that probable causes of leg ulceration may be 
identified but that these may be circumstantial.  Other authors have encountered similar 
challenges in undertaking work that has an empirical base but requires application to 
the real-life circumstances involved in nursing (Giuliano, 2003). ‘Contemporary 
empiricism’ is the term used by Giuliano (2003) as a method to deal with the dilemma 
associated with the objectivity of empiricism and the subjectivity of human experience 
more associated with nursing individuals. Contemporary / Scientific / Critical realism 
are closely overlapping approaches. The blurring of the edges of established 
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philosophical ideas such as empiricism appears to be an emerging theme within the 
nursing literature and is used as a way of dealing with the application of research into 
the vagaries of nursing practice. 
 
Philosophical stance for this study 
Critical realism is the approach which will underpin this study, allowing consideration 
of a number of factors and is based on three levels of reality: 
 The ‘empirical’, comprised of experienced events such as leg ulceration. 
 The ‘actual’, consists of events whether experienced or not such as the drug 
using history, but also of other things that may not have been considered by the 
researcher. 
 The ‘causal’, which consists of structural mechanisms which generate events 
such as the environment, or the injected drug (Porter, 1998, p171). 
 
This is not a hard and determinist philosophical stance, it does not consider that events 
will always cause things to happen in a particular way.  It accepts that many systems or 
events may be occurring at any one time, all potentially having an influence on 
outcome. Critical realism allows the rational interpretation of evidence to examine what 
exists and to point a way forward (Porter, 1998, p179). The opportunity to investigate 
aspects of leg ulceration in PWID by determining the extent of the problem, and then 
exploring it further, is rooted in critical realism and this study provides a basis to 
inform practice and from which other studies may follow. 
 
Therefore a mixed methods approach was proposed, to maximise the information 
gathered, by exploring both the experiences, and behaviours together with 
circumstances, of the injector who has or has had leg ulceration. Mixed methods 
research studies are defined by Tashakkori and Teddlie (2003, p11) as using 
‘qualitative and quantitative data collection and analysis techniques in either parallel or 
sequential phases’. In this study, empirical data were acquired to determine the extent 
of leg ulceration and possible factors involved in the development of leg ulceration in 
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PWID, by asking specific questions to build up a picture of drug using activity and then 
these aspects, specific to leg ulceration, were further explored in more detail by using a 
qualitative approach (Carter and Henderson, 2005, p216).   
 
Qualitative research is often seen as diametrically opposed to empiricism however, this 
view has been questioned (Clark 1998; Paley, 2001; Martin and Stenner, 2004) and 
similarities between qualitative and quantitative research are apparent. The two 
methods can complement each other (Carter and Henderson, 2005, p216). The 
quantification of research is clear within both methods, as a statistical count and 
inference is apparent within the analysis of quantitative methods, whilst identifying 
themes and number of occurrences within the qualitative narrative is broadly similar in 
approach. Therefore the mixed methods approach for this study uses two methods of 
data collection, and requires two different methods of analysis, but both methods must 
be open to scrutiny, and be transparent, valid and reliable. Statistical methods of 
analysis were utilised for the quantitative data and are widely accepted as scientifically 
valid and will be discussed in more detail later in this chapter.  
 
In the qualitative stage, analysis of the narrative acquired through semi-structured 
interviews may be viewed as less scientific. It is more time-consuming, and to be 
accepted it is even more important that the route to analysis is transparent and reliable 
and this will also be discussed later in this chapter.  
 
The two separate methods – quantitative and qualitative have different epistemological 
stances but a combined approach and subsequent analysis requires an adjusted 
philosophical paradigm (Tashakkori and Teddlie, 2003). The research aims and 
questions should be answered by using all approaches to understand the problem 
(Creswell, 2014). The approach evolved further from the original postpositivist and 
realist stance into a more pragmatic view. Giddings (2006) argues that mixed methods 
is a pragmatic research approach that fits comfortably with postpositivist epistemology 
which suggests the same world view (Creswell, 2014) remains throughout.   
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The pragmatist approach allows more than one method to be used in research, and 
looks to many approaches toward collecting and analysing data – depending on what 
best fits the research question. In this study the research question cannot be answered 
by one method alone so a pragmatic approach and the resulting mixed methods of an 
explanatory sequential design has been used (Creswell, 2014, p224).  It may be argued 
that a mixed methods approach in terms of theoretical and philosophical underpinning 
is still developing (Giddings, 2006) and as such there are many approaches, all of 
which can contribute to mixed methods. 
 
Chapter 2 showed that the evidence relating to leg ulceration in young PWID is limited.  
Equally, the causative, contributory and contextual factors are also unknown. It would 
therefore be appropriate to conduct an empirical study to produce data that may both 
inform and help develop existing policy and practice by identifying the scale of this 
problem but also provide a foundation of knowledge for practice and create a baseline 
for future studies related to patient care (Giuliano, 2003).  
 
Quantitative research aims to deal with quantities and relationships between variables 
and is useful for collecting numerical or measurable data. A large number of 
observations may be made, and by using a process of induction, it will be possible to 
draw conclusions (Parahoo, 2006, p34) but it is always difficult to achieve absolute 
rigour, especially within human studies. The inductive method involves moving from 
the specific to the general and consists of description, classification, correlation, 
causation and prediction (Parahoo, 2006, p34; Powers and Knapp, 1995, p86).  
 
Conclusions may be drawn but they may not be regarded as absolutely factual as so 
many variables will exist within human studies. Quantitative studies may also include 
qualitative elements, such as points of clarification or further explanation within a 
questionnaire, and vice versa, qualitative research may also include quantitative 
elements where, for example, numbers of respondent answers may be counted.  
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However, nursing promotes well-being and any nursing theory takes into account 
context and environment and therefore nursing research must extend beyond the 
medical model,  biological models and basic empirical science (Rocha et al, 2000).  
 
Qualitative research aims to explore attitudes, behaviours and feelings, within context, 
and may be more useful to explore what exists especially when so little is known about 
a phenomenon. For example, a number of injectors may state that they inject into their 
legs. The number could be counted and a numerical value gained. However, other types 
of enquiry are needed if why they inject into their legs is to be explored (Giuliano, 
2003). This sort of information would be better gathered using qualitative techniques 
such as semi-structured interviews, allowing exploration, rather than questionnaire data 
which can limit answers.   
 
Therefore using the two approaches, quantitative and qualitative, appears to suit this 
study where the information required extends beyond empirical data. The use of both 
qualitative and quantitative methods within one study may be termed ‘mixed methods’ 
and each ‘method’ will be addressed in detail in this chapter (Creswell and Plano Clark, 
2011, p3). 
 
This study will aim to generate knowledge that will guide clinical practice, so it is 
important that the methods adopted should lead to the generation of data that could be 
generalised to a wider group. Generalisation would require an explicit chain of 
reasoning between the general knowledge accrued, the individual data and the context 
from which it is derived (Lincoln and Guba, 1985, p110). Generalisation may be 
accepted for quantitative research due to sampling and statistical methods which are 
representative, but is less accepted in qualitative research.  
 
However, the results from both methods should help inform future practice, whether or 
not they are truly generalisable. Methodology, methods, reliability, validity, analysis 
and presentation therefore all need to be transparent to readers, and will be discussed in 
detail within this chapter. 
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3.2 Aims of research design 
The main aim of the study was to develop a greater understanding of the risk and causal 
factors involved in the development of chronic leg ulceration in young PWID.  
The secondary aim was to analyse these findings and use them to suggest appropriate 
harm reduction methods to prevent chronic leg ulceration. 
 
3.3 Research design process 
Research designs used with PWID within Scotland were explored to identify the best 
and most practical approach for this study within the given time frame of a PhD degree.  
3.4 Quantitative designs 
Randomised controlled trial 
The gold standard of empirical research is considered as the ‘randomised controlled 
trial’ (RCT). To undertake such research, a sample population that can be identified and 
followed and compared is essential and outcomes may require to be measured and 
observed over time (Gerrish and Lacey, 2006, p239). This would be difficult as the 
sample population of PWID is largely unknown and challenging to follow. However, 
this may be useful for a follow-up study once more is known about the injecting 
population who have wounds. As ‘the gold standard’ cannot be applied, it is even more 
important that the methods chosen are clearly articulated and rigorously conducted so 
as not be viewed as a ‘second best’ option, rather than an alternative approach.  
 
Case control studies 
Several studies have used case-control methods to identify risk factors in disease 
development in PWID (Passaro et al, 1998; Bellis et al, 2001; Roy et al, 2004; Taylor et 
al, 2005). However, all had access to case notes or relevant information from drug 
misuse databases. The Information Services Division (ISD) of the Scottish Government 
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maintains The Scottish Drug Misuse Database (SDMD) which is a national information 
source on the misuse of drugs in Scotland. The SDMD is based on systematic recording 
of a national dataset on clients seen at a broad range of services. The database holds 
information on demographic and behavioural characteristics of new clients coming to 
the attention of medical services (for example general practice or hospitals) and 
specialist drug services.  Information relating to wounds and leg ulcers is not available 
on the ISD database, and case notes are not easily accessible, and so would not provide 
the type of information required for this study. 
 
Longitudinal studies 
Pieper and Templin (2001) recommend longitudinal studies to discover patterns in 
disease development and the effects of interventions but they do not describe how this 
might be undertaken in order to achieve success with this population. However, as the 
long-standing Edinburgh Addiction Cohort studies and the DORIS study in Glasgow 
have shown, it is possible to follow up a significant proportion of PWID (McKeganey 
et al, 2008; Macleod et al, 2010). However, recruitment and the long-term nature of 
prospective and longitudinal studies may be challenging and time-consuming in PWID 
due in part to the often transient and chaotic nature of their lives, frequent incarceration 
and early mortality, as well as the difficulty in achieving follow-up with individuals 
who may have no fixed address or reliable contact details (Pieper and DiNardo, 1998; 
Martin and Stenner, 2004; Syed and Beeching, 2005; Kemm, 2006). Whilst a 
longitudinal design might have been useful there was limited time available to achieve 
the necessary follow-up. 
 
Adaptive methods 
Atkinson’s study conducted with homeless men in Glasgow adopted an interventional 
adaptive approach to investigating a vulnerable population (Atkinson, 2000, pxi). The 
researcher visited homeless men within their hostel accommodation to make 
assessments and referrals and then to evaluate the effect of the interaction on the men. 
 73 
Using an interventional approach with a group of PWID with leg ulcers would not 
enable the scale of the problem and causative factors to be identified. Providing 
interventions such as assessment and wound management would limit participatory 
numbers, be fraught with ethical dilemmas, and reduce time available for data 
collection, but would have been a useful way to assess prevalence of infection.  
 
Epidemiology 
Epidemiology is the study of ‘how often health related events occur in different groups 
of people, why variations in the pattern of health and disease exist between populations 
and the application of this study to the control of health problems’ (Martin, 2005). In 
relation to the epidemiology of leg ulceration, there is some knowledge about the 
incidence and prevalence within the Scottish population (Scottish Leg Ulcer Trial 
Participants, 2002) and some more dated, but seminal, evidence relating to aetiology 
(Dale et al, 1983; Callam et al, 1987). However, there is no record in the literature of 
the incidence or prevalence of leg ulceration in PWID.  Drug injecting is simply not 
reported as an aetiological factor in these studies and others (Callam et al, 1987; 
Moffatt and Franks, 1994; Moffatt et al, 2004). Whilst it may be presumed that there is 
a relationship between injecting into veins and the development of venous disease, of 
which the end-stage is regarded as ulceration (Burnard et al, 1982; Eklof et al, 2004), 
the factors which contribute to this are not clear. For example, do all individuals who 
inject into their legs develop ulceration? What is the likely time frame for this to occur? 
Is there a relationship between different types of drug injected and ulceration? Is there a 
relationship between the technique of injecting and skin breakdown? If these questions 
can be answered, then they should indicate how ulceration can be prevented.  
 
With the limited knowledge currently held, it is impossible to develop a single 
hypothesis or set of theories by which to question participants. An open and critical, 
realistic, epidemiological approach allows such exploration and, by using a process of 
induction, ideas and knowledge about leg ulceration in PWID can be gained.  
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Survey methods 
Surveys can be used to collect data within the variety of quantitative approaches 
described (Bowling, 2005, p190).The researcher collects data on the occurrence or 
progression of an outcome of interest without intervening, or attempting to alter 
circumstances (Martin, 2005, p101).   
 
Pieper writes prolifically about venous disease in PWID (for example, Pieper and 
Dinardo, 1998; Pieper et al, 2000; Pieper et al, 2010a) but has not specifically examined 
prevalence, nor risk. However, she describes using robust and fairly consistent survey 
methods successfully in her research such as an administered questionnaire at a primary 
care clinic to investigate non-attendance (Pieper and DiNardo, 1998). She also 
administered a questionnaire with a physical examination of the lower leg to investigate 
chronic venous insufficiency (Pieper and Templin, 2001), and an administered pain 
assessment tool and questionnaire, at a primary care wound  clinic where 80% of 
attendees had venous ulcers as a result of injecting drug use (Pieper et al, 1998). 
Utilising a survey allowed a large amount of relevant data to be collected quickly which 
would be helpful for gathering prevalence and risk factor data. 
 
Cross-sectional retrospective design 
Abelson et al (2006) developed a cross-sectional retrospective study design to identify 
differences between early and late onset injecting and recruited participants by 
convenience sampling to obtain a broad spectrum. Structured questionnaires were 
administered by face-to-face interview and participants were asked a range of questions 
relating to their injecting careers. Whilst the study relied on accurate recall, it had 
advantages in that participants could be approached and interviewed at first opportunity 
and therefore had not to rely upon appointments or follow-up. This design would allow 
data to be gathered on skin breakdown, history, injecting behaviours and risk factors 
which was a practical option for this study.  
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In summary 
None of the quantitative approaches alone could have been used to answer all of the 
research questions.  However, using an applied health research approach with a cross-
sectional survey enabled the collection of prevalence data and information about 
injecting habits and skin breakdown to start to answer the research question ‘What is 
the extent of skin problems and chronic leg ulceration in young PWID?’  and to some 
extent, the second research question ‘What causes chronic leg ulceration in young 
PWID?’. 
 
Adding a second qualitative study to explore the survey data in depth and gather 
information about harm reduction from injectors themselves provided answers to the 
third research question ‘What are appropriate harm reduction measures in young 
PWID?. Two studies like this comprised a ‘mixed methods’ design.  
 
In the next section qualitative designs are explored to identify the best approach to a 
subsequent study.  
 
3.5 Potential qualitative designs  
Utilising a qualitative approach, sometimes viewed as interpretivism, allows an in-
depth understanding of people’s thoughts or behaviour (Parahoo, 2006, p62). The view 
of interpretivists is that human behaviour can only be understood within the context 
that it occurs, and the thinking processes involved are studied. For example, injectors 
may know that using clean needles will reduce the risk of vein damage, but may reuse 
old needles (behaviour) as they are not keen to visit the local needle exchange, and are 
unable to acquire fresh ones from another source (context). Parahoo (2006, p63) 
describes qualitative research ‘as a means to understand perceptions and actions of 
participants’, which is exactly what this study needed to do. Interpretivists see their 
methods and approaches as representing reality as closely as possible which is similar 
to the postpositivist approach of critical realism (Parahoo, 2006, p43). Further adopting 
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the realist approach allowed a more holistic exploration of leg ulceration in young 
PWID by investigating participants’ own perceptions of the problem and the contextual 
factors such as environment, social issues and practical issues such as injecting 
equipment which may have affected their ulceration.  
 
Phenomenology  
Phenomenology looks at the meaning of experiences and could be a useful approach if 
the experience of living with a leg ulcer was to be explored (Briggs and Flemming, 
2007). However, phenomenology would not help identify all the elements that 
contribute to leg ulceration occurring in young PWID or allow exploration of risk or 
harm reduction methods. 
 
Grounded theory  
Grounded theory looks at how individuals and groups make meaning together (Gerrish 
and Lacey, 2006, p190), and how particular concepts and activities fit together to form 
theory. The ‘theory’ is inductively derived from the phenomenon under investigation 
(Lathlean, 2006, p418). Drug injecting may be a cultural activity, but it also occurs in 
lonely habitats. Whilst interactions are important and may be very relevant to 
developing ulceration such as when individuals inject each other, there is some more 
basic physical data that need to be gathered that would not necessarily or so fully be 
obtained by using grounded theory.  Often emerging data are compared to the existing 
literature as an ongoing process. Where there is virtually no literature, as with leg 
ulceration in PWID, this approach would be difficult to apply and it would not be 
possible to undertake a meaningful grounded theory study to answer the research 
questions posed.    
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Ethnographic approach  
Ethnography seeks to study behaviour, interaction, customs and rituals, values and 
institutions within a culture or subculture (Gerrish and Lacey, 2006, p535). It is a useful 
method to help understand patterns in drug injecting habits, and factors that might 
relate to techniques or behaviour, but often ethnographic studies will involve data 
collection over a long period of time (Hammersley and Atkinson, 1995, p24).  The 
period of time required for this approach is impractical for this mixed methods study.  
However, it is important to consider the culture of drug use carefully as it cannot be 
separated from the individual, who will be providing the information required to 
develop the insight into the practices and behaviours that might lead to leg ulceration 
(Murtagh, 2007). For example there must be interaction between the drug injectors and 
the supplier of the drug, and often with others who may, possibly, teach techniques 
such as injecting.  
 
Taylor undertook an ethnographic study in which she was a participant observer 
amongst a group of over fifty women over a period of fifteen months (Taylor, 1993, 
p8).  Her study of a female injecting community was the first to examine the lives of 
women drug users in this way, and the ethnographic method ensured that the research 
was grounded. Taylor describes an initial naivety to her approach because of 
unfamiliarity with PWID, despite background reading and theoretical knowledge. 
Taylor’s philosophical approach utilised Weber’s theory of social action that in order to 
understand social actions, the meaning attached to those actions by individuals 
undertaking them must be understood (Weber, 1947, cited in Taylor, 1994, p7). Taylor 
used the symbolic interactionist perspective (Blumer, 1969, and Mead, 1939, cited in 
Taylor, 1993, p7), with the aim of being able to witness and participate in the ‘action’ 
that was being investigated, and she used a feminist approach as her study concentrated 
on women, but from a perspective that viewed them as rational active individuals and 
not as stereotypical ‘pathetic’ creatures often portrayed in the media.  
 
Observing drug users’ injecting habits, within their own environment and culture, 
would be very interesting and informative but would not necessarily provide empirical 
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answers to the question of what causes leg ulcers. The researcher would be developing 
assumptions about what might cause skin breakdown and create ulceration but these 
would be subjective and potentially biased.  
 
Familiarity and knowledge as well as speculative assumptions had been developed prior 
to starting this investigation, specifically through working with PWID, but now an 
empirical study was needed to prove causation by examining a large sample and using a 
consistent approach to ensure rigour. Exploring aspects of leg ulceration, within a 
physical environment familiar to drug injectors, such as their local IEP service, in 
which they feel safe, will combine a practical approach with the ideal. Gathering 
qualitative data using a quasi-ethnographic approach would appear to be appropriate for 
use in this study. It is ‘quasi’ because the study timescale, and the immersion within the 
drug user’s culture and environment will be very limited, but the cultural aspects of 
ethnography are essential (Murtagh, 2007).  
 
Case studies 
The extent to which a case study approach might inform the questions being addressed 
in this thesis was limited. Case study research allows a phenomenon to be explored 
within its context (Gerrish and Lacey, 2006, p302), and allows a holistic view to be 
developed by induction (Giuliano, 2003).  A case could be a current or former injector, 
who either had a leg ulcer or had previously had a leg ulcer. Case studies would allow a 
depth of exploration into individual circumstances, as participants could be interviewed 
in familiar environments, such as needle exchanges and drug treatment agencies, about 
their own circumstances – a ‘naturalistic enquiry’ (Lincoln and Guba, 1985). This 
means the research remains true to the nature of the phenomenon under investigation 
(Porter, 1993). Each participant ‘case’ could be explored using interviews and could be 
combined with document analyses, observation, and physical assessment (Zucker, 
2001; Yin, 2003). Potentially, clinical case note review and patient assessment may 
corroborate and enhance the data collected from case study interviews. 
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However, due to the complex nature of leg ulcer investigation and treatment, it was 
impractical to conduct clinical assessment or seek access to medical or nursing notes.  
 
There are already many published case reports or histories, but many of these are dated 
or are of  limited value due to missing details such as demographics, medical and social 
history, drug usage and specific wound information(e.g. Hussey and Katz, 1950; 
Ritland and Butterfield, 1973; Butcher, 2000; Acton, 2008). Adding to these, even in an 
empirical way, would be of little benefit. 
 
Focus groups 
Focus groups with participants were considered as a method to collect the data but 
rejected as it would be challenging to make arrangements to gather a group of 
potentially chaotic individuals together at a pre-determined time and place (Carter and 
Henderson, 2005, p221).  In addition, PWID participate in illegal activities, and 
expecting the sharing of personal information about drug injecting habits with other 
injectors would be unethical and breach confidentiality. Also, bringing a group of 
potentially volatile and unpredictable individuals together in a group with a sole 
researcher might be unsafe.  
 
In summary 
This study needed to build on what had gone before by specifically focussing on what 
was already known, developing that knowledge further and eliminating gaps. Never 
having been injector, and despite having insight from working with PWID, there is a 
limit to the depth of understanding without personal experience. It was thought highly 
likely that PWID would have ideas themselves about what has caused their skin to 
breakdown, such as ‘a bad hit’. The definition of a ‘bad hit’ to one drug injector might 
be missing a vein, whilst to another it may be using too much acidifier. By using an 
open method of questioning, such definitions and contributory factors were explored 
and clarified.  
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The information gained therefore, was drawn directly from participants who had 
experienced leg ulceration and without the ‘contamination’ of a view from other 
healthcare professionals (such as in case-notes). In-depth interviews conducted with 
participants had the capacity to describe, explain and explore issues from the 
perspective of participants (Gerrish and Lacey, 2006, p338).   
 
Individuals with existing ulcers were able to provide information regarding recent 
behaviours and injecting practices that illuminated the problem. Those that had 
experienced ulceration and healed had views about what caused their own ulcers. 
 
A risk with this method was the uncontrolled amount of data that could have been 
generated, and the potential level of subjectivity that interpretivist inductive methods 
might contain (Giuliano, 2003). However, the researcher was cognisant of reaching 
data saturation once no new relevant concepts emerged (Gerrish and Lacey, 2006, 
p200). 
 
3.6 Qualitative analysis 
Key features of qualitative analysis are definition of concepts, mapping the range and 
nature of phenomena, creating typologies and finding associations, providing 
explanations and developing strategies (Ritchie and Spencer, 1994, p176).  There are a 
number of different approaches to analysis and the correct selection of methods is 
paramount, especially as concerns have been raised about the reproducibility and 
validity of results generated from qualitative data analysis and generalisability (Ritchie 
and Spencer, 1994, p175; Schofield, 2000). 
 
Qualitative data have been criticised and disregarded because of the lack of visible 
access to both the research process and the analysis, possibly because of the difficulty 
in managing and presenting such a large volume of generated data. Often the material 
gathered is unwieldy and unstructured (Ritchie and Spencer, 1994, p175).  
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If the research findings were to be useful in policy making and in practice, and 
potentially applicable to a wider population, it was vital that the analytic method was 
transparent in order that it was clear how the findings were obtained.  
 
Analytic induction 
The analyst tries to formulate generalisations that hold true across all of the data 
(Lathlean, 2006, p418), and the researcher gathers data until no further data emerges 
that is inconsistent with a hypothetical explanation of phenomena (Lathlean, 2006, 
p421). As a hypothesis is difficult due to the dearth of literature, data collection may 
take a very long time to reach saturation. Although this method shares attributes of 
positivism and realism concurrent with the study approach, there are problems, not least 
because of the necessary, if tentative, hypothesis (Burns and Grove, 2005, p555).  
 
Analytic induction may help identify circumstances that allow a condition to occur, for 
example injecting is likely to be linked to leg ulceration as this is already known, but 
analytic induction will not explain why all injectors do not develop ulceration. Since 
this is the very question that needs to be answered, this form of analysis is not suitable 
(Lathlean, 2006, p421).   
 
Framework analysis 
This study drew on framework analysis of the data collected given its suitability to 
policy research contexts and to applied research where key investigative objectives are 
set out in advance. It was initially described by Ritchie and Spencer (1994) and has 
several key features which were central to the framework’s development: 
 
 Grounded or generative: it is heavily based in and driven by, the original 
accounts and observations of the people it is about. 
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 Dynamic: it is open to change, addition and amendment throughout the analytic 
process. 
 Systematic: it allows methodical treatment of all similar units of analysis. 
 Comprehensive: it allows a full, and not partial or selective, review of the 
material collected. 
 Enables easy retrieval: it allows access to, and retrieval of, the original textual 
material. 
 Allows between - and within-case analysis: it enables comparisons between, and 
associations within, cases to be made. 
 Accessible to others: the analytic process, and the interpretations derived from 
it, can be viewed and judged by people other than the primary analyst. 
(Taken From Ritchie and Spencer, 1994, p176) 
 
This provides a systematic and transparent process that is useful as it provides a clearly 
defined procedure and uses deductive methods. The method has been designed so that it 
can be viewed and assessed by people other than the primary researcher (Pope et al, 
2000; Lathlean, 2006, p420; Ward et al, 2013; Spencer et al, 2014). It follows a well-
defined procedure, but allows responsiveness, reconsideration and re-working of ideas 
as data is collected and analysed as an on-going process (Morse et al, 2002; Furber, 
2010). Reliability of the data can be apparent as the data can be consistently assigned to 
the same category, either by different researchers, or the process can be viewed by 
others where each should reach the same conclusion as the researcher, as the method is 
transparent (Silverman, 1993, p145).  
 
It may be ideal to allow participants to read and review transcripts of their own 
interviews, in order to check for accuracy and true meaning (Palfreyman et al, 2007). 
However, it may be challenging to arrange follow-up with PWID (Millburn and 
Brittenden, 2006) and similarly, a high proportion of PWID have difficulties with 
literacy (Yates, 2006) and may be unable to read a lengthy transcript. Therefore a 
method of analysis that can clearly demonstrate results that may be reproduced with the 
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same data by another researcher is ideal. For this reason, methods have been explored 
that may reduce the subjectivity of qualitative data interpretation, analysis and results.  
Framework analysis is becoming increasingly popular in health services research 
(Donovan and Sanders, 2005, p532) and has been used successfully in a previous study 
of PWID – investigating quality of life in those with leg ulceration (Palfreyman et al, 
2007). 
Another study used Ritchie and Spencer’s framework to identify themes when 
exploring user views of prison health services (Condon et al, 2007). The detail and 
implementation of the framework is not explained within their published paper 
however, they do not describe the analysis as a limitation and their aim, of exploring 
user views, is similar to that of this study in identifying drug user’s views on causative 
factors and harm reduction for leg ulceration.  
 
The framework can be used to analyse different types of questions such as contextual, 
diagnostic, evaluative and strategic. As this study sought to answer questions related to 
‘context’ – identifying what exists and ‘diagnostic’ – seeking the reasons or causes for 
what exists (Ritchie and Spencer, 1994, p174; Spencer et al, 2014, p336), it therefore 
was a suitable method for analysing the data generated from this study. The validity and 
reliability of the data will be apparent as the method of analysis allows itself to be 
transparent and open.  
 
Framework analysis is compatible with QSR NVivo, the software package used to chart 
and organise the data but interpretation is still required (Ward et al, 2013). 
 
Data collection was more structured than in some qualitative studies, and the method 
was useful within a tight timeframe where data needs to be linked with other findings. 
It involved five key stages: 
1. Familiarisation – the researcher becomes familiar with the range and diversity 
of material gathered  and begins the process of abstraction and 
conceptualization, making research notes. 
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2. Identifying a thematic framework –  research notes are reviewed, key issues, 
concepts and themes are identified, examined and referenced- this involves the 
setting up of a thematic framework within which the material could be sifted 
and sorted, drawing upon the original research aims, making sure the original 
research questions are addressed. It involves making judgments about meaning, 
about the relevance and importance of issues and about connections between 
ideas. 
3. Indexing – refers to where the thematic framework is systematically applied to 
the textual data which are the interview transcriptions. All the data are read and 
annotated against the framework and an indexing system applied. Judgments are 
made about the meaning of the data and although this process may be viewed as 
subjective, by indexing, the process is transparent and can be viewed and 
checked by others. Several themes can be identified within one sentence and 
from the coding it is possible to see patterns developing within the data, with 
repetition of codes. 
4. Charting – at this stage a picture of the data as a whole is developed and the data 
are lifted from their original context and grouped according to their appropriate 
thematic reference. Charts are devised with headings and subheadings derived 
from the research questions or the thematic framework and summaries of the 
data are entered into the charts. 
5. Mapping and interpretation - once all the data has been sifted and charted within 
core themes, the analyst pulls together the key characteristics of the data and 
maps and interprets the data as a whole, returning to the original key criteria for 
qualitative analysis identified earlier.  Patterns are identified, and clarity and 
importance of different issues are weighed up.  
(Taken from Ritchie and Spencer, 1994, p178). 
These stages formed the framework by which the qualitative data in this study were 
analysed.  
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3.7 Sequential explanatory mixed methods design 
None of the methods described on their own provided an ideal model for identification 
of prevalence and risk factors, but a combination was drawn upon to create a mixed 
methods approach to answer all the research questions.  
 
There is criticism of this approach (Fakis et al, 2014) in that quantitative and qualitative 
methods are polarized and cannot be combined and that the theoretical underpinnings 
are so different as to be in conflict. However, others argue that the synthesis of two 
approaches is not only possible but desirable and that the need for exploring questions 
from all angles is suited to mixed methods (Creswell, 2003).  
 
In this study the research questions required to be explored using the two approaches 
and the synthesis of the analysis will allow the research aims and objectives to be met, 
which would not occur with either method alone. An essential component of rigour in 
research designs is to ensure the choice of correct methodologies and philosophical 
underpinnings (Wilson and McCormack, 2006). ‘Mixed methods’ in this study was a 
sequential explanatory design comprising a quantitative study which informs a 
subsequent qualitative study.   
 
3.8 Research design  
A questionnaire survey eliciting quantifiable data as the first phase of the mixed 
methods study allowed a broad sweep of information to be gathered from PWID. The 
results were analysed enabling a possible theory or theories to be developed about 
causative factors and influences. The data were then used to generate hypotheses that 
were explored in depth within Phase 2 using in-depth interviews with a smaller sample 
of PWID with experience of leg ulceration as a sequential explanatory mixed methods 
study. The data gathered from the quantitative approach were combined and matched to 
the findings of the qualitative approach to enrich the study outcomes and generate 
conclusions to the research and thus this was a sequential explanatory design.  
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Phase 1 is the quantitative date collection and this will be described in the next section. 
 
3.9 Phase 1 method 
A retrospective descriptive survey of young PWID was conducted using structured 
interviews with a specially designed and piloted questionnaire to try to discover the 
extent of the problem, acquire information about individual experiences, and identify 
patterns in injecting habits. This method was selected to allow a wide spread of data to 
be collected in a short time frame to identify the extent and range of skin problems, and 
leg ulceration, and likely risk and causal factors. The research was conducted within 
environments familiar to participants such as drug treatment agencies and needle 
exchanges, allowing a naturalistic inquiry (Lincoln and Guba, 1985).  
 
3.10 Questionnaire development 
The questionnaire (Appendix 2) was developed specifically for the purposes of this 
study although it had been influenced by other studies that have utilised questionnaires 
with PWID (Smith et al, 1989; Makower et al, 1992; Passaro et al, 1998; Pieper et al, 
1998; Pieper and Templin, 2001; Darke et al, 2001; Boys et al, 2002; Taylor et al, 
2005; Abelson et al, 2006; Andresz et al, 2006).  
 
The questionnaire needed to be administered quickly, so required to be relatively short 
as many PWID tend to be in a hurry – especially if they have attended a needle 
exchange to pick up their injecting equipment and have already acquired their drugs. 
 
The questionnaire was split into sections: 
 Demographics 
 Questions about current injecting 
 Questions about past injecting (for former injectors and long-term injectors)  
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 Questions about skin and or leg wounds 
 General questions about participant’s physical health   
 
Brief demographics were collected consisting of initials, gender, date of birth and area 
of residence (postcode) – this was to provide a picture of the sample and to enable 
elimination of duplicate interviews (Taylor et al, 2005). There were also questions 
about length of time that injecting had occurred, and how old the participants were 
when they started injecting. 
 
There were two similar sections about injecting – one for current activities and one for 
past habits. For those who had been injecting for over 25 years, if their habits had 
changed then both sections were completed – for current practice, and what they used 
to do, for descriptive analysis only. 
 
Questions were asked about drug preparation techniques, and injecting activities 
(including skin cleansing), sharing of drugs and equipment, use of injecting 
paraphernalia, routes, and amounts of drug injected.  Most of these were standard 
piloted questions drawn from either the NESI survey, which utilised an interview 
administered questionnaire which had been used successfully to measure injecting risk 
behaviours within similar settings, (Health Protection Scotland and the University of 
the West of Scotland, 2008) or from Taylor’s study investigating an infective outbreak 
in Glasgow in 2000 (Taylor et al, 2005). 
 
Additional questions related to injecting habits were also developed specific to this 
study and drawn from findings within the literature review. Questions such as cleansing 
of the skin and washing hands, licking of needles and use of saliva in preparing drugs 
as these had been reported as a risk factors in other studies (Binswanger et al, 2000; 
Murphy et al, 2001; Mottahedeh and Da Silva, 2003; Mercure et al, 2008; Phillips et al, 
2013). 
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Questions were asked about ease of finding a vein, injecting in which body sites, hand 
dominance as that may affect technique, and whether participants had skin and muscle 
popped as these activities are implicated in skin breakdown (Murphy et al, 2001). 
 
Known risk for leg ulceration 
Specific questions which are common components of leg ulcer assessment were asked. 
These related to known venous and arterial signs such as varicose veins or claudication 
together with known risk factors for vascular disease: tobacco smoking; alcohol intake; 
BMI (Body Mass Index); nutritional intake; medication; cardiac history; diabetes; joint 
and mobility problems; DVT; cellulitis; leg fractures and occupations that involved 
standing for long periods; parity (for females), as well as clinical signs of venous 
disease: varicose veins and skin changes such as lipodermatosclerosis or skin staining 
(Eklof et al, 2004; SIGN, 2010). 
 
Questions about infection, with the exception of abscess, were not asked as the 
complexity of definition and the requirement for recall of very specific signs was 
problematic and discussed earlier within Chapter 2.   
 
Prevalence 
The gathering of prevalence data consisted of counting the number of participants who 
had experienced a leg ulcer, and then counting of specified skin problems experienced 
at any time following the commencement of injecting activity. 
 
Definition of skin problems 
Previously, the definition of particular skin problems had been poorly addressed in the 
literature and injecting injuries were often referred to as ‘soft-tissue infection’, 
‘abscesses’ or ‘ulcers’, yet these tended not to be defined and were very subjective 
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terms (Schnall et al, 1994; Reese and Sullivan, 1997; Graham et al, 2003; Takahashi et 
al, 2003).  
 
One Scottish study (Scott, 2008) investigating the impact of supply of  injecting 
paraphernalia in two Scottish cities used skin problems and injecting injuries as an 
outcome measure. These injecting injuries, apparent in the skin, were defined, which 
was helpful, but the source documents for the definitions were largely unclear though a 
pharmaceutical manual was referred to. The definition of ulcers included ‘skin redness’. 
This is not a standard ‘wound’ or ‘tissue viability’ definition.  
 
Terminology was important and clear definitions for skin problems and even for a 
venous leg ulcer has been difficult to find in previous studies (Hall et al, 2014). As no 
published definitions of injecting wounds could be found that were comparable, terms 
of known skin complications arising from injecting were developed and refined to 
ensure rigour based on existing literature and on clinical expertise (Darke et al, 2001; 
Finnie and Nicolson, 2002a; Scott, 2008). These are displayed in Table 2. 
 
Utilising the same researcher and the same set of definitions ensured maximum 
accuracy in the documentation of skin problems, within the limitations of self-report 
and recall. Participants were asked for clarification of the meaning of words they used 
to describe injecting injuries such as ‘abscess’ or ‘acid burn’, in order that the same 
definitions were applied to the same type of description.  
 
The position of lower extremity wounds was ascertained carefully to avoid confusion 
between the reporting of foot wounds and the reporting of leg ulcers. Previous work has 
recognised the importance of clarity of position of wounds especially when the term 
‘ulceration’ is used which can be misunderstood (Firth et al, 2010).  
 
Chronic refers to any wound that has been present for 4 weeks or more (SIGN, 2010).  
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Skin problem Definition 
Leg ulcer A break in the skin between the knee and the ankle that remains 
unhealed  for four weeks or more 
Lumps Hard swellings without broken skin, not red or hot or particularly painful 
Track marks Scratch marks, raised red veins, raised hardened veins 
Abscesses Raised red hot painful lumps, with or without obvious pus / broken skin – 
possibly required lancing/ surgery or have spontaneously burst 
Acid Burns Painful, blistered or broken skin directly attributed to use of acid 
Broken skin  Injecting injury that has caused a break in the skin, wounds, or scabs that 
have healed in less than 4 weeks 
Chronic wounds Any break in the skin (not a leg ulcer) that has been present 4 weeks or 
more 
Rashes Multiple red or pink spots, raised or flat, that last longer than the short 
period following injection 
Other Any skin changes as a result of injecting that are not listed above 
Table 2 Definition of skin problems 
 
General health 
Questions were asked about physical health to identify any significant co-morbidity, to 
identify risk factors that are known to impact on the development of leg ulceration or 
affect skin breakdown and subsequent healing. This included questions on smoking 
with known cardiovascular risk, alcohol, blood-borne viruses, medication and nutrition. 
Participants were also asked if they had access to empathetic healthcare.  
 
Good nutrition is an essential component of wound healing and it is known that PWID 
are often malnourished and vitamin deficient (Johnston, 2007; Neale et al, 2011). Many 
go hungry because they cannot afford food and instead channel their income towards 
drugs (Anema et al, 2010). Advice was sought from a nutritionist in order to include  
simple questions on nutrition and body mass index (BMI).  
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This was also an opportunity to acquire useful insight from participants so space for 
free text comment was provided on what participants thought might cause wounds in 
some injectors but not in others. Participants were also given an opportunity to raise 
any questions with the researcher on completion.    
 
Recall 
A literature review undertaken by Darke (1998) examined self-report data in relation to 
drug use and comparators of criminal records, biomarkers, and collateral interviews. It 
concluded that self-report data was sufficiently reliable and valid to provide accurate 
descriptions of drug use, drug-related problems and history even after ten years has 
elapsed.  
 
McElrath et al (1994) acknowledged potential difficulties with data collection amongst 
PWID who were required to recall events such as risk-taking behaviour. They 
undertook a longitudinal study with 366 PWID, using structured interviews to gather 
data, following up participants and asking them to recall behaviours reported previously 
at 6, 12, 18 or 24 months. Their findings supported the reliability of the use of 
retrospective self-reports.   
 
Morrison et al (1997) approached PWID attending needle exchanges and asked them to 
participate in a study about injecting-related harm. The method comprised a semi-
structured questionnaire and a medical examination, thus allowing a comparison 
between self-reported injuries and a clinician’s assessment. PWID accounts of their 
injecting-related problems were found to be consistent with the clinician’s findings. 
Another small but multi-centre study undertaken with 196 PWID across five cities in 
the US found self-reporting on injecting practices, drug use and sexual behaviours to be 
consistent and discrepancies only arose in relation to poorly worded questions (Needle 
et al, 1995). 
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A later large study (Napper et al, 2010) evaluated the validity of self-reporting heroin 
and cocaine users (n = 4027) about recent amphetamine use and compared this to urine 
samples. Self-reports demonstrated moderate to high validity and good reliability in 
test-retest data. 
 
In addition, a number of previous studies have demonstrated that recall is more reliable, 
given the use of psychoactive drugs, than might have been expected (Mossey and 
Shapiro, 1982; Idler and Benyamini, 1997; Morrison et al, 1997; Pieper and Templin, 
2001; Bell and Salmon, 2012).   
By using interviews, acquiring accurate retrospective data is entirely dependent on the 
ability of participants to recall correctly, but these studies appear to show that this was a 
reasonably reliable method of gathering data. The questionnaire naturally focused on 
asking what was ‘normal’ or ‘usual’ for the participant in terms of injecting behaviours 
however, it may not have been the ‘usual’ practices that caused the skin problems. It 
may well be that on occasions the participant was ‘rattled’ (drug withdrawal 
characterised by sweating, shaking and malaise), desperate, injected by others, or 
unable to remember what caused the problems, and it may be possible that these 
incidents could not be captured at all. The limitation is that the data could not be 
verified against medical records or other objective means (Roose et al, 2009).  
 
Reliability and validity  
The questionnaire allowed data to be collected in a standardised manner and was 
administered by the same researcher each time and most answers were fixed responses 
which aided validity. Many of the components within the questionnaire had been 
utilised by other researchers in other studies and the development of key definitions for 
skin problems ensured that the same meaning was recorded for each participant by the 
same researcher providing content validity (Bowling, 2005; Bannigan and Watson, 
2009).  
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The main issue relating to reliability was recall and whether the same participant would 
answer the same question in the same way if asked repeatedly (Rattray and Jones, 
2007). The reliability of recall in drug users was discussed earlier in this chapter and 
appeared to be good.  
 
3.11 Sample Phase 1 
Geographical base 
It has been estimated that in Scotland alone there are almost 60,000 problem drug users 
(ISD, 2011) but it is unclear exactly how many of these are injecting due to the 
difficulties in capturing the information (Hay and Smit, 2003; Hay and Gannon, 2006; 
ISD, 2012). It is known that Glasgow, West of Scotland’s major city,  has the highest 
rate of problematic drug use in Scotland, with prevalence rates remaining consistent in 
the last five years, and thought to be around 13,900 individuals (ISD, 2011) and 
including the largest number of injectors in Scotland (ISD, 2012).  
 
Glasgow was selected as the study area. Problem drug use and its associated challenges 
are common and there are a number of statutory and non-statutory drugs agencies based 
in the city. Drug use is concentrated within areas of deprivation although there are IEP 
and methadone services across the city. As drug use has its own sub-cultures and PWID 
often educate peers within their own geographical areas, actual injecting practices can 
vary from suburb to suburb (Macleod et al, 1998). A wide geographic sample even 
within one city, therefore, was important to ensure variations due to locality were 
captured. Participants were recruited from eight different venues (IEP services and 
methadone clinics) in the north, south, east, and west of Glasgow.  
 
Defining ‘young’ PWID 
Leg ulceration is typically a disease of elderly people, but it was important to define the 
term ‘young’ to differentiate between elderly individuals who develop ulceration as a 
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progression of disease partly attributable to old age, and the presence of leg ulceration 
in younger people which is unusual. It is the appearance of ulceration in young people 
who are or have been drug injectors which is being investigated.  
 
By including older people within the study population, there was increasing likelihood 
of age-related disease becoming a factor in the development of leg ulceration and 
therefore the epidemiological picture would become blurred.  The upper age was 
selected as an age classed often as entering middle age (44 years) and beyond, where 
general health may start to demonstrate features of aging. This may further complicate 
the history of individuals by introducing systemic disease which could be associated 
with the development of ulceration such as vascular problems, diabetes and rheumatoid 
disease.  
 
The majority of drug injectors fall into the 15 – 44 years age range (ISD, 2012), and the 
research has deliberately excluded under-age participants to avoid the challenges of 
including children, so only those aged 16 years and over have been included. 
Additionally excluding drug injectors over the age of 44 years aimed to reduce the 
influence of age-related disease impacting on ulcer development.  
 
Sampling strategy Phase 1 
An ideal sample is a miniature version of the population, but it was not known 
accurately how many injectors there were in Glasgow, how many were male and 
female, and what the age groups were. It was impossible within the constraints of 
practical research to survey the whole of the drug injecting population within Scotland 
(the target population) to identify the true scale of skin problems (Gerrish and Lacey, 
2006, p173) and it was more practical to identify a smaller sample. However, sampling 
strategies for drug using populations are fraught with difficulties as many drug injectors 
have unstable accommodation, are frequently incarcerated, and engaged in chaotic life 
styles which meant arranging appointments for interview or follow-up was difficult or 
impossible (Robinson et al, 2006; Powell, 2011b). 
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Geographical sampling, taking a sample of people resident from a particular part of the 
city, is not ideal because drug injectors are often difficult to locate. There is also a 
proportion of ‘hidden’ PWID as they do not present at drug treatment agencies and can 
hold down jobs and live a relatively ‘normal’ life away from authorities (Sieber, 1992, 
p133; Shewan and Dalgarno, 2005). Some information regarding demographics can be 
gleaned from the SDMD (ISD, 2012) but this information is obtained from the 
completion of SMR25a forms (Scottish Morbidity Record) which are completed within 
substance-misuse organisations. The SDMD does not therefore pick up the ‘hidden’ 
unengaged and so the population of PWID as a whole is unknown. 
 
A potential recruitment method was via the internet which might enable contact with 
hidden populations. However, a review by Miller and Sonderlund (2010) indicated that 
although internet recruitment might be useful, it was unlikely to lead to samples from 
which generalisable conclusions could be made, and in any case it is unknown how 
many drug injectors would have access to and use the internet. Therefore this was not 
going to be used in this study.  
 
After considerable discussion with other researchers and workers in the field, it was 
concluded unlikely that there was any practical method of sampling the ‘hidden’ 
population of drug injectors because these individuals may, or may not, access IEP 
services, and in many cases may not wish to be identified (Robinson et al, 2006).  
 
Similarly the very chaotic drug injectors who do not access drugs services in any form 
were also going to be difficult to track down. PWID who attend IEP services may not 
necessarily attend the same one on a regular or frequent basis and may visit various 
centres for paraphernalia, depending on what is most convenient for them at a particular 
time.   
 
Therefore the drug injecting population is a rather unknown quantity, as ages, gender, 
and addresses are largely unclear. These problems made developing a sampling frame 
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difficult, and equally, whilst the study aimed to be representative, it could not truly be, 
as the population was not known. With assistance from service providers and taking the 
‘best’ from previous studies, a plan for sampling was developed.  
 
Probability sampling relies on having a sampling frame and a known population, so 
non-probability sampling needed to be used, which is typical for an exploratory study 
(Gerrish and Lacey, 2006, p175). 
 
A previous example of this was a study undertaken successfully by Morrison et al 
(1997) who approached all PWID (n = 147) attending IEP services within Glasgow 
during late 1995 and asked them to participate. The researchers used quota sampling 
because of wide variations in numbers attending each exchange; 112 agreed to 
participate, and of the 35 that refused, 86% of them said they were short of time, an 
issue that will likely have led to under-representation of those with more chaotic 
lifestyles. Limitations of this method of sampling are that the sample may not be 
representative and may be skewed but larger numbers can be achieved.   
 
For this study a convenience sample was selected as the best compromise. 
Opportunistic quota sampling was used which is a non-probability method, and used 
where a large number of people fitting a particular category need to be recruited, such 
as young PWID, but where selection of the sample is not otherwise specified for 
example, the population is constantly shifting, is geographically transient, and precise 
demographics are unknown (Robinson et al, 2006; Gerrish and Lacey, 2006, p182; 
Howie, 2008). Quota sampling also provided the best opportunity for a cross-sectional 
(by geography) sample by approaching all PWID, who met the inclusion criteria, 
accessing the busiest IEP services and methadone services across the city until the 
desired number was reached.  
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Reimbursement / Inducement  
It is possible that participants may be inconvenienced by taking part, giving up free 
time to answer questions that may have no direct benefit for them (Aveyard and 
Hawley, 2007, p353). Some participants may agree to take part voluntarily, particularly 
where there is an existing relationship (Mustasa, 2001). However, it is widely 
recognised that PWID do not participate in research unless they are offered some form 
of payment (Sieber, 1992) and many previous studies with PWID  have offered ‘an 
inducement’ or ‘honorarium’  for participation in research, sometimes in the form of 
reimbursed travelling expenses (Dietze et al, 2005, Mackridge et al, 2010), or food 
(Taylor et al, 2005), cash (Binswanger et al, 2000; Davis and Rhodes, 2004) or 
vouchers (Passaaro et al, 1998; Craine et al, 2004). The local police also offered £10 for 
participation in ID parades.  
 
Other authors have described offering health promotion literature (Craine et al, 2004), 
free BBV testing, and counselling (Kwiatkowski et al, 2002) instead of payment. 
Payment may be seen as coercion or offering money for drugs and this could be 
considered ethically unacceptable (Ensign, 2003; Ensign and Ammerman, 2008). 
However, PWID often forego food and can be malnourished and hungry and for these 
reasons, and in common with other studies with this client group (Pieper and DiNardo, 
1998; Darke et al, 2001; Shewan and Dalgarno, 2005; Craine et al, 2004; Taylor et al, 
2005; Ensign and Ammerman, 2008) it was intended to offer a small food voucher by 
means of thanks. 
 
Advice was sought from local researchers as other studies within Glasgow offered a 
reward for participation and it was important to be comparable but not to provide cash 
to fund illicit habits. ‘Payment’ amounts have varied, and seem to relate to the amount 
of time or inconvenience experienced.  
 
Phase 1 took about 10 to 25 minutes to take part and a £2 shopping voucher was given 
as an acknowledgment of time.  
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For Phase 2, which took 40 – 50 minutes, a drink and a biscuit were offered, together 
with a £20 shopping voucher.  
 
In addition, information was provided to each participant giving details of services they 
could access for healthcare and substance misuse subsequent to each interview 
(Appendix 3). 
 
McKeganey et al (1989) explored HIV related risk behaviour in Glasgow and asked 
questions relating to demographics, length of injecting, and sharing of equipment. They 
acknowledged the brevity of their questionnaire and noted the need not to interfere with 
the service from which the recruitment was found. They also felt that it was important 
to retain a friendly and informative approach to questioning which meant that all the 
questions could be asked each time without compromising the informality. Given that 
so many studies have taken place amongst PWID in Glasgow (McKeganey et al, 2008) 
it was vital, and of course expected, that this study would treat the participants well, 
and leave them with a good experience such that they might be willing to participate in 
future studies. 
 
3.12 The Pilot Study 
The pilot study tested the planned research tools and proposed method and analysis for 
the main study, and was conducted with ten participants in a busy needle exchange 
within NHS Lothian. Feedback was sought from participants on the method.  The 
interviews took an average of 15 minutes to do (ranging from 10 – 25 minutes). 
Recruitment was achieved within four afternoon sessions. Participants were happy with 
the method and research tools. 
 
It was decided not to amend the timings within the information sheet which stated that 
it may take 25 minutes to answer the questions, although most interviews took less. 
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However, some amendments were made to the questionnaire. These were principally 
changes to coding to make data entry easier. Some questions were re-ordered; there 
were some minor additions to fixed responses, and typographical errors were corrected.  
An additional question was suggested following a review by the staff within needle 
exchange which was ‘Do you ever lick the needle prior to injecting?’ These were minor 
amendments that did not require re-referral for Ethical Review.   
 
3.13 Data Collection 
Venues for data collection 
Within Glasgow, the Pharmacy team at Addiction Services (GAS) helped identify 
suitable venues for recruiting a wide geographical spread of participants across the city, 
utilising areas where there were known to be larger populations of drug injectors, and 
therefore busier services. Glasgow has a Drug Crisis Centre (GDCC) which offers 
short-term detoxification, rehabilitation, stabilisation and an IEP service. Also many of 
Glasgow’s retail pharmacists offered methadone administration and IEP (Roberts and 
Hunter, 2004). Such venues were places which PWID visited regularly and were 
familiar with, and were generally non-authoritarian. These locations had a private space 
in which interviews could be undertaken but where health professionals, support 
workers, or other staff were close at hand. This ensured privacy for the interviewee and 
also if a problem arose, help could be summoned easily. 
 
The pharmacist from GAS made an initial approach to potential recruitment areas, and 
distributed information packs with details of the study, including ethical and 
governance clearance, contact numbers, and copies of other paperwork such as the 
questionnaire. Subsequently information leaflets (Appendix 4) and posters (Appendix 
5) were distributed for display. Posters in each place of recruitment allowed potential 
participants the opportunity to consider taking part and information leaflets explained 
the purpose of the study, the possible advantages and disadvantages of taking part, 
together with the participant’s rights such as to withdraw at any time without giving a 
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reason or affecting treatment or services. This was similar in technique to that used 
successfully by Darke et al (2001) and Davidson et al (2002). 
 
The researcher telephoned each service to arrange a start date, and to answer any 
queries from the service leads. Staff in each venue had the opportunity to read 
information, or discuss the study with the researcher, in advance of recruitment and 
were supplied with cards containing contact details for the researcher in case any 
potential participants wished to find out more. Due to the nature of drug using activities 
and potentially chaotic lives, where drug injectors can find it difficult to stick to 
routines and keep appointments, as much information as possible was provided within 
the study venues, in advance of a potential participant being approached to take part. 
The researcher checked that the posters and leaflets were displayed two weeks prior to 
the commencement of recruitment in each area. A dedicated mobile phone and phone 
number were used for the study. 
After completion, a letter was written to each service lead thanking them for their 
assistance and offering a copy of the results when these were available. 
 
Recruitment 
Participants were recruited to the study by being approached and asked if they would be 
interested in taking part in some research. Depending on the venue, either the 
researcher did this, or a member of staff. Current and former drug injectors were 
identified as those attending for IEP (likely to be current injectors) or methadone clinics 
(likely to be either current or former injectors). Drug injectors are notorious for failing 
to attend appointments, and therefore once potential participants were approached, if 
they were agreeable, then the questionnaire was administered very shortly afterwards 
(O’Brien and Schroedl, 1991; Roy et al, 2003; Millburn and Brittenden, 2006).   
With the exception of intoxicated participants, all potential participants were 
approached as an attempt to reduce selection bias within the sample (Gerrish and 
Lacey, 2006, p180). It was impossible to keep a tally of the number of exclusions or 
refusals to take part as in some areas the service staff preferred to approach the 
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participants themselves. There were individuals willing to participate but were excluded 
as they were too old or they had never injected. 
 
Inclusion / exclusion criteria 
Inclusion criteria were any individuals with a current or previous history of injecting, 
aged 16 to 44 years, who could understand and speak English. The nature of the sample 
meant that some individuals were visibly under the influence of alcohol and / or drugs 
in such a way that would affect their competence to participate and a judgement 
regarding competence was made by staff and / or the researcher at each study site prior 
to potential participants being approached. If it became apparent during the interview 
that the participant was intoxicated, the interview was terminated and any data gathered 
before that point was destroyed.  
 
Interviews 
Empathy and a non-judgemental stance were imperative when obtaining a history from 
a participant. It was important to put the participant at their ease, to be welcoming and 
encourage them to talk and disclose information in response to the questions. It was 
also useful to have a working knowledge of Glasgow slang and street drug terminology 
(Pieper, 1996a) and to use language that was familiar, accessible and clear.   
 
The researcher began by informing potential participants of the nature of the study by 
providing an information sheet (Appendix 6) and offering to read this out.  She then 
checked eligibility to participate to ensure inclusion criteria was met. Strenuous 
attempts were made to ensure that participants had every opportunity to ask questions 
about the research prior to, during, and after, the interview. Participants were assured 
that their participation, or non-participation would not in any way affect their medical 
care, services or benefits and it was explained that they were under absolutely no 
obligation to take part and could withdraw at any time, including after the data has been 
collected without any repercussions whatsoever.  
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Interviews required participants to discuss their drug use which included illegal activity 
and it was explained that any information provided for the study would be confidential 
and anonymised, and would not be passed onto a third party except where activities 
might be divulged that suggested serious harm to self or others (other than injecting), 
such as child protection issues. In Taylor and Kearney’s study (2005) respondents were 
thought to be more likely to provide truthful answers if the resulting responses were not 
thought to be used to incriminate them, so this was made clear. Self-reporting may be 
inaccurate if the person perceives their answers as being interpreted as socially 
undesirable or perceives negative consequence as arising from the giving of the 
answers (Pieper and Templin, 2001). This possibility of divulgence was explained to 
participants and should risk to self or others become apparent then contact with an 
appropriate professional would be made in order to acquire the correct support for 
them. Participants were made aware of this both verbally and in writing.  
 
Consent to participate was sought in all cases and a consent form and copy to keep was 
discussed and signed by both participant and researcher (Appendix 7). It was possible 
that the research questions might have raised issues that participants found distressing 
for whatever reason. Support was identified for each participant (usually the 
participant’s own drugs worker or another member of local staff) in order that any 
issues raised could be discussed, independently of the research. Written contact details 
of support, including various health and drug treatment agencies, was given to all the 
participants on an individual basis.  
 
The questionnaire was administered within a short face-to-face interview, and all 
questions were read out as dyslexia and difficulties with literacy are prevalent amongst 
PWID (Yates, 2006).  Every interview was conducted by the same researcher. Whilst 
the question responses were fixed within the questionnaire, these were not given to the 
participant but instead their answer to the questions was matched to the best fit 
response. If it was unclear what the participant meant they were asked to choose the 
best answer of those responses provided. 
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3.14 Data Entry 
Data were entered into SPSS version 15.0 (SPSS Inc) on a personal computer. Files 
were dated and saved consecutively and securely, and backed-up on a flash drive and 
another computer in a different location.  
 
A code number was allocated to each participant. Identifiers of initials and dates of 
birth, which were entered on the questionnaires, were used purely to ensure there were 
no duplicate participants as data was gathered across a number of sites over 35 days.  
These identifiers were deleted from the database once recruitment was complete. 
 
The majority of potential participants who were approached agreed to take part, and 
recruitment went very smoothly. Some of this may be attributed to good planning and a 
familiarity on behalf of the researcher with the participant population but good working 
relationships and a lot of goodwill from service providers also helped. This research 
was embedded in over seven years of clinical practice with drug injectors and may have 
avoided some of the initial challenges faced by other researchers, such as negotiating 
access (Taylor, 1993; Yates, 2006). It is possible that word of mouth might have 
encouraged potential participants to take part. The approach to recruitment was similar 
to other local studies which had successfully overcome many of the traditional 
problems of recruitment of injectors (University of the West of Scotland, Health 
Protection Scotland, University of Strathclyde and the West of Scotland Specialist 
Virology Centre, 2012).   
 
3.15 Recruitment Phase 1 
Data collection occurred over 35 days, from 12.08.08 until 05.12.08 (Table 3). Sample 
numbers were recruited fairly quickly and smoothly. 204 participants were interviewed. 
Interviews were conducted across the city within eight venues which provided IEP and 
methadone services (Table 3).  
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Venue Type of 
venue 
Area Number of 
recruitment 
sessions 
Number 
people 
recruited 
Number 
excluded 
Total  
 
1 Methadone 
service 
South-
east 
2 8 0 8 
2 Pharmacy Centre 6 56 1 incomplete 
1 duplicate 
54 
3 Drugs 
service 
South-
east 
10 43 1 duplicate 42 
4 Pharmacy West 2 10 0 10 
5 Pharmacy North 3 16 0 16 
6 Pharmacy South 5 22 0 22 
7 Pharmacy  
no exchange 
Centre 2 12 1 duplicate 11 
8 Pharmacy East 5 37 0 37 
Total   35 204 4 200 
Table 3 Recruitment venues and participant numbers 
 
On three occasions, participants who the researcher thought had been interviewed 
before were adamant they had not previously been interviewed. The researcher felt 
obliged to conduct a second interview. When initials and dates of birth were checked, 
the three interviewees were found to be duplicates.  The participants knew of the 
incentive / honorarium and may have wished to collect another £2 voucher.   The data 
from these second three interviews were removed from the database. Following this, 
the researcher carried a print-out of client identifiers (initials and dates of birth) to 
ensure further duplication did not occur. A fourth interview (27) was abandoned mid-
way as the participant disclosed information that suggested they were a danger to 
themselves. The participant requested that the interview cease, and discussion centred 
on suitable sources of support for the participant. The service lead was notified of the 
situation and contacts were made to individuals who knew the participant and who 
could offer support. Incomplete data from the fourth interview were also removed and 
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not included in the analysis. This left 200 participant interviews; all questions were 
answered and there were no missing data.  
However, some questions were not applicable to all participants such as questions about 
current injecting habits, to those who were no longer injecting, and the questionnaire 
was designed in such a way that questions could be divided into sections for each 
group. For the purposes of SPSS analysis some of these ‘not applicable’ questions were 
coded as ‘missing’ using the SPSS definition as this allowed the ‘not applicable’ 
answers to be excluded from analysis. At times further explanation was required such 
as defining or elaborating on terms used, e.g. question F125 asked participants if they 
got pain in their calf on walking (claudication). The question was designed to identify 
whether the participant suffered from ischaemic pain in their leg as opposed to 
muscular pain and if the participant answered ‘yes, they got pain in their leg on 
walking’, then further exploration was used by the researcher to ensure this was the sort 
of pain relieved by resting to allow the calf muscle to revascularise and for walking to 
resume. 
 
3.16 Consistency Checks 
Ideally data would have been entered twice and compared to ensure accuracy, or every 
entry checked against the hard copy (Tabachnick and Fidell, 1996, p58). However, with 
the sample size and large number of variables, it was more practical to produce a 
random sample of 10% of data entered into SPSS for checking. 
 
Twenty questionnaires were drawn and each data entry was matched against the hard 
copy. Checks for consistency were made by an independent source familiar with 
statistical packages.  For each identifier there were 153 variables. Of the total of 3060 
variables entered, there were 6 errors. These errors were incorrect or a transposed code 
entry. This was an error rate of 0.19%. This level of error was negligible and could be 
regarded as ‘noise’. However further checking was undertaken to ensure there were no 
erroneous outliers amongst the entered data and data were plotted and counted to check 
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for this. The detected errors were checked against the hard copies and amended where 
necessary.  
Identifiers of initials and dates of birth were removed.  
 
Recoding 
Where a high number of variables existed, such as the 72 different codes for venous 
injecting sites (Questions C25, C26, C27, C28 and D59, D60, and D61), the codes were 
revised to provide more meaningful groupings for analysis. Single injecting sites such 
as the response to ‘where do you usually inject?’ were categorized into arms and hands, 
groins, legs, feet, thighs, and neck, irrespective of whether participants injected into the 
right or left side. Questions C26 and D59 ‘Which sites have you used ever?’ produced a 
range of 72 possible variations. These too were aggregated into eleven variables as it 
was important to analyse the development of skin breakdown in relation to specific 
injecting sites. 
 
Question C44 and D77 asked whether the participants had skin or muscle popped. If 
they had, then the subsequent question (C45, C78) was ‘in which site?’. The sites were 
grouped into popping in buttocks and / or upper body, popping in thighs and above, 
popping in lower legs and above, popping in feet and above, and popping in lower legs 
only. 
 
Question F121 asked what medications participants took, prescribed or otherwise. 
Again, there were many given answers. These were examined for frequencies and 
grouped, providing ten categories. The predominant medication was methadone, either 
alone or with combinations of hypnotics, antidepressants, and antipsychotic drugs. A 
few participants took inhalers for asthma and some took analgesics. 
 
Question C15 and D50 asked about what was injected in addition to what they inject 
most often. For the purposes of coding multiple drug use, ‘cocaine’ and ‘crack’ were 
both grouped together as cocaine. Those injecting more than one other drug were very 
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few and were also grouped into either ‘cocaine and one or more drugs’ or ‘two or more 
drugs’.  
 
Types of filter (Questions C38 and D71) yielded straightforward responses, but five 
participants used  two or more types of filter and a code 9 was added as a group for 
these ones. 
 
3.17 Phase 1 Analysis 
Power 
A sample of 200 was sufficiently powerful to be able to detect a small to medium effect 
size at p = .05 and power = .80 for the types of statistical analysis done (Cohen, 1992). 
Previous studies of drug injectors in Glasgow suggested that this level of recruitment 
was possible, and the number was practical to attain the data within the timescale of the 
study similar to other studies (Morrison et al, 1997; McKeganey et al, 2008). 
 
Statistical analysis 
Data were analysed using descriptive and inferential statistics. The confidence interval 
used is 95% for all tests, a level of confidence generally accepted as minimizing the 
risk of a Type 2 error whilst not unduly increasing the likelihood of a Type 1 error.  
 
The sample was analysed as a whole or, where appropriate,  in two groups current 
injectors (n = 128)  defined as those that were currently injecting or had injected in the 
last 6 months (24 weeks), and former injectors  (n = 72),  those that had stopped 
injecting or had not injected for over 6 months (over 24 weeks). Groupings for analyses 
will be explained within each section of the results (Chapter 4). 
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There were eight long-term injectors (who were also current injectors) who had been 
injecting for 25 years or more and their practice had sometimes changed over time and 
where relevant this is also described. 
 
Where appropriate, results have been presented in percentages, and these have been 
rounded to the nearest 0.5%. Statistical tests of association Pearson R Chi-Square, and 
Fisher’s exact test, where small numbers are in categories within 2 x 2 tables, were used 
to detect significance between two categorical variables (Greasley, 2008, p75; Watson 
et al, 2006, p161).  
 
Logistic regression tests were used to predict if leg ulceration was caused by specific 
factors by controlling for other variables that happened at the same time such as age, 
length of injecting career, or progression to groin injecting (Pallant, 2007; Field, 2009).  
It is possible that some of the statistically significant results could be falsely apparent, 
due to the presence of confounding variables, or co-factors such as length of injecting 
history going hand in hand with the likelihood of beginning to groin inject as other sites 
become unavailable. It was necessary therefore to examine and control for some of 
these co-factors by utilising regression testing.  Regression can ascertain associations 
once confounding variables are adjusted (Field, 2009, p264). However, questions such 
as those asked in this study tend to have categorical outcomes, and therefore an 
extension of regression, called logistic regression may be used (Field, 2009, p265). 
 
Logistic regression is a form of multiple regression, with an outcome variable that is 
categorical (e.g. have you ever had a leg ulcer – yes / no), with predictor variables that 
are continuous (length of injecting time) or categorical (have you had a DVT - yes / no) 
(Field, 2009, p265).  Logistic regression is often popular in the health sciences as the 
discrete outcome in logistic regression can be disease / no disease (Tabachnick & 
Fidell, 1996, p575). This makes logistic regression highly suitable for further analysis 
on the data from this study as the factors that predict leg ulcer are of interest. 
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Logistic regression can be used to generate models to predict such things in medicine 
e.g. such as whether a DVT will lead to a leg ulcer (Field, 2009, p265).  
 
Logistic regression is more flexible than some other techniques and does not require 
predictor variables to be linear, parametric or of equal variance (Tabachnick & Fidell, 
1996, p575). Logistic regression analysis examines the relationship between a 
dichotomous variable (having a leg ulcer) and one or more explanatory variables.  
 
Some data entered into SPSS were recoded to allow further regression analysis using 
SPSS. Dichotomous variables were all recoded into categories that were aligned to ‘0’ 
for a negative response or ‘no’, and ‘1’ for a positive response or ‘yes’ (Pallant, 2007, 
p173).  
 
Recoding occurred where scales were used, which amended graduated numbered 
responses to simply ‘yes’ and ‘no’, dichotomous variables. Therefore the above 
question was recoded as follows, using 0 to reflect ‘no’ and 1 to represent ‘yes’: 
Do you use a filter? Always 5/  Most of the time 4/  Rarely 3/  Never 2 / Unsure 1 
Became: 
Do you use a filter? Always 1/  Most of the time 1/  Rarely1 /  Never 0 / Unsure1 
Those who were unsure were grouped into the least positive response depending on the 
question. For example- those unsure if they always washed their hands were classed as 
a negative – ‘no’ or ‘0’. 
 
The researcher felt that where respondents were unsure it seemed they were reluctant to 
admit to a poor practice. If respondents knew they ‘should’ wash their hands, but if they 
didn’t, they were perhaps reluctant to admit this and just said they weren’t sure. 
Similarly they might know it was not good practice to lick their needle, and so by 
saying they were unsure they were not admitting to a practice they did. However, this is 
supposition on behalf of the researcher, but there were only small numbers who were 
‘unsure’. 
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For the purposes of regression analysis, and in order to analyse the sample as a whole, 
the data were grouped into one sample group, not distinguishing between current and 
former injectors. The majority of participants (n = 128) were ‘current injectors’. Recall 
was likely to be more accurate for recent activities and so it was decided to select the 
most recent response of the eight long-term injectors for the regression analysis. 
The development of the direct logistic regression models are explained within Chapter 
4. 
 
Utilising a questionnaire limited the depth and breadth of knowledge acquired about 
skin problems and for this reason, a further study (Phase 2) was conducted utilising 
qualitative methods which were designed to gain greater insight (McGrath and Phillips, 
2007). Comparing the data gathered with Phase 1, and corroborating evidence between 
the two phases, improved rigour for the study as a whole. 
 
Phase 2, the qualitative study, will be described in the following section, followed by 
the processes of ethical and governance approval. 
 
3.18 Phase 2  
Building on the empirical data obtained in the first phase, Phase 2 explored with current 
or former young PWID who had leg ulceration their behaviours, perceptions and 
thoughts about the causes of leg ulceration, and about harm reduction methods. This 
phase was designed to generate in-depth knowledge related to chronic leg ulceration 
from the participants’ view point and answer the remaining research question: ‘What 
are appropriate harm reduction measures for leg ulceration in young PWID?’ 
 
3.19 Interviews 
A framework for semi-structured interviews was developed, based on the findings from 
the empirical data (Appendix 8). The framework formed a guide for questions, but there 
was scope for altering the questions and exploring more deeply, depending on the 
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participant responses (Gerrish and Lacey, 2006, p226). This method had been used 
successfully to explore quality of life with a sample of seven PWID (as part of a larger 
study) with venous ulcers (Palfreyman et al, 2007).  Participants also had opportunities 
to expand on areas they thought were important. The framework for questions was 
developed and defined once the empirical data had been analysed from Phase 1.   
 
Credibility 
At all stages rigour was achieved through ensuring that processes of reliability and 
validity within data collection and analysis were applied (Morse et al, 2002). Lincoln 
and Guba’s (1985) inquiry method using the ‘trustworthiness’ criteria which includes 
credibility, applicability, dependability and confirmability was used. This parallels the 
conventional criteria of scientific inquiry of internal and external validity, reliability 
and neutrality respectively which are often cited as a method to ensure validity of a 
qualitative study. The concept of ‘trustworthiness’, mimicking the empirical definitions 
of reliability and validity, utilises standards of evaluation to determine overall 
significance, relevance and impact of qualitative research. However, these evaluative 
attempts at determining rigour are usually applied at the end of a study, when it may be 
too late to correct serious problems (Morse et al, 2002). Instead, verification strategies 
were applied within the conduct of the study itself. Firstly, methodological coherence 
such as checking that the method was suitable to answer the research question, and then 
checking back when data were gathered ensured the interview schedule had been 
followed, for each of the interviews as it was conducted. 
 
Secondly, the sample must be appropriate, and consist of participants who best 
represented or have knowledge of the research topic. As the sample comprised only 
current drug injectors, or former drug injectors, who had experience of leg ulceration, 
this criterion was met. 
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Thirdly, collecting and analysing material concurrently formed a mutual interaction 
between what is known and what one needs to know, and this also helped identify when 
data saturation was reached.   
 
Fourthly, thinking theoretically – ideas emerging from the data were confirmed in the 
new data gathered and fresh ideas that emerged were also reflected in data already 
collected so a continual process of reflecting back and looking forward with the data 
occurred, along with checking and rechecking. 
 
Finally, theory development occurred between the micro-perspective of the data, and 
the macro-perspective of theoretical understanding. This verification strategy has been 
adapted from Morse et al (2002). 
 
Reflexivity was also important as the researcher approached the research with an 
existing identity, associated experiences and preconceptions which might influence the 
interpretation of data.  Being aware and reflective of this potential influence and bias 
was important (Lathlean, 2006, p420; Watt, 2007). The responsiveness of the 
researcher to the generated data  contributed to rigour, particularly in relation to 
analysis where categorisation needed to be supported by data and the investigator 
needed to be creative, sensitive and insightful (Morse et al, 2002). Themes and 
subsequent conclusions from the research needed to be supported by robust evidence 
and a method of analysis that allowed this to be transparent was essential. 
 
Sample Phase 2 
A representative sample was sought of males and females, young, current or former 
drug injectors (aged 16 – 44 years) with new (4 – 24 weeks), existing (25 weeks or 
more), and healed leg ulceration, taking into account similarities such as gender balance 
identified from Phase 1.  
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Inclusion / Exclusion Criteria 
Inclusion criteria comprised individuals with a current or previous history of injecting, 
leg ulceration active or healed, and aged 16 to 44 years (as for Phase 1), who could 
understand and speak English.  As discussed earlier in the definition of skin problems 
section (3.10), a leg ulcer was defined as ‘a break in the skin between the ankle and the 
knee that has been present four weeks or more’ (SIGN, 2010).  
 
Clinic staff approached all clients that to their knowledge had been a drug injector and 
had a leg ulcer, unless they deemed them as not fit to consent. Participants were 
excluded if they did not appear competent to either understand what they were 
consenting to take part in, or to be able to answer questions. This sort of warning or 
awareness is common practice within drug services to ensure the safety of all parties 
and occurred successfully in Phase 1.  
 
Participants and / or data were excluded if they did not meet the inclusion criteria, if 
they had never injected and had never had a leg ulcer, and were outwith the age range 
of 16 – 44 years. 
 
Sampling strategy: Phase 2 
A sampling frame, shown in Table 4, was devised based on the demographics of Phase 
1, designed to capture a similar representative proportional sample.  
 
Gender 25% females (3) 75% males (9) 
Injecting status 50% current injectors 
(6) 
50% former injectors (6) 
Leg ulcers  50% present  4 – 24 
weeks (6) 
50% present 25 weeks or 
more or healed (6) 
Table 4 Sampling frame 
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Convenience sampling was used for recruitment. Potential participants were likely to 
have engaged with healthcare services for treatment so areas known to treat PWID with 
leg ulceration were selected for recruitment.  
 
Recruitment 
Data collection was planned with the staff from the Physical Health Team for homeless 
people in NHS Glasgow and Clyde. The researcher met with the staff in advance to 
explain the study and deliver posters (Appendix 9) and leaflets to be distributed and 
displayed two weeks prior to the commencement of recruitment within the areas of the 
Health Centre and the Drug Crisis Centre where data collection would take place. 
 
Patients who met the inclusion criteria were approached by clinical staff and asked if 
they wished to take part and either an interview date was arranged to coincide with 
clinical care, or participants were invited to attend on suitable dates pre-arranged so that 
the researcher would be present at the venue. Recruitment took place from  April 2012 
until December 2012. Most of the interviews were conducted in a private room within 
the Health Centre, and on three occasions within participant’s homes where the 
researcher was accompanied by NHS staff who were undertaking clinical care at the 
same time. 
 
Data collection 
On the interview day, the researcher introduced herself to participants and reiterated the 
purpose of the research interview and the proposed duration together with topics for 
discussion. An information sheet (Appendix 10) was given to each participant and time 
to read or go through the sheet with the researcher was provided. Verbal consent to 
proceed was given and the participants signed a written consent form (Appendix 11), a 
copy of which was retained by the researcher and another copy by the participant. 
Participants were advised that they were not obliged to take part, and they could 
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withdraw themselves and any data they provided, without penalty at any time. They 
were given an opportunity to ask any questions. As before, support for each participant 
was identified and details of appropriate health and social care agencies were given.    
 
As discussed in the section on reimbursement (3.11), each participant received an 
honorarium of a £20 voucher as an acknowledgment of their time and willingness to 
take part. On conclusion a letter was written to each service lead thanking them for 
their assistance and offering a copy of the results when these were available. 
 
Seventeen interviews were conducted using a semi-structured interview schedule 
(Appendix 8) with current or former injectors who had experienced a leg ulcer. 
Thirteen interviews were conducted in the first two months which initially populated 
most of the sampling frame however, the last few participants, particularly females, 
were exceedingly difficult to recruit due to low numbers attending clinical services at 
that time. Arrangements and appointments were made with a number of potential 
participants who failed to turn up.  
 
An extension to ethical approval and governance was sought and granted three times, 
and the eventual decision was then made to stop recruiting in January 2013, when 17 
interviews had been completed. The termination of recruitment was a practical decision 
and whilst the sampling frame was not fulfilled exactly as planned (Table 5), all 
participants had injected and experienced leg ulceration. It appeared to the researcher 
that data saturation was occurring relatively early in relation to the key aims and 
research questions. 
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Gender 25 % females (planned 3)  
actual = 4  
75% males (planned 9)  actual 13 (2 
excluded) = 11   
Injecting status 50% current  (planned 6)  
actual = 7 
50% former injectors (planned 6) actual 10 
(2 excluded) = 8 
Leg ulcers  50% 4 – 24 weeks 
(6) actual = 5 
50% 25 weeks or more or healed (6) actual 
12 (2 excluded ) = 10  
Table 5 Completed sampling frame 
 
All interviews were recorded on two digital microphones. Each file was downloaded 
onto a password-protected computer and transferred to the transcriber by password-
protected ‘drop box’. Each interview was numerically coded and transcribed verbatim 
thus ensuring reliability (Silverman, 1993, p149). Each transcription was checked 
against the recordings for accuracy by the interviewer.  
 
3.20 Sample 
As PWID are often difficult to locate for follow-up studies, it was originally intended to 
ask those participants who had experienced a leg ulcer whether it would be possible to 
contact them to participate in Phase 2.  Fifteen participants agreed to be contacted.  An 
information sheet was given and they were asked to provide written consent to be 
contacted again. Contact details were collected, and kept separately from other 
information in a locked drawer for the researcher’s own use.  
On completion of Phase 1 recruitment in December 2008, a letter was written to those 
who had provided a postal address, and phone calls to update on progress were made to 
the other potential participants or their contact person. Agreement was made that each 
potential Phase 2 participant would be contacted again in Spring 2009, once it was 
clearer what Phase 2 might entail. Three of the letters were returned as undelivered.  
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As some time had passed since Phase 1, discussions with NHS staff revealed that a 
number of the leg ulcer patients that they had treated that were likely to have 
participated in Phase 1, had died. It was felt that looking for these original participants 
might distress relatives who were generally named as the first point of contact by the 
participants. So no participants from Phase 1 were approached again to take part in 
Phase 2.  
 
Of the 17 people recruited to the Phase 2 study, 13 were male, and 4 female. One male 
participant (participant number 7) was excluded as he was 49 years of age and outwith 
the inclusion criteria. He had been recruited by NHS staff who had been unaware of his 
age when he had agreed to take part and he was desperate to receive his honorarium. 
The interview went ahead but the data gathered from the interview was not included in 
the analysis although his contribution was valuable in providing further insight. The 
data gathered from the first interview (participant number 1) were effectively used as a 
trial run, and were also excluded. 
 
The research aims were very specific: 
- To analyse potential causal / risk factors in the development of chronic leg 
ulceration in young PWID. 
- To identify appropriate harm reduction measures relevant to service delivery 
and treatment in Scotland and beyond.       
 
During the interviews participants talked about the impact of ulceration on their lives 
and this impact related closely to potential harm reduction messages. Therefore the 
three explored areas were causes of leg ulceration, impact of ulceration and harm 
reduction. 
 
3.21 Phase 2 Analysis   
In line with the sequential explanatory design, the qualitative stage was explicitly 
linked to the earlier quantitative stage and sought to confirm, elaborate and explain the 
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quantitative results as well as providing further detail and new knowledge, built on 
what was learned in the first phase (Creswell and Plano Clark, 2011, p221 - 234).  
 
The data analysis sought to find associations, seek explanations for ulceration, the 
impact of ulceration on participant’s lives and develop new ideas about the causation 
and possibilities for prevention.  
 
Representation of qualitative data in an empirical manner such as in tables, (a graphical 
or visual approach), and devising ratios to note numbers of themes, may assist readers 
in interpreting qualitative data more accurately (Bachor, 2002), so some data were 
tabulated within the findings. 
 
3.22 Procedure for framework analysis 
Stage 1: Familiarisation 
This stage related to data management – becoming familiar with the transcripts / data 
by reading and re-reading, identifying the initial themes and developing a coding matrix 
and assigning data to the themes and categories in the coding matrix (Smith and Firth, 
2011). 
 
The transcripts were copied directly into QSR NVivo Version 10, whilst being read and 
re-read to create familiarity. This immersion in the data was made easier as the 
researcher also conducted the interviews and checked all the transcripts so there already 
was a degree of familiarity. As part of this stage, notes were made about themes and 
issues arising.  
 
Stage 2: Identifying a thematic framework 
During the earlier first stage, familiarisation occurred but at the same time the process 
of abstraction and conceptualisation began to occur (Ritchie and Spencer, 1994, p179; 
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Spencer et al, 2014). From this material, themes, key issues and concepts arose and 
were recorded, drawing on the a priori issues such as the original research question, 
themes and issues and questions raised by participants. 
 
Key themes that arose from the data were:  
 causes of leg ulceration 
 impact of injecting and of leg ulceration (this was useful in identifying key harm 
reduction messages) 
  harm reduction  
 
These themes were entered into NVivo and sub-themes linked to the main themes were 
added as the data were interrogated.  
Causes of leg ulceration – sub-themes: 
Abscesses Acidifiers used Cause of ulcer Diet 
Drugs injected Family history Groin injecting Hit arteries 
Homelessness How injecting started How the ulcer started Injecting into wounds 
Injecting technique Mental health Personal hygiene Thrombosis 
Tools used 
Table 6 Themes of causation 
Impact of injecting and leg ulceration – sub-themes:  
Effect on mobility Embarrassment Exudate or discharge Family impact 
Infection Itch Lack of sleep Other ill health 
Pain Risk Scarring Smell 
Social impact Swelling or oedema Thrombosis, clots or DVT Venous disease 
Table 7 Themes of impact of injecting and ulceration 
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Harm Reduction – sub-themes: 
Prevention How ulcer heals Denial 
Table 8 Themes of harm reduction 
 
Stage 3: Indexing 
Data from the transcripts were applied to the themes and sub-themes with NVivo – at 
this stage some of the themes were re-worked, as the interviews were re-visited (Ward 
et al, 2013). The transcripts were read and re-read again, and data reapplied to the 
themes (or nodes in NVivo) to ensure nothing was missed and as the themes and sub-
themes developed the data were matched back again. This process was done three 
times. As the interviews were semi-structured, questions and discussion varied between 
participants with the intention of enabling conversations to ‘flow’ and for participants 
to talk freely. As a result the questions were broadly similar for each participant but not 
all the same questions were asked.  This was not unusual where the interview technique 
was flexible and responsive (Pope et al, 2007). 
 
Stage 4: Charting 
This stage allowed the data to be reduced and summarised within framework matrixes 
in NVivo. These matrices allowed the direct quotes to be linked to the summary so that 
there could be checking and matching across the themes and attributed to the original 
text. These summaries formed the beginning of true analysis and interpretation with the 
researcher making sense of the texts and drawing together the data succinctly within 
matrices in NVivo (Pope et al, 2007). Three matrices were developed and linked to the 
study aims and research questions – ‘Cause of ulceration’, ‘Impact of ulceration’ and 
‘Harm Reduction’. These matrices contain illustrative quotations where these are 
interesting or explanatory and were used to illustrate interpretation in the next stage 
(Gale et al, 2013). 
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Stage 5: Mapping and Interpretation 
The notes, framework matrices and text data were reviewed and the range of data 
explored again (Pope et al, 2000). The textual interview data had been ‘managed’ 
within NVivo and ordered into themes to facilitate interpretation. During interviews 
notes were taken simultaneously to allow some demographics to be recorded such as 
the age of the participant, gender and postcode. This information was tabulated to 
create a summary of the participants and rule out duplication. It was also possible to 
tabulate other information gathered during the course of the interviews in which similar 
information was acquired for each participant such as length of injecting career or site 
of the ulcer. These data could be counted and a summary of simple information 
produced (Pope et al, 2007). Some of these data were also used to describe a case, e.g. 
participant number, age group, gender, injecting status and whether an old or recent leg 
ulcer (all variables from the sampling frame), within the framework matrices. These 
data were tabulated and presented in Chapter 5. 
 
The final stage of framework analysis was to synthesise the data and descriptive 
summaries were incorporated into explanatory accounts (Furber, 2010). The ‘scaffolds’ 
of matrices were useful in making sense of the data and allowing interpretation between 
cases to illuminate each of the themes arising from the interviews based on the research 
questions (Smith and Firth, 2011). 
 
The findings are presented in Chapter 5. 
 
3.23 Synthesis of Phase 1 and 2 
The quantitative results from Phase 1 informed the development and execution of Phase 
2. The results of Phase 1 are presented in Chapter 4. The qualitative findings from 
Phase 2 are presented in Chapter 5. The results from both phases were brought together 
within Chapter 6 and the extent to which the findings from both phases were 
convergent and complementary are considered (Erzberger and Kelle, 2003). 
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3.24 Ethics, Access and Data Management  
User involvement 
Whilst vulnerable groups may be more readily coerced, harmed or manipulated by 
researchers, conversely they may also be stigmatized and excluded from conventional 
types of research (Pieper, 2005; Exchange supplies, 2007). The drug using population 
is often considered vulnerable, disenfranchised or marginalized. However, this may not 
be recognized or agreed by PWID and it is important not to exclude such individuals 
from research because of an assumed possibility that they may be vulnerable (Steel, 
2004). In fact, many PWID are survivors of very difficult circumstances and can be 
articulate and eager to share experiences (Taylor, 1993, p8; Ensign, 2003).  
 
Social circumstances and living arrangements may be misunderstood by researchers, 
often leading to a lack of cultural sensitivity and / or difficulties undertaking research 
both in accessing areas to undertake research and recruit participants, and in developing 
sound methods by which to answer research questions (Sieber, 1992, p109 & p128; 
Steel, 2004). Ensign (2003) describes the ethical challenges of conducting research 
amongst vulnerable populations such as homeless youths. There is significant overlap 
between homeless populations and PWID and Ensign’s (2003) observations were 
helpful in defining ethical boundaries for research with such a group. Ensign’s further 
experience (Ensign, 2006) led her to recommend that participants within a group of 
homeless young people should be involved in the development of the research design.  
 
The research tools in this study were piloted with a small group of service users at an 
IEP service in Lothian and their views were sought and incorporated into the research 
design.  
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Confidentiality and data storage 
All data collected were anonymised. Only the researcher and her supervisors had access 
to the data.  Hard copies of data collection materials that may potentially identify an 
individual such as completed questionnaires and consent forms were kept separately 
and locked within a fireproof cupboard within the University.  The questionnaires will 
be stored and destroyed ten years after study completion.  The consent forms were 
destroyed after the completion of the study.  
 
All electronic data were anonymised, and will be stored within password-protected files 
for ten years. Code numbers were used to differentiate between participants within the 
data analysis. Such information was stored, and will be later destroyed, in accordance 
with the Data Protection Act (1998).  
 
Participants were assured that their personal data and information were confidential and 
would not be passed to a third party and would not be used for any other purpose. All 
data used in the presentation and dissemination of results will be completely 
anonymous.   
 
Researcher and nurse 
There were ethical dilemmas arising as a result of being both a researcher and a nurse. 
Data were collected in a city where the researcher had both trained and worked as a 
nurse and more recently had worked specifically with services for homeless people and 
PWID. Her experiences with this client group and relationships with service staff were 
very helpful in informing the research design, and ensured a practical, workable, and 
successful method of recruitment. Whilst she withdrew from clinical practice in 
Glasgow prior to commencing this study to avoid any conflicts in care, feelings of 
obligation on behalf of NHS patients, or breaches of confidentiality she nevertheless 
encountered, and interviewed, former patients whom she had cared for, which 
potentially contaminated some of the data, given that she had been informally enquiring 
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of patients what they thought was causing their skin problems and musing about the 
possibilities. 
 
It was challenging to change from the ‘nurse’ to the ‘researcher’ and at times the roles 
were very difficult to separate, and indeed the participants also considered that she had 
both roles. Participants raised concerns or asked questions that as a nurse she could and 
should have answered. However, as a researcher, it was not her place. This was a 
challenge that had to be considered and reflected on as to what was best for the 
participant sitting in front of her, with contradictions in duty of care, and professional 
responsibilities towards referral for on-going support. The support of clinical colleagues 
was helpful, providing support to participants when required. 
 
Support for the Researcher and Personal Safety 
Researcher safety 
A safety protocol was established for each venue in order to ensure researcher safety 
when interviewing participants in private. A mobile phone and portable alarm were 
carried by the researcher at all times. 
 
In accordance with other studies (Taylor et al, 2005), no questions were asked about 
individual dealers or sources of specific batches of heroin which could lead to 
divulgence of criminal activity and knowledge that could cause subsequent risk to the 
researcher. 
 
It was possible that undertaking the research and listening to participants divulge 
information about their personal lives might have caused inadvertent distress to the 
researcher.  Professional colleagues were identified who were willing to provide 
support / debriefing for the emotional burden that might be experienced by the 
researcher. 
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Ethical Approval 
This study adhered to ethical principles essential in research. Appropriate and necessary 
ethical permission was sought separately for each phase of the study, and obtained from 
the University’s Ethics Committee, and also Greater Glasgow NHS Research Ethics 
Committee prior to each part of the study commencing.  
 
The Department of Nursing and Midwifery Research Ethics committee (DREC) 
required students to submit for ethical approval through the Department prior to 
seeking NHS approval. The study received approval from DREC to proceed to NHS 
approval in May 2008.  
 
As the study involved recruitment at two Health Board sites – NHS Lothian (for the 
pilot study) and NHS Glasgow and Clyde (for the main study), the study was classed as 
‘multi-centre’ and therefore required the approval application to be channelled through 
the Central Allocation System.  The study was allocated to Glasgow West Ethics 
Committee 1. The application was reviewed on 2
nd
 June 2008 and, subject to some 
minor amendments, was approved (reference 08/S0703/78) on 7
th
 July 2008. 
 
Ethical approval for Phase 2 was sought and obtained from the West of Scotland NHS 
Research Ethics Committee 1 (reference 10/S0703/52) on 13
th
 September 2010. 
 
The researcher received an enhanced disclosure check from Disclosure Scotland 
(number 120100054895822) and subsequently a PVG scheme membership (number 
200000000327865). Indemnity insurance for the researcher was in place. 
 
3.25 Governance and Access 
Governance approval to undertake the Pilot Study was gained from NHS Lothian 
Research and Development Office in June 2008. Research Governance approval from 
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NHS Glasgow and Clyde was obtained in July 2008. Access was negotiated with each 
of the NHS areas within which the researcher gathered data.  
 
Governance approval from NHS Glasgow and Clyde for Phase 2 was granted in 
September 2010, and access was sought and permitted by the Health and Homelessness 
Team within NHS Glasgow and Clyde. 
 
Chapter summary 
This study comprised two phases in a sequential explanatory mixed methods design. 
The first, Phase 1, grounded within a critical realist approach, sought to answer the first 
research question –‘What is the extent of skin problems and chronic leg ulceration in 
young PWID?’  by utilising a survey technique within an epidemiological approach.  
Phase 2 was grounded within postpositivism and pragmatism and utilised semi-
structured qualitative interviews to complete the answer to the second - ‘What causes 
chronic leg ulceration in young PWID? and answer the third research question ‘What 
are appropriate harm reduction measures for leg ulceration in young PWID?’. 
 
The next chapter, Chapter 4, will outline the results from Phase 1 and the findings from 
Phase 2 will be described in Chapter 5. 
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Chapter 4  
Phase 1: Results and Analysis  
Introduction 
The thesis, so far, has set out why the gap in knowledge relating to leg ulceration in 
young people who inject drugs is important. This next chapter builds on the methods 
described in Chapter 3 and reports the results of Phase 1, the quantitative survey. 
Within the first section basic descriptive statistics will be reported providing an 
overview of the sample’s demographic composition, physical health, and key points 
related to injecting.  The prevalence of leg ulceration and skin problems within the 
sample is outlined. The next section will detail risk factors of significance for leg 
ulceration. Concluding this chapter is a discussion of these findings.  
 
4.1 Study Sample 
The final dataset comprised 200 people of whom 148 were males (74%) and 52 were 
females (26%). The age of the participants at the time of interview ranged from 21 to 
44 years old (Mean 34.62 years SD 5.61). Table 9 provides an overview of the sample’s 
characteristics including injecting status and length of injecting career. 
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Demographics of sample
No. % No. % No. %
Gender 148 74.0 52 26.0 200 100.0
Age group 20 - 24 yrs 6 4.0 5 9.5 11 5.5
25 - 29 yrs 20 13.5 9 17.5 29 14.5
30 - 34 yrs 38 25.5 12 23.0 50 25.0
35 - 39 yrs 47 32.0 18 34.5 65 32.5
40 - 44 yrs 37 25.0 8 15.5 45 22.5
Total 148 52 200
Injecting status Current injector 97 65.0 31 60.0 128 64.0
Former injector 51 35.0 21 40.0 72 36.0
Total 148 52 200
Length of injecting career (years) Less than a year 13 9.0 6 11.5 19 9.5
1- 5 years 35 23.5 12 23.0 47 23.5
6 - 10 years 35 23.5 14 27.0 49 24.5
11- 20 years 44 30.0 15 29.0 59 29.5
Over 20 years 21 14.0 5 9.5 26 13.0
Total 148 52 200
Age when started injecting (years) Under 16yrs 28 19.0 7 13.5 35 17.5
16-19 yrs 42 28.5 15 29.0 57 28.5
20-24 yrs 38 25.5 17 32.5 55 27.5
25-29 yrs 23 15.5 9 17.5 32 16.0
30-34 yrs 13 9.0 4 7.5 17 8.5
35-39yrs 4 2.5 0 0.0 4 2.0
Total 148 52 200
Male Female Total
 
Table 9 Sample demographics 
 
More than half of the sample were current injectors (64%, n = 128), and 36% (n = 72) 
had stopped injecting more than 6 months previously.  
Participants had injected for varying lengths of time ranging from less than a year to 31 
years with a mean of 10.26 years (SD 7.7).  
A small number (9.5%, n = 19) had injected for less than a year, and similarly at the 
other end of the scale, only 26 (13%) had injected for more than 20 years.  
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The youngest started injecting when they were 12 years old, and the oldest aged 39 
years, with a mean age of 21.19 years (SD 5.9). The majority of participants (73.5%, n 
= 147) were injecting before they reached their twenty-fifth birthday. 
 
Geographical spread 
The sample represented a wide geographical spread of areas across the city centre with 
peaks in known areas of high drug use (City-centre and East-end). There were some 
participants from other areas (3%, n = 6) and some were of no fixed abode (NFA) (4%, 
n = 8) (Table 10). 
Recruitment Areas
Areas of Glasgow
Number of 
participants %
Centre 49 24.5
North 24 12.0
South 27 13.5
South-east 2 1.0
South-west 9 4.5
East 52 26.0
West 17 8.5
Other 6 3.0
NFA 8 4.0
Total 200 100.0  
Table 10 Recruitment areas 
 
Housing 
At the time of interview, half (n = 100) were living in their own home – either a 
tenancy, private rental or mortgaged property, 22.5% (n = 45) were living in a hostel or 
supported accommodation, 19% (n = 38) were living with friends or relatives, and 3% 
(n = 6) were living in a bed and breakfast. 1.5% (n = 3) were sleeping rough and 4% (n 
= 8) were NFA.  
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The majority (80.5% n = 161) had been homeless at some time in their lives. Only 39 
(19.5%) participants had never been homeless. 83 participants (41.5%) had been 
homeless within the last 6 months.  
 
4.2 Physical Health 
Participants were asked about their physical health, their medical history and about 
known risk factors for leg ulceration. 
 
Nutritional status 
Most participants considered themselves normal weight for their height (Table 11). 
A quarter of participants (27.5%, n = 55) reported no fixed eating pattern, and 9.5% (n 
= 19) snacked all day, but 44.5% (n = 89) did report managing to eat 2 or 3 meals a day 
and 18.5% (n = 37) ate one meal a day.  
Only 23% (n = 46) ate fruit every day, and almost half the participants ate fruit less 
than once a day (42.5%, n = 85). 34.5% (n = 69) never ate fruit. 
 
No. % No. % No. %
Nutrition
Body Mass Index estimate (BMI) underweight 55 37.0 12 23.0 67 33.5
normal weight 75 51.0 24 46.0 99 49.5
overweight 18 12.0 14 27.0 32 16.0
obese 0 0.0 2 4.0 2 1.0
Total 148 52 200
Male Female Total
 
Table 11 Nutritional status 
 
Smoking and alcohol use 
Almost all participants were tobacco smokers and the greatest proportion were heavy 
smokers (43.5%, n = 87) consuming more than 20 cigarettes or ½ oz. of tobacco daily. 
25.5% (n = 51) were moderate smokers, consuming 10 – 20 cigarettes daily or ¼ - ½ 
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oz. tobacco. The remaining participants (30%, n = 60) were light smokers, smoking less 
than ten cigarettes or ¼ oz. tobacco daily.  
 
No. % No. % No. %
Smoking status
Current smoker Yes 147 99.5 51 100 198 99
No 1 0.5 1 0.5 2 1
Total 148 52 200
Male Female Total
 
Table 12 Smoking status 
 
Most smoked tobacco (roll-ups) (43%, n = 86) citing this as a cheaper option. 24% 
smoked cigarettes (n = 48), 0.5% (n = 1) smoked a pipe, and 5% smoked cannabis (n = 
10).  26.5% (n = 53), smoked a combination of these items. 
 
Participants were asked about their alcohol consumption in the previous six months. 
50% (n = 100) had not had alcohol in the last 6 months. 9% (n = 18) drank alcohol once 
a month or less, and 4.5% (n = 9) drank twice a month. 8.5% (n = 17) drank once a 
week, 8% (n = 16) drank two - three times a week, and the rest drank four or more 
times a week (20%, n = 40). 
 
Medications 
Participants were asked if they took any medication (other than what they injected), 
prescribed or otherwise. 97% (n = 194) were taking other medications, 3% (n = 6) took 
nothing else.  Five people who took no other medication were current injectors.  
Of the medications taken, 91% of the sample (n = 182) took an opiate substitute. 43.5% 
(n = 87) of those taking an opiate substitute were also currently injecting.  
A high percentage (47.5%, n = 95) were taking medication acting on the central 
nervous system (CNS), whether this was antidepressants, antipsychotics or anti-manic 
medication or combinations.  Of these, 89 (43.5% of sample) were also taking an opiate 
substitute in combination with a CNS active drug.  
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Blood-borne viruses (BBV) 
40.5% (n = 81) reported that they had been diagnosed with a BBV such as hepatitis or 
HIV.  
 
Cardiac disease 
A small number of participants (13.5%, n = 27) had been diagnosed with a heart 
problem.  
 
Claudication 
A sign of arterial disease and / or peripheral vascular disease is often claudication (pain 
in their calf on walking). Further exploration was sometimes required to ensure that the 
pain described was that of claudication which might indicate ischaemia, rather than 
muscular or ulcer pain. Following explanation, 16% (n = 32) of participants reported 
suffering from claudication. 
 
Diabetes 
Only four participants had been diagnosed with diabetes (2%, n = 4).  
 
Walking problems 
Almost a fifth had problems with mobility or been diagnosed with joint problems or 
arthritis (19.5%, n = 39). 
 
Hand dominance 
Most participants (84.5% n= 169) were right-handed, 9.5% (n = 19) were left-handed 
and 6% (n = 12) described themselves as ambidextrous.    
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Access to healthcare 
Most participants had contact with health professionals such as a GP or Practice Nurse. 
(99%, n = 198). Only two participants did not.  
Of those who did have contact with a health professional, a fifth felt they were unable 
to talk to them (20%, n = 40). 
Most would go to their GP or Practice Nurse for advice about a skin problem (66.5%, n 
= 133). 16% (n = 32) would consult their drugs worker or a worker at the needle 
exchange, 8.5% (n = 17) would go to Accident and Emergency (A & E) and 6% (n = 
12) would seek advice from other sources. 3% (n = 6) would not seek advice from 
anyone. 
 
4.3 Signs of Venous Disease 
Varicose veins 
Just over a quarter (29%, n = 58) had varicose veins. A third knew of a family history 
of venous disease such as varicose veins or leg ulceration (32% , n = 64), whilst the 
remainder either did not know, or thought there had not been a family history (68%, n = 
136).  
 
Skin staining 
Fifteen percent  (n = 30) reported skin staining on their legs and 21 of these people had 
also experienced a leg ulcer.  
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Known risk for venous disease  
Known risk factors for venous disease were reported by some participants (Table 13). 
Present Absent 
Risk Factor - venous disease Number % Number % Total
Deep vein thrombosis (DVT) leg 65 32.0 135 67.5 200
Fractured legs 56 28.0 144 72.0 200
Cellulitis 36 18.0 164 82.0 200
Standing for long periods 149 74.5 51 25.5 200  
Table 13 Known risk of venous disease 
 
Parity 
There were 52 females in the sample, and 80% (n = 42) had given birth. Table 14 
denotes the number of births. 
Parity Number of women
0 babies 10
1 baby 20
2 babies 9
3 babies 9
4 or more babies 4
Total 52
 
Table 14 Number of births 
 
4.4 Injecting Habits of the Sample 
These results are displayed in Table 15 (injecting habits). 
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Injecting habits
No. % No. % No. %
Drugs injected most often heroin 105 82.0 63 87.5 168 84.0
cocaine 22 17.0 4 5.5 26 13.0
amphetamine 1 1.0 1 1.5 2 1.0
benzodiazepines 0 0.0 1 1.5 1 0.5
other 0 0.0 3 4.0 3 1.5
Total 128 100.0 72 100.0 200 100.0
How often inject on average Less than every 2/3 days 30 24.0 7 9.5
Every 2/3 days 17 13.0 3 4.0
Once a day 23 18.0 11 15.5
Twice a day 24 19.0 14 19.5
Three times a day 17 13.0 18 25.0
Four times a day 4 3.0 6 8.5
More than 4 times a day 13 10.0 13 18.0
Total 128 100.0 72 100.0
How often inject at most Less than every 2/3 days 17 13.0 7 9.5
Every 2/3 days 10 8.0 2 3.0
Once a day 11 9.0 2 3.0
Twice a day 13 10.0 4 5.5
Three times a day 16 13.0 11 15.5
Four times a day 8 6.0 3 4.0
More than 4 times a day 53 41.0 43 59.5
Total 128 100.0 72 100.0
Current injector Former injector Total
 
Table 15 Injecting habits 
 
Drugs injected 
Most of the participants were or had been heroin injectors. Most injected at least once a 
day and sometimes far more frequently.  
When asked what other drugs were injected current injectors also reported injecting 
cocaine or crack (n = 43, 34%), some reported mixing it with other drugs (n = 13, 
10%).  Four people also injected benzodiazepines (3%). One injected amphetamines. 51 
(40%) did not inject anything else.  
Former injectors also reported injecting cocaine (n = 15, 21%), and 18 (25%) reported 
mixing cocaine with one or more other drugs. Eight reported injecting benzodiazepines 
(11%), one reported injecting buprenorphine, and three (4%) reported other drugs such 
as Diconal. Six people reported injecting two or more different drugs (8%).  
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Initiation into injecting  
The majority of injectors were taught to inject by a friend or by watching others (Table 
16). The participants differentiated between ‘friends’ i.e. people who they trusted, and 
acquaintances - people they knew. 
Initiation
Current 
Injector %
Former 
Injector % Total %
Dealer 1 1.0 0 0.0 1 0.5
Friend 46 36.0 33 46.0 79 39.5
Partner 14 11.0 9 13.0 23 11.5
Watching others 48 37.0 18 25.0 66 33.0
Family 8 6.0 5 7.0 13 6.5
Acquaintances 5 4.0 5 7.0 10 5.0
Baby Sitter 1 1.0 0 0.0 1 0.5
Prison mate 0 0.0 1 1.0 1 0.5
Other 5 4.0 1 1.0 6 3.0
Total 128 100.0 72 100.0 200 100.0  
Table 16 Who taught injectors to inject 
 
Who undertakes injecting  
Most participants injected themselves (Table 17). Of those that did not, friends, 
acquaintances and partners helped. 
Who undertakes injecting
Current 
Injector %
Former 
Injector % Total %
Always inject themselves 97 76.0 41 57.0 138 69.0
Sometimes inject themselves 14 11.0 12 17.0 26 13.0
Never inject themselves 17 13.0 19 26.0 36 18.0
Total 128 100.0 72 100.0 200 100.0  
Table 17 Who undertakes injecting 
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First injecting site 
Participants were asked which vein site they had first injected into. The majority (95%, 
n = 122) of current injectors started injecting in their arms or hands. The remaining 5% 
started in their groin (3%, n = 4), legs (1%, n = 1) or feet (1%, n = 1).  
96% (n = 69) of former injectors had also started injecting in their arms and hands. The 
remaining 4% started injecting in their groin (n = 2) and feet (n = 1). 
 
Injecting sites 
Most injectors had used their arms and hands to inject into.  A wide variety of vein sites 
were used (72 different permutations) so for the purposes of analysis, these sites were 
grouped into upper body, and specific areas of the lower body (Table 18).   
Injecting sites
No. % No. %
Injecting sites used most often Arms/hands 77 60.0 46 64.0
Groin 39 30.5 22 30.5
Lower legs 9 7.0 2 2.5
Thighs 0 0.0 1 1.5
Arms and groins 2 1.5 0 0.0
Arms groins and lower legs 1 1.0 0 0.0
Arms and lower legs 0 0.0 1 1.5
Total 128 100.0 72 100.0
Other sites injected Upper body only 33 26.0 22 30.5
Groin 0 0.0 2 3.0
Upper body and feet 4 3.0 3 4.0
Upper body, groin, lower legs & feet 7 5.5 9 12.5
Upper body, groin, thighs, lower legs 0 0.0 1 1.5
Upper body, thighs, lower legs & feet 2 1.5 2 2.5
Upper body and lower legs 9 7.0 7 9.5
Upper body, groins, thighs, lower legs, feet 40 31.0 13 18.0
Upper body, groins and feet 5 4.0 4 5.5
Upper body and groin 19 15.0 2 3.0
Upper body, groins, lower legs 6 4.5 1 1.5
Upper body, lower legs, and feet 2 1.5 6 8.5
No other site 1 1.0 0 0.0
Total 128 100.0 72 100.0
Current injector Former injector
 
Table 18 Injecting sites 
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‘Popping’ (injecting into skin or muscle) 
Just over a third of current injectors (37.5%, n = 48) had injected into skin / 
subcutaneous tissue or muscle. Almost half of former injectors (47%, n = 34) had 
injected into skin / subcutaneous tissue or muscle.  
 
Skin hygiene  
It was more common amongst injectors to clean their skin before injecting than wash 
their hands, and a variety of skin cleansers were used. If using alcohol swabs, not 
everyone allowed the skin to dry (Table 19). 
No. % No. %
Hygiene Always wash hands 51 40.0 15 21.0
Mostly wash hands 0 0.0 5 7.0
Sometimes wash hands 15 12.0 0 0.0
Rarely wash hands 17 13.0 7 9.5
Never wash hands 45 35.0 43 59.5
Unsure 0 0.0 2 3.0
Total 128 100.0 72 100.0
Clean skin before injecting Always 69 54.0 34 47.0
Most of the time 0 0.0 8 11.0
Sometimes 11 8.5 0 0.0
Rarely 23 18.0 10 14.0
Never 0 0.0 20 28.0
Unsure 25 19.5 0 0.0
Total 128 100.0 72 100.0
Skin cleanser used Soap and water 0 0.0 2 4.0
Alcohol swab 102 98.0 50 96.0
Saliva 0 0.0 0 0.0
Other 2 2.0 0 0.0
Total 104 100.0 52 100.0
Allowed alcohol to dry Always 37 36.0 12 24.0
Mostly 0 0.0 7 14.0
Sometimes 16 16.0 0 0.0
Rarely 34 33.0 6 12.0
Never 4 4.0 21 42.0
Unsure 11 11.0 4 8.0
Total 102 100.0 50 100.0
Current injector Former injector
 
Table 19 Skin hygiene 
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4.5 Injecting Equipment 
Water  
The majority of injectors used tap water to make up their drugs (Table 20). 
Type of water
No. % No. %
Tap water 91 71.0 52 72.0
Bottled water 11 8.5 6 8.5
Boiled water 26 20.5 11 15.0
Sterile water 0 0.0 2 3.0
Other 0 0.0 1 1.5
Total 128 100.0 72 100.0
Current injector Former injector
 
Table 20 Water used 
 
Acidifier 
The majority of current injectors used the pharmaceutical citric acid distributed in 
sachets by drugs services. Other acidifiers were also used (Table 21). 
Acidfier used
No. % No. %
Acidifier Citric acid 118 92.0 64 89.0
Vitamin C 0 0.0 1 1.5
Lemon juice 1 1.0 1 1.5
Vinegar 0 0.0 3 4.0
Other 1 1.0 0 0.0
Don't use 8 6.0 3 4.0
Total 128 100.0 72 100.0
Other acidifiers used Citric acid 0 2
Vitamin C 1 1
Lemon juice 34 17
Vinegar 11 17
Non-pharmaceutical vitamin c 2 0
Combinations of acids 5 2
Other 1 3
Total 54 42
Current injector Former injector
Table 21 Acidifiers used 
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Needles and syringes 
Most injectors used a new needle and syringe every time (Table 22).  
No. % No. %
Used new needle and syringe Yes 80 62.5 37 51.0
No 48 37.5 35 49.0
Total 128 100.0 72 100.0
Used 1ml insulin syringes yes 98 77.0 53 74.0
No 30 23.0 19 26.0
Total 128 100.0 72 100.0
Current injector Former injector
 
Table 22 Equipment used 
 
The majority of injectors used insulin syringes, the standard integrated 1ml needle and 
syringe, issued by IEP services at that time. 
 
Those participants who did not usually use insulin syringes were asked what needles 
and syringes (barrels) they used instead. Most injectors used blue needles (long and 
short) and 2ml barrels. Very few used green needles and 1ml barrels (n = 2). Insulin 
syringes, which were most commonly distributed at the beginning of this study, were 
fragile and intended for subcutaneous use only and this practice has since changed. 
 
However, many of those who had been injecting for over 25 years reported previously 
using whatever they could ‘get their hands on’, and commented that they had often 
stolen new or used paraphernalia from hospitals. This was before needle exchanges 
were set up in the city. One former injector reported that there was no pattern or 
consistency to his use but that he used ‘larger’ needles for Diconal injections (an 
analgesic used more commonly in the past).  
 
Filters 
Almost all participants filtered their drugs. 98% (n = 126) of current injectors always 
used a filter, and one person used one most of the time. One person never used a filter.   
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99% (n = 71) of the former injectors used a filter, with 96% (n = 69) always using a 
filter. 
Various types of filter were used (Table 23). Only a few used the sterile filter available 
from some drugs services as this was generally viewed as unsuitable.  
 
Filters used
No. % No. %
Cigarette filter 99 77.0 60 83.0
Roll-up filter 6 4.5 2 3.0
Sterile filter 2 1.5 2 3.0
Home-made 12 9.5 7 9.5
Pillow or cushion 1 1.0 0 0.0
Old sock 2 1.5 0 0.0
Two or more types 5 4.0 0 0.0
No filter 1 1.0 1 1.5
Total 128 100.0 72 100.0
Current injector Former injector
 
Table 23 Filters used 
 
Participants were also asked if they used a fresh unused filter each time they injected. 
60% (n = 77) of current injectors always used a fresh filter, whilst 28% (n = 36) used 
one most of the time. Of the former injectors, 67% (n = 48) always used a fresh filter, 
and a further 35% (n = 18) used one most of the time. 
 
4.6 Injecting Technique 
99% of current injectors injected in the same way each time. 97% (n = 70) of the 
former injectors injected in the same way each time whilst 3% (n = 2) injected in the 
same way most of the time.  
 
Licking needles 
69 participants had licked their needles (34.5%) although the frequency was not 
consistent (Table 24). 
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Licked needle
No. % No. %
Always 8 6.0 8 11.0
Most of the time 9 7.0 8 11.0
Rarely 26 20.0 10 14.0
Never 85 67.0 46 64.0
Total 128 100.0 72 100.0
Current injector Former injector
 
Table 24 Licking needles 
 
Finding a vein 
Participants were asked if they always found a vein. Of the current injectors most (63%, 
n = 81) claimed to always find a vein. Just over half the former injectors (53%, n = 38) 
always found a vein. 
 
Hitting nerves or arteries 
Participants were asked about hitting nerves and arteries as part of their injecting 
experience.  Of the current injectors 61% (n = 78) had hit a nerve and 60% (n = 77) had 
reported hitting an artery.  Of the former injectors 49% (n = 35) reported hitting a 
nerve, and 46% (n = 35) had hit an artery.  
 
4.7 Leg Ulcer Prevalence 
Thirty participants had experienced a leg ulcer:  21 males (14% of the total males) and 
9 females (17% of the total females); 17% (n = 12) of former injectors and 14% (n = 
18) of current injectors. Five people (of eight)  who had been injecting for more than 25 
years had a leg ulcer and 14 (7% of the sample) had active ulceration at the time of the 
interview. 
 
Participants who had had a wound on their leg were asked questions relating to whether 
it had healed, recurred, whether they had injected in the area and how the wound had 
been cared for. Thirty-five participants (17.5%) had had a wound on their leg. Of those, 
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29 had wounds that healed up. Of the 29 who healed, 13 wounds subsequently recurred. 
Of those that recurred, three had a solitary recurrence, in three people the wound 
recurred twice, and in seven people the wound recurred three or more times. Six leg 
wounds did not heal. 
 
Five participants had had a wound on their leg which was described as an abscess by 
participants, and all had healed up. 
 
Despite the number of recurrences for some, the participants who had had a leg ulcer 
were able to say conclusively where they lived when they had it. Thirteen were in their 
own home, sixteen were homeless and one was incarcerated. 
 
Injecting in the leg wound area 
Of the 35 who had developed a leg wound, 26 had injected in the area previously to the 
wound appearing. 
Subsequent to the wound developing, 7 participants used it to inject into, 2 always used 
that site, 1 injected into it for 3 years, 1 used it when most chaotic and 3 were unsure 
how often they used it. 
 
Treatment of leg ulceration 
Nineteen participants of the thirty participants who had had a leg ulcer had a Doppler 
test, which is a pre-requisite to compression therapy. All reported having compression 
therapy.  
 
4.8 Prevalence of Skin Problems   
In response to the question ‘Have you ever had a skin problem?’, 60% (n = 120) said 
yes. Participants who had experienced skin problems were asked further questions 
about the type of skin problem they had. These were defined and explored with each 
participant to ensure that a standard definition (see Table 25 below) was used. 
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Skin problem Definition 
Lumps Hard swellings without broken skin, not red or hot or particularly painful 
Track marks Scratch marks, raised red veins, raised hardened veins 
Abscesses Raised red hot painful lumps, with or without obvious pus / broken skin – 
possibly required lancing/ surgery or have spontaneously burst 
Acid Burns Painful, blistered or broken skin directly attributed to use of acid 
Broken skin  Injecting injury that has caused a break in the skin, wounds, or scabs that 
have healed in less than 4 weeks 
Chronic wounds Any break in the skin (not a leg ulcer) that has been present 4 weeks or 
more 
Rashes Multiple red or pink spots, raised or flat that last longer than the short 
period following injection 
Table 25 Definitions of skin problems 
 
Of these, the majority complained of abscesses. 5% (n = 11) complained of other skin 
problems and these were bruising and varicose veins, phlebitis, cellulitis, haematoma, 
scarring and thin skin. Some participants had more than one skin problem (Table 26). 
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No. % No. % No. %
Individuals reporting a skin problem 80 67.0 40 33.0 120 60.0
Type of skin problem Leg ulcer 17 8.0 13 11.5 30 9.0
Abscesses 58 27.0 32 28.0 90 27.0
Lumps 40 18.5 18 16.0 58 17.5
Track marks 40 18.5 16 14.0 56 17.0
Acid burns 21 9.5 8 7.0 29 9.0
Chronic wound 17 8.0 11 9.5 28 8.5
Broken skin 15 7.0 10 8.5 25 7.5
Other skin problems 6 2.5 5 4.5 11 3.5
Rashes 2 1.0 1 1.0 3 1.0
Total 216 114 330
Males         
(n = 148)
Females 
(n = 52) 
Total      
(n = 200)
No. % No. % No. %
Type of skin problem by gender Leg ulcer 21 9.5 9 8.5 30 9.0
Abscesses 65 28.5 25 24.0 90 27.0
Lumps 38 16.5 20 19.5 58 17.5
Track marks 37 16.5 19 18.5 56 17.0
Chronic wound 20 9.0 8 7.5 28 8.5
Acid burns 19 8.5 10 9.5 29 9.0
Broken skin 15 6.5 10 9.5 25 7.5
Other skin problems 9 4.0 2 2.0 11 3.5
Rashes 2 1.0 1 1.0 3 1.0
Total problems 226 104 330
Current Injector Former Injector Total
 
Table 26 Frequencies of skin problems for current and former injectors / males and 
females 
 
4.9 Risk Factors for Leg Ulceration 
The proportion of participants with leg ulceration was quite low and therefore drawing 
causal links with statistical significance for some of the factors described was not 
possible due to the small numbers. Numbers were too small to test for significance for 
age group, hand dominance, interview location, postcode, frequency of injecting, drugs 
injected, substance used to dissolve heroin, types of water used, types and use of filters 
and acidifier, washing hands and cleaning skin, types of skin cleanser used, whether 
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participants injected themselves, who taught them to inject, site injected first, site 
injected most, frequency of injecting, injecting at wound site, parity, drinking alcohol, 
body mass index (BMI), nutrition, smoking, and having diabetes. 
 
In the following section risk factors are described where statistical tests were conducted 
and those of importance in the development of leg ulceration are identified (Table 27). 
The use of only larger numbers helped avoid a Type 1 error. 
 
As can be seen from Table 27 those variables that were not found to be significant in 
the development of leg ulceration for this sample were gender, homelessness, history of 
leg fracture, licking needles, skin or muscle popping and pregnancy. 
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Table 27 Risk factors for leg ulceration
 Risk Factors No. % No. % No. % p value * c2 Test used Cramer's V
Gender Male 21 70.0 127 74.5 148 74.0 0.588 .294 Pearson Chi-square .038
Female 9 30.0 43 25.5 52 26.0
Total 30 170 200
Homeless ever Yes 26 86.5 135 79.5 161 80.5 0.355 .855 Pearson Chi-square .065
No 4 13.5 35 20.5 39 19.5
Total 30 170 200
Injected 5 years or less Yes 3 10.0 63 37.0 66 33.0 0.004* 8.444 Pearson Chi-square .205
Injected  6 years and more Yes 27 90.0 107 63.0 134 67.0
Total 30 170 200
Used (insulin) 1ml syringes Yes 15 50.0 34 20.0 49 24.5 < 0.001* 12.407 Pearson Chi-square .249
No 15 50.0 136 80.0 151 75.5
Total 30 170 200
Used a new needle and syringe 
each time Yes 12 40.0 105 62.0 117 58.5 0.026* 4.976 Pearson Chi-square .158
No 18 60.0 65 38.0 83 41.5
Total 30 170 200
Licked needle Yes 12 40.0 57 33.5 69 34.5 0.492 .472 Pearson Chi-square .049
No 18 60.0 113 66.5 131 65.5
Total 30 170 200
Used  a filter Yes 29 96.5 169 99.5 198 99.0 0.56 Fisher's exact test .022
No 1 3.5 1 0.5 2 1.0
Total 30 170 200
Lower leg injector Yes 24 80.0 54 32.0 78 39.0 < 0.001* 24.939 Pearson Chi-square .353
No 6 20.0 116 68.0 122 61.0
Total 30 170 200
Groin injector Yes 28 93.5 83 49.0 111 55.5 < 0.001* 66.242 Pearson Chi-square .576
No 2 6.5 87 51.0 89 44.5
Total 30 170 200
Hit an artery Yes 27 90.0 82 48.0 109 54.5 < 0.001* 17.937 Pearson Chi-square .299
No 3 10.0 88 52.0 91 45.5
Total 30 170 200
Hit a nerve Yes 24 80.0 88 52.0 112 56.0 0.004* 8.251 Pearson Chi-square .203
No 6 20.0 82 48.0 88 44.0
Total 30 170 200
Always find  a vein Yes 9 30.0 110 64.5 119 59.5 < 0.001* 12.746 Pearson Chi-square .252
No 21 70.0 60 35.5 81 40.5
Total 30 170 200
Skin or muscle popping Yes 17 56.5 105 62.0 122 61.0 0.058 3.581 Pearson Chi-square .134
No 13 43.5 65 38.0 78 39.0
Total 30 170 200
Blood borne virus Yes 18 60.0 63 37.0 81 40.5 0.018* 5.569 Pearson Chi-square .167
No 12 40.0 107 63.0 119 59.5
Total 30 170 200
Smoking Yes 29 97.0 170 100.0 199 1 1.000 Fisher's exact test .030
No 1 3.0 0 0.0 1
Total 30 170 200
Heart problems Yes 11 36.5 16 9.5 27 13.5 < 0.001* Fisher's exact test .285
No 19 63.5 154 90.5 173 86.5
Total 30 170 200
Claudication Yes 18 60.0 14 8.0 32 16.0 < 0.001* Fisher's exact test .504
No 12 40.0 156 92.0 168 84.0
Total 30 170 200
Walking problems Yes 15 50.0 24 14.0 39 19.5 < 0.001* 20.916 Pearson Chi-square .323
No 15 50.0 146 86.0 161 80.5
Total 30 170 200
History of leg fracture Yes 12 40.0 44 26.0 56 28.0 0.112 2.521 Pearson Chi-square .112
No 18 60.0 126 74.0 144 72.0
Total 30 170 200
Pregnancy (n = 52 females) Yes 8 89.0 34 79.0 42 81.0 0.497 .462 Pearson Chi-square .940
No 1 11.0 9 21.0 10 19.0
Total 9 43 52
*p < .05
Yes had leg ulcer Never  had leg ulcer Total
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4.10 Injecting behaviours 
Injecting career 
A Pearson Chi-square test of association between leg ulceration and length of injecting 
career (0 - 5 years and 6 years and over) was conducted and it was found that the length 
of injecting career was statistically significant in the development of leg ulceration (p = 
0.004). 
 
Insulin syringes  
A test of association between whether or not participants had used 1ml insulin syringes 
and the development of leg ulceration was undertaken and found to be statistically 
significant (p < 0.001).  Participants with a leg ulcer are more likely to have used an 
insulin syringe. 
 
Using a new needle and syringe 
A test of association between the use of a new needle and syringe every time and the 
development of leg ulceration was statistically significant (p = 0.026) and so 
participants with leg ulcers were less likely to use fresh equipment.  
 
Leg injecting 
The data gathered for all participants were compiled to identify which participants had 
ever used the legs as an injecting site. 30% (n = 78) of participants had injected in their 
legs, and of these, 24 had developed a leg ulcer. The association was found to be 
statistically significant (p = ≤ 0.001).  
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Groin injecting 
55.5% of the sample had used the groin to inject (n = 111) and a test of association 
demonstrated that groin injecting was positively associated with developing leg 
ulceration (p = ≤ 0.001). 
 
Hitting nerves or arteries 
A test of association showed that hitting an artery when injecting was statistically 
significant in the development of leg ulceration (p ≤ 0.001) and so was hitting a nerve 
(p = 0.004). 
 
Finding a vein 
Those less able to find a vein were more likely to develop leg ulceration (p ≤ 0.001).   
 
4.11 Physical health 
Blood-borne viruses 
A Chi-square test was used to determine whether the diagnosis of a BBV (such as HIV 
or Hepatitis B or C) was a risk factor in the development of leg ulceration. The 
association was found to be significant (p = 0.018). This result does not take into 
account those participants who had never been tested (and could also have been 
positive), and therefore answered that they had never been diagnosed with a BBV.  
 
Heart problems  
A Fisher’s exact test was used to determine the statistical significance of being 
diagnosed with heart problems and developing leg ulceration, p ≤ 0.001, and therefore 
those diagnosed with heart problems are more likely to develop leg ulceration. 
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Claudication  
A Fisher’s exact test was undertaken to determine whether claudication was associated 
with leg ulceration, p ≤ 0.001, so claudication is associated with leg ulceration.  
 
Walking problems 
A Chi-square test showed that arthritis, joint and walking problems are associated with 
leg ulceration (p = ≤ 0.001). However it is not clear whether these problems preceded 
the ulceration, or were a consequence of the ulceration. 
 
4.12 Risk factors for venous disease 
Turning to known risk factors for venous disease, most of these were similar to non-
injecting groups (Moffatt et al, 2007, p78). As can be seen from Table 28 the variables 
that were not found to be significant in the development of leg ulceration for this 
sample were family history of venous disease and standing for long periods.  
Potential Risk Factors
No. % No. % No. % p value * c2 Test used Cramer's V
Deep vein thrombosis (DVT) Yes 29 96.5 36 21.0 65 32.5 < 0.001* 66.242 Pearson Chi-square .576
No 1 3.5 134 79.0 135 67.5
Total 30 170 200
Family history venous disease Yes 11 36.5 53 31.0 64 32.0 0.552 .353 Pearson Chi-square .042
No 19 63.5 117 69.0 136 68.0
Total 30 170 200
Varicose veins Yes 22 73.5 36 21.0 58 29.0 < 0.001* 33.690 Pearson Chi-square .410
No 8 26.5 134 79.0 142 71.0
Total 30 170 200
Skin staining Yes 9 30.0 9 5.5 18 9.0 < 0.001* Fisher's exact test .647
No 21 70.0 161 94.5 182 91.0
Total 30 170 200
Cellulitis Yes 20 66.5 16 9.5 36 18.0 < 0.001* 56.634 Pearson Chi-square .532
No 10 33.5 154 90.5 164 82.0
Total 30 170 200
Standing for long periods Yes 22 73.5 127 74.5 149 74.5 0.874 .025 Pearson Chi-square .011
No 8 26.5 43 25.5 51 25.5
Total 30 170 200
*p < .05
Yes had leg ulcer Never  had leg ulcer Total
 
Table 28 Risk factors for venous disease 
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Deep vein thrombosis (DVT) 
Some participants had experienced more than one DVT; 23 had DVTs in the lower 
legs, 41 had DVT in the upper legs, and 3 were unsure where their DVT was. 
A Chi-square test was undertaken which showed that DVT was associated with leg 
ulceration (p = ≤ 0.001).  
 
Varicose veins 
A Chi-square test showed that varicose veins are associated with the development of 
leg ulceration (p = ≤ 0.001).  
 
Skin staining on legs  
A Fisher’s exact test showed that skin staining on the leg was associated with leg 
ulceration in this sample (p ≤ 0.001). However, it is unclear again whether or not this 
preceded the development of leg ulceration. 
 
Cellulitis  
A  Chi-square test showed that cellulitis or ‘red leg’ is associated with leg ulceration in 
PWID (p ≤ 0.001).  However it is unclear whether or not this preceded the development 
of leg ulceration. 
 
DVT and injecting in lower legs 
The association between those with a DVT and those that injected in the lower legs 
ever was also tested using a Chi-square test of association (Table 29). This was 
statistically significant (p = ≤ 0.001). 
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DVT and groin injecting 
The association with DVT and groin injecting was also tested using a Chi-square test of 
association. This was statistically significant (p = ≤ 0.001). 
DVT and injecting
No. % No. % No. % p value* c2 Test used Cramer's V
Injected in lower legs Yes 40 61.5 38 28.0 78 39.0 < 0.001* 20.562 Pearson Chi-square .321
No 25 38.5 97 72.0 122 61.0
Total 65 135 200
Groin injecting Yes 61 94.0 50 37.0 111 55.5 < 0.001* 57.332 Pearson Chi-square .535
No 4 6.0 85 63.0 89 44.5
Total 65 135 200
*p < .05
DVT No DVT Total
 
Table 29 Association between DVT and injecting in the groin and lower legs 
 
Skin problems and the link to leg ulceration 
Chi-square tests of association were undertaken to identify if there was statistical 
significance between developing leg ulceration and experiencing some skin problems. 
Most skin problems were significant in developing leg ulceration unsurprisingly 
indicating that leg ulceration is more likely to occur where there are other skin 
problems also. The numbers were too small to analyse for rashes or ‘other’ skin 
problems. 
Type of skin problem c2 p
Lumps 5.609 0.018*
Track marks or scratches 6.429 0.011*
Abscesses 4.8 0.028*
Acid burns 3.826 0.05*
Broken skin 16.616 < 0.001*
Chronic wounds 88.046 < 0.001*
*p < .05  
Table 30 Relationship between skin problems and leg ulceration 
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Regression questions and results 
Many of the associations identified in the previous section may have been confounded 
by other variables.  
Direct logistic regression was thus used to ascertain if statistical relationships remained 
once these potential confounders were adjusted. 
 
As injectors grow older they may be more likely to develop age-related problems such 
as venous disease. Whilst this was managed within the sample by only including those 
aged below 44 years of age, it is possible that injectors are more likely to develop 
ulceration as they are older and this coincides with injecting for a long time. Similarly 
if PWID have progressively damaged their veins as their injecting continues, they are 
then more likely to access riskier sites such as groin. Injecting in the groin carries the 
risk of hitting arteries and nerves which were significantly associated with leg 
ulceration earlier. So which of these variables are significant? The first three models 
will examine which of the variables, while controlling for the others, are significant. 
The evolving models are detailed in Tables 31, 32 and 33. 
 
 
Model 1: Are injectors more likely to get a leg ulcer if they are older or because they 
have injected for a long time? How significant are age and length of injecting career 
on the development of leg ulceration?  
The model assessed the impact of two factors:  length of injecting (grouped into 0 - 5 
years and 6 years and over) and age now (under 35 or 35 years and over).The full 
model was statistically significant (X
2 
(2, n = 200) = 25.18 p ≤ 0.001) indicating that the 
model was able to distinguish between respondents who had and had not had leg 
ulceration. As shown in Table 31, both of the independent variables made a uniquely 
statistically significant contribution to the model. The strongest predicator of 
developing a leg ulcer was age with an odds ratio of 7.62. This indicated that those 
aged over 35 years were over 7 times more likely to develop leg ulceration than those 
who were younger than 35 years, controlling for length of injecting career. However, 
there were only two age groups.  The odds ratio of injecting career was 3.61 indicating 
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that the longer someone injects for they are more than 3 times more likely to get a leg 
ulcer controlling for other factors in the model. 
 
 
Model 2: Injectors are more likely to use their groin if they have been injecting for a 
long time. So how significant is groin injecting when controlling for age and length of 
injecting career? 
The logistic regression model was then revised to add in groin injecting to length of 
injecting career and age. The model containing three predictors was statistically 
significant (X
2 
(3, n = 200) = 38.06 p ≤ 0.001) indicating that the model was able to 
distinguish between respondents who had and had not had leg ulceration.  As shown in 
Table X, two of the independent variables made a uniquely statistically significant 
contribution to the model, groin injecting and age. The strongest predicator of 
developing a leg ulcer was groin injecting (p = 0.004) with an odds ratio of 9.23. This 
indicated that groin injectors were over nine times more likely to develop leg ulceration 
than those who were not groin injectors, controlling for age and length of injecting 
career. Those aged over 35 years were over six times (odds ratio 6.89) as likely to 
develop a leg ulcer as those under 35 (p = 0.003). 
 
 
Model 3: As PWID become older, they are more likely to develop chaotic injecting 
habits and inject in more risky places such as the groin. Injecting in the groin increases 
the likelihood of hitting a nerve or an artery. These are individually statistically 
significant in the development of leg ulceration, but which of these factors was most 
likely to cause leg ulceration? 
The model contained three independent variables (groin injecting ever, ever hit a nerve, 
ever hit an artery). The model was statistically significant (X
2 
(3, n = 200) = 46.213 p ≤ 
0.001) indicating that the model was able to distinguish between respondents who had 
and had not had a leg ulcer.  Only one of the independent variables, groin injecting, 
made a uniquely statistically significant contribution to the model.  This was the 
strongest predictor of developing a leg ulcer recording an odds ratio of 6.17. This 
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indicated that participants who had a leg ulcer were over six times more likely to have 
groin injected than those who did not, controlling for hitting nerves and arteries. Poor 
technique, such as hitting nerves and arteries, is less important than simply injecting in 
the groin. 
 
Groin injecting was significant in the last model, but as people continue to inject for a 
long time they may also inject into their legs.  
Logistic regression predicting the likelihood of developing a leg ulcer 
Odds ratio Lower Upper p Odds ratio Lower Upper p
Model 1 Length of injecting career and age
Age under 35 or over 35 years 9.434 2.757 32.279 .000 7.623 2.197 26.448 0.001*
Injecting up to 5 years and over 5 years 5.299 1.545 18.179 .008 3.611 1.017 12.820 0.047*
Constant .150 .000
Note R2 =  0.62 (Hosmer and Lemeshow), 0.118 (Cox and Snell), 0.207  (Nagelkerke)
Model 2 Length of injecting career, age and groin injecting
Age under 35 or over 35 years 9.434 2.757 32.279 .000 6.686 1.897 23.557 0.003*
Injecting up to 5 years and over 5 years 5.299 1.545 18.179 .008 1.809 .465 7.039 .393
Groin injecting .068 .016 .295 .000 9.235 2.014 42.345 0.004*
Constant .005 .005
Note R2 = 0.99 (Hosmer and Lemeshow), 0.173 (Cox and Snell), 0.304 (Nagelkerke)
Model 3 Groin injecting and hitting nerves and arteries
Groin injecting .068 .016 .295 .000 6.170 1.180 32.160 0.03*
Ever hit a nerve 3.727 1.450 9.578 .000 1.760 .634 4.900 .280
Ever hit an artery 9.659 2.823 33.049 .000 3.190 .785 12.980 .100
Constant .010 .000
Note R2 =  0.831 (Hosmer and Lemeshow),  0.138 (Cox and Snell),  0.243 (Nagelkerke)
Adjusted Odds Ratio (95% CI)Unadjusted Odds Ratio (95% CI)
Table 31 Prediction of developing a leg ulcer 1 
 
 
Model 4: Age was a strong predictor of developing leg ulceration. As people get 
older and their injecting career lengthens they may be more likely to inject into the legs 
and / or groin.  
The model contained four independent variables (age, length of injecting career, 
injecting into the legs and injecting into the groin). The model was statistically 
significant (X
2 
(4, n = 200) = 49.272 p ≤ 0.001) indicating that the model was able to 
distinguish between respondents who had and had not had a leg ulcer.  As shown in 
Table 32 three of the independent variables (age group, groin injecting and leg 
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injecting) made a unique statistically significant contribution to the model.  The 
strongest predictor was groin injecting at an odds ratio of 11.051.  Leg injecting was 
also a predictor of developing a leg ulcer recording an odds ratio of 5.306. This 
indicated that participants who groin injected were over eleven times more likely to get 
a leg ulcer, and if leg injecting, more than five times as likely. 
 
Logistic regression predicting the likelihood of developing a leg ulcer 2 
Odds ratio Lower Upper p Odds ratio Lower Upper p
Model 4 Age, length of injecting career and injecting into the groin and legs
Age under 35 or over 35 years 9.434 2.757 32.279 .000 4.692 1.274 17.280 0.02*
Injecting up to 5 years and over 5 years 5.299 1.545 18.179 .008 .948 .219 4.113 .943
Groin injecting .068 .016 .295 .000 11.051 2.363 51.678 0.002*
Leg injecting 8.593 3.320 22.242 .000 5.306 1.854 15.182 0.002*
Constant .004 .000
Note R2 = 1.179 (Hosmer and Lemeshow), 0.218  (Cox and Snell), 0.383  (Nagelkerke)
Model 5 Age, injecting into the groin and legs, and using insulin syringes
Age under 35 or over 35 years 9.434 2.757 32.279 .000 4.720 1.275 17.469 0.02*
Groin injecting .068 .016 .295 .000 8.495 1.754 41.146 0.008*
Leg injecting 8.593 3.320 22.242 .000 5.227 1.891 14.445 0.001*
Insulin syringe used 4.000 1.782 8.977 .001 1.713 .659 4.456 .269
Constant .002 .000
Note R2 =  2.046 (Hosmer and Lemeshow), 0.223  (Cox and Snell),  0.391(Nagelkerke)
Model 6 Age, injecting into the groin and legs, and inability to find a vein
Age under 35 or over 35 years 9.434 2.757 32.279 .000 4.406 1.128 17.208 0.033*
Groin injecting .068 .016 .295 .000 14.551 2.967 71.368 0.001*
Leg injecting 8.593 3.320 22.242 .000 7.445 2.467 22.464 0.000*
Inability to find a vein .234 .101 .542 .001 .190 .068 .533 0.002*
Constant .005 .000
Note R2 =  2.168 (Hosmer and Lemeshow), 0.261 (Cox and Snell),  0.485(Nagelkerke)
Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
 
Table 32 Logistic regression predicting the likelihood of developing leg ulceration 2 
Earlier the non-use of 1ml insulin syringes was found to be associated with the 
development of leg ulceration. 
 
 
Model 5: The older the drug injector, the more likely they are to develop a leg ulcer. 
Is the leg ulcer a consequence of age or of risky injecting practices such as non-use of 
small (insulin) syringes, leg and groin injecting? 
The model contained four independent variables (age, injecting into the legs and 
injecting into the groin and use of insulin syringes). The model was statistically 
significant (X
2 
(4, n = 200) = 50.494 p ≤ 0.001) indicating that the model was able to 
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distinguish between respondents who had and had not had a leg ulcer.  As shown in 
Table 32 three of the independent variables (age group, groin injecting and leg 
injecting) made a unique statistically significant contribution to the model.  The 
strongest predictor was groin injecting at an odds ratio of 8.495.  Leg injecting was also 
a predictor of developing a leg ulcer recording an odds ratio of 5.227. Use of insulin 
syringes was not significant, so the next model will examine whether with the known 
predictors, (controlling for age, groin and leg injecting) poor technique and inability to 
find a vein is significant. 
 
 
Model 6: The older the drug injector, the more likely they are to develop a leg ulcer. 
Is the leg ulcer a consequence of age, or of leg and groin injecting or inability to find a 
vein? 
The model contained the four independent variables and was statistically significant (X
2 
(4, n = 200) = 60.620 p ≤ 0.001) indicating that the model was able to distinguish 
between respondents who had and had not had a leg ulcer.  As shown in Table 32 three 
of the independent variables (age group, groin injecting and leg injecting) as before 
made a unique statistically significant contribution to the model.  The strongest 
predictor was groin injecting at an odds ratio of 14.551.  Leg injecting was also a 
predictor of developing a leg ulcer recording an odds ratio of 7.445. Inability to find a 
vein was significant but the odds ratio was low. 
 
As DVT was significant in the development of leg ulceration the next two models 
examined its role along with leg and groin injecting. 
 
 
Model 7: Many leg injectors develop DVT. Therefore this test was to establish 
whether leg injecting or DVT was more significant in the development of a leg ulcer. 
The model contained two independent variables, leg injecting and DVT and was 
statistically significant (X
2 
(2, n = 200) = 76.826 p ≤ 0.001) indicating that the model 
was able to distinguish between respondents who had and had not had a leg ulcer.   
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As shown in Table 33, both leg injecting and DVT made statistically significant 
contributions to the model.  Participants who had a leg ulcer were over 80 times more 
likely to have had a DVT, and nearly 5 times as likely to have leg injected. DVT was 
the most significant indicator. 
Logistic regression predicting the likelihood of developing a leg ulcer (DVT) 3
Odds ratio Lower Upper p Odds ratio Lower Upper p
Model 7 Leg injecting and DVT
Leg injecting 8.593 3.320 22.242 .000 4.803 1.617 14.266 0.005*
Deep vein thrombosis (DVT) 107.944 14.218 819.551 .000 80.601 10.473 620.289 < 0.001*
Constant .004 .000
Note R2 =  0.584 (Hosmer and Lemeshow), 0.319 (Cox and Snell),  0.559 (Nagelkerke)
Model 8 Groin injecting and DVT
Groin injecting .068 .016 .295 .000 1.436 .225 9.160 .702
Deep vein thrombosis (DVT) 107.944 14.218 819.551 .000 89.189 9.705 819.679 < 0.001*
Constant .006 .000
Note R2 = 0.464 (Hosmer and Lemeshow),  0.288 (Cox and Snell), 0.506  (Nagelkerke)
Model 9 Leg injecting, groin injecting and DVT
Leg injecting 8.593 3.320 22.242 .000 4.884 1.638 14.560 0.004*
Groin injecting .068 .016 .295 .000 1.691 .252 11.349 .589
Deep vein thrombosis (DVT) 107.944 14.218 819.551 .000 63.144 7.134 558.893 < 0.001*
Constant .003 .000
Note R2 = 1.698 (Hosmer and Lemeshow),  0.320 (Cox and Snell), 0.561 (Nagelkerke)
*p < .05
Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Table 33 Logistic regression predicting the likelihood of developing a leg ulcer (DVT) 
3 
 
 
Model 8: Many groin injectors develop DVT. Therefore this test was to establish 
whether groin injecting or DVT was more significant in the development of a leg ulcer. 
The model contained two independent variables, groin injecting and DVT. The model 
containing both predictors was statistically significant (X
2 
(2, n = 200) = 68.076 p ≤ 
0.001) indicating that the model was able to distinguish between respondents who had 
and had not had a leg ulcer.   
As shown in Table 33, only DVT made a statistically significant contribution to the 
model.  This indicated that participants who had a leg ulcer were over 89 times more 
likely to have had a DVT. 
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Model 9: From the above, three predictors have appeared most strongly indicative of 
developing leg ulceration.  Therefore this test was to establish whether groin injecting 
or leg injecting or DVT was more significant in the development of a leg ulcer. 
The model contained three independent variables, and was statistically significant (X
2 
(2, n = 200) = 77.123 p ≤ 0.001) indicating that the model was able to distinguish 
between respondents who had and had not had a leg ulcer.   
As shown in Table 33, only DVT made the most statistically significant contribution to 
the model.  This indicated that participants who had a leg ulcer were over 63 times 
more likely to have had a DVT. Leg injecting was also predictive of leg ulceration with 
an odds ratio of almost 5. Interestingly, in this model groin injecting was not 
significant.  
 
Summary of statistical testing 
The earlier tests of association yielded a number of variables of significance in the 
development of leg ulceration which were tested using regression. These were:  
 Increasing length of injecting career 
 Groin injecting 
 Injecting in the legs 
 Difficulty finding a vein 
 DVT 
 
As PWID get older they were more likely to have age-related problems and change 
habits in response. The regression testing showed that DVT was the greatest predictor 
of leg ulceration followed by injecting in the leg and groin injecting.  
 
Some other variables were also significant – BBVs, heart problems and claudication, 
mobility issues (joint and arthritic problems) however, each of these was not specific 
and the questions were not precise enough to be truly useful. Also, varicose veins and 
cellulitis were statistically significant in the development of ulceration however, as 
these often precede ulceration, they were known to be part of the progress of venous 
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disease towards the endpoint of ulceration and suggesting that these were causative 
factors would be inappropriate.  
 
4.13 Participants’ views on the cause of leg ulcers 
Participants who had experienced leg wounds 
The participants (n = 35) who had a wound on their leg were asked what they thought 
caused it. Four participants answered ‘don’t know’ and the remaining answers were 
grouped into emergent themes (Burns and Grove, 2005, p553). 
 
Hygiene 
The predominant theme related to hygiene – whether it was ‘sleeping rough and not 
able to get clean’ , or ‘not taking care of yourself’, or something within the drugs – 
sometimes described as a ‘dirty hit’ - ‘injecting the wrong way – under skin turned to 
poison and went septic, maybe a dirty hit’ , ‘dirty needle something on it’ ‘injecting in 
leg ?dirty hit’. 
Two participants described poison travelling down their leg: ‘injecting into groin – 
poison going down the way because I had a DVT and the poison had to get out 
somewhere….’ ‘poison travelled down the leg’. 
 
Abscess 
Some participants talked about the ulcer starting as an abscess: ‘through injecting, 
became a lump and then started breaking up’ ‘ an abscess –started as a red patch’ , 
‘abscess not healed …..got antibiotics but not healed up’, ‘ulcers appeared from 
abscesses sometimes would appear overnight 3 or 4 at a time at different sites from 
where injected – caused scarring’. 
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Injecting technique 
Injecting technique was also implicated : ‘desperation – withdrawal and not taking 
usual care’, ‘way I was injecting’, ‘hitting in wrong place, continuously using the same 
place’.  
Some of the participants related the leg wound to what they injected – two related this 
to injecting ‘jellies’, and four participants mentioned using cocaine, as well as MST and 
temazepam (or mixing as a speedball). Four participants put the ulceration down to 
injecting in the groin or injecting in the leg. 
 
Treatment 
Some mentioned forms of treatment- ‘a midwife pulled off the scab and it never healed 
up’, and ‘formaldehyde treatment for a DVT’. One self-treated with problematic results: 
‘ bad hit – blood blister and took a Stanley knife to them to clean it out and then 
abscess formed – and then got worse’. 
 
Delayed presentation 
Some reported the leg ulcer appearing later, sometimes a long time after the event  
‘don’t know – happened years after injecting’; ‘used to inject into leg years ago, 
knocked it against the car door and then an abscess formed- it’s been a year now’ , 
‘hitting jellies and MST – wounds appeared four weeks later’.  
 
Of those that actually had a wound on their leg there was no overarching theme to the 
responses. There was no true agreement between the participants. 
 
All participants’ views on causation 
The final question, asked of all participants, was ‘Why do you think some injectors get 
wounds on their legs and others don’t?’ 
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The answers were grouped into themes. Some answers comprised data that matched 
several themes, and responses were copied into more than one theme if appropriate. 
Some of the participants elaborated on their earlier opinions but essentially the 
responses were similarly diverse. Only fourteen (7%) answered ‘don’t know’. 
 
Technique 
The majority of responses related to technique. Some of these responses related to sites 
– reusing the same site, or injecting into sites where there was already a problem, 
letting others inject (and possibly sharing equipment) or a lack of knowledge about 
technique:  
‘Hygiene, still injecting into same area when already damaged’                                                                                                                                                                                                                                                                                                                                                    
‘people just give up and don't care - keep going in the same places, not keeping clean’        
‘careless injecting, possibly hygiene’                                                                                                                                                                                                                                                                                                                                                                         
‘don't know what they are doing and think they know what they are doing’                                                                                                                                                                                                                                                                                                                                          
‘people not being clean not injecting using proper procedure’ 
 ‘not taking their time and doing it right’    
‘don't know what they are doing’   
‘good hygiene, injecting bits of filters, injecting jellies in the past’    
‘not doing it right, letting others give them a hit - after they have given themselves’                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Some participants talked about being careless and injecting in a rush, sometimes when 
desperate for a hit:  
 ‘too much of a rush, can't do it right -don't care just want the hit’ 
‘carelessness - being careful helps and hygiene - finding veins help’                                                                                                                                                                                                                                                                                                                                             
don't know what they are doing, don't care when choking for a hit                                                                                                                                                                                                                                                                                                                                                
 ‘people rushing - not taking time’                                                                                                                                                                                                                                                                                                                                                                                
‘can't get it in - keep going into the same site - can't get it especially when full of it’                                                                                                                                                                                                                                                                                                                  
‘Don't take care how they inject - jab in - impatience - too rushed’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
‘a lot to do with looking after themselves, don't care how they get it into them’                                                                                                                                                                                                                                                                                                                    
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‘desperate - trying to get it in - too full of it and not being able to see what they are 
doing’ 
 
Injecting sites 
Others talked about choosing injecting sites without due care:  
‘sticking it in anywhere - blowing veins - not caring - makes a mess’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
‘using the same sites’                                                                                                                                                                                                                                                                                                                                                                                           
‘keep going into same bits all the time’                                                                                                                                                                                                                                                                                                                                                                          
‘injecting too much in the same place - muscle popping’                                                                                                                                                                                                                                                                                                                                                           
‘starting to inject in the groin first’      
 ‘putting it in anywhere, not caring about themselves’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
‘missing veins, vein blows and still using in, using the same place repeatedly’              
 ‘muscle popping, not getting in right vein’                                                                                                                                                                                                                                                                                                                                                                        
‘don't take care - people picking scabs on legs causing it to get worse - mainly women’                                                                                                                                                                                                                                                                                                                            
‘multiple popping, bang in anywhere'   
‘Injecting when high and missing – scratching’      
 ‘injecting - going in the fine veins all the time - using surface veins’                                                                                                                                                                                                                                                                                                                                           
‘injecting technique, missing or reusing same veins - using same place’     
‘not doing it right, dinnae know what way to put needle in – flushing’                                                                                                                                                                                                                                                                                                                                             
‘surface veins - injecting into surface veins, raising veins till they blow up’                                                                                                                                                                                                                                                                                                                                     
 
Hygiene 
Also rating highly were issues relating to hygiene:  
‘not looking after themselves, not enough cleanliness’                                                                                                                                                                                                                                                                                                                                                             
‘groin injecting- filthy hands and nails, poor facilities in hostels’                                                                                                                                                                                                                                                                                                                                              
‘not taking care not cleaning themselves enough’       
‘scratching the site, not washing hands’  
‘Don't take care - using too many swabs too often- touching it all the time instead of 
washing hands - not keeping clean’ 
‘dirty people, dirty clothes and not washing’                                                                                                                                                                                                                                                                                                                                                                      
 164 
‘dirty - hygiene - living in squalor and don't clean themselves (can't)’                                                                                                                                                                                                                                                                                                                                           
‘hygiene, not washing - morals go down the drain a lot of folk are homeless and can't 
wash’          
 
Self-neglect 
There was some emphasis placed on self-neglect which linked to hygiene, with 
comments about injectors not looking after themselves and not caring about 
themselves: 
‘not looking after themselves, not enough cleanliness’,                                                                                                                                                                                                                                                                                                                                                             
‘looking after themselves, cleanliness, rushed to have a hit and don't take care’                                                                                                                                                                                                                                                                                                                                 
‘don't look after themselves- cleanliness - you become lazy when strung out on heroin’      
‘not looking after themselves, letting others do their hits’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
‘the way they look after themselves – hygiene’                                                                                                                                                                                                                                                                                                                                                                    
‘homeless and being dirty, not living in clean environment - neglect themselves’                                                                                                                                                                                                                                                                                                                                  
‘putting it in anywhere, not caring about themselves’                                                                                                                                                                                                                                                                                                                                                             
‘people just give up and don't care - keep going in the same places, not keeping clean’                                                                                                                                                                                                                                                                                                                            
 
Drugs injected 
Types of drug injected were mentioned by some – in particular cocaine and temazepam 
(previously available as ‘jellies’), and the risk associated with the anaesthetic effects of 
cocaine: 
 ‘Cocaine - don't feel when veins are missed - keep injecting into wounds persisting’ 
‘people who are mixing their drugs and do it a lot, out of control’                                                                                                                                                                                                                                                                                                                                         
‘hitting MSTs and street jellies for a long time  - also the stuff coke is cut with’                                                                                                                                                                                                                                                                                                                          
‘constant drug use - vein abuse, what they inject especially temazepam’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
‘cocaine caused this - no-one had problems with just heroin - with coke you are 
injecting much more often - people aren't using filters with cocaine but still a lot of 
problems with legs’                                                                                                                                                                                                                       
‘Cocaine, amateurs missing veins’                                                                                                                                                                                                                                                                                                                                                                                 
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‘when people mix heroin and cocaine together - miss a vein and then an abscess comes 
and that’s it after it pops’ 
 ‘missing veins - depends on what its been cut with - people in Glasgow inject crushed 
temazepam - more chaotic users - no vit C to use - use a lot more in Glasgow and 
purer’   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
Injecting in the groin or leg 
Whilst a small number of participants linked the leg problems to groin injecting, none 
were absolutely clear about the problems to the venous system. Injecting in the groin or 
leg area was suggested by smaller numbers: 
‘going in the groin, using the same hole every time, running out of veins and long 
standing users - over 20 years’     
‘Injecting in legs, groin injecting’       
‘don't know but injecting into groins might be it’                                                                                                                                                                                                                                                                                                                                                                
‘injecting too often, injecting into leg’                                                                                                                                                                                                                                                                                                                                                                          
‘groin injecting, nicking femoral artery when injecting and citric - building up and 
working out through skin - livelihood - if not eating well or taking medication for 
wounds’   
‘Using groin’  
‘use legs more than other sites’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
‘injecting into legs when something is wrong’ 
‘persistent jagging in legs and body is rundown - scratching from the kit causes skin 
breaks down and gets infected then’                                                                                                                                                                                                                                                                                          
‘injecting in legs- don't keep it clean -don't get treatment’               
‘not using groin would help – DVT’                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                             
Injecting equipment  
Equipment was an issue for some, and some admitted to sharing: 
‘not taking their time to look for veins, might go through vein, that much of a hurry to       
get a hit. Not cleaning it right and using other people’s tools’                                                                                                                                                                                                                                                           
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 ‘cleanliness using old needles and reusing dirty needles, not looking after themselves’                                                                                                                                                                                                                                                                                                                            
‘using dirty needles - not using the right stuff’                                                                                                                                                                                                                                                                                                                                                                  
‘using dirty syringes / equipment’                                                                                                                                                                                                                                                                                                                                                                                 
‘Using old tools / not cleaning tools’                                                                                                                                                                                                                                                                                                                                                                             
‘Sharing others needles, dirty surfaces, reusing filters, not using a vein, reusing 
needles, not cleaning the skin’           
‘Reusing tools, sharing, going into the same place all the time, popping if can't find a 
vein. If rattling will do anything to get it in’                                                                                                                                                                                                                                                                        
‘not taking care of their equipment, sharing equipment, doing it on dirty surfaces, not 
being hygienic’                                                                                                                                                                                                                                                                                                            
 ‘Not cleaning needles or the heroin- where putting the needle in’              
                                                                                                                                                                                                                                         
Physical health 
Other raised suggestions related to a poor immune system or nutritional status: 
‘Depends on immune system run down, not enough nutrition in system’                                                                                                                                                                                                                                                                                                                                                           
‘how rundown someone is - how healthy they are’        
‘rundown, not looking after themselves not eating properly reusing same bit’                                                                                                                                                                                                                                                                                                                                       
‘how they look after themselves - if they have eating problems- pot luck’                                                                                                                                                                                                                                                                                                                                      
 ‘part diet / part laziness - not bothering to seek treatment and injecting in legs or 
groin’                                                                                                                                                                                                                                                                                                                       
‘own genetics, everyone is different’. 
‘not looking after themselves should get multivitamins when getting methadone at 
chemist’  
 
Infection    
Only two participants thought ulceration may relate only to an infection:                                                                                                                                                                                                                                                                                                                                                         
‘Flesh eating bug’                                                                                                                                                                                                                                                                                                                                                                                                 
‘infection’                      
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Vascular system 
A few participants suggested that the vascular system may be affected: 
‘poor circulation’        
‘Clots - blown a hit - vein too small and blown when injecting’ 
‘depends on individuals veins’                                                                                                                                                                                                                                                                                                                                                                                
‘varicose veins, ?had a knock on leg’                                                                                                                                                                                                                                                                                                                                                           
‘injecting when young, DVT restricting blood flow’         
                                                                                                                                                                                                                                                                                                                                          
A few remarks were difficult to classify some relating to age:  
‘Age - older users - using for a long time’                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
‘when stuff goes wrong and don't go for medical help’                                                                                                                                                                                                                                                                                                                                                              
‘Older generation get it, not younger people, Been using too long, injecting in silly 
places taking /reusing tools in desperation, when they start hitting the surface veins, 
people who don't wash and used to be in hospitals allow themselves to get so dirty 
that they'd get more money when begging’                 
                                                                                          
There was no overarching theme within these free text answers, and no participant 
clearly identified risk factors of groin injecting and thrombosis so it was difficult to 
conclude anything from the qualitative data that was different from the statistical 
conclusions.  
 
4.14 Phase 1 Results:  Discussion  
This section discusses the key results obtained from Phase 1.  
4.15 Sample characteristics 
The opportunistic quota sampling approach aimed to recruit a cross-section of the 
Glasgow injecting community, and whilst wide geographical spread was achieved, it 
was impossible to determine if the participants provided a cross-section of the injecting 
community, as the true representation of the population of PWID within a transient and 
mobile population was unknown.  
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However, the sample characteristics were comparable to the NESI study sample (Table 
34) which recruited injectors from across Scotland in 2010 and is possibly the most 
recent and similar study to match against (University of the West of Scotland, Health 
Protection Scotland, University of Strathclyde and the West of Scotland Specialist 
Virology Centre, 2012) . 
 Study sample NESI Sample 2010 
Male / female 74% / 26% 72% / 28% 
Mean age  35 years 35 years  
Mean age to start 
injecting  
22 years 23 years  
Homeless in last 6 
months 
41.5% 22% 
Table 34 Comparison between sample and NESI study sample 
 
74% of the participants were male and 26% female. This was similar to the NESI study 
and other Glasgow studies for example, Hay and Gannon (2004) estimated a proportion 
of approximately 70% males to 30% females and Shewan and Dalgarno (2005) used 
purposive chain referral sampling methods to recruit heroin users (75% male, 25% 
female).  
Glasgow may have a different drug culture from other cities and comparative studies of 
both injecting habits and skin problems have not previously been published. 
 
Sampling aimed to recruit participants between the ages of 16 and 44 years, however no 
participant recruited was under the age of 21 years. The data indicate that almost three 
quarters of participants started injecting before they were 25 years of age, with 17.5 % 
starting before they were 16 years. 46% were injecting before they were 20 years old. 
All potential participants were approached within each area and none was excluded on 
the basis of being too young, although a number were excluded as they were too old 
(aged over 44 years). It would appear that young injectors are not engaging with the 
drugs services used as recruitment sources within this study. This may be due to a 
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number of factors: services may not be attractive to younger people; it may be that new 
injectors are not approaching and using services, or it may be that the recruitment areas 
chosen for this study were not those that were used by young people. Dates of birth 
were possibly given incorrectly or perhaps younger people were not using these drugs 
to the same extent as previously, or some other unknown factor.   
 
The number of participants who reported leg ulceration and /or skin problems was a 
small proportion of the total sample population. In the case of leg ulceration this meant 
that although a higher proportion was found than expected, the actual quantification of 
participants was small (15% of the sample, n = 30) and therefore some planned analysis 
such as comparing groups of current and former injectors was difficult to do with  
meaningful statistics and ran the risk of error. Comparing groups within the sample 
such as those people who have diabetes and leg ulceration with those that do not have 
diabetes but have leg ulcers, when the number of participants with known diabetes was 
only four, would not have been worthwhile as the numbers were simply too small.  
Future larger studies could address this. 
 
4.16 Prevalence of leg ulceration 
The findings indicate an unexpectedly high prevalence of leg ulceration in the sample 
of young PWID. 15% of the sample population had experienced a chronic leg ulcer, 
whilst 7% had an active ulcer at the time of interview. Comparatively, 1% of the 
general adult populations within Western countries are likely to have a chronic leg ulcer 
at some time (Dale et al, 1983). Later studies have agreed with this seminal study 
(Cornwall et al, 1986; Nelzen et al, 1991), and therefore the prevalence within this 
injecting population is worryingly high. This figure verifies the anecdotal claims from 
community nursing practitioners who were seeing rising numbers of young people with 
leg ulceration in their clinical practice (Male et al, 2006; Devey, 2007; SIGN, 2010). As 
those with leg ulceration seek treatment, the increasing numbers of PWID will impact 
on leg ulcer services. 
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Ulceration often outlasted the injecting career. In this sample, thirteen participants who 
had leg ulceration were no longer injecting, and all had stopped over three months 
before, some many years before. Of those with active ulceration at the time of 
interview, all had stopped injecting at least six months previously.  Six current injectors 
had never healed up and of these, three had a Doppler test and compression, and three 
had not.  
 
With correct treatment some authors have indicated that pure venous ulceration could 
heal within three months (Blair et al, 1988; Moffatt et al, 1992). This was not evident in 
this sample but treatment was not discussed in depth.  
 
Nineteen participants had a leg assessment using a Doppler test, which is a pre-requisite 
to compression therapy (SIGN, 2010) and nineteen individuals reported then having 
compression therapy. This means eleven individuals who had a leg ulcer did not have a 
Doppler test or compression therapy.  
 
It was not within the scope of the questionnaire to investigate why this did not happen. 
It may have been individuals failing to access services, services being unavailable, or 
health professionals simply not following guidelines. Anecdotal reports indicate that 
some health professionals will treat PWID differently and actively withhold treatment 
as it is not perceived as worthwhile (Finnie and Nicolson, 2003; Ford et al, 2008). Also, 
leg ulcer treatment traditionally commences with compression bandaging applied 
weekly. If PWID are finding it difficult to engage and to keep weekly appointments for 
treatment, then they are likely to have treatment withheld as there may be a perceived 
risk in applying compression bandages to a patient who fails to return for re-
assessment, re-application or review. It is possible they were unsuitable for 
compression, but this is unlikely as the main reason for that would be an arterial deficit 
which could only be determined by Doppler testing. 
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Ulcer recurrence 
As was noted in the results session, of the 24 that had a healed ulcer, 13 (54%) 
subsequently recurred. For seven people the ulcer recurred three or more times. Three 
participants with recurrence had never had a Doppler test or treatment with 
compression.  
Slightly over half experienced a recurrence which is not unexpected with a failure to 
treat appropriately nor actively prevent recurrence (SIGN, 2010). Although small in 
number, the recurrence rate underlines the chronic nature of leg ulceration and the 
importance of early treatment.  
 
Prevalence of skin problems 
60% of participants had a skin problem at some stage in their injecting careers.  
 
There was a particularly high prevalence of abscesses, and a number of other wound 
types which do not appear to have been previously defined or explored within the 
literature. For example the ‘Shooting Up’ report of 2013 states ‘28% reported that they 
had experienced an abscess, sore or open wound during the last year’, all of which may 
be completely different types of wound (Public Health Groups, 2014).  
 
Similarly Hope et al (2008) explored the frequency, factors and costs associated with 
‘injection site infections’ and again defined these as ‘either an abscess (pus filled 
swelling) or an open wound / sore at an injection site as these symptoms are most likely 
to be due to bacterial infection’. Differentiation between wound types had not occurred.  
The ‘open wounds’ described in these studies may have included acid burns, leg ulcers, 
abscesses, and other open wounds – and none, or all, or a proportion of them, might 
have been infected or there may have been infection during some of the time the wound 
was ‘open’. Venous ulcers which are also ‘open sores/ wounds’ can occur away from 
the site of injection and also might never be infected.  This is an area that requires 
further work to address the definition of the soft tissue infections in PWID, and to stop 
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all open wounds being assumed to be infected which could lead to consequences of 
inappropriate prescribing of antibiotics for wounds that are not infected (Leaper, 1998). 
PWID will often use A & E departments or their GP for advice on injecting injuries, 
and will commonly receive antibiotics for redness, swelling and tenderness, abscess, or 
a sore / open wound (Hope et al, 2014). Unfortunately it is unclear in Hope’s study 
whether any of these wounds were truly clinically infected. 
 
The inappropriate use of antibiotics is of concern. Novick and Ness (1984) identified 
that a number of PWID were able to obtain antibiotics without prescription either from 
friends, or by using old prescriptions or by purchasing on the street. They interviewed 
197 patients admitted to a New York Hospital, USA, about their recent antibiotic usage 
and identified 13 patients who had recently abused antibiotics. No patient identified as 
abusing antibiotics had taken either the correct drug or the correct dose. Five patients 
cultured methicillin-resistant staphylococcus aureus from cutaneous ulcers. The authors 
also warned that PWID may present with apparent infection, but bacterial cultures may 
yield negative results as growth may be suppressed by the illicit use of antibiotics. On 
the other hand, injectors may have positive cultures but no clinical signs of infection 
and antibiotics are given because the open wound is assumed and misunderstood to be 
infected. 
 
As this was 1984, long before the current global anxiety about multi-resistant 
organisms, and known over-prescribing of antimicrobials, this was an interesting 
finding. Subsequently, Binswanger et al (2000) reported similar antibiotic access and 
Roose et al (2009) in a survey investigating self-management of wounds in PWID also 
found a small number who had acquired antibiotics without prescription. Callahan et al 
(1998) similarly acknowledged that some PWID will self-medicate with antibiotics. It 
would appear that PWID have access to a wide range of pharmaceutical preparations 
without prescription and the ease of access to antibiotics in this group is concerning.  
 
It would be interesting to explore the drug-related death data to see whether there are 
deaths from multi-resistant organisms given the reporting of frequent prescribing of 
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antibiotics, the street trade in antibiotics and the inappropriate taking of street 
antibiotics and likely non-adherence to completing full courses of antibiotics. At the 
moment these data do not appear to be known (ISD, 2011). 
 
In this study, identification of true infection would have been difficult without clinical 
assessment and unlikely to be accurate. However, given the emphasis on soft tissue 
infection in the literature and the apparent difficulty with definition, this would be 
interesting to explore in future.  
 
4.17 Risk Factors for Ulceration 
The logistic regression tests showed strongly that the greatest risk for leg ulceration in 
this sample was DVT. However, this was strongly associated with injecting in the groin 
and also injecting in the legs. Participants were more likely to proceed to groin injecting 
or lower limb injecting the longer their injecting career lasted. The length of injecting 
career rather than simply age was also significant in developing ulceration. The tests for 
significance revealed other factors that were significant although none quite as 
important as thrombosis linked to groin and leg injecting. This is a key finding in the 
development of new knowledge surrounding the cause of leg ulceration in young 
PWID. 
 
Deep vein thrombosis (DVT) 
The statistical data are clear. A third of participants had been diagnosed with a DVT, 
which is the most significant risk factor for leg ulceration in this sample. DVT was also 
associated with leg injecting and groin injecting. Following a DVT, post-thrombotic 
syndrome can develop which is characterised by poor blood flow and which can lead to 
swelling, pain and ulceration and long-term implications for quality of life. Participants 
experienced DVT in both upper legs (thighs) and lower legs, both of which could 
precede post-thrombotic ulceration.  It was not clear whether the ulcer occurred 
overlying an area where the DVT occurred.  
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DVT was explored further in Phase 2.  
 
Leg injecting 
Leg injecting was strongly associated with the development of a DVT and with 
subsequent leg ulceration. The questionnaire was not sensitive enough to identify 
whether those that injected at specific points on their leg went onto develop ulceration 
at the same site, or indeed whether DVT occurred at the same site as injecting. 
However, it would not be surprising if injecting damage at a particular site should then 
lead to ulceration at some point in time.   
 
Groin injecting 
Approximately one third of all participants injected in their groin and used the groin 
most commonly. Six people started injecting in the groin as a first access point. Groin 
injecting is culturally acceptable and common in Glasgow, and it can be assumed that 
knowledge of the technique is shared and perhaps recommended and perpetuated 
between injecting groups.  
Groin injecting, with the persistent trauma of needle puncture creating an inflammatory 
reaction and clotting, leads to scarring, and narrowing of the femoral vein can lead to 
thrombosis (Senbanjo et al, 2012). The presence of a DVT in the femoral vein or any 
vein above the lower leg is likely to cause a venous back pressure, hypertension and 
damage which can lead to ulceration (Moffatt et al, 2007, p76).  
 
Around half of the participants reported hitting arteries or nerves, which was 
significantly associated with development of leg ulceration. Those who reported this 
were also more likely to be groin injectors as the femoral vein lies close to the femoral 
artery and nerve in the groin. Injecting in an artery can have limb- and life-threatening 
implications. The impact of damaging the arterial system can be long-term, and 
possibly have implications for the development of ischaemic ulcers in the lower legs 
(Milburn and Brittenden, 2006). The high percentage of reported injuries to nerves and 
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arteries does indicate that injecting technique could be improved and that groin 
injecting is not necessarily as complication-free as some injectors suggest. 
 
Injectors sometimes regard the groin as the answer to their injecting difficulties. It is a 
site they can access frequently and can be hidden from view. The femoral vein is large 
and thick-walled and can tolerate frequent puncturing, so from an injector’s point of 
view it is a good result. However, medically there are huge risks such as 
pseudoaneurysms, DVT, femoral bleeds, abscesses and infection as well as vascular 
problems distally in the venous, arterial and cutaneous systems (Roszler et al, 1989; 
Welch et al, 1990; Woodburn and Murie, 1996; Mackenzie et al, 2000). 
Susceptibility to abscesses and pseudoaneurysms in the groin that impinge on blood 
supply to the lower limbs is a serious risk and may need surgical intervention affecting 
arterial supply to limbs, which could ultimately cause arterial ulceration. There is also a 
risk of amputation (Maliphant and Scott, 2005; Georgiadis et al, 2005). It is unclear 
why the groin is such a favoured site, given these risks and so this was considered 
worthy of further exploration in Phase 2. 
 
Injecting career 
The length of injecting career - the longest in this study was 31 years - was statistically 
significant in the development of leg ulceration, and also in the development of skin 
problems generally. Concurrently with injecting for a long time, the individuals also 
became older. With age comes disease processes, but even controlling for age, the 
length of injecting career was significant in the development of leg ulceration. Despite 
injecting for a long time, and the prolonged opportunities to engage with harm 
reduction, participants still did not link risky activities to leg ulceration.  
 
Injecting habits 
Whilst some individual habits had changed over time in some ways, these were difficult 
to draw any significance from, as the questionnaire lacked time specificities. Almost all 
the participants claimed to make up their drugs and inject in the same way every time.  
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The ritualistic practices associated with their habits seemed important and some 
expressed this as part of the attraction. They actually enjoyed the process and the 
anticipation (McBride et al, 2001). Clearly if the ritual included risky or unsafe 
practices then these would be perpetuated. This would need to be considered when 
planning harm reduction as habits and ritualistic practices may be particularly 
challenging to change.  
 
Some questions related to activities that occurred over many years, such as injecting 
technique. What some participants did at the beginning of their injecting career such as 
the type of acidifier used, was different from the end. It unlikely that all activities 
would be remembered, and the questionnaire was not sensitive enough to reflect 
changes over time or what was done on a day-to-day basis, if it varied at all, limiting 
some of the analysis relating to cause and effect. Practices did change over time as 
evidenced by the long-term injectors’ discussions around what they used to do and 
what they do now and it was clear that there had been some element of reduction of risk 
such as the advent of freely available paraphernalia which reduced the need to clean, 
share, steal and re-use. 
 
The questionnaire focused on asking what was ‘normal’ or ‘usual’ for the participant in 
terms of injecting behaviours but it may not have been the ‘usual’ practices that caused 
the skin problems. It may well be that it was the occasions when the participant was 
‘rattled’, desperate, injected by others or unable to remember that caused the problems.  
 
Drugs injected 
Most of the participants (87.5%) injected heroin. Cocaine and ‘jellies’(temazepam) 
were both mentioned by participants as possible causative factors in leg ulceration 
though numbers were too small to reach significance. Cocaine is a known anaesthetic 
and the normal signs of warning pain when a needle has been inserted badly may not be 
felt due to the anaesthetic effect (Lloyd-Smith et al, 2008).  It is rare for ‘jellies’ to be 
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injected now however, those that injected a long time ago may have ongoing problems 
as a result of solidification in the veins (Forsyth et al, 1993).  
 
Interestingly, the recruitment phase coincided with an apparent ‘heroin drought’. This 
was reported widely by service users, and was presumed to be due to successful police 
operations. There appeared to be a concurrent reduced demand for injecting equipment 
at needle exchanges. In Dundee, a similar heroin drought was reported within the media 
and drugs services were noting an increase in abscesses and injecting injuries, possibly 
due to the existing heroin becoming contaminated. This could have been due to the 
necessity of increasing bulk (and therefore apparent supply), with users also accepting 
poorer quality heroin and / or seeking alternative dealers or alternative drugs in 
response to the reduced availability of their usual drug (BBC Radio Scotland 
Newsdrive 30/07/08). 
 
The heroin drought had potential implications for this study but there are difficulties in 
obtaining information around supplies of illicit drugs, and what they are adulterated 
with.  It was not possible to identify sources and dealers. Similarly it is not possible, 
without acquiring supplies of heroin and conducting laboratory tests, to know what is 
within the compound that may potentially cause skin problems.  
 
Injecting sites 
When the injecting sites were investigated, participants were asked where they started 
injecting, where they inject currently and where they had injected most often. Most 
started injecting in their upper body, usually arms and hands.  
Initially, when the questionnaire was being developed, it was considered that possible 
causes of skin breakdown may include poor injecting technique and it may be that in 
order to reach certain parts of the body the non-dominant hand might be required to 
hold the injecting equipment, therefore being less skillful (Maliphant and Scott, 2005). 
However, the complexity of linking sites of breakdown with dominance retrospectively 
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was difficult, as the large number and variety of injecting sites were not anticipated 
prior to data collection.  
Participants also reported that ulcers appeared at different sites to the injecting site, 
often on the pretibial aspect of the leg which is unusual, and were not apparently 
associated with trauma or arterial disease. Pretibial ulceration has been previously 
reported in drug injectors (Williams and Southern, 2005). 
 
Although uncommon, injecting into wounds is known to occur and in this study 7 of the 
35 participants who had a leg wound used it as an access point for drugs to be absorbed 
(Phillips et al, 2013). This is likely to prevent healing. 
 
Difficulty in finding a vein and ‘popping’ 
Just fewer than half the participants had at some time failed to find a vein and had 
‘missed’ or injected into tissue or muscle, with over a third knowingly skin or muscle 
‘popping’.  When the ‘popping’ occurred, and the timing of ulceration is unclear. More 
of the long-term injectors ‘popped’, suggesting that as injecting careers progressed 
‘popping’ became more prevalent as the veins collapsed and become useless for 
injecting into.  This ‘popping’ is significant in the development of ulceration and is 
worthy of further exploration. 
 
Fresh needles and syringes  
Many long-term injectors had little or no access to clean needles and syringes when 
they began their injecting careers. Some reported that a local medical supplier sold 
injecting equipment, but when it closed they had no option other than to steal from 
hospitals and medical centres. The participants not only reported stealing sterile 
equipment but also a trade in sharps disposal bins which they broke open to extract 
used injecting equipment. This appeared to be usual practice in the late 1970’s and 
early 1980’s when heroin use became more commonplace, prior to IEP in Glasgow. 
Despite harm reduction attempts to persuade PWID to use a new needle and syringe for 
every injection, it appears this is not widespread and standard practice. Nonetheless, in 
 179 
this study, participants who used a fresh needle and syringe every time were less likely 
to develop leg ulceration, although those who had been injecting more recently would 
have easier access to clean injecting equipment. 
 
The nomenclature change of ‘needle exchange’ to ‘injecting equipment provision’ with 
the emphasis on provision should have helped with the distribution of fresh equipment. 
However, during data collection within pharmacies which provided IEP, the researcher 
frequently witnessed staff members demanding returns and stating that IEP would be 
withdrawn if returns were not given.  Whilst ‘exchange’  has been a long held argument 
in terms of public health related to disposal of equipment, there has been a stronger 
argument put forward for freely available equipment which may prevent sharing and 
thus the transfer of BBVs (Scottish Government, 2010). 
 
Insulin syringes 
Unsurprisingly those who were using insulin syringes appeared less likely to develop 
leg ulceration. This may be because the needles are smaller, and are pre-packed with an 
attached syringe. Hence there is less touching and contamination in preparing the drugs.  
Harm reduction initiatives already recommend using the smallest needle possible.   
 
Filters 
Filters are used by heroin users during the preparation of their injection to remove the 
insoluble adulterants from their drugs but using a fresh filter every time was not 
significant.  Filters are available within some needle exchanges, though at the time of 
the questionnaire these were not routinely available in Glasgow. Participants in this 
study used a variety of filter materials, most commonly cigarette filters, but also socks, 
pillows, cushions, cotton wool, and it is possible that fibres or particulate matter from 
the filters are injected. Some injectors save up used filters for a time when they have no 
drugs, and cook up the filters in an attempt to yield another hit of heroin. The filters 
may also serve to blunt a needle, making injecting more traumatic for the vein and 
leading to potential problems.  Statistically it was impossible to tell from the small 
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numbers whether different types of filter would be significant. However, filtering drugs 
before injection is part of safer injecting advice. 
New syringes which incorporate a filter within the syringe have been marketed since 
the data were collected and these may help prevent skin problems.    
 
Licking needles  
Licking needles is rarely addressed in harm reduction literature in the UK  although a 
recent study had found that over 30% of subjects in a small sample of PWID licked 
their needles prior to injecting (Deutscher and Perlman, 2008). Results of this survey 
suggest that this seems to be a practice that is not unusual.  
 
Licking needles was not statistically significant in terms of development of leg 
ulceration. However, more people who licked their needle had leg ulcers than those 
who did not. From the literature (Orangio et al, 1984; Henriksen et al, 1994; Summanen 
et al, 1995; Binswanger et al, 2000), bacterial culture of wounds and abscesses in 
PWID reveals growth of oro-pharyngeal organisms. This suggests a transfer of saliva or 
oral fluids into wounds by some mechanism. Only one participant reported licking their 
skin to clean it prior to injecting, whereas much greater numbers reported licking 
needles.  No participant reported using saliva to mix up their drugs. This could be given 
greater attention when discussing harm reduction.  
 
Acidifier  
The role of acidifiers in the breakdown of skin is unclear.  Almost all participants used 
an acidifier to break down the heroin and this was usually citric acid provided by drugs 
services.  Surprisingly, despite the availability of sterile ‘citric’, other unsterile 
substances were also being used such as vinegar, lemon juice, and non-pharmaceutical 
vitamin C which can cause harm (Albini et al, 2007). Although pharmaceutical citric 
acid has only been available in recent years, the use of alternative acidifiers appeared to 
be more widespread with frequent mention of using lemon juice and / or vinegar, and 
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there were comments from participants about using any acidifier they could get their 
hands on, including effervescent vitamin C tablets.   
 
The quantity of acid may be important and much less than is contained within the 
commercial sachets is needed to dissolve the average heroin ‘score’ (Scott et al, 2000).  
It would be useful to explore further the role of injected acid in skin breakdown, and 
whether harm occurs within the vein or only when hits are missed. 
 
Gender 
Interestingly, there was no link between gender and leg ulceration in this sample, 
despite females being known to be more prone to leg ulceration due to having finer and 
smaller veins (Topp et al, 2008; Human et al, 2009).  A slightly greater percentage of 
females (17%, n = 9) than males (14%, n = 21) had ulceration but this was not 
statistically significant. This difference may be due to sampling bias. Males may be 
more likely to attend exchanges and collect equipment for their female partners 
(Barnard, 1993).  
 
Housing 
A surprisingly high number of participants (over 80%) had been homeless at some time 
in their lives, and at the time of interview 50% were homeless.  The impact of 
homelessness on health (Stratigos et al, 1999; Badiaga et al, 2005; Keaney et al, 2011) 
cannot be underestimated and will impact on all aspects of a person’s life. However, 
this does not appear to be significant in the development of either skin problems or 
specifically leg ulceration in the sample population. A study by Stratigos et al (1999) in 
Boston (US) investigating skin disease in a homeless shelter found a range of relatively 
minor dermatological conditions, but similarly no leg ulcers and no abscesses.  
 
In this study, when the leg ulcer was experienced, almost half of participants were 
living in their own home. Being unable to maintain good hygiene was thought by many 
of the participants to be a factor in the development of leg ulceration, and good hygiene 
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practices may be difficult to achieve when a person is homeless and unable to wash 
hands, clean skin, prepare drugs in a clean environment, or wash themselves properly. 
Injecting outside and in public places, through necessity and lack of a safe place to go, 
also impaired an ability to wash hands and keep clean. Although numbers were too 
small to test for significance in leg ulceration, those who had poorer hygiene practices 
had a greater proportion of leg ulceration, and perhaps with a larger study this might 
have been more meaningful. However, it is quite possible that some participants despite 
stable housing did not maintain their own personal hygiene or take care of their legs. 
 
Part of harm reduction advice relates to hand washing and skin cleansing. Some studies 
have argued for the importance of skin cleansing prior to injecting but there is little 
empirical data to support this, although it makes good sense (Vlahov et al, 1992; 
Murphy et al, 2001; Mercure et al, 2008; Dwyer et al, 2009; Phillips et al, 2013). 
Mercure et al (2008) describe a Canadian educational activity to reduce injecting-
related infection by skin cleansing, with drug injectors who were then able to pass 
information on to peers. Practical workshops on infection transmission and skin care as 
well as identification of skin problems enabled positive behavioural changes and may 
be something to explore as part of harm reduction.  
 
4.18 General health and co-morbidity 
Smoking and vascular disease 
Almost all participants were tobacco smokers (99%) and almost half were heavy 
smokers, smoking over 20 cigarettes or 1/2oz of tobacco a day.  It is possible that the 
impact of smoking on peripheral vascular disease and subsequent leg ulceration may 
become apparent much later in life, and beyond the age-group within this study. 
Although smoking was not significant in this study, it is known to have a long-term 
impact on health, and is closely linked to heart disease and peripheral vascular disease 
(PVD) (SIGN, 2006). Heart problems, and claudication, which is a sign of ischaemia in 
the lower limb and an indicator of PVD, were both significantly linked to leg ulceration 
indicating that a level of arterial vascular disease was already being experienced by 
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these young PWID. This suggests that all leg ulcers in injectors cannot be assumed to 
be venous, and underlines the importance of identifying an arterial deficit through a 
Doppler test. 
 
Venous signs  
Venous leg ulceration is regarded as end-stage venous disease and there are signs that 
usually precede its development. It was not possible to undertake a clinical assessment 
at this stage in the study, but questions about venous disease indicators were asked 
instead (Eklof et al, 2004; SIGN, 2010).  Unsurprisingly, classic venous disease 
indicators such as DVT, cellulitis, and varicose veins were associated with the 
development of ulceration. Other indicators such as family history, parity and obesity, 
were too few in number to reach significance in this sample. However, the 
questionnaire was also not sufficiently specific to determine whether these signs 
preceded ulceration or were present following ulceration or indeed were associated with 
the active ulceration. 
 
Mobility 
Those diagnosed with mobility difficulties, joint problems, or arthritis were more at risk 
from leg ulceration however, it is unclear whether the mobility and joint problems 
preceded or were a result of the ulceration (Moffatt et al, 2007, p54). Fractured lower 
limbs were not statistically significant in the development of leg ulceration in this 
sample, though it is known that fractures are linked to the development of venous 
disease. Fractures may have more of an implication in later life.  
 
Standing 
Occupations or hobbies that involve standing for long periods of time are associated 
with the development of varicose veins and venous disease (Tuchsen et al, 2000). In 
this sample, standing was not associated with the development of leg ulceration but it is 
likely that the interview schedule was not specific enough. Many of the participants 
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focused their answers on the job aspect rather than anything else, although the 
researcher did emphasise that hobbies were also of interest.  Many had never been 
employed but may have sold the ‘Big Issue’ magazine, often standing on street corners 
or other pitches, or been begging, or had a hobby such as fishing or watching football 
that may have involved standing for long periods. A proportion said they were painters 
and decorators, which did involve standing, but the researcher later learnt that this was 
a trade often acquired within prison services and may not be anything that the 
individual had undertaken for any length of time. The length of time for which an 
individual stands for in order to acquire venous disease is unknown and this variable 
may have been significant in an older group. 
 
Blood-borne viruses 
Those diagnosed with a BBV were more likely to have had leg ulceration. This was 
surprising as BBV are not commonly associated with skin breakdown. HIV and 
Hepatitis are prevalent amongst Glaswegian injectors and can be asymptomatic 
(Hutchinson et al, 2004; Hutchinson et al, 2006; Nambiar et al, 2015). The figures for 
this study may have been under-represented as the question asked if participants had 
been diagnosed, and of course there may have been many who had not engaged with 
health services and were potentially positive, but had never been tested. 
This may apply to other questions asked about health. There may have been pre-
existing conditions that the participant was unaware of. If they are unable to talk to a 
health-care practitioner, then they would probably not be comfortable when presenting 
for well-person checks or similar appointments to identify disease. 
 
Nutrition 
It was difficult to assess the nutritional significance for those with leg ulceration as 
numbers were too small. A small number of participants were overweight (17% of the 
sample) but some said this was due to the high sugar content of methadone (Preston, 
2008). A third considered themselves to be underweight. Being either underweight or 
overweight may impact on venous disease and on healing and some of the participants 
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felt their ulceration could be linked to their eating habits. Certainly insufficient intake 
of food links with a number of harms and not simply poor wound healing (Anema et al, 
2010). Nutritional supplements may be worth considering in those with ulceration but 
there is school of thought that PWID obtain nutritional supplements in order to avoid 
having to buy food and thus divert money to service the addiction (Sillars, 2013).  
 
Medication 
For a young population, all under 44 years old, it was surprising that 97% took 
medications other than that which they injected. This sample includes a high number of 
‘dual diagnosis’ participants who were prescribed medications for co-occurring mental 
illness and substance misuse. Almost half were taking medication acting on the central 
nervous system (CNS), whether this was antidepressants, antipsychotics or anti-manic 
medication or combinations of these.  Of these, 89 (43.5% of sample) were also taking 
an opiate substitute in combination with a CNS active drug.  
The co-occurrence of substance use and mental disorders have been well-documented 
in the literature, the most prevalent appears to be anxiety disorders, major depression 
and personality disorders (Mackesy-Amiti et al, 2012) and up to 85% of patients in 
drug and alcohol treatment have a concurrent mental health problem (Hamilton, 2009). 
Mental ill-health may impact on a participant’s ability to engage with services.  
 
91% (n = 182)  were taking an opiate substitute (methadone or buprenorphine), and of 
the 99 injectors, only 12 were not taking an opiate substitute. So, most PWID were 
injecting whilst taking a prescribed opiate substitute. Clearly the substitute prescribing 
is not replacing illicit substance use, or injecting, in this sample. Also if PWID are 
receiving substitute prescriptions and continuing to inject, this may be against a 
prescriber’s wishes or knowledge (Shewen, 1992). If the injecting behaviour is hidden, 
then it is probable that injectors will not seek help readily when they have injecting 
harm or injury, potentially leading to chronic or deteriorating wounds, increased harm 
and infection, and possibly crisis presentation at hospital (Morrison et al, 1997). 
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Parity 
Pregnancy can lead to venous problems in the legs due to raised abdominal pressure, 
similar to obesity (Evans et al, 1999). However in this sample, 42 of the 52 women 
participating had had a baby, (81% of the female sample) and neither having a baby, 
nor having more than one baby, was statistically significant in the development of leg 
ulceration, but numbers were very small. It may have been more accurate to ask more 
specific questions about abdominal size and pregnancies that went to term however, as 
many PWID have children taken into care, this is a highly sensitive area and could 
possibly be explored in a different study (Chandler et al, 2013). 
 
Access to care 
The majority of participants (99%) had access to a health care professional such as a 
GP or Practice Nurse, but only 79% (n = 158) felt they could  talk to that professional 
and the reason for this could be varied and not always clear. However, the majority of 
participants (n = 133) would consult the healthcare professional about a skin problem 
related to their drug use. Although the majority of participants (60%) would go to a GP 
if they needed advice for a skin problem related to injecting, it is possible that the GP 
will deal with the problem presented in front of them, such as an abscess requiring an 
antibiotic.  
However, GPs may not have time, knowledge or training to discuss injecting 
techniques in order to reduce the incidence of further infections or injecting 
complications. It is notable that more participants would attend a GP than a drugs 
service and only 16% would attend a needle exchange or drugs worker for advice. This 
merits further exploration. Given that wound care services are not generally available in 
these places, it would indicate that a reasonable proportion of PWID do not have access 
to specialist skin or wound care advice and indeed may consider that drug services are 
not places to seek advice around physical health (Scottish Government, 2010). If skin 
problems are not addressed early and appropriately, then wounds are more likely to be 
chronic or problematic later. Problems may manifest themselves long after injecting 
and drug misuse has ceased (Pieper, 1996b; Lawson, 2010) and so care providers may 
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not understand that wounds were related to past activities. Opportunities for health 
promotion and harm reduction in relation to injecting may then be missed and hence 
costs of treatment will be unnecessarily increased.  
 
4.19 Participant views on risk and causation 
Those who had a wound on their leg were asked what they felt had caused it. The 
answers were extremely varied and there was no common and consistent theme and no 
conclusion could be drawn. This was surprising and unexpected. In clinical practice the 
researcher had found that most patients with a leg ulcer did suggest a theory of 
causation, and these were often similar, such as a traumatic event resulting in a non-
healing wound.  
 
The wider sample also did not identify links with leg ulceration. This suggests that the 
participants did not know that developing chronic wounds was a possibility, nor did 
they understand the link between the risks of leg and groin injecting and consequences 
of venous disease and ulceration.  
 
The main themes emerging from participants’ opinions were injecting technique, 
hygiene, self-neglect, abscesses, infection, treatment, and injecting site.  More 
specifically, there was little consensus from participants who had experienced 
ulceration as to what had caused the wound. 
 
Interestingly, the responses were very diverse but all of the responses had in some way 
been mentioned earlier during the interview relating to possible risk factors such as 
homelessness, skin cleansing and injecting equipment. This could be viewed as 
validation of the questionnaire which appropriately covered all relevant topics related to 
injecting and leg ulceration, or simply because the participants had been given ‘ideas’ 
earlier that they merely repeated, as many started off their answers with ‘I don’t know,  
but it could be ….’.   
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Chapter summary 
The first phase was designed to answer the first research question ‘What is the extent of 
skin problems and chronic leg ulceration in young people who inject drugs?’  A high 
prevalence of leg ulceration and skin problems was identified within the sample of 
young PWID. 
The second question, ‘What causes chronic leg ulceration in young PWID?’ has been 
answered in part. A number of important factors have been explored. Statistical 
significance was found specifically for groin injecting, leg injecting, and DVT. 
However these risks were perceived of little importance to participants as most could 
not identify them as causes of leg ulcers. Potential causal / risk factors, based on these 
findings, required further investigation especially with young PWID who had 
experienced leg ulceration. Questions specifically about the ulceration and what might 
be done to prevent it, were needed. This would help to begin to answer the third 
research question: ‘What are appropriate harm reduction measures for leg ulceration 
in young PWID?’ 
 
Within the next chapter, the findings of Phase 2 sought to clarify perceived causal and 
risk factors for leg ulceration based on the results of Phase 1, exploring from the 
participant’s perspective what caused the ulcers and then examining what might be 
done to reduce harm and prevent ulceration.  
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Chapter 5  
Phase 2: Findings 
Introduction 
The quantitative study in Phase 1 was conducted to gather empirical data which 
answered the preliminary research question of the prevalence of skin problems and leg 
ulceration in young people who inject drugs.  The second question, ‘what causes 
chronic leg ulceration in young PWID?’ was also answered, in part, by this first phase. 
Risk factors for causation were identified but lacked detail and full explanation.  
 
A more probing qualitative second phase explored the findings of the first phase and 
helped to provide a better understanding than a single ‘stand-alone’ approach 
(Creswell, 2014, p4).  The participants were able to discuss their injecting habits and 
lifestyles which  may have contributed to the leg ulceration, and most significantly, to 
discuss what might contribute to successful harm reduction, and answer the third 
question: ‘What are appropriate harm reduction measures for leg ulceration in young 
PWID?’.  
 
The postpositivist critical realist approach to developing the aims and research 
questions was helpful in executing the ‘epidemiological’ first phase. In that, it was 
acknowledged, there was no absolute certainty and the researcher and her views were 
not wholly detached from enquiry so results could not be universally generalisable and 
applicable to all situations (Clark, 1998). However, as the second stage lent itself more 
appropriately to exploration and a qualitative approach, the philosophical stance of 
postpositivist critical realism proved to be more reflexive and problem-centred (Weaver 
and Olson, 2006). 
 
Semi-structured interviews (Appendix 8) explored injection history and behaviours, 
how the ulceration started and what the participants attributed it to. Risk factors that 
emerged from Phase 1 such as injecting in the groin or leg and presence of a DVT were 
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also probed in more depth. Participants provided detail on the experience of leg 
ulceration, behaviours that may have contributed to the disease process, and potential 
methods of harm reduction.  The interviews lasted between thirty and sixty minutes, 
with some participants very willing to volunteer information and elaborate on issues, 
whilst others were much less keen to divulge information. Consequently the interview 
transcripts varied in length depending on how well the interview developed, as some 
responses were very brief. This was because the researcher felt unwillingness from 
some participants to be allowed to probe too deeply even though the approach was 
empathetic and reflexive. However, this was not unexpected given the illicit nature of 
drug use and the personal questions being asked about topics that were at times 
unpleasant to discuss.  
 
5.1 Analysis 
The data analysis sought to find associations, seek explanations for ulceration, examine 
the impact of ulceration on participant’s lives and develop new ideas about the 
causation and possibilities for prevention.  
 
Framework analysis was used and described in detail in Chapter 3.  Key themes that 
arose were: 
1) the causes of leg ulceration 
2) the impact of leg ulceration 
3) harm reduction 
Within each of these themes were sub-themes (listed in Tables 6, 7 and 8, Chapter 3). 
These thematic ‘scaffolds’ allowed the data to be refined and interpreted. Figure 1 
illustrates the thematic interpretation developed from the themes and sub-themes.  
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Figure 1 Thematic interpretation 
 
5.2 Findings 
Fifteen participants, four females and eleven males, were interviewed with an age range 
of 29 to 43 years.  Postcodes demonstrated that participants had been recruited from 
across the city.  All participants had been injectors and all had open ulceration at the 
time of interview. Six of the participants had a recurrent ulcer.  
Seven participants were current injectors, and eight had not injected for 6 months or 
more. Five had developed leg ulceration within the last 6 months, ‘recent ulceration’, 
whilst 10 participants had experienced ulceration for longer than 6 months, ‘old 
ulceration’ (Table 35).  
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Table 35 Phase 2 sample characteristics  
 
As all the participants were asked similar questions it was possible to further tabulate 
the ulcer history and injecting behaviours of the sample in Tables 36 and 37. 
All of the participants had injected heroin and most had also injected cocaine. Over half 
had injected benzodiazepines – with most specifically stating they had injected the gel 
form of temazepam. Most had injected other substances as well such as 
dextromoramide, buprenorphine, and amphetamines. To mix with the heroin, all except 
Participant code 
number 
Gender Age  Area of 
city 
Former/ current 
injector 
Recent / old 
ulceration 
2 m 36 NFA Current Old 
3 m 42 Centre Current Old 
4 m 40 North Former Old 
5 f 41 East Current Old 
6 m 42 Centre Former Old 
8 m 41 Northwest Former Old 
9 f 29 NFA Current Recent 
10 m 37 East Former Old 
11 m 40 Southwest Current Recent 
12 m 43 West Former Old 
13 m 38 Southeast Former Recent 
14 f 29 North Former Old 
15 m 43 Centre Current Recent 
16 f 39 East Former Old 
17 m 34 South Current Recent 
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one had used an acidifier other than citric acid – commonly lemon-juice. Very few had 
used clean sharp needles every time and most had shared their equipment (Table 37). 
 
All Phase 2 participants had injected for five years or more and most had injected for 
over ten years. All except one participant developed their leg ulceration more than ten 
years after starting injecting and all except one continued to inject once the ulcer had 
occurred. 
 
All had injected in their groin although one participant said he had only done this once. 
All but one had also injected in their lower legs and ten participants had ulcers at a site 
of injection.  Almost all had experienced ulceration in their left leg. Five had 
experienced ulceration in both legs and they had all injected in both groins. Eleven 
participants had experienced ulceration after DVT. All participants had had a DVT. 
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Table 36 Ulcer history 
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2 2000 both 13 years 1998 Heroin, cocaine yes yes  both, before 
ulceration 
DVT after ulcers yes 
3 2004 L then R 26 years 1986 Jellies, heroin, cocaine yes yes both DVT after groin 
injecting then 
ulcer 
yes 
4 2002 right leg  10 – 12 
years 
1992 Jellies, heroin, cocaine yes yes  yes in both  thighs yes 
5 2008 one leg 
only 
19 years 1991 Cocaine, heroin , temgesic, jellies yes yes yes both  no 
6 2011 left leg Not for 
years  
1991 Jellies, heroin, crack, cocaine yes yes both yes – left leg no 
8 2000 L then R 20 years 1986 Temgesics, temazepam/jellies, heroin, speed yes yes both DVT in right leg  
only 
yes 
9  6 wks ago left leg 11 years 2001 Heroin, cocaine, valium yes yes both DVT left leg yes 
10 2001 L then R 13 years 1991 Heroin, temazepam/ jellies yes yes yes  yes 
11 5 mths ago L then R 24 years 1988 Temgesics, speed, heroin, cocaine yes yes both  right leg  yes 
12 1999 R then L 22 years 1981 Heroin, temgesics, peach palfium, white palfium,  ‘everything and 
anything’, valium, speed, coke 
yes yes both yes yes 
13 18 mths 
ago 
left leg 5 years 2001 Heroin no yes yes no 
14 2007 left leg 11 years 1999 Heroin, cocaine, valium yes yes yes yes 
15 2012 left leg 20 years Not 
known 
Heroin, cocaine, peach palfium, diconal, temgesics, temazepam  yes 
 
 
yes yes yes 
16 2005 left leg 20 years 1991 Temgesics, heroin, temazepam, cocaine yes yes yes yes 
17 2012 right leg 14 years 1998 Heroin, crack, cocaine  yes yes yes no 
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Table 37 Ulcer history and injecting habits 
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2 Scabs that broke out Groin injecting Not always  No Abdine, citric, lemon juice no 
3 Scratch on R shin, burst open Cocaine. Groin injecting, homelessness / cleanliness Not  
always 
No Vinegar, citric yes 
4 Purple marks  Jagging jellies  in groin yes Shared spoons and 
filters  
Citric ?abdine 
  
yes 
5 Cleg bite Not eating, homelessness yes ?no Citric, abdine yes 
6 Painful crack in skin Bad circulation no yes Citric, lemon juice  yes 
8 Scab from a hit turned black and ulcerated injecting  no yes Citric, abdine No  
9 A wee kind of hole – thinks had a fall Hygiene, blood clot no yes Not asked yes 
10 After the clot, a bang, got tingly then a smidge of 
pus 
Homelessness, hygiene Not asked Not asked Abdine, citric, vinegar  yes 
11 Wee blisters after a hit Hygiene / homelessness/ citric  yes no Citric, abdine Yes  
12 Banged them, a wee scab then an indentation  Dirty kit 
Bad bit of acid 
 
no yes Vinegar , irn bru, tiser, cola, 
oranges,  
diluting orange,  fresh orange 
juice 
yes 
13 Wee spots, that weeped It’s a dirty thing no yes Citric yes 
14 Black spot injecting no yes Citric, vinegar yes 
15 Cellulitis The phlebotomist not changing the needle after trying the 
arm 
no yes Citric , lemon juice, wine, irn 
bru 
yes 
16 Cleg bite No healing process in leg due to drug abuse damaging the 
veins 
no yes Abdine, lemon juice, citric acid yes 
17 Not sure – 3 little spots and spread  Possibly injecting or a knock mostly yes Lemon juice, citric yes 
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5.3 Theme 1: Cause of Leg Ulceration 
How the ulcer started 
All participants were asked how the ulcer had started and although the answers varied, 
all described a hindered healing process: 
‘I woke up the next morning in some guys house and I didn’t even know how I got there and I woke up 
and my leg was like, well it just started off like as kind of like a wee kind of mark. A wee kind of hole sort 
of thing, like I’d had a fall or something like that and as the days went on it progressed bigger and bigger’ 
(Participant 9). 
 
‘It started in 2005 I was on my lunch, I was out on a prison workplace and I was sitting having my lunch 
and a cleg bit me and with me being an intravenous user for years, for like twenty years, there is no 
healing process in my left leg. And I scratched it and it went into a cut and it ended up ulcerating and I had 
that on and off, from 2006 it’s cleared up - I’ve lapsed, it’s opened up’ (Participant 16). 
 
Some were unsure of how it started but they were aware of some pain or discomfort 
and scratching the area: 
‘It was just my skin, see the likes of a normal bit of skin, it was, there was nothing going on there or 
nothing. It just got dead itchy and I was scratching and dead painful. There was nothing really, it was a 
tiny, tiny, just like a wee crack in my skin. But the pain was just unbelievable. Then as the weeks went on 
it started getting bigger and bigger’ (Participant 6). 
 
 Others were injecting in the area – all but one had injected in their lower legs: 
‘I had a hit on my leg one day do you know what I mean there, you know what I mean and then the next 
minute there was wee blister things do you know what I mean, they were bursting and I ended up getting 
big holes in my leg everywhere in this leg’ (Participant 11). 
 
Abscess vs ulcer 
Participants were asked about their history of abscess and this was explored to ensure 
that meaning was consistent between cases. Two participants thought their ulcer had 
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started as an abscess. Most were very clear that there was a difference between 
ulceration and abscess and most, but not all, had experienced an abscess at some time in 
their injecting career: 
‘I know exactly what an abscess is and an ulcer, I could actually tell somebody, a lot of people ask me, 
you know for advice what do you think is that an abscess and if it’s an abscess I’ll say it’s an abscess and 
get it checked and if it’s an ulcer I’ll say it’s an ulcer, a lot of people ask me that’ (Participant 12). 
 
‘It’s definitely, definitely ulcers that is the problem it’s not abscesses, the ulcers, the abscesses are sore 
and all but it’s the ulcers. The abscess it’s short-term the ulcers it’s long, long term’ (Participant 2). 
 
Participant perception of cause 
All participants were asked what they thought was the cause of their ulceration. 
Two participants said their diagnosis was a surprise: 
‘I got a hit on my leg and I went to my doctor when I came back and I said I’ve got an abscess and they 
went that’s not an abscess that’s an ulcer. I says what? Telling me I’ve got an ulcer, you don’t get ulcers 
in your legs, right that’s how daft I was. You don’t get ulcers in your legs; you get ulcers in your stomach 
or your tongue whatever. But he says it’s an ulcer and from there it progressed from that size to that size 
and ended up having them all over the place’ (Participant 8). 
 
‘Doctor Smith2 came and he says you’ve got leg ulcers you are in a bad way and he gave me a 
methadone script there and then that was how bad I was because I couldn’t even walk to go and get a 
methadone script because of the leg ulcers, I didn’t even know I had ulcers at this time I thought it was 
just scabs that had broke out and that was just the start of the leg ulcers’ (Participant 2). 
 
Some participants denied that the ulcer was related to injecting habits for various 
reasons: 
‘So I know it’s nothing to do with injecting do you know what I mean because I’ve not touched my groin for 
years’ (Participant 12). 
 
                                                 
2
  All names changed for confidentiality purposes 
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‘it was a shock so it was when I got that. I don’t have an ulcer, I don’t inject in there’ (Participant 9). 
 
‘No, no, I got a, nothing hen, nothing sparked them off, I am like that to myself, why is this happening to 
me? 
I don’t know hen because I don’t know what causes them, I am wondering to myself, why after seven 
years of not touching anything am I getting this on my leg’ (Participant 13). 
 
Many were unsure, and didn’t necessarily relate their ulceration to injecting – one felt it 
was due to trauma not associated with drug use:  
‘I don’t think it’s to do with anything with injecting no I don’t think so but probably if you go back years and 
years, yes to do with the blood clot, I got that through injecting but I don’t know. I think it was just a bad 
fall that made it erupt I don’t know because I don’t go in that leg so that’s why I am still kind of puzzled. 
But em no I don’t think it was the injecting, I think it was just that blood clot that’s made it come, come up 
that way’ (Participant 9). 
 
Another thought it was just luck: 
‘Just pot luck with you, do you know what I mean. Get an ulcer do you know what I mean and pot luck that 
you are not getting an ulcer or a blood clot do you know what I mean’ (Participant 11).  
 
Participant 12 related it to injecting but had various thoughts on the specific cause: 
‘don’t know maybe it was dirty kit, maybe it was a bad bit of acid, maybe because I am using all sorts of 
different stuff, like because a lot of my mates they would use brand new needles, they had to be brand 
new, the citric had to be brand new, nobody used to be able to take the first bit out the packet, we used to 
be able to buy a box of citric, they would take the first bit out and then as soon as everybody else put their 
hands in they wouldn’t touch it after that’ (Participant 12). 
 
Another related it unequivocally to injecting but considered many options a possibility:  
‘it could be something off that hairs in your vein or, do you know what I mean it could be anything, it could 
be something in the smack it could be something in the citric, something in the water that I am using, 
something in the filter, do you know what I mean because I’ve not used clean filters and all that I’ve not 
used clean water before I’ve used water out of a puddle to inject, I’ve used wine I’ve used ‘irn bru’ do you 
know what I mean to actually inject. So who’s to say what it is really’ (Participant 15). 
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Only two participants related it to clots. Participant 6 noted that an ulcer appeared years 
after injecting had ceased, but appeared to make the link between drug use, clots and 
ulceration.  
‘I’ve no even thought about it that much but because of my clot, you usually find it’s people with clots 
because that boy I was telling you, Andy, he had a blood clot, and I know another guy who told us, his 
name is George as well the same as mine, he had a blood clot and he also had an ulcer, so I think a lot of 
it is to do with that. That place I was telling you Green Street, my wee pal worked there, wee Jimmy 
Brown he was a worker and he ended up having to take time off because an ulcer just appeared in his leg 
do you know what I mean and he’d been off it for three or four years, it just appeared. So it doesn’t, it’s 
quite hard to make sense of why they appear’ (Participant 6).  
 
Participant 10 was more definite: 
‘it caused the clot and the clot caused the ulcer’ (Participant 10). 
 
Most had experienced homelessness and some felt this was related to poor hygiene as a 
result:  
‘See eighty five percent of the people that I know with ulcers they are skippered’ (slept rough) (Participant 
3). 
 
 ‘Hygiene, I think so definitely it’s a lot to do with hygiene because like you say there is a lot of people 
sleeping, skippering, sleeping rough, they don’t have the means to, I don’t know, there is plenty places 
you can go and get needles but at the time they are just wanting their hit and it doesn’t matter if the tools, 
they’ve had the tools for a while’ (Participant 9). 
 
Another made the link between keeping the ulcers clean when housed but not when 
homeless: 
‘They weren’t as bad as that do you know what I mean, you know what I mean, because I had a house to 
stay in do you know what I mean and I was cleaning it all the time. Aye, aye, because I was sleeping 
outside out by Springburn under bridges, anywhere do you know what I mean, the dirt was getting into it 
do you know what I mean’ (Participant 11).  
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However, one participant was adamant that personal hygiene could be maintained 
whilst homeless: 
‘But see the places they stay in, they’ve got soap and there are razor blades in it. I only takes five 
minutes of your time to go and wash yourself because there is soap and showers provided for them - like 
this place. Now if I was homeless I would use them because I stayed in London on the run for, when I was 
done for a murder, I had to get out of Glasgow, went to London because it wasn’t me that done the 
murder, they were trying to frame me with it. I went to London for two years and survived two years in 
London and then I came back up here so I know if I wanted to get a wash or a shave all’s I would do is 
walk into one of them and do it. They can walk round the corner and they choose not to do it’ (Participant 
13).  
 
There was a realisation that diet was important to some: 
 ‘I think it’s because I never ate and all that as well, due to my health’ (Participant 5). 
 
 ‘Your diet I think it’s to do with your food, your diet, whatever, what they give you to live on is atrocious 
and when you are unfit for work what are you meant to do’ (Participant 16). 
 
Being homeless also affected dietary intake: 
‘I think it’s all down to that. no eating right and all that. 
In they hostels you are not having your three square meals you know, you are not doing everything you 
would do in your house do you know what I mean. 
No your body is kind of run down as well do you know what I mean. 
It’s cleanliness and vitamins and irons and all that in your body. Eighty five percent of people that are in 
there are run down do you know what I mean’ (Participant 3). 
 
So whilst participants had various suggestions as to causation, they were not united in a 
common view and no hints or broad themes emerged. 
 
Routes into injecting 
If ulceration is related to injecting then the route into injecting is of interest. All 
participants had injected before the age of 21 years and one as young as 12.  
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Most were introduced to injecting by their peers: 
‘I was hanging about with people that were older than me and I just, at that time that’s what everybody 
was doing. Well not the ones that were my age but the ones that I were going about with they were 
sniffing tems (buprenorphine) and stuff like that you know…. 
Aye so, I don’t know just the progress from there, we were all sitting one night and we were sniffing the 
tems and we didn’t, after a couple of months we were like that these aren’t working anymore and 
somebody pulled a needle out and said listen we’ll get a charge out of this do you know what I mean. I 
just can remember getting somebody to give me a hit because the next again day my arm blew up like a 
big balloon and I was like that, is that the way it’s supposed to go and all that and I didn’t end up taking it 
then but I smoked it, I started heavily into it when I turned nineteen, twenty or something like that’ 
(Participant 12). 
 
Most had smoked illicit drugs before they injected:  
‘I was sitting smoking four or five bags and my pals were sitting injecting…… 
Oh I don’t know, just curiosity basically I think because I had the best of jobs and all that, but as I say 
injecting was, watching my pals sitting, having a fiver bag, hitting it or a tenner bag and sitting there…. 
smashed and I am still sitting like that burning, burning, burning, bag after bag. But they only needed a 
fiver or a tenner and they were gone. But I was sitting there like that still burning that’s why I started 
injecting to be honest’ (Participant 15). 
 
Some grew up in areas where drug use was prevalent: 
‘The Calton has got the highest epidemic for heroin abuse right. See when I was a boy I used to see my 
uncles and things and they were all doing good and big motors and all that and I never seen my family 
going out and doing brick laying jobs or anything like that. I seen all my families going out and driving big 
BMWs and that and I was like what kind of job is that to myself as a young boy and then as I got older I 
started doing it myself. So when you are born into something like that you just carry on doing it and 
through doing that I had the stuff about me so I started abusing myself a bit’ (Participant 13). 
 
One was introduced to injecting by her mother:  
‘I knew what it was, like I used to see my ma injecting in front of me when I was three years old. I used to 
protect my wee sister, I used to have to protect my wee sister from no seeing it when I was four or five 
years old because I knew what was happening and Laura didnae. So I said to her who does that belong 
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to - she said it’s your uncle Neil’s do you want to try it - and that her exact words to me and I thought ma 
ma’s not going to do anything, she’s not going to give me anything that’s going to harm me is she so I 
accepted and she gave me two lines and they two lines made me run into the bathroom and I was being 
sick for a day and a half, I missed an exam. 
Did she inject you?  
Not that time, she injected me six months later, but that time she made me miss an exam and a half. 
So six months later - you were still fourteen or fifteen by then?  
No I was sixteen by then’ (Participant 14). 
 
A family history of leg ulceration was cited by two participants – one had a sister and 
one a mother who were injecting drug users and both had leg ulceration.  
‘So you didn’t know about ulcers at all?  
I didn’t know anything about them – but my mum had ulcers – she had them for years and years. 
What do you think caused your mum’s ulcers? ‘ 
It was drugs’ (Participant 14). 
 
Most participants were introduced to drugs at an early age and within their own local 
culture. Friends and family taught them to inject and one was aware that ulceration in 
her mother had been caused by injecting drugs.  
 
Drugs injected 
Not only were participants starting their injecting career at a young age, they were also 
using a variety of drugs: 
‘my mum and dad split up when I was thirteen and I got into the smoking hash and that, drinking and then 
when I was sixteen I started injecting temgesics then from temgesics, speed and that and then heroin.  
When I was eighteen I had heroin and then from then on from heroin right on then cocaine and all that, 
injecting ‘(Participant 11). 
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‘Aye them, valium, I injected speed, coke, I injected the lot, anything you could dissolve into a set of two 
mls I’ve done it‘ (Participant 12). 
 
The heroin injectors also used acidifiers, commonly citric acid, and previously a 
substance called ‘abdine’, which participants described as no longer available. It was an 
indigestion powder which was available over the counter. Lemon juice was also used 
but there was concern about the side effect of blindness that it could cause: 
‘There is a few things you can use we knew we could go into the Chinese shop but lemon juice was the 
main one but that was making people blind so that was a no go but if you didn’t have anything you would 
use lemon juice because you could go into a shop and just buy it. 
Yeah like a wee jiff lemon?  
Aye, you could just buy that but you had to use, well not plenty but a lot of it, so you did. 
Do you think that did any harm?  
Aye, I would say aye, as I say I know people who have went blind with it do you know what I mean, it was, 
you could actually smell it and taste it after a day or two or maybe when you were injecting it like you 
know when you can taste the heroin you know what I mean you could taste this do you know what I mean 
and that’s not right it should be the heroin you are tasting but you were tasting the lemon juice you know 
in your throat and things like that. When you have a hit you taste the heroin and you know you’ve had a 
hit like you’ve not popped’ (Participant 15). 
 
The varieties of drugs injected are also listed in Table 36.   
 
Injecting sites: groin 
Phase 1 identified a link between injecting in the groin and the legs with ulceration. All 
but one of the participants reported using a multitude of sites for injections but all of the 
participants injected in their groin. Almost half had hit arteries during the process: 
‘Yeah I have had problems, sometimes, you know if I get myself into a flap or whatever or if there is 
people around and I am trying to do it quickly, I don’t know, sometimes I’ve hit like an artery before and 
whereas the needle will kind of pop out and the blood just comes spurting out do you know what I mean 
because you’ve hit that artery. Or sometimes it’s not done that and I’ve pushed it in and I’ve shot to the 
floor in like pain because I don’t know it must be very close to the vein or something. I need to read up 
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because I am rubbish at this stuff and I should be clued up on it. But it must be close to the vein or 
whatever do you know what I mean and you are just going right next to it and it’s just coming popping out. 
Or if I am too busy yapping away I’ll just start pushing it in and the pain is unbelievable. It’s horrible pain 
so it is’ (Participant 9). 
 
‘So when I’ve been drawing back when it’s been going into it I’ve not been realising it’s been artery blood 
and when I am injecting it the cocaine is numbing it so instead of, if it had been just heroin I would have 
hit the roof, the tools would have flew out my legs and whatever but because it was cocaine and it was 
numbing it so I was just hitting it’ (Participant 15). 
 
‘I started on the left for some reason, I don’t know if it was true or not, but apparently the vein is slightly 
bigger on the left because your heart is on the left side. That’s probably rubbish but that’s just something I 
heard. But I started on the left but then for some - I think the vein and the artery are a wee bit closer 
together on the left and I was hitting the artery a few times and there is not any pains like hitting the artery 
- the needle flies out - you scream at the top of your voice it’s like, it is like having electrodes wired to your 
brain’ (Participant 17). 
 
Participants were asked about their groin injecting in more detail, particularly why they 
used their groin. Some talked about it being a better ‘hit’, a better ‘buzz’:  
‘Some people have really, really good veins and some folk don’t have like really good veins. But a lot of 
people I don’t know if this is a myth, it probably is a myth, but people either go in the neck or the groin 
because it’s like having their first hit again, they say. So that’s what people are doing, they are just 
chasing it after that first hit, that they get that first buzz and they say going in their groin and their neck 
gives them that because I don’t know it just seems to go to their brain quicker, I don’t know, it’s probably a 
myth, a load of rubbish like, but that’s what they say anyway. So a lot of people, when you say you are 
going in the groin, folk kind of, oh I wouldn’t do that, do you know what I mean, if I had to go the groin that 
would be the day that I would have to stop. But I don’t know, I am in the groin now and I never thought I’d 
go there but I have so ‘(Participant 9. 
 
Some talked about it being a site that could be hidden: 
‘Yes, I done that and my neck, they were the first places I really done so I could try and hide it’ 
(Participant 5). 
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‘I find that you are better off in your groin then people look at your arms and you don’t see any needle 
marks do you know what I mean. When you hit your groin nobody can see anything do you know what I 
mean you get the people now they are homeless now they are begging, ‘aye you are a drug user’, ‘no I’m 
no’, ‘well let’s see your arms’ you know you pull it up what I mean no needle marks, no marks at all 
because they don’t know about your groin’ (Participant 11). 
 
‘some people go for it straight away to hide it so nobody can see any track marks on them and 
that’(Participant 6).   
 
The simplicity of accessing the femoral vein was repeatedly mentioned: 
‘Ah well because it was better you know what I mean, because you were getting yourself right away 
instead of mucking about with your arms or your leg or your feet all the time do you know what I mean but 
in your groin you were in right away and then in and out do you know what I mean’ (Participant 11). 
 
‘It’s just quickness I think it’s just canny be bothered farting about for ages they just want a quick, and that 
is quick, shoot and get it right away’ (Participant 2). 
 
‘I started on the left for some reason, I don’t know if it was true or not, but apparently the vein is slightly 
bigger on the left because your heart is on the left side. That’s probably rubbish but that’s just something I 
heard. But I started on the left but then for some - I think the vein and the artery are a wee bit closer 
together on the left and I was hitting the artery a few times and there is not any pains like hitting the artery 
– the needle flies out – you scream at the top of your voice it’s like, it is like having electrodes wired to 
your brain’ (Participant 17). 
 
Whilst access was initially reported to be easier in the groin, participants also 
experienced scarring and sinus formation:  
 ‘So I was like that, well I’ll go for my groin because everybody said oh put it in, two seconds and that’s 
you its done and dusted and all that. Little did I know that I’d end up with a big hole that size and a big 
hole that size in each end do you know what I mean, I’ve had all sorts of infections in them and 
everything. But that one there has got, it’s got a good bit where you can just put your pinkie in it now, you 
used to be able to get your two fingers right in and  that side and that one actually, that’s kind of 
disappearing you still get the hole but it’s a lot wee’er. So I am kind of healing do you know what I mean I 
am actually healing for a change’ (Participant 12). 
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Bigger needles were required for femoral access: 
‘As it got harder and harder to get to the groin, I used to use 1mls in the groin at first and then it would be 
the wee blue spike and then you would go onto the big blue spike and then before you knew it you’d 
pushed it back that far you needed the big green goddess’ (Participant 4). 
 
Some participants talked about the groin being the site of last resort: 
‘I was actually using veins in my legs before I went to my groin because I, I kind of thought the groin was 
the last resort you know. Which is, any vein is the last resort if you like but a drug addicts point of view 
that was the last place I would have wanted to went to so’ (Participant 10). 
 
‘And some people like, it took all my veins to collapse before I went to my groin because I didn’t fancy 
going towards my groin at all, that’s how I ended up using my arms and my legs and even my fingers and 
my neck before I went to my groin, I just didn’t want to go there at all. As the need arises I ended up going 
there’ (Participant 6). 
 
Some participants made the link between groin injecting and the downward spiral of 
addiction describing it as the worst thing they had done or expressing regret because of 
the consequences: 
‘Somebody put a marker in my groin, put like, they felt for the vein and put like a wee dot so I was able to 
go in that myself. So after that, that’s where I’ve just went ever since. Either side of my groin. But I wish I’d 
never started going there do you know what I mean it’s the worst thing I’ve ever done. Injecting altogether 
is the worst thing I’ve ever done. It’s left really big scars at either side of my groin, do you know what I 
mean, you can actually put your finger kind of, not right in, it’s not as bad as some peoples but there is a 
big mark there and the same with the other side. But the other side is kind of swollen as well sort of there. 
I need to get that looked at, it’s not sore or anything to touch it but it’s just, that side is flat down but that 
side kind of goes into a swollen lump and you can feel it down the leg there’ (Participant 9). 
 
Another participant was less clear about the link to ulceration but nevertheless linked 
groin injecting to the potential loss of her limb, which would be due to non-healing 
ulceration: 
‘I think that was the main reason it never started to heal, it never started to heal because I was still using 
drugs intravenously and on that leg near where the ulcer was. ……. it was from my ankle upwards and 
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then I started in my groin and once my groin was buggered I never went anywhere 
else………………………… 
I never thought for one second that I’d end up the way I am just now I never thought that it would come to 
the conclusion where my leg might need to be amputated or else I would have tried my best to stop’ 
(Participant 14). 
 
Groin injecting and clots  
A consistent feature was groin injecting and deep vein thrombosis. All the participants 
had injected in their groin and all had developed a DVT after this practice had started. 
As already mentioned, one explicitly made the link: 
 ‘it caused the clot and the clot caused the ulcer’ (Participant 10). 
 
Another participant made the link but not so explicitly: 
‘They’ve just ended up being lucky and they’ve not went to their groin, they’ve not injected into their groin, 
they’ve not got blood clots, they haven’t got blood clots, I am saying that the now but some people, the 
likes of mine just appeared and people could experience it further down the road’(Participant 6).  
 
On asking what caused the clot:  
‘Well injecting in your groin, sometimes if you are getting full of it and then you are maybe gouching for 
fifteen minutes, twenty minutes and then you’ll maybe pull some blood back and then push the rest of it 
then and that blood has been lying there in the barrel for ages you know and it just gets put back in so I 
don’t know if it breaks down’ (Participant 10). 
 
‘I got this, this leg got a blood clot in it in 1996, I was in the hospital…….Aye, left leg and that was about 
eighteen weeks in the hospital because I had a groin infection as well. And then I was injecting in the 
groin. So it’s never been the same. So this leg has always had bad circulation my left leg. And just what I 
take for that is, that’s why I’ve got the ulcer, I don’t know….’ (Participant 6). 
 
Others thought there may be a link between the drugs injected and a clot – all had 
injected more than one drug – commonly heroin, but also cocaine and in particular 
some expressed concern about injecting temazepam, known as ‘jellies’:  
208 
 
‘Well I was injecting in my groin, left and right and it was getting nae hassle whatsoever and I started 
about 1987, 1988 jellies were going about -temazepam liquid and I started injecting them and that’s when 
my troubles, my problems started. It caused me to get DVT on my right leg and I started using my other 
side a lot more because my left side, my right side was swollen up all the time. Apparently, I found out 
maybe five or six years later it was the gel fix in the capsules when I was injecting them, when they cooled 
down they were solidifying in my body so it was causing the veins to clog’ (Participant 3). 
 
‘when I started injecting myself with kit was in my left groin. I think that’s how I ended up getting a blood 
clot at the start, was the jellies’ (Participant 6). 
 
‘I had read a book, actually it was by the guitarist from Guns and Roses and he was saying he was 
addicted to injecting OxyContin so I thought well I will give it a shot. But it’s just the way it was available 
that day. I don’t know if that caused this, I know injecting Subutex is a no, no, you know I phoned a few 
people who, let’s say they are very experienced drug users and they all said do not do it. And, sorry for 
the benefit of the tape, so I don’t know if that caused that but the DVT started around that time’(Participant 
17.) 
 
Injecting sites: leg 
All but one participant reported injecting in their legs, but no-one considered the leg or 
foot to be a problem:  
‘Well not in both legs just both feet because I didn’t have any problems at the time’ (Participant 17). 
 
‘I was actually using veins in my legs before I went to my groin’ (Participant 10). 
 
‘Aye I injected in my legs, I still injected in that leg after I came out the hospital, you know into surface 
veins and things like that’ (Participant 15). 
 
One person started injecting in their leg as it was a ‘hidden’ area:  
I started smoking heroin and it wasn’t getting me anywhere after about a year and somebody suggested 
what about injecting it. I’ll inject you in the leg and nobody will see it so I said aye that sounds brand 
new……So I was spending maybe sixty, eighty pounds a day and it wasn’t getting me up nor down so I let 
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my pal inject me at the side of the leg and all of a sudden I was spending eighty pounds a day and when 
he started injecting, I was only spending twenty pounds a day. I thought it was great, I am saving sixty 
pounds here, after a couple of weeks that never got me anywhere so I kept injecting there. In the same 
place so they veins eventually ran out and then I started using my hands, I’d big fat veins in my hands but 
obviously they are away now, both hands, they went away (Participant 2). 
 
Difficulties with injecting 
Although no-one reported resorting to injecting into their existing wounds / ulcer, most 
participants reported increasing difficulty accessing veins as their injecting career 
lengthened. One had researched this carefully: 
‘I used to go into charity shops and read Gray’s Anatomy just to find out where the veins were 
 I’d been injecting wherever I could but I was struggling, running out of veins to find I was losing hits even 
and at a tenner a go that’s not very nice. See you get blood in it, but you lose the vein, it congeals and 
you’ve got to throw it away. Anyway then somebody showed me how to get me groin and I started using 
my right groin. So that was three or four years ago. So yeah and then about a year ago I started getting 
swelling down this leg’ (Participant 17). 
 
It was clear that there were progressive difficulties experienced with injecting over time 
resulting in the use of riskier sites such as the groin and the legs. 
 
Injecting technique 
Many described what would be considered poor injecting technique – using larger 
needles especially in the groin:  
‘Everywhere, everywhere in my body I’ve injected, both sides of my groin, my legs, my arms, my neck, my 
feet, the bottom of my feet, you name it I’ve used there. In the palms of my hands once I injected in the 
palms of my hands as well. In between my fingers I’ve injected. Sometimes I didn’t even know I was that 
mad with it I didn’t even know I’d wake up the next morning and I’d be lying, the needle would still be in 
my groin, I’d be lying with a big set of 5mls, a big giant needle’ (Participant 12). 
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‘I went from 1mls to 2mls and the blue spike, the big blue spike, the wee blue spike first and then the big 
blue spike. Nothing bigger than a big blue with 2mls, the 2mls always used to hold seven jellies exactly 
that would do you so you always knew that’ (Participant 6). 
 
or re-using needles: 
‘Maybe it’s not always a blood clot that kind of brings it up it’s maybe using dirty needles over and over 
again’ (Participant  9). 
 
or preparing the injection: 
‘I’ve used dirty water out of a car park puddle and along in the NCP in the town a few times I’ve done it 
but I’ve always been alright. 
 I go and buy a bottle of wine on my own and I buy a bag and then I go somewhere for a hit where I know 
the police aren’t going to come to me in a car park or something say and I’ve no water, I’ve got everything 
else but I’ve no water, I am going to use the wine or I am going to use the ginger, I’ll use it because I 
know it’s wet’ (Participant 15). 
 
Most had shared and reused tools: 
‘any junkie that says they have never shared is lying. When it comes to sitting there rattling, you will 
maybe give it a flush out with boiling water, maybe go as far as a bit of bleach but nobody is going to 
knock back a hit just because somebody else has used the needle if you are feeling that way. They are 
talking shit if they say they have never shared, everybody has shared’ (Participant 17). 
 
‘I shared with my girlfriend at the time. But I used the same tools, because it wasn’t as feasible now as it 
is now to get tools at that time. So you would try and keep the same sets for as long as possible’ 
(Participant 6). 
 
Another tried hot baths to get a vein: 
‘I would try and get a vein to, do you know what I mean, I’m talking about jumping into hot baths and 
sitting in a pure big and roasting bath you know what I mean, and looking and then going oh look at the 
blue line there and trying to get myself in pure roasting water’ (Participant 4). 
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Participants described a variety of risky injecting behaviours which may have 
contributed to skin breakdown but generally were not united in their views. This will be 
discussed later within this chapter. 
 
5.4 Theme 2 Impact of Ulceration 
Participants reported the impact of leg ulceration on their lives in quite dramatic terms: 
‘I was right embarrassed because I’ve got leg ulcers. I’m dead, dead self-conscious that way I don’t tell 
anybody I’ve got leg ulcers I don’t let anybody know, I’m dead self-conscious do you know what I mean, 
it’s embarrassing, really embarrassing’ (Participant 2). 
 
‘I’d been in hospital, I’ve lost like tenancies or places that I’ve been in due to being in hospital for a few 
weeks and that’ (Participant 5). 
 
‘it makes me feel less of a man and I don’t deserve that’ (Participant 13). 
 
‘I’ve not really got a quality of life, it’s wrecked my life completely, they are saying they are going to end up 
taking my leg off and if they take my leg off I’ve got nobody to look after me’ (Participant 14). 
 
The impact of the ulceration was then explored in more depth and both physical and 
social implications were described. 
 
Pain 
Pain was the most predominant feature complained about:  
‘My leg oh aye it’s agony constantly. Absolute agony. When I am in the project I can walk about without 
crutches but when I am in like the street I always need to make sure I’ve got crutches with me.  
I just need to get the pain away a wee bit that’s all it is it’s just the pain, the pain is absolutely excruciating. 
I’d rather go through labour ten times than go through this pain every day definitely’ (Participant 14).  
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‘since then I am in constant agony see when I sit down I am in agony, see when I stand up I am in agony, 
see when I walk I am in agony, I am in pain twenty four hours a day. See the pain it’s starting to get, it’s 
starting to get into my head, I’m in that much pain I just want to attack’ (Participant 13). 
 
‘I’ve sat with the pain that I’ve had, if there had been a saw I would have sawed my leg off, that’s how bad 
I’ve got’ (Participant 16). 
 
‘But the pain was just unbelievable.  It’s a pain that is with you constantly that you don’t need. 
It’s like a, if you think of somebody with a hot screw driver and they are jagging into your ankle you know, 
it’s murder, torture sometimes I can hardly put, well most times I will walk for about five minutes and then 
I’ll stop. 
 Aye it’s torture the pain, when you see it you think how can there be so much pain coming off this wee 
thing. But it’s murder and you keep going on and on about it wherever you are staying but you get that 
sick of talking about it because it drives you pure crazy. It affects your sleep, it affects your mood you are 
constantly thinking about it, you know it affects you walking, it affects you taking part in any sports and all 
that stuff, so it really grinds you down. It’s on your mind constantly all the time’ (Participant 6). 
 
One participant complained that the treatment (compression hosiery) made the pain 
worse: 
‘they gave me one of they stockings and they didn’t like tell me much about it they just gave me it, they 
never told me to take it off at night and I was in, I was in fucking agony it was so painful I was sending my 
girlfriend out to buy pain killers and all that and my mate was bringing me around mogadon so I could 
sleep. I was in severe fucking pain with it and people were saying you are not meant to wear them at night 
you are meant to take them off you know’ (Participant 17). 
 
Participants also complained that their pain was not managed well: 
‘sometimes it’s like fighting a losing battle when you explain to the nurse how much pain you are in trying 
to get painkillers, it’s really, really, really sore, it’s really sore. Anything just touches it that’s it, it’s 
excruciating,  
you can just imagine somebody opening your leg up and an open wound and then somebody touching it, 
it’s really, really sore do you know what I mean’ (Participant 2).  
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‘the big thingmy down there it burns all the time. I’m to see the doctor after I leave here you know what I 
mean, I need to get pain killers. I need pain killers now to get for the pain. They gave me pain killers 
paracetamol but they are no good paracetamol, I says I’ll end up taking, you are only meant to take eight, 
I’ll end up taking twenty of them. Last time when I got took to the hospital the last time I was in pain, they 
gave us painkillers they gave us co-codamol and they worked do you know what I mean, I had two of 
them and the pain was away. Five minutes and the pain was away; brilliant’ (Participant 11). 
 
One noted that once the effect of injecting wore off the pain was evident:  
‘after I stopped injecting, that’s when I felt the full pain’ (Participant 4).  
 
One participant whose ulcer had healed had not forgotten the pain:  
‘oh the pain is, I used to cry  for that way  in the morning every time I got up but I elevate them every 
night, make sure they are up and I am alright, I can walk fine now. But I still get a wee bit of pain and I 
don’t want to go and get, I was on tramadol, gabapentin, amitriptyline, and I don’t want any tablets you 
know I’ll just deal with the pain myself and I came off them all. Just run it down. I was on methadone as 
well I came off that like that. It was sore but, it was, it was really sore but I survived. 
 It’s the most painful thing you can get, it’s like somebody burning you with a hot iron and somebody 
putting a fag into your face, the pain is unbearable. I was, many times I’ve cried because of the pain, I 
couldn’t handle it but I push through it and I am still here. 
The worst pain, yes, definitely, a hundred per cent. 
And I’ve said to people now, even in here and outside, they go my leg is sore, I’ve got a trapped nerve, 
I’m like you are fucking lucky because see if you had ulcers you know what pain is’ (Participant 8). 
 
Pain also impacted on sleep in one participant: 
‘the pain, I don’t sleep with the pain do you know what I mean, I just lie there and read a book. Sometimes 
I will doze off for half an hour and I feel as if I’ve been sleeping for days but it’s not it’s half an hour sleep 
and it does it depresses us so it does and she kind of moans because she gets her full eight hours sleep 
no bother and she is like, you don’t even sleep, you are up and you are doing things and you don’t even 
get a sleep, see if that was me I’d go mental but I kind of think I am used to it now so once I get a doctor I 
am going to ask him, I need my pain killers back because I was getting the amitriptyline and the 
gabapentin for nerve pain and they were working cracking so they were don’t get me wrong they only 
work they only work for about four, five hours and then the pain was back but see for that four or five 
hours I could relax and just sit and relax and it was cracking you know what I mean’ (Participant 12). 
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Mobility 
Others complained about pain on walking: 
‘The pain, it’s as if the back of my calves are seizing up’ (Participant 3). 
 
‘it was sore even when I was out walking you could feel it kind of throbbing do you know what I mean’ 
(Participant 9). 
 
'My ulcer has affected my quality of life big time, see trying to walk it’s absolutely excruciating. Usually 
every morning I’d take my pain killers and I’d wait have a wee cup of tea after my painkillers that will 
dissolve them, they will kick in. I can get out my bed and start doing whatever I need to do and that’s it. 
But if I didn’t have those pain killers I wouldn’t be able to do anything’ (Participant 14). 
 
‘it’s really embarrassing do you know what I mean you are struggling to walk and you are on crutches and 
that it’s embarrassing’ (Participant 2). 
 
‘I had to learn to walk again and things like that, I had a Zimmer for six months 
 I couldn’t walk I was, every time I was trying to walk I was just collapsing because this leg just wouldn’t 
take any weight or nothing.  
when I walk anywhere I’ve got to either stop or sit down or go slow  
It’s like a half a leg, I canny play football, I can only run, I canny run, I can run twenty yards and I would 
collapse on that leg’ (Participant 15). 
 
Embarrassment 
A number expressed embarrassment associated with the smell and the appearance of 
the ulceration: 
‘I can smell it, it’s throbbing, it’s constant pain really and uncomfortable, really, really uncomfortable and 
there is nothing worse if you are sitting in company or whatever and you can smell your leg and other 
people canny, you know you are sitting there and you are thinking this isn’t right I shouldn’t be sitting here 
it’s really, really awkward. It’s embarrassing’ (Participant 15). 
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‘at the start of it it was just horrible, oh and like I say I’d  be next to somebody and you could smell it, I was 
embarrassed all the time, embarrassed about it’ (Participant 9). 
 
‘you could see it was kind of, pus and stuff like that, sorry it’s disgusting.  
all the pus and stuff like that and it was really kind of like a dark kind of brownie colour it was horrible the 
infection and obviously that was all the stuff trying to come out of it’ (Participant 9). 
 
‘I felt right embarrassed, I was right embarrassed because I’ve got leg ulcers. I’m dead, dead self-
conscious that way I don’t tell anybody I’ve got leg ulcers I don’t let anybody know, I’m dead self-
conscious do you know what I mean, it’s embarrassing, really embarrassing’ (Participant 2).  
 
Physical Effects 
Most participants described infections such as cellulitis or an abscess with some 
requiring surgical intervention for debridement or excision: 
‘in surgery, well obviously I was out but they just scrubbed the hell out of it because I think it was quite 
bad at the time. Really like furry and you know like, I don’t know if you find a dead body in a marsh you 
know that’s probably what you’d expect it to look like you know. So they gave it a really good scrub, 
dressed it up and sent me on my way telling me to come back and to get a hand, put me on antibiotics 
and telling me to come back and to keep appointments’ (Participant 17). 
 
Scars resulting from injecting were mentioned often: 
‘Injecting altogether is the worst thing I’ve ever done. It’s left really big scars at either side of my groin, do 
you know what I mean, you can actually put your finger kind of, not right in, it’s not as bad as some 
peoples but there is a big mark there and the same with the other side.  
I am only twenty nine and I’ve got all these scars and marks all over me it’s horrible. I am just that self-
conscious about it especially the one in my arm you can see’ (Participant 9). 
 
Some participants reported an itch associated with the ulceration:  
‘my legs get right, right hot and itchy and I try not to scratch them you know what I mean and I was with a 
partner there for six years and she used to be like that, I’m sick of hearing myself going, gonnae stop 
scratching Bob gonnae stop scratching Bob, go on stop scratching Bob and sometimes she would burst in 
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the toilet and I would be standing there on the toilet pan like that pure scratching and the blood would 
actually be all over my hand dripping in the lavvy pan and she was like that, but I was like Fiona you don’t 
know how good this is, this feels brilliant man. Don’t get me wrong the blood would be pishing out of it and 
I’d be like that, this is fucking brilliant and if you ask anybody  a good scratch man it’s fucking great’ 
(Participant 4). 
 
One participant removed her dressings as the itch was so bad:  
‘But now it’s not too bad it’s just the itchiness, I think so that’s why I took the plaster off. 
 So that’s why I took that off the other night because it was fair itchy. But it’s a lot better now I’ve let the air 
get at it so it is’ (Participant 9). 
 
Venous signs 
All but one participant reported obvious signs of venous disease – varicose veins or 
skin staining, and most reported swelling or oedema in their legs – some resulting from 
thrombosis.  
‘Aye I’ve got varicose veins’ (Participant 11). 
 
‘it’s like brown and then it’s like pink in the middle where the ulcers have been but it’s all brown round 
round about them do you know what I mean’ (Participant 2). 
 
‘the skin colour changed to black, it went black and very, very sensitive. It went black and it went purple 
and sometimes it would be red and sometimes it would be pink, there was all sorts of changes towards 
the colour’ (Participant 14). 
 
Social circumstances 
One participant described the impact on social circumstances:  
‘Well in prison for a start you’ve got to hide in the cubicle and not get dressed outside the same as 
everybody else because you are embarrassed, if you are sharing a cell with somebody you don’t even 
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want to get undressed because you are embarrassed. Same if you are outside you get a girlfriend you 
don’t want to say oh how you are doing I’m…….and I’ve got leg ulcers. You don’t want to show that side 
it’s really embarrassing do you know what I mean you are struggling to walk and you are on crutches and 
that it’s embarrassing, it’s very, very embarrassing. It’s no life to have man. I’ve got two sons they don’t 
even know I’ve got leg ulcers and I am right self-conscious that way, right embarrassed about it’ 
(Participant 2).  
 
Another reported the impact of the ulceration in a confined space:  
‘you are sitting on a bus and you can actually smell your legs and it just smells like dead flesh ken what I 
mean, and it was really bad at one time and I wouldn’t go out the house because it was that bad do you 
know what I mean and even when, when I used to get my legs dressed, I had to get them dressed if 
Helen was away see an hour later it would be back and they would put they big pads on with charcoal 
with the big pads that’s supposed to stop the smell but it actually made it worse for me because my leg 
was sweating with four bandages on and I used to hate sitting on a bus because you could tell people 
would be like that, what’s that smell and all that. 
I wouldn’t go on a bus I wouldn’t get in a taxi do you know what I mean because it was embarrassing do 
you know what I mean. 
…they smell, see when I had the dressings on they were bad, really bad, they actually made me feel sick 
with the smell do you know what I mean. But when I pull the dressings off you canny smell anything like 
now’ (Participant 12). 
 
The ulceration also caused problems for clothing and bedding because of the exudate 
from the wounds: 
‘I ruined my full bedding, I had to buy a new duvet, quilt, I had to buy mostly everything I slept in that 
weekend, to pyjamas all the way down to a brand new sheet, well because I bought a new duvet I bought 
two new pillows too. But aye it ruined everything because even that bandage I was putting around on the 
inadine, the orange was coming right through the bandages plus the liquid of the size of the holes that I’ve 
got on my leg, it’s just constantly, as soon as you take the bandage off it its  just constantly liquid dripp ing 
off my leg’ (Participant 4). 
 
‘there is hundreds of yellow water keeps coming out of that for some reason  
it’s brand new socks I’ve got on and every time I put socks on they turn yellow with the stuff that comes 
out it’ (Participant 12). 
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Most described an impact on their social and family lives as result of the ulceration and 
how it prevented them doing normal activities such as walking or swimming: 
‘I wouldn’t be able to take my baby in for the swimming for the first time. Aye the things I’ve missed out 
with my kids. every time the summer comes in I seem to have ulcers you know what I mean and I can’t 
wear three quarter length trousers or that you know what I mean. I’ve always got to be in denim or 
tracksuit bottoms. Now I canny wear a pair of shorts and as I said I canny do things with my kids, I canny 
go down to the beach with a pair of shorts on or that if we go away, canny you know what I mean, when I 
am away in Spain and that, I’ve been in Spain and that and I’m down at the beach sitting with a pair of 
joggers on and people are like that looking at you and that you know what I mean and they must see 
because I wear sandals 
you miss out on a lot of things you know what I mean, you canny, like see my pals have been when we’ve 
been abroad and that, been scuba diving, I canny do things like that, I canny do a bit of mountain climbing 
or that, go away see when I am with Phoenix, I canny go, participate well I can do a wee bit of canoeing 
and that but I’ve got to watch I canny go down rough waters or that you know what I mean, I can only play 
in the dry water, they will not let me go down anything at all because of my leg, but I can swim, but it’s 
your leg’ (Participant 4). 
 
Treatment 
Once the ulcer had developed participants had various treatments – some obviously 
understood the importance of seeking appropriate healthcare: 
 ‘They gave me like a black sock, that’s what it was, just a sock and it was really tight, tight to get on but 
that was just to keep it all packed in nicely so it could heal’ (Participant 9). 
 
‘the compression bandages are a lot of help because that helps your circulation and that’ (Participant 2). 
 
‘well go to Hunter Street, you will get it changed every two days, they will clean it for you and they will put 
another bandage on it and they will tell you to come back every two days to get it changed. A month or 
two months down the line your legs will be all clean’ (Participant 11). 
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Another participant was frustrated that nothing was explained to him once the ulcer did 
occur: 
‘I can sit and tell you about how  Doppler shifts or I used to measure receding galaxies you know, I know 
about fucking astral-physics you know what I mean. They wouldn’t explain why they were putting a bloody 
thing on my leg you know.at times when I’ve been in hospital they just seem to have this idea you are a 
drug addict you are probably not very bright you know they don’t fucking explaining things very well they 
don’t bother telling you what they are doing. Right maybe if I was a bit smarter I wouldn’t be in this 
situation but I mean I read a lot and I would say I am a fairly intelligent person. I would say I can 
understand what they are telling me but sometimes I ask them a question and they just fob me off you 
know. I am not going to bother explaining this to a junkie you know’ (Participant 17). 
 
Other participants were clear that there was a link between their ulcer deteriorating and 
continuing to inject, but also of the necessity of treatment: 
‘if I was still using in that leg I would have probably have had to have had it cut off, I don’t want my leg cut 
off, that’s what she says, your leg is getting better John because you are coming in all the time and 
getting it changed all the time’ (Participant 11). 
 
Self-help 
Some participants described denial and a reluctance to get treatment and improve their 
chances of healing, for example by self-help:  
‘I didn’t want to go to a clinic to get dressings and all patched up and that so I used to just leave it and it 
started to smell, smell and a lot of discharge came out of it so, I had it about fourteen, fifteen months by 
this time and it was about the size of an orange by then. I went to my doctor then’ (Participant 3). 
 
‘I can only speak for me, I can maybe speak for my brother but it wouldn’t sink in for him either because 
he says his legs are brand new and he’s still got leg ulcers like that. Well he might tell you a wee white lie 
now and again because he says his legs is alright but they are no. They are alright compared to what they 
were, he had a hole that size in his legs and they were leaking and everything, I had to give him dressings 
the other day, well the last time Barbara and Helen (nurses) came I had to give him dressings. You should 
have seen him putting them on he’s like that. I’ll not put them on I don’t need them; I’m like you fucking do 
need them’ (Participant 8). 
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I think it’s like how your life is you know what I mean, where you are staying and if you are eating and 
things like that, I was running about but you are supposed to take the weight off it and all that. I didn’t do 
that and I was out drinking….. 
And then when I am inside like a hostel and I am doing well it seems to clear up with your health do you 
know what I mean if you are eating and the nurses are getting to you like twice a week’ (Participant 5). 
 
‘If I was in a project where I was able to eat fresh food and have a decent diet then I think it would have 
helped’ (Participant 14). 
 
The predominant impact of ulceration was pain and embarrassment, but it also affected 
social circumstances.  
 
5.5 Theme 3 Harm Reduction 
Participants were asked what health professionals and others could do to help PWID 
reduce harm from injecting, and particularly groin injecting.  
 
Preventing injecting 
Some of the participants felt that preventing injecting in the first place should be a 
priority as once addiction took hold they would ignore health risks:  
‘…back then years ago if you were to show me pictures of what you could get and things like that doing it, 
it probably would have put me off. But likes when I’ve came in here and in Dumfries in the waiting area 
like when that anthrax was out, it just had pictures of what that could do to you and I was looking through 
them do you know what I mean, I wasn’t really, I knew that it could do to you but I was still going out there 
buying it and doing it’ (Participant 9). 
 
‘I’ve always said, see my mum, see my mum’s legs, my mum’s legs are ten times worse than mine and 
I’ve always said to myself, there is no danger that I will end up with legs like my mum has, no danger but, 
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I was too strung out and too busy running across the town to get squared up, do you know what I mean I 
didn’t pay any attention to those things I just wanted squared up? It wasn’t until I ended up half dead - 
that’s when I started paying attention to all the leaflets and all the correspondence that is out there for all 
this kind of stuff. 
Any information, any information at all would help because I‘d read it, I would read every single leaflet. 
I think in pharmacies and chemists, see you get the wee booths where chemists send the methadone 
patients, I think in there if you were to put them in there people would lift them up. 
Nobody is going to stop injecting until something really, really bad happens to them, until they have a bad 
experience’ (Participant 14). 
 
Some participants were clear that nothing would make much impact once the addiction 
was formed as the desire to obtain drugs was too strong, and overwhelmed other needs. 
Two female participants illustrated this by describing behaviours they were ashamed of 
that were driven by the addiction: 
‘you are just out there to get your money do you know what I mean and that’s it. But I would, I’ve not got 
the guts to do what the lads, but like I said it’s dangerous what I am doing, jumping into, I mean what kind 
of person jumps into a motor you don’t even know the guy. Anything can happen because you’ve heard 
stories on the telly that girls get taken away and they are never brought back and I am linked into the 
Base 75, that’s just down the road in the town and they help out working girls they’re brilliant and they let 
you go in there for a shower and talk to you and help you. But she was telling me stories and stuff like that 
about some guys like they are wanting girls that are twelve, thirteen and dressed in school uniforms and I 
think to myself I must be sick in the head going to go out there and walk through here and jump into a 
motor do you know what I mean but like I say I need to keep my habit going’ (Participant 9). 
 
‘You know what I mean I actually had a brick in my handbag when I was standing at a cash line machine 
and rob somebody, hit them with the brick in the bag, that’s how, to the extent I went to’ (Participant 5). 
 
Reducing injecting harm 
Another participant felt that assistance from professionals with injecting would make 
the habit safer, and suggested the insertion of a cannula:  
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‘Maybe even if there was one vein so if they started off in their arm if they put something on to use that 
vein so if they are going to use, put something in like a bus or something, put in a vein so that they could 
be using and then come every so often and move it about. Like so you could be in control, so you could 
do it you could put a bit of water in and then you could put something in you know the way you get a drip’ 
(Participant 5). 
 
Another participant felt that alternative routes needed to be encouraged:  
‘Everything is getting done isn’t it, just guiding people towards smoking, I would advise anybody to smoke 
it rather than inject it because you don’t know what’s in the kit nowadays, anybody I ever see I say you 
should just smoke that because there is brick dust and everything in the kit nowadays. I don’t know how 
you could kind of promote just smoke it instead of inject it though, some people think it’s a waste of time 
smoking it because you get a rush when you thingmy. So its, it’s hard’ (Participant 6). 
 
Education 
Most participants felt that education was important but at a much younger age than 
when they started using drugs – many suggesting within the middle years at primary 
school, but taught by those who had experience of drug use: 
‘Aye especially young ones and that you know what I mean who have just started taking drugs they see 
that on a picture they are going to be like ‘oh I don’t want my legs looking like that’ do you know what I 
mean because once you’ve got that its a scar for life’  (Participant 11). 
 
‘Aye at school level aye, I think aye, definitely, but no, like at this level just now. At school level you could 
get people to really frighten kids with showing them pictures of, like pictures of ulcers and pictures of 
wounds and all that kind of stuff. Showing them, showing them statistics and all that. Get a drug user in 
that’s actually got an ulcer and ask the drug user to show the children the ulcer, let them see it close up, 
to realise, like this is what is going to happen to you if you start using drugs. 
Aye I was fifteen when I started using but I was eight, seven or eight when I started trying to protect my 
wee sister. 
No I would say about ten, about ten, ten years old. 
Before secondary school or maybe if some teachers are not too happy with it first year at the earliest well 
at the latest I would say, first year at the very latest’ (Participant 14). 
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Participant 16 felt that slightly older children should be shown pictures of injecting 
damage:  
‘I just think making intravenous users aware of the outcome of what can happen and then showing them 
the harsh reality like pictures of what it is like. 
No I just think like what you are doing is good but I think showing younger people what the outcome of 
injecting would do and what’s happened to people that’s carried on doing it. 
High school, high school I wouldn’t think is too young because people are leaving high school and that’s 
when they are starting to dabble in drugs. 
About fourteen or something’ (Participant 16). 
 
A minority felt it would never happen to them and that very little could be done to 
prevent injecting starting:  
‘at that age I was daft and stupid and I always knew that I would do myself damage but at that time, once 
you are in, once you are trapped in that addiction you’re shut off to all the consequences that are going to 
happen later do you know what I mean, so you are not really open, your mind is not really open to all the, 
if you are sitting rattling and somebody says to you in ten to fifteen years later this is going to happen to 
you, you would still take your charge’ (Participant 6). 
 
A direct approach was suggested by another participant: 
‘just spit it out and say look you will end up dying, that’s it, it’s simple that’s how I stopped it ……’ 
(Participant 8). 
 
Another felt that frightening people would put them off:  
‘Aye show people the real bad ulcers, take photos of them, show people, put posters of them. This is what 
happens if you use heroin in your legs. 
Aye because if I had seen that as a young boy it would have put me off. 
I don’t know, it’s up to yous, it’s up to yous, I can’t say my head is all over the place I can’t tell you’d how 
about out there, right outside there, put it on the walls all along Gallowgate let people know, you need to 
spread the word. 
What you need to do is frighten people and you need to show, you need to get photos of bad ulcers and 
put them about the place and say this is what happens when you inject in your legs and it will stop people. 
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Take pictures of bad ulcers and show them and don’t say it’s such and such’s ulcer just put this is what 
can happen to you, you’ll soon see a change. I know Glasgow’ (Participant 13). 
 
Many expressed concern about the visual appearance and suggested that images of 
ulceration and femoral sites could act as a deterrent for some: 
‘make a video to show a kid what way a leg goes with ulcers and that’s what you get through injecting. 
See if you were to see my leg you would be like that, it would put anybody off, it would have put me off if 
I’d had seen it when I was younger. See the likes of, see the likes of somebody coming into the schools 
and showing you things, I think that would have put me right, right off the track’ (Participant 4). 
 
‘Aye I think that would be a good idea, the effects of, the difference of smoking it and injecting it, if you 
smoke it this is the damage you can do and if you inject it this is the damage, this is the more damage you 
can do or something. Aye show people how horrible, groin infections are and things like that, because 
that’s where most people end up going and just bad ulcers. Because I  don’t  think you  get ulcers with 
smoking, smoking kit for some reason I don’t know why I say that, I could be totally wrong but I think it’s 
more down to the injecting all the shite, sorry for the language, all the shite that is in the tools, in the kit. 
It’s meant towards; it contributed to having ulcers. 
Show them pictures of a bad groin infection, that would discourage them a lot. Because people don’t like 
to hear about that area being used or anything it’s kind of dodgy jagging, I don’t know how you can do 
that, I don’t know how she can do that so it’s just kind of tarnishing that a wee bit worse’ (Participant 6). 
 
‘The pictures aye and whatever else do you know what I mean, pictures of people’s groin and that you 
know the state they are in, I’ve seen people’s groin in some state big holes like that do you know what I 
mean. You get somebody who will volunteer as long as you don’t see their face you can say do you know 
what I mean, it will put young people off do you know what I mean. I’ll not do that do you know what I 
mean, they’ve just started taking drugs do you know what I mean. 
Aye you could put them in chemists now pictures and all that, chemists, health centres, homeless places 
and all, people who are in homeless places in there and all’ (Participant 11). 
 
‘look at me - if I had to  undress to show them what it’s done to me I would show them because it’s not 
nice to see the marks I’ve actually got on my body’ (Participant 15). 
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One participant had put this idea into practice and had dissuaded family members from 
using drugs as a result of his experiences. The following long quote describes well his 
determination to use his experiences to limit the damage in others:  
‘I managed to put my wee nephew started smoking cannabis and so did my other nephew he’s twenty 
three now and my other one is twenty and now they won’t touch a thing do you know what I mean. 
Just showed them the state that my legs were in,…….. If somebody would have showed me the way my 
legs were the now I would never have touched a needle. See if I’d had seen photos of that in a catalogue 
of people’s legs, no faces or nothing just legs, some of the people that I’ve seen they’ve had big chunks 
took out of their legs do you know what I mean. So if I’d had seen something like that I’d be like that, I’d 
never do that do you know what I mean. Back at that time when I, you hardly knew anything about 
anything like that do you know what I mean, I never knew what a leg ulcer was until I was twenty nine, 
you know what I mean, twenty nine, thirty then I knew what a leg ulcer was. 
Aye, aye, any health centres the likes of the health centres, where you go to get your methadone or even 
see the likes of going to schools before they start leaving school and that. See if you, if somebody had 
come into my school and showed me a big catalogue of people’s legs through injecting drugs. 
That’s what I mean but see, to me it’s just like a short, sharp shock do you know what I mean that would 
put the majority people off the now because people think they are all wee tickets and stuff like that and if 
you see it right, if you actually see them, like of I got asked to go to a couple of schools and actually show 
them my legs do you know what I mean and they said listen you can do it, you can cover yourself with a 
screen. I was like no, I’ll do it I’ll go to the school and I’ll do it I’ll show them. 
I went to that school, I went to that school do you know what I mean. I went in and there wasn’t there was 
about thirty eight people there it was, to me it was all the older ones that were ready to leave school and I 
was thinking maybe you could catch them, you’ve got to catch them around about twelve year old, 
thirteen because that’s what age I was, catch them then. But see the people that I spoke to after I’d 
shown them my legs and what it does to you and stuff like that you could see that they were shocked 
because some of them had parents that were injectors but they didn’t have the problems that I had do you 
know what I mean. So maybe they are like that he’s just a one off but I told them, look my brothers had 
them, all my friends blah, blah got them, it’s just sheer luck if you don’t get any problems do you know 
what I mean it’s luck. And a lot of them were thingmy but a couple of them, you could see a couple of 
them were like that, I’m no bothering my arse about him he’s talking a lot of nonsense but even if I could 
get through to the likes of one or two people do you know what I mean and they didn’t do it, then I’ve done 
what I set out to do do you know what I mean. we’ve got four under twenty fives here and they think it’s all 
a joke, do a group, is it alright if we do a group on your legs and show them, I’ll take a group …….. You 
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can see they are kind of interested because I’ve been asked a couple of times go on ask Stevie to take 
the group tomorrow again because they are coming to see someone like me that’s been there done it 
wore the T-shirt done the lot. And it is, to me if it gets through to some of them do you know what I mean, 
you are never going to get through to everybody but if I get through to just one or two people then I’ll be 
happy with that’ (Participant 12).  
 
Most of the participants focussed heavily on interaction with young people as having 
the biggest impact: 
‘I think it’s all about educating young ones you know, it’s hard as it may seem, showing them horror 
stories about how they could end up, not everybody ends up like that because I know guys that have 
been injecting in the past for years and years, ten, fifteen years and they’ve not got a blemish you know. I 
might just be one of the unlucky ones. 
Schools and even community centres. 
Aye, aye because I don’t know if you remember one of the magazines we done years ago when my legs 
were really bad you know I think that would shock a few people. 
it’s the next generation that we need to worry about really in terms of drug use because a lot of them are 
getting into it earlier and earlier and earlier, you know it’s not a case of a specific group it’s, I think it’s 
getting earlier and earlier and earlier, thirteen, fourteens want to have a wee toot or they have a wee burn. 
Maybe, in some of the, I don’t mean stupid but some of the naiver ones say give us a wee hit to see what 
it’s like and then they get a good stone and  they think this is brilliant and keep doing it and keep doing it 
and keep doing it. 
Because lately a lot of primary school kids have been bringing hash into school and heroin as well you 
know and pills you know, that was never heard of when I was young you know, that was a no, no, so’ 
(Participant 10). 
 
Others also felt dissuasion by experienced users would work:  
‘there is that much information there but a lot of people aren’t getting it, a lot of kids aren’t getting it and if 
they do get the information at that age it’ll just go over your head anyway you don’t want to know about it.  
Unless you are going to listen or you know somebody in your family who’s been using and you are seeing 
them do you know what I mean, you know what they are going through and you’ve watched them going 
through it’ (Participant 15). 
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Education of health care workers 
Some felt that healthcare workers needed better education also: 
‘Aye, they are actually asking you about them do you know what I mean I’m like you are a nurse or a 
doctor you should know about this but they don’t you know what I mean, some of them,…….. But there is 
a lot of them that hasn’t got a clue, not got a clue’ (Participant 12) . 
 
Poor attitudes were reported by some of the participants: 
‘at times when I’ve been in hospital they just seem to have this idea you are a drug addict you are 
probably not very bright you know they don’t fucking explaining things very well they don’t bother telling 
you what they are doing. Right maybe if I was a bit smarter I wouldn’t be in this situation but I mean I read 
a lot and I would say I am a fairly intelligent person. I would say I can understand what they are telling me 
but sometimes I ask them a question and they just fob me off you know. I am not going to bother 
explaining this to a junkie you know’ (Participant 17). 
 
‘She (the Practice Nurse) did nothing for me, she wanted me out of the place as quick as possible 
because the sun was out and it was a Friday, she wanted home, she said they’ll send you a letter for the 
ulcer clinic two months ago and I am still waiting on a letter, they don’t care about you, see because you 
are on methadone they think you are a junkie. I ain’t no junkie hen I can tell you that the now, I am a drug 
addict. I hate that, a junkie, a junkie is a person that is a bit smelly, doesn’t wash himself and doesn’t 
shave, keeps unkempt, doesn’t eat. I ain’t that hen’ (Participant 13). 
The participants had clearer views on reducing harm than they did on causation. These 
findings will now be discussed. 
 
5.6 Discussion  
The data from Phase 2 corroborated the risk factors of significance found in Phase 1 
such as DVT, groin and leg injecting, which were common to the majority of Phase 2 
participants. 
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5.7 Theme 1 Causes of leg ulceration 
It was interesting that there was little agreement on the cause of ulceration, despite the 
ulcer having a major impact on the participants’ lives. An eclectic mix of contributing 
factors was discussed such as homelessness, lack of hygiene, and diet and nutrition.  In 
some cases the formation of an ulcer was a surprise and appeared to come out of the 
blue, whereas other injecting complications, such as abscesses and blood-borne viruses, 
were known and understood.  
 
Site of injecting 
All but one had injected in their lower legs.  However, in those who had injected in the 
lower legs, an ulcer only developed subsequently at some of those sites, but for others 
the ulcer was at a site where no injecting had occurred. This may indicate that injecting 
in the legs causes venous damage, which can cause skin to breakdown in other sites, 
due more to the vascular problems than the breached  integumentary system.  
 
Groin injecting 
In this sample some participants described getting a better ‘hit’ from using the groin 
site,  whilst others discussed the advantage of an injecting site which was hidden under 
clothing and not a visible sign of injecting. This was beneficial for those in 
employment, including those working in the sex industry as there were no visible track 
marks or similar that would alert customers to a drug injector.  Another benefit 
described was ease of long-term access – the development of a sinus could be seen as 
advantageous as there was no need to search for a vein – the visible ‘hole’ was the 
access point. A hit could be obtained quickly and participants described the ease of 
injecting in public places because they could access the femoral so fast with no need for 
a tourniquet and no time spent searching for venous access.  
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Some participants described the groin site as the site of ‘last resort’, somewhere they 
really wanted to avoid, whilst others expressed regret at using the groin once the 
consequences of scarring and leg ulceration had developed. Many described problems 
with the site related to infection and swelling and described increasing difficulties 
accessing the groin over time. The vein apparently became more difficult to access and 
larger needles needed to be used, potentially doing more harm. 
 
Few participants linked leg or groin injecting and clots to ulceration, despite all 
participants having had a DVT and all had injected in the groin and all but one had 
injected in the lower legs. No participant linked thrombosis with ‘gouching’ – long 
periods of static movement due to drug intoxication. Some claimed they had not 
injected where the ulcer had developed and they therefore could not see any 
relationship between the two.   
 
It was clear that there was significant gap in knowledge relating to long-term effects of 
injecting in the groin or the leg. 
 
Substances injected 
Some of the older injectors related problems with groin injecting to the injection of 
temazepam (‘jellies’) which was available in gel capsules. These tended to solidify in 
the vein causing damage.  
 
However, all except one of the participants injected more than one type of substance. 
All had injected heroin, and most had injected cocaine, buprenorphine, diazepam, and 
crack. Some had injected both cocaine and heroin together. One significant 
disadvantage of this, in terms of vein damage, is that no pain is experienced if the 
needle misses the vein because of the anaesthetizing effect of cocaine. 
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All of the participants had added an acidifier to their heroin to create a solution for 
injection. Within the city, citric acid was readily available as part of IEP, and most of 
the participants had used this. Those injecting for longer reported the use of a substance 
called ‘abdine’, an indigestion remedy, which is no longer manufactured. Many had 
also used a mixture of other substances including lemon juice, vinegar, wine, orange 
juice, and other fizzy drinks such as ‘Irn Bru’ and cola. The impact of injecting these 
substances is unknown, but it is clear that, when desperate, participants would not be 
selective about their acidifier or their diluent but would use whatever was available.  
Differentiating between the damage caused by individual substances over a long period 
of time was close to impossible.  
 
5.8 Theme 2 Impact of ulceration 
The participants talked about the impact of the leg ulceration in strong language 
describing it, for example, ‘as having wrecked their life completely’ (Participant 14). 
Psychosocial issues such as embarrassment about smell and appearance were prominent 
and unseen aspects such as pain and lack of sleep were also significant. 
 
Pain 
Pain was a predominant feature described by participants, even though most were 
prescribed an opiate substitute or were still using opiates which would be expected to 
reduce ulcer pain. This was interesting given that venous ulcers are reputed not to be 
significantly painful (e.g. compared to arterial ulcers) and it is often assumed that drug 
users should not experience pain due to the level of circulating opiates in their blood 
stream.  
However, the physiology behind the experience of pain may be altered in long-standing 
opiate users, resulting in opiate-induced hyperalgesia which increases sensitivity to 
even minimal stimulus (McCreaddie et al, 2010). It would appear that some opiate 
users therefore will experience heightened pain from ulceration (Pieper et al, 1998). 
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This could partly explain why the participants described the pain as being the most 
significant impact of ulceration on their lives. It affected their sleep, their mobility, and 
had a psychological impact. 
Pain is not something that can be seen or easily measured. It is difficult to convey to 
others who have not had similar experiences and it is often assumed that the opiate use 
will mask any pain. Describing the terrible pain experienced by those with ulceration 
may therefore be a difficult message to get across within harm reduction. 
 
Embarrassment 
Participants complained that the embarrassment surrounding the odour emanating from 
the ulcer affected their lives. Some felt they were unable to go out and they couldn’t use 
public transport as they would be within a small space where the odour was most 
noticeable. They linked the odour to the exudate from the ulceration, and some 
preferred not to have dressings on, not to be treated, as the smell was less if the wound 
dried out. The quotes relating to embarrassment were powerful and could be utilised to 
describe the impact of ulceration as part of harm reduction. 
 
Psycho-social 
The ulceration affected many aspects of life – the ability to socialise even with close 
family was affected by the embarrassment of malodour. Similarly the exudate which 
was described as soaking through clothing and bedding impacted on participants’ 
willingness to leave their homes, whether this was for appointments, shopping or 
visiting other people. 
Close relationships also suffered due to the consequences of developing ulceration, as 
participants expressed worries about the ‘liquid dripping off’, and the smell. Similarly, 
one participant described the itch from the leg as being so bad that he had to go into a 
separate room to relieve the irritation by scratching.  
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Scarring  
Although leg ulceration is usually hidden under clothing, some participants were 
concerned about the scarring that drug use had caused. Repeated injection and 
particularly when using a poor technique, such as ‘digging’, can result in scarring. The 
potential for disfigurement may be something that could be given greater publicity in 
harm reduction messages.  
 
Venous disease 
Venous disease occurred in the majority of participants, mostly without a recognized 
family history but with visible signs such as staining, varicose veins, and oedema. 
These signs were not linked to injecting by participants and this could be a role for 
education. Whilst DVT was usually diagnosed by health professionals, it appeared that 
information was not given to participants of the benefits of ongoing compression or 
possible sequelae. There could also be a role for education of health professionals about 
this topic (Prandoni et al, 2004; Meetoo, 2010).  
 
Mobility 
A frequent complaint from participants was the impact that their ulceration had on their 
ability to walk, and subsequently to take part in what they considered to be normal 
activities. They complained about pain from the ulceration and general pain within their 
legs affecting walking. Some needed mobility aids such as a Zimmer frame or crutches 
whilst another ended up in a wheelchair. The issues with walking were not solely 
confined to the consequences of ulceration, but also with the pain and swelling caused 
by thrombosis which was linked to this. All these were related to injecting. 
 
Those who wanted to do more, such as playing football, hillwalking, or swimming with 
their family, reported being unable to do so because of the ulceration and pain in their 
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legs. The issues with mobility and of independence appeared to be a surprise to most 
participants. This could be of value to raise awareness in appropriate harm reduction 
programmes. 
 
Desperation 
Participants described dangerous behaviours in relation to their drug use, such as 
participating in criminal activity like robbery. Undertaking risky sex work in order to 
raise money featured in the responses from two female participants. Both had insight 
into their behaviour as something they were ashamed of, but the over-riding desire for 
money to fund their drug habit took precedence. Incarceration in prison seemed to be 
little deterrent and just something that went hand-in-hand with their habits. When 
discussing dissuasion from injecting, some participants admitted that nothing would 
make any difference. If they were desperate for that hit, any thoughts of consequences 
simply were not considered. 
Routes into injecting remain a global issue which is beyond the scope of this study. 
 
5.9 Theme 3 Harm reduction 
Participants were asked what health professionals could do to reduce harms and to 
prevent leg ulceration occurring.  The initial focus was on preventing injecting rather 
than harm reduction. 
 
Routes into injecting 
Most participants focused on preventing injecting in the first place, by informing and to 
some degree shocking others.  A common theme was specifically focusing on children. 
All participants in Phase 2 had injected before the age of 21 years but most indicated 
that their awareness of drugs, and participation in a drug culture, started long before 
this age.  
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Many participants talked about the influence of their family and friends in relation to 
commencing drug use and injecting. Some grew up in an environment where drug use 
or dealing was commonplace and progression to their own use seemed a natural 
development: 
‘So when you are born into something like that you just carry on doing it’ (Participant 13). 
 
One participant’s mother gave her the first injection. Her expectation was that her 
mother would do her no harm:  
‘I thought ma ma’s not going to do anything, she’s not going to give me anything that’s going to harm me 
is she so I accepted’ (Participant 14). 
 
No-one referred to any education or guidance from family members or peers, in fact, 
the opposite applied. There appeared to have been no dissuasion away from the drug 
culture amongst the participants in this sample. 
 
Early education 
The majority of participants indicated that the time to start prevention would be during 
primary schooling. One participant had started injecting at the age of 12 years. 
Secondary schooling usually begins around the age of 11 or 12 so the suggestion of 
drug education before the potential start date of drug use is viable. However, all 
participants in this phase were aged 29 years or older and there have been changes in 
the education of young people in relation to drugs that may not have been considered or 
implemented when they were at school. 
 
Harm reduction related to leg ulceration 
It would appear that there is little information or education about the development of 
ulceration in injecting drug users. Ulcers may have developed in areas or sites where 
the participant had not injected, or appeared long after injecting had ceased, so 
participants were puzzled by this. They were mostly unable to make a link between 
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previous behaviours, for example injecting in the groin linked to a wound in their lower 
leg. In fact, some participants denied that the ulcer was related to injecting habits, and 
so it would appear that education relating to the causes of ulceration is an identifiable 
gap in harm reduction provision.   
 
One participant noted that healthcare staff were poor at explaining things about the 
ulcer to him and he felt that this was because he was a ‘junkie’. Poor attitudes from 
healthcare staff in generalist settings were repeatedly reported by drug users, though, as 
most interviews took place within a setting familiar to drug users, they were 
complimentary about the staff directly treating them there.  
 
Visual images 
Many participants were concerned about the visual impact of their ulceration. A 
number of participants had ceased injecting and in desiring to participate in more 
mainstream activities such as sport, their appearance had become a major issue for 
them. As such, they felt that the appearance of their ulcerated leg would be an inhibitor 
for those considering injecting, and some had demonstrated this in their personal lives 
by showing others their legs. Others referred to infection and the appearance of an 
infected groin injecting site as something worth showing others. A predominant theme 
was that the use of visual images was strongly influential, such as the campaign which 
encouraged the use of fresh needles by using an image of a magnified blunt and barbed 
needle to demonstrate what happens when needles are re-used. Strong advertising 
images could also be useful for those not fully literate, which is not uncommon in the 
drug using population (Yates, 2006). 
 
Injecting advice 
A few participants felt that greater help should have been made available once injecting 
was established, such as help with locating veins and possibly establishing access using 
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a venous port of some kind. No participants mentioned injecting rooms or changes to 
legislation surrounding drug use.  One was keen that education about alternative routes 
such as smoking would be useful. 
 
It is interesting that, despite huge initiatives within harm reduction and the extensive 
provision of injecting equipment, many gaps still exist. Recommendations for harm 
reduction arising from this study will be discussed in Chapter 6.  
 
Chapter Summary 
This chapter examined the findings from interviews held during Phase 2. Risk factors 
that emerged in Phase 1 were explored further and the findings corroborated the results 
of the first phase, in that ulceration was linked to injecting in the legs or groin and 
followed a DVT.  
The participants’ thoughts on the cause of leg ulceration showed a variety of views, and 
most were unsure of causes. Few related it to injecting. However, all described the 
negative impact that ulceration had on their lives, in particular the pain, the 
embarrassment and the effect on their family and social lives.  
 
The participants’ views on harm prevention and reduction in relation to leg ulceration 
can be summarised in the following ways:  
1) Try to stop injecting occurring in the first place - something participants felt 
could be done within school education, with potential for the use of images of 
the consequences of injecting. 
2) Reduce harm to the lower limb by promoting topic-specific education that will 
target areas of risk, such as groin injecting and injecting in the lower limb.  
 
Phase 2 helped to answer the final research questions ‘What causes chronic leg 
ulceration in young PWID? and ‘What are appropriate harm reduction measures in 
young PWID?’. Chapter 6 will discuss the integration of the findings of both phases. 
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Chapter 6 
Synthesis and Discussion 
Introduction 
In this sequential explanatory mixed methods study two distinct phases were completed 
with the earlier results informing the second stage of the study.  
This chapter considers the extent to which the findings from both phases (Chapters 4 
and 5) are convergent and complementary, and explores the answers to the original 
research questions. The subsequent discussion draws on literature, some of which 
emerged during the course of the study, and concludes with limitations on the study and 
subsequent reflections. 
 
6.1 ‘What is the extent of skin problems and chronic leg 
ulceration in young people who inject drugs?’   
This research question was addressed within the first phase. The high prevalence of leg 
ulceration at 15% of the sample compares poorly with a 1% prevalence of ulceration in 
the UK general population (Hall et al, 2014).  The identification of a high prevalence of 
skin disease at 60% was less surprising as the skin has to be breached in order to inject 
and, with all of the risk factors discussed previously in Chapter 4, skin is the first organ 
to be affected. 
 
6.2 What causes chronic leg ulceration in young people who 
inject drugs?  
The statistical results from Phase 1 about causation linked well to the experiences 
described by Phase 2 participants. 
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Deep vein thrombosis (DVT) 
The statistical results demonstrated primarily that DVT was the most significant 
predictor of leg ulceration as 97% of those with a leg ulcer in Phase 1 had also had a 
DVT.  This was corroborated in Phase 2 where all of the participants, who all had leg 
ulceration, had sustained a DVT. 
 
Injecting in the legs 
Injecting in the lower legs was a strong predictor of developing leg ulceration in Phase 
1, and these results were also corroborated as all but one of the Phase 2 participants had 
injected in their lower legs. Ten participants in Phase 2 had ulceration at the site of an 
injection. 
In Phase 1 DVT was strongly associated with injecting in the lower legs. 
 
Groin injecting 
All of the Phase 2 participants had injected in their groin and had a DVT. In Phase 1 
DVT was also strongly associated with injecting in the groin. 
 
Leg and groin injecting is a strong predictor of damage to the venous system within the 
leg, and the limb is likely to deteriorate progressively, especially if a clot forms. These 
are the most likely causes of leg ulceration in young PWID. 
 
6.3  ‘What are appropriate harm reduction measures in young 
people who inject drugs?’  
Harm reduction was a topic raised specifically in Phase 2. However, participants in 
Phase 1 were unable to articulate a rationale behind the development of ulceration in 
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some injectors and not others. If harm reduction approaches had addressed the 
development of ulceration as a consequence of injecting no participant taking part in 
Phase 1 alluded to knowing it.  A number of harm reduction suggestions were made by 
Phase 2 participants.  
 
Existing knowledge 
None of the Phase 1 participants were able to articulate that groin and leg injecting 
were major risks to the venous system within the leg. This was surprising because so 
many injectors were sufficiently knowledgeable to be able to describe both how blood 
flowed in the veins and articulate safer injecting techniques. There was a lack of 
understanding  about the ‘bigger picture’, that injecting into an individual vein was 
injecting into part of a whole body system and that damage in one area, such as the 
groin, could impact further away in the body such as the lower leg.  Only one 
participant in Phase 2 could categorically state what the link was to their leg ulceration 
– ‘injecting in the groin caused the clot and the clot caused the ulcer’ (Participant 10).  
 
Existing knowledge about long-term consequences was therefore found to be very poor. 
Participants felt that harm reduction needed to address first of all the prevention of 
routes into injecting, which is largely beyond the scope of this study. Secondly, 
education should be targeted around the physical impact of the consequences of 
injecting to both people who inject drugs, and also to the staff who work within the 
services with which injectors interact. 
 
School-based education 
The majority of Phase 2 participants felt that education regarding drug-related harm 
should begin in school thereby preventing routes into drug use or injecting in the first 
place.  
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In Phase 1 there were no participants who were under the age of 21 years but nearly 
20% were injecting before they were 16 years of age, and almost half before they were 
20 years old. It appeared that younger people were not engaging with services that 
recruited to the study, and therefore were not in touch with harm reduction providers. 
Similarly, in Phase 2, all had injected before the age of 21 years and most had been 
introduced to illicit drugs before the age of 16 years.  
It could be suggested that education needs to happen before people encounter drugs for 
the first time, with the aim of stopping drug use all together and preventing routes into 
injecting. The participants in Phase 2 suggested that education needs to be delivered in 
primary school partly because a number of participants reported being taught to use 
drugs by family members and had become second generation users. 
 
Tactics were suggested where images of skin breakdown such as an infected groin, or 
leg ulceration, could be shown as a dissuasive visual tool, as something people would 
appreciate and remember. Images might also be more successful due to the lower levels 
of literacy amongst drug users as written pamphlets and wordy posters may be 
inappropriate (Treloar et al, 2011). 
 
6.4 Discussion 
This study has found that there is a very high prevalence of chronic leg ulceration in 
young PWID. This empirical finding comes as no surprise to healthcare professionals 
treating injectors with leg ulcers, but within the literature the definition of skin 
breakdown requires to be tightened in order to be clear about the ongoing extent of the 
consequences of injecting on the skin and venous system. 
 
6.5 Definitions 
The existing literature was discussed in Chapter 2 and it was frustrating to find a lack of 
definition by so many authors. It would appear that there is a general assumption that 
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all authors understand a common meaning when this is simply not the case (Topp et al, 
2008).  There is frequent reporting of ‘soft tissue infection’ which may have become a 
blanket definition for many types of injecting wounds including leg ulceration. As leg 
ulcers are open wounds, and can be chronic, they can be prone to infection, but 
predominantly they are caused by venous damage, not infection, and by improving 
venous return, the ulcer heals. Infection can occur, and should be treated concurrently 
to the venous damage, but if the infection alone is treated the ulcer would tend not to 
heal without addressing the underlying venous problem (Moffatt et al, 2007, p192).  
 
Therefore categorising ‘sores’ or ‘open’ wounds as soft tissue infection (Pubic Health 
Groups, 2014; Pubic Health Groups, 2015) is incorrect and can be misleading, 
potentially leading to an over-reporting of infections and an under-reporting of chronic 
leg ulceration.  
 
Over the course of this study, attempts to define skin problems in the literature have 
improved, but could be better. For example, an Australian study looked at lifetime 
prevalence of injecting-related injury (Topp et al, 2008). The authors gathered data on 
problems including abscess and injecting site infection by a self-report questionnaire 
and acknowledged the potential for significant debate on definition and categorisation 
of injecting-related injury and disease, but stated that these are commonly reported, 
although not necessarily understood, by injectors completing their survey. They stated 
that it was ‘not practicable to provide definitions or descriptions of conditions’ for their 
study. They reported a slightly lower abscess prevalence of 27% than other studies 
(Public Health Groups, 2015) but there was no mention of leg ulceration.  Clearly, if 
there is misunderstanding about meanings, the data cannot be accurately compared. 
 
Another Australian study examined injecting-related injuries in a sample of 393 PWID, 
and drew up a list of symptoms associated with particular injecting injuries (Dwyer et 
al, 2009). Respondents had to experience every symptom in a list to be classified by 
interviewers as having had that particular injury.  The authors acknowledged that the 
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interviewers were not medically trained and therefore the findings were indicative, but 
not diagnostic, or definitive, of any given complication. Interestingly, they reported a 
lower abscess rate of 16% and separately reported venous ulcers (1%) though they 
acknowledged that they were relying on self-report and that a clinical assessment would 
have improved confidence in the prevalence identified. 
 
An American study published in 2014 undertook a survey of injecting practices in a 
mobile needle exchange to identify self-care factors associated with chronic wounds 
(Smith et al, 2014). Chronic wounds were defined as ‘open areas on the skin that had 
been present and non-healing for 8 weeks or more’. 19.7% of participants had a chronic 
wound which was visually verified. Wound position was not reported, and ‘chronic 
wounds’ could have included leg ulceration or any other type of wound as there was no 
differentiation between wound types or appearances. Whilst the definition was 
technically correct for a chronic wound, it was too broad to provide any meaningful 
comparisons. 
 
It would appear that many wounds might have been misreported within the literature 
and therefore it was difficult to compare other studies with this one which defined each 
skin problem carefully (Coull et al, 2014). 
 
6.6 Risk factors for ulceration:  
Leg injecting 
This link between leg injecting and ulceration is similar to Pieper’s work which found 
that chronic venous disorders were more associated with injecting in the groin, legs and 
feet as compared with other sites (Pieper et al, 2009b).  
In this study, injecting in the lower legs was strongly associated with DVT. Injecting in 
the legs is clearly dangerous, and the serious consequences of injecting peripherally 
needs to be made clear to injectors and those that provide care for them.   
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Groin injecting 
Groin injecting is known to lead to scarring and narrowing of the femoral vein. The 
resulting inflammation may lead to distal clotting, and subsequent DVT in the vein 
distal to the injecting site (Senbanjo et al, 2010). 
In Phase 2, most participants had ulceration in their left leg. As most people (certainly 
within Phase 1) had right-handed dominance they were more likely to inject in their left 
side and therefore the damage could mostly be on that side (Maliphant and Scott, 
2005). 
 
Unfortunately the use of the groin in Glasgow appears to have become normalised and 
six people in Phase 1 started their injecting careers by being taught to go straight into 
the femoral vein. Not everyone did this and some referred to the groin as the site of 
‘last resort’, but everyone in Phase 2 used their groin site eventually. Many described 
progressive difficulties with the groin as the vein became thicker and deeper and 
needed larger needles to access it. Hitting nerves and arteries was also positively 
associated with the development of leg ulceration, presumably because this was a 
problem associated with groin injecting due to the close proximity of the femoral vein, 
nerve and artery. 
 
There is much debate surrounding harm reduction relating to groin injecting with some 
authors concerned that teaching safer groin injecting techniques contradicts the 
opposing advice that groin injecting is dangerous and should not be undertaken at all 
(Rhodes et al, 2006a; Zador et al, 2008; Miller et al, 2009; Hope et al, 2015).  
 
Concern has been expressed that, in attempting to reduce harm amongst users who 
femoral inject, service workers are crossing ethical boundaries by providing 
information to assist injectors and the message that this is a dangerous activity, rather 
than an acceptable activity, is not getting across.  Not one participant in this study said 
groin injecting was dangerous which suggests that advice regarding the practice might 
have a place. 
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The commercial harm reduction leaflets may say ‘don’t do it’ but then provide detailed 
information about how to access the groin / femoral vein in the safest way possible 
(Preston and Derricott, 2007; Kemplay, 2015). Much of the ‘danger’ alluded to in the 
literature relates to aneurysm and groin infection and whilst ulceration is mentioned as 
a possibility there is a lack of  emphasis on venous damage and the chronic recurring 
nature of ulceration caused by injecting (Gan et al, 2000).  
 
Injectors seemed unaware that persistent difficulties with accessing the femoral vein 
might be a warning sign that they needed to stop. In Phase 1 the groin was a favoured 
injecting site for many and the popularity of the site continued through Phase 2 but 
there was an almost complete lack of awareness of any long-term consequences. A 
recent study indicated that groin injecting is becoming more prevalent nationally and 
internationally (Hope et al, 2015) and it is increasingly urgent that attention is drawn to 
the long-term consequences. 
 
Whilst other countries use injecting rooms, the UK has yet to adopt this strategy 
(Rhodes et al, 2006b) and this has been a cause for argument for some time (Parkin and 
Coomber, 2011).  Whilst no-one suggested injecting rooms within this study, one 
participant expressed a desire for professional assistance with injecting safely.  A study 
by Harris and Rhodes (2012) has demonstrated that many injectors who experience 
increasing difficulty with venous access will eventually end up injecting in the groin. 
Harris and Rhodes (2012) recommend that intervention opportunities are not missed by 
service workers, and offering better injecting advice may reduce public health risks and 
slow the transition to groin injecting by preserving peripheral veins, and encouraging 
the use of sterile and sharp needles. In their study, participants were keen to obtain 
advice on safer injecting techniques and how to access veins safely as some of the harm 
reduction advice of ‘just say no’ or ‘smoke it’ was ridiculed as ‘just not getting it’.  
 
Similarly, Maliphant and Scott (2005) considered the use of structured safer injecting 
training to improve injecting techniques and promote the use of available peripheral 
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sites on upper limbs to avoid the potentially high-risk groin site. They also suggest that 
this initiative could be based within safer injecting facilities. Drug users often inject 
rapidly, preparing their hit quickly and in a concealed fashion to avoid detection by the 
public and police, and the groin is a popular site; this can lead to risk taking and 
injecting in less safe places. 
 
There is clearly room for further discussion on harms associated with the normalisation 
of groin injecting, and options to consider in terms of safer injecting advice facilities 
and education for both PWID and service providers 
 
DVT and Post-thrombotic syndrome (PTS) 
All of the Phase 2 participants had experienced a DVT, but only one linked this to 
ulceration.  
Post-thrombotic syndrome (PTS) can follow DVT in 20 to 50% of cases (Pirard et al, 
2008) and may be characterised by signs of chronic venous insufficiency with limb 
swelling, pain, skin changes, difficulty walking and venous ulceration (Kolbach et al, 
2003). These were symptoms complained of by the majority of participants in Phase 2 
and it is possible they had post-thrombotic venous ulceration as most developed their 
ulceration after they had been diagnosed with a DVT (Kahn and Ginsberg, 2004; 
Neglen, 2006).  
 
PTS has been known about for many years (Linton, 1953) but is not well-researched. 
Ulceration may form as part of PTS (Kahn and Ginsberg, 2004) and if this is the case, 
although the evidence is weak and studies have not been conducted in drug injectors, it 
is possible that the sequelae that follow DVT could be prevented in up to 50% of 
thrombosis sufferers by the use of compression hosiery (Kahn and Ginsberg, 2004; 
Prandoni et al, 2004; Musani et al, 2010; Arumugaswamy and Tran, 2014).  
246 
 
Compression can have a dramatic effect on reducing painful symptoms (Ettridge, 
2011), and pain was a key complaint of all but one of those participants within Phase 2 
who had recurrent ulceration.    
 
Whilst clinical assessment would be required to investigate whether the participants in 
this study with leg ulceration were suffering from PTS, it seems a likely hypothesis, 
and services to provide compression hosiery following a DVT should be considered.  
However, reducing the risk of DVT in the first place by avoiding leg and groin 
injecting would be good advice, and should a DVT occur, a clear message of likely 
sequelae should be given to those continuing to inject. 
 
6.7 Harm Reduction  
Harm reduction services alone are not enough to improve the circumstances of PWID. 
Recovering addicts also need to be able to develop a ‘non-addict’ identity and public 
health interventions must address social factors such as housing, imprisonment and low 
socio-economic status amongst PWID (McIntosh and McKeganey, 2000; Galea and 
Vlahov, 2002). Whilst these factors may be outwith the scope of this study, an ideal 
aim would be to stop all risky behaviours, including the total use of illicit drugs, but a 
realistic and pragmatic assessment would accept that a balanced approach enabling 
people to make informed choices.  
 
Preventing drug use through school education 
According to Stead et al (2007) drug education is now well-established within the early 
years of primary school; however, it does vary in topics delivered, and by whom.  
External teachers in schools often have greater credibility as they speak from personal 
experience (Stead et al, 2007). Some participants in this study had already provided 
education within schools. 
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Whilst effective drug education does now happen in schools (Stead et al, 2007; Scottish 
Government, 2008), it is possible participants in this study were not offered or missed 
such education when  young, and the education they received would not have focused 
on outcomes of injecting such as venous disease. Phase 2 participants were all aged 
over 29 years and their school education would have been completed at least eleven 
years previously. The Scottish Government’s Recovery strategy offers a number of 
recommendations around school-based education and following the findings of this 
study, there is potential for including some of the physical effects of injecting within 
that education (Scottish Government, 2008). 
 
Existing harm reduction information 
Smith et al (2014) readily acknowledged that whilst local and national harm reduction 
measures had focussed on risky behaviours, efforts had not been directed at raising 
awareness of long-term consequences of venous damage related to injecting by PWID 
which can lead to chronic venous insufficiency and ulceration. An earlier study by 
Williams and Abbey (2006) also found a lack of basic knowledge about the risks of 
DVT amongst injectors. Much of the knowledge about drug culture is shared between 
users so if there is a gap in knowledge about the causes of leg ulceration then this 
would be perpetuated – these older, experienced participants in this study who act as 
potential ‘teachers’ did not make the links between injecting and ulceration.  
 
In Phase 1, all participants were asked what they thought caused wounds on legs but 
very few of the total sample had actually experienced wounds on their legs and the 
responses lacked any uniformity.  
This included the thirty participants with leg ulceration in Phase 1 who were also asked 
this question, and no consistent theme emerged. In fact, almost every answer was 
different. Few participants with ulceration in Phase 2 seemed to have even a vague idea 
of what might have contributed to the ulceration, and there was some denial that it 
might be anything to do with drug use as one participant put it:   
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‘So I know it’s nothing to do with injecting do you know what I mean because I’ve not touched my groin for 
years’ (Participant 12). 
 
This is a gap which should be filled. PWID need to be better informed of the risks they 
take when injecting in the legs and groin.   
 
The main focus in most harm reduction messages seemed to be on addressing blood- 
borne viruses (Preston and Derricott, 2013). Specific literature related to groin injecting 
exists, and pamphlets are explicit about the dangers and harms of groin injecting 
including ulceration, for example, ‘In the Groin. Femoral Injecting’ (Preston and 
Derricott, 2007) and ‘Going in the Groin’ (Kemplay, 2015), but these seem to have 
made little impact on the participants in this study. Whilst venous disease is mentioned 
it does not appear to have been emphasised enough, or that PWID have not seen these 
leaflets or taken on board their message. 
 
Some web-based guidance for injectors (http://helpingaddicts.net; Hardacre et al, 2005) 
offers safer injecting advice and practical advice about injecting sites. It states that one 
of the risks of groin injecting is developing circulatory damage including deep vein 
thrombosis and ‘varicose ulcer in the lower part of the legs’. Later on under ‘long-term 
consequences of substantial vein damage’ the authors state that ‘one possible result of 
serious deterioration of circulation can be ‘painful areas of broken skin known as 
ulcers’  and ulcers ‘can take years to heal’. Whilst this is one of the few publications 
for drug users that mention the formation of ulcers, it isn’t an aspect that is highlighted 
or to which attention is drawn. It does however have the merit of differentiating 
between ulcers, abscesses, cellulitis, phlebitis and local infections. This was web-based 
information and would require users to access the information via the internet and to be 
literate enough to do so.  
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The main harm reduction theme arising from Phase 2 participants concerned visual 
deterrents and education, whilst addressing prevention through early school-based 
education.  
 
Visual deterrent 
Senbanjo et al (2012) instigated health checks for groin injectors and undertook 
ultrasound examination of the femoral area. They found that the images of damaged 
femoral veins were a useful resource for discussion about risk. The impact of a visual 
deterrent such as this may be very useful to consider, as damage to the femoral vein 
will likely precede the venous changes in the leg.  
 
Ulceration is end-stage venous disease and the limb is likely to have progressive and 
visible changes as venous disease escalates (Eklof et al, 2004). If injectors were shown 
corresponding visible images of early signs of venous disease such as ankle flare, skin 
staining and varicose veins on themselves (Moffatt et al, 2007, p81), then they might 
begin better to understand the damage to their veins. Similarly, they may become able 
to identify signs of damage on their peers.  An identification of early signs and the 
knowledge that these were part of a sequence of events leading to ulceration may well 
dissuade those from continuing with injecting.  As one participant said: 
 ‘If somebody would have showed me the way my legs were the now I would never have touched a 
needle. See if I’d had seen photos of that in a catalogue of people’s legs, no faces or nothing just legs, 
some of the people that I’ve seen they’ve had big chunks took out of their legs do you know what I mean. 
So if I’d had seen something like that I’d be like that, I’d never do that do you know what I mean’ 
(Participant 12). 
 
Formal or informal peer-to-peer education amongst drug users is a common approach 
known to be successful (Treloar et al, 2011), and is worth considering as part of harm 
reduction approaches.   
 
250 
 
Impact of pain and reduced mobility 
The impact of leg ulceration on the lives of drug users has not previously been used as 
part of harm reduction messages. People tend not to think about their legs until they are 
injured or in pain, and problems are easily hidden under clothing, (Pieper and Templin, 
2001) yet leg changes with CVI may hamper mobility, quality of life and employment 
(Pieper and Templin, 2003).  Participants were not asked about pain in Phase 1 yet it 
was of major significance in Phase 2 with one of the participants summing it up well: 
‘the most painful thing you can get, it’s like somebody burning you with a hot iron and somebody putting a 
fag into your face, the pain is unbearable. I was, many times I’ve cried because of the pain, I couldn’t 
handle it…….The worst pain, yes, definitely, a hundred per cent’ (Participant 8). 
 
For participants to express such severe pain was a surprising finding because of the 
level of opiate use and also because venous ulceration is often considered not to be 
painful (Moffatt et al, 2007, p216). However, Pieper et al (2013) examined pain in 
PWID and considered that the pain from ulceration reduced mobility and found that 
inadequate pain management could cause former injectors to relapse into drug use or 
resort to alcohol use. Although pain management was not explored in this study, the 
severe pain experienced was something that participants wanted to be able to convey to 
less experienced users as a dissuasive measure. 
 
Participants also described considerable embarrassment as a result of the appearance, 
the smell, and the experience of reduced mobility due to venous disease (Pieper et al, 
1998; Pieper et al, 2008a; Pieper et al, 2010a; Pieper et al, 2010b).  In Phase 1 the 
reduced mobility was statistically significant in leg ulceration but it was unclear how 
much this preceded the ulceration or was caused by ulceration. In Phase 2 it became 
clear that leg ulceration and the pain and swelling associated with it had a direct effect 
on the participants’ ability to be independent and mobilise freely.  In relatively young 
people, being unable to walk is important and a message worth communicating as 
significant risk.  
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Timing of harm reduction interventions 
Focus groups with drug users led by Phillips et al (2013) to investigate risk reduction 
interventions found that withdrawal symptoms negated consideration of risk reduction 
strategies. So when a drug user is craving then that is not the time to intervene. When 
PWID collect their injecting equipment, this is usually after they have acquired the drug 
to use, and are therefore beginning to withdraw (McKeganey et al, 1989). This would 
suggest that this is not the time to intervene, but somehow to consider access to drug 
users either when drug use is finished or when they are not about to use. That may be 
challenging, but timing seems important.  
 
Knowledge and education of service staff 
It became increasingly clear throughout the study that there was a gap in the knowledge 
of drug injectors of the impact that injecting had on their legs, but also an apparent 
deficit in the knowledge of the healthcare workers who interacted with these injectors. 
Interestingly, the most recently published textbook on the topic (‘Leg Ulcer 
Management’ by Moffatt, Martin and Smithdale, 2007) and recent guideline 
(‘Simplifying Venous Leg Ulcer Management’ by Harding et al, 2015) fail completely 
to mention injecting drug use as part of the risk of CVI and leg ulceration.   
 
Despite all Phase 2 participants having attended for treatment for a leg ulcer neither 
they, nor the healthcare professional treating them, appeared to have attributed the ulcer 
to a specific aspect of  injecting habits, if indeed the link to injecting had been made at 
all. 
 
For healthcare professionals, it would be usual practice to offer explanations for disease 
process when discussing conditions, for example, linking smoking to heart disease, but 
this explanatory link appeared to be missing. Even though a significant proportion of 
people do develop chronic venous ulceration before middle age, and thus it is not rare, 
the lack of explanation was surprising (MacKenzie et al, 2003).  
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Chronic venous insufficiency is a progressive disease and although signs and symptoms 
may develop long after a person has ceased injecting, usually there are visible signs of 
damage that could be pointed out to PWID such as varicose veins, ankle flare, 
lipodermatosclerosis or skin staining. These may all precede ulceration (Pieper et al, 
2006a & b; Beynon et al, 2010).  Service staff who interact with drug injectors could be 
trained to identify these signs. Raising awareness of the risk with drug users before 
ulceration occurs may be very helpful in preventing extension of disease,  or treatment 
can be implemented earlier and create a better chance of healing (SIGN, 2010).   
 
It is possible that wound care experts and those normally charged with tissue viability 
services do not have the knowledge or feel equipped with the necessary skills to work 
with substance misusers (Gilchrist et al, 2011). Training should be available to help 
them deal with the particular needs of substance misusers as well as identify physical 
problems specific to drug users, including signs and symptoms of chronic venous 
insufficiency.  
 
Equally, addictions workers may be ill-equipped to deal with physical health problems, 
and training should also be available for identifying venous damage within limbs. 
 
Many injecting drugs users in Scotland acquire their injecting equipment or methadone 
at pharmacies (Matheson et al, 2002) and pharmacy staff are key people who should be 
educated in both harm reduction information relating to groin and leg injecting, and 
also in encouraging help-seeking behaviour for those with chronic leg ulcers who 
require assessment and treatment (Scott and Mackridge, 2009; Mackridge et al, 2010).  
 
 A & E services often see drug users and the one-off opportunities for harm reduction 
related to skin and injecting, and also in reducing mortality, could be utilised (van Beek 
et al, 2001). Brief interventions can be effective even though they are often 
opportunistic or quick (Hamilton, 2009) and training in these should be considered for 
nurses, especially for interventions with drug users where there may only be one first 
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chance to make a difference. Those with psychiatric co-morbidity and substance use 
may be more likely to attend A & E more frequently (Curran et al, 2008), and this also 
creates a training need for staff, many of whom focus primarily on physical health 
needs (Jones et al, 2002).  
 
Wound care services 
More than a third of those with ulceration in Phase 1 had never been properly assessed 
or treated despite current guidelines (SIGN, 1998; SIGN, 2010). Thirteen participants 
with ulceration also reported recurrence and three of those people had never had any 
assessment or treatment for the ulceration.  It is unclear why this did not happen, but 
early assessment and treatment improves healing rates. Of the eleven Phase 1 
participants who were not assessed, six were living in their own homes, so even with 
stable domestic situations they did not receive appropriate care. This may be due to 
chaotic lifestyles, a lack of accessible services, a failure to treat, or a difficulty engaging 
with mainstream services. Devey (2010) described the problem of drug users as always 
being ‘in a rush’ and unwilling to remain long enough in a clinical service for an 
assessment using a Doppler test to be undertaken. Compression treatment should not be 
applied without a satisfactory ABPI result (SIGN, 2010).  
 
Recent empirical work indicated that ABPI in young people may be normally elevated 
(Male et al, 2007; Niblo and Coull, 2013).  Published case reports of young PWID with 
ulceration showed that most were venous in origin, and all were suitable for 
compression treatment (Butcher, 2000; Acton, 2008; Devey, 2010). For some time the 
leg ulcer protocol within Glasgow also stipulated specialist referral if an ABPI reading 
was above 1.3 as this could suggest calcification (Finnie, 2003). Patients who were 
referred to hospital for further assessment found it difficult, or were unwilling to attend, 
so a full assessment and subsequent treatment did not take place. This raises questions 
about access to appropriate healthcare provision (Meetoo, 2010). It is likely that 
elevated ABPI readings may be normal and as drug injectors are likely to have almost 
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wholly venous damage, then compression should be applicable and the treatment of 
choice, and specialist referral is unnecessary.  
 
Targeted services provided through, for example, IEP facilities may address these 
issues (Hope et al, 2014). A bridging solution has been developed in Yorkshire (UK) 
with the creation of ‘well-being’ nursing posts to meet the needs of drug users. 
Specialists in mental health have had additional specialised training in wound 
management and leg ulcer management (Cook and Jordan, 2010). These authors 
consider that utilising community nursing teams or wound management specialists to 
deliver care for drug users creates a fragmented service. The ‘well-being nurses’ were 
not trained to apply compression bandages but instead were supported to become 
skilled in using leg ulcer compression hosiery kits. They worked in collaboration with 
the vascular nursing service who undertook initial assessments and reviews. Whilst this 
management would not suit highly exuding wounds, it appears to have been very 
effective, and could be considered more broadly for other services.  
 
The earlier that leg ulceration is treated then the more successful the outcome is likely 
to be (SIGN, 1998). Sometimes drug injectors may feel forced to self-manage due to 
negative attitudes and mistreatment by healthcare workers, a lack of appropriate 
provision of wound care services, or a denial of the seriousness of the wound.  PWID 
appear to be able to self-diagnose and treat, to a limited extent, their own wounds, and 
only seek medical care when absolutely necessary (Roose et al, 2009; Devey, 2010; 
Phillips et al, 2013).  
 
Manipulation of their own wounds and acquiring antibiotics without prescription 
should be discouraged because of worsening infection and potential resistance to 
antibiotics (Roose et al, 2009) and perhaps earlier intervention by health care staff 
might prevent crisis management in A & E services.  
In the Phase 2 interviews there appeared to be an element of disbelief or denial, as this 
participant described: 
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 ‘I says what? Telling me I’ve got an ulcer, you don’t get ulcers in your legs, right that’s how daft I was. 
You don’t get ulcers in your legs; you get ulcers in your stomach or our tongue whatever’ (Participant 8). 
 
Also, once the ulcer started an element of ignorance about the serious non-healing 
nature of leg ulceration could result. Participants also took time to seek professional 
help, as one put it:  
‘…I started scratching it and it finished it burst open. I thought it would just a scab on it, I picked the scab 
off it awright, right, but because I kept on using it, I don’t know if it was the citric or whatever, drugs, it 
started getting bigger. But at that time I didn’t want to go to a clinic to get dressings and all patched up 
and that so I used to just leave it and it started to smell, smell and a lot of discharge came out of it so, I 
had it about fourteen, fifteen months by this time and it was about the size of an orange by then. I went to 
my doctor then’ (Participant 3). 
 
Access to early specialist assessment and treatment needs to be improved; this may 
occur if there is better recognition of ulceration by PWID, and also if the importance of 
early assessment and intervention is understood. 
 
Attitudes by services 
Drug users will often delay seeking treatment until they reach a crisis point (Hope et al, 
2014). However, it would appear that there are limited facilities for drug users to 
approach without fear of discrimination, and these delays may reflect a number of 
issues such as competing priorities of acquiring money and using drugs, non-
compliance with prescribed medication as well as barriers to accessing care. 
 
The suggestions made by participants in this study with regard to service provision for 
wounds related more to attitudes rather than the services themselves. In this study, 
almost all participants in Phase 1 had contact with a healthcare professional, but 20% of 
these felt they were unable to talk to them.  There is stigma associated with PWID 
which affects not only the public view of them but also those of health professionals 
(Simmonds and Coomber, 2009; Whittaker et al, 2015). PWID have a reputation for 
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being difficult and demanding, and may exhibit unpredictable behaviour and poor 
compliance (Dunlop and Steedman, 1985; Carroll, 1996).  
 
Health professionals have reported that the care they give to users of illicit drugs is 
often the most negative, unrewarding and unpleasant experiences of their careers 
(McLaughlin and Long, 1996).  Patients presented ‘considerable problems for both 
medical and nursing staff’, citing blood-borne viral risk, withdrawal symptoms, and a 
lack of peripheral vascular access inhibiting induction of anaesthesia and administration 
of intravenous antibiotics. Poor compliance, including a high non-attendance rate at 
follow-up clinics, complicated all forms of treatment (Fullarton, 1983). Whilst these 
two studies are dated it would appear that little has changed over time, as a recent 
Scottish study, examining healthcare practitioners approaches to drug using parents, 
confirmed (Whittaker et al, 2015).  
 
Harris and Young (2002) suggest that the assumption that PWID are irresponsible 
about their own health is incorrect, and that if treated appropriately in a user-friendly 
and non-judgemental environment, PWID will utilise services. This is similar to the 
comments made by Finnie and Nicolson (2002a) about a drop-in wound clinic set up in 
Glasgow for PWID where a non-authoritarian, non-judgemental approach was found to 
result in good attendance figures and return rates. 
 
The importance of straight talking and engaging trust to ensure regular attendance for 
treatment, especially when ulcers are chronic, was reiterated amongst the sample within 
Phase 2 but staff should beware of  judgment-based remarks that are inappropriate as 
healthcare professional behaviour can be very influential on drug users seeking help in 
future (Butcher, 2000; Greene, 2010; Fowler et al, 2014). Amongst health professionals 
there needs to be greater understanding of traumatic histories experienced by drug 
users,  and services need to be more inclusive and welcoming (Stewart et al, 1998; 
Neale, 2004b; Schwartz et al, 2006; Shand et al, 2011).   
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Reduction of stigma may increase their own control and self-esteem of drug users and 
possibly reduce risky behaviour in a move towards recovery (Simmonds and Coomber, 
2009). Mothers in particular have reported alienation from mainstream services due to 
negative attitudes by nurses and midwives (Raeside, 2003; Fowler et al, 2014). Having 
an injecting injury is a visible sign of illicit behaviour and this can make substance 
users defensive and keen to conceal their wound for fear of authoritarian approaches, 
particularly in relation to child protection. Aggressive policing of injecting behaviour is 
thought to contribute to moving injecting behaviour into more secluded locations, 
causing increased harm and risk of overdose (Fitzgerald et al, 2004). It is possible that 
an authoritarian approach by health professionals also may encourage drug users to 
hide the evidence of their drug use (e.g. track marks, injecting injuries and wounds), 
thereby preventing access to appropriate healthcare when required (McLaughlin and 
Long, 1996; Ritson, 1999). 
 
Nevertheless, further skills training of service staff engaging with drug users would be 
useful and merit some consideration by managers and policy makers to ensure that 
services to assess and treat physical harms from injecting are available (Whittaker et al, 
2015). 
 
Service provision 
A consensus statement on reducing injecting-related harm has stated clearly that IEP 
services should be made available in every area and provide, amongst other services, 
‘wound care advice and treatment’ (Exchange Supplies, National Needle Exchange 
Forum, and UK Harm Reduction Alliance, 2007). 
 
In 2010, The Scottish Government recommended that all IEP services should be able to 
either provide or refer to accessible services for primary healthcare, including 
dressings, and wound care (The Scottish Government, 2010).     
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Of course, even when provided with harm reduction information, if given a choice the 
drug user may choose pleasure over risk and the standard model of reducing harm by 
education of risk simply does not work (Dwyer, 2008). This was summed up well by 
Participant 15:  
 ‘You are not going to stop anybody injecting if they are going to inject they are going to inject it’s your 
choice do you know what I mean. Whether you do it or not is a different matter. But trying to deter people I 
find it hard, I would find it hard to try and stop somebody it doesn’t matter what you tell them. Look at the 
state of my legs, look at this, look at that, if they are going to do it they are going to do it it’s simple’ 
(Participant 15). 
 
Only one participant thought they might lose a leg and although she was still using 
drugs, she had stopped injecting. There is a minority of drug users who have an 
ambivalent approach to disease and death, in which case little may be done to influence 
that trajectory (Miller, 2009). Other studies have shown a fatalistic approach by some 
drug users in that if they know, for example, that they have a blood-borne virus, their 
approach to risk worsens (Korthuis et al, 2012). It may be similar once an ulcer 
develops. Some individuals are thought to deliberately undertake risky practices and 
health promotion is likely to be ineffective for these individuals (Peretti-Watel and 
Moatti, 2006). 
 
6.8 Limitations  
The literature was searched repeatedly throughout the planning and execution of this 
study but there was very little empirical work to draw upon with which to compare the 
findings. Also the inconsistent terminology, lack of definition, and misinterpretation of 
skin problems meant that any existing evidence generally lacked clarity and made 
comparisons with the findings of this study very difficult. Although relevant work in 
the field has previously been done by Pieper and her team in the US (for example 
Pieper and Templin, 2003; Pieper et al, 2015) and whilst venous disease and leg 
ulceration is regarded by them as a major issue, the types of drugs injected are different 
(typically purer heroin with cocaine and methamphetamine) and are not mixed with 
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acidifier as in the UK. Also US health policy on harm reduction differs to some extent 
in that injecting equipment provision is inconsistent and often lacking (Phillips et al, 
2013). These factors made international comparison difficult which is unfortunate since 
this author’s work is most closely aligned to this study. 
 
Sampling 
Of particular concern at the beginning was the ethical review and subsequent 
recruitment to the study. PWID are notoriously difficult to engage with, but pre-
existing clinical links had already been forged, and colleagues within the NHS were 
more than willing to help. Data collection was largely smooth due to the generous 
assistance of the Pharmacy Team of Glasgow Addiction Services and the staff of the 
Physical Health Team from NHS GGC. The opportunistic quota sampling used within 
the first phase ensured a pragmatic approach to recruitment and was similar to other 
studies with similar populations (Morrison et al, 1997; University of the West of 
Scotland, Health Protection Scotland, University of Strathclyde, and the West of 
Scotland Specialist Virology Centre, 2012).  
 
However, recruitment to Phase 2, when a specific sample was needed, proved difficult 
and future studies would require to develop a less opportunistic recruitment plan. The 
initial plan was to include some Phase 1 participants within Phase 2, but due to various 
practical barriers, this did not happen. The inclusion of these Phase 1 participants (with 
leg ulceration) might have contributed to an earlier completion of the sample as a range 
of potential participants with leg ulceration had been identified who were willing to 
take part in Phase 2. The inclusion of participants who were not engaging with the 
Physical Health Team (where Phase 2 participants were recruited from) might have 
created a more heterogeneous sample.   
 
The sampling frame devised for the second phase was a proportional match to those 
recruited within phase 1 – similar ratios of males to females. It was intended to recruit 
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equal numbers of people with recent leg ulceration and ‘old’ leg ulceration, and current 
and past injectors. However, this proved difficult and time-consuming. In the end the 
sample fell slightly short of that anticipated.  
 
The sample for Phase 2 was drawn from a group of PWID who were attending one 
service for treatment of leg ulceration. Therefore all of those in Phase 2 were engaging 
with services in some way, and their perspectives may have been influenced by each 
other, and by those who were caring for them. The group may have been slightly 
homogenous in this regard and their views may have been different from a population 
who were not engaging, and not attending for care.  It may be difficult to generalise 
from the study due to the homogenous nature of the sample, the potential difference 
with other groups of PWID, and therefore applicability to other cities in the UK and 
abroad is possibly limited. 
 
Perceptions of cause 
Within Phase 2, by the very nature of the questioning, leg ulceration was linked to 
injecting and the study title which included the words ‘injecting’, ‘drug use’ and 
‘ulceration’ also drew attention to potential causation. This may have influenced some 
of the participants to consider links between behaviours where previously they may not 
have given it any thought. 
 
Under-reporting or over-reporting 
Given the nature of drug use, information is understandably hard to come by due to the 
reluctance of PWID to divulge illegal behaviour. Similarly not all PWID will readily 
disclose skin problems and admit potentially poor technique resulting in injuries as 
many take pride in their ritual (McBride et al, 2001; Lloyd-Smith et al, 2005). Punitive 
behaviour from health professionals can result in methadone prescriptions being 
withdrawn if visible signs of concurrent injecting are seen. There is therefore a 
possibility that the prevalence in this study is under-reported. 
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Similarly the prevalence may be over-reported. This sample was drawn from a drug-
using population who were engaging with services, but a number of PWID do not 
engage with any services and may have problems arising from their injecting habits. 
The population is an unknown quantity and hence it may be difficult to generalise the 
reported prevalence to wider injecting groups.  
 
Clinical examination 
Some studies, for example Senbanjo et al (2010) and Pieper and Templin (2003) 
verified disease by clinical examination which may be of value when identifying 
prevalence of a visible skin disease. Whilst recall was found to be reliable, clinical 
examination could have provided more clarity of signs and symptoms experienced and 
an accurate assessment of venous disease. Future studies should explore the degree of 
congruence between self-reporting and clinical examination. Accurate reporting of skin 
breakdown would improve rigour and comparability between studies and could be 
considered for future work, although serial assessments might need to be considered in 
order to capture the true nature of evolving disease and also the incidence of infection.  
 
Wound definition 
Clearly clinical examination would have assisted in ensuring rigour around wound 
identification and confirmation of definition. It is possible that participants may have 
misunderstood or not remembered what their skin looked like over the course of their 
injecting careers. Whilst the researcher attempted to make sure there was clarity and 
explanation around definitions and appearances of skin and wounds, the potential for 
misunderstanding and failure to recall remained. Possibly the use of images may have 
assisted participants but this also would have been challenging as few wounds or skin 
problems are identical. Future studies might seek to combine accurate definition with 
examples of wound type in a visual form and so potentially reduce the risk of 
ambiguity or misunderstanding.  
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Substances injected 
There was a lack of knowledge about the true chemical content of injected substances 
including the adulterants and acidifiers which are injected over long periods of time. 
This creates a further question about aetiology. Is it the injected substance that causes 
the clots or the skin to breakdown?  This was not something that could be explored 
within this type of study but is worthy of consideration for future studies.  
 
Interpretation of findings 
The lack of pre-existing robust evidence about of leg ulceration in PWID leads to some 
difficulties in interpreting the study’s findings. There are so many ‘unknowns’ within 
the field:  the injecting population (Robinson et al, 2006), the substances injected 
(Coomber, 1997c), injecting techniques (Taylor et al, 2004a), where and why clots 
form (Williams and Abbey, 2006) together with systemic processes that impact on skin 
breakdown and wound healing (Moffatt et al, 2007). Utilising a pragmatic and practical 
mixed methods approach allowed clear statistical inferences to be drawn from the 
information gathered, and these were, to some extent, corroborated within Phase 2. 
However, due to the unknown factors around which data could not be gathered the 
findings from this study should perhaps be regarded as a first, small step towards 
increased knowledge for prevention, assessment and treatment of leg ulceration in 
PWID.   Much more research requires to be done to understand the physical impact of 
injecting. 
 
6.9 Reflections 
Critical realism as a philosophical approach. 
The use of critical realism as a methodological approach to the research was helpful. 
The use of two methods was a pragmatic and practical response to answering unique 
research questions within a challenging population. This study had three aims which 
were met by using both empirical and interpretivist approaches.  Striving for rigour but 
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recognising within the fieldwork that the convergence of ‘idealism’ and ‘reality’ could 
conflict. In some ways critical realism is a ‘middle-ground’ between empiricism (a 
largely quantitative questionnaire survey) and interpretivism (using semi-structured 
interviews) and therefore can endorse a range of designs according to the study aims. 
The empirical questionnaire also included qualitative sections, and tabulation was used 
within the interpretation of the interview data so neither of the two phases were pure 
approaches to one quantitative or qualitative method or indeed a specific philosophical 
view. For that reason critical realism, which does not commit to one single type of 
research design was a good fit for this study. It allowed reflexivity and responsiveness 
to the research questions without being bound to a pure and rigid approach.  
 
However, critical realism also regards all knowledge as potentially fallible in that a 
scientific account of a particular phenomenon, in this case the likely causative factors 
for leg ulceration, may only be a partial account. Indeed whilst deep vein thrombosis 
linked to groin and leg injecting are significant indictors for causation of leg ulceration 
in PWID in this sample, there may be a number of other factors occurring which could 
not be observed or explored. The constituent elements of the drugs injected are a case 
in point where the cutting agents, the diluents, the ph., the acidifier and the contextual 
circumstances surrounding injecting are all variables which in the main are unknown 
but could have influenced the findings.  
 
The explanatory nature of the sequential design permitted triangulation which enabled 
the results inferred from Phase 1 to be confirmed within Phase 2 giving the entire study 
a better balance and perspective (McEvoy and Richards, 2006).  The knowledge gained 
is meaningful for this applied health research but the critical realist accepts that further 
exploration would be worthwhile (Schiller, 2016). Therefore recommendations for 
further research are made within Chapter 7. 
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Use of mixed methods and the linkage between two studies 
The explanatory and sequential nature of the research design meant that the data 
analysis had begun before all the data were collected, and this was necessary for Phase 
1 to inform Phase 2. However, at the conclusion of both phases, the data from each 
were reviewed and links made retrospectively between the Phase 2 findings and the 
earlier Phase 1. One of the strengths of this mixed methods approach was that the data 
from two studies were brought together to allow a better understanding of the 
phenomena under investigation (Onwuegbuzie and Teddlie, 2003).  
 
There were, albeit small, overlaps within each study where a qualitative element within 
Phase 1 asked participants views about what caused leg ulcers. Within Phase 2, there 
was a quantitative element where data from the participants was tabulated and counted 
to further validate the results from Phase 1- this was specifically related to the number 
of participants who had groin, and leg injected and those that had a DVT within the 
leg(s) that had ulcerated.  
 
The ‘triangulation’ – the search for concurrent or convergent results by means of 
different methods (Erzberger and Kelle, 2003) - of the results of both phases allowed 
added depth and insight to the research questions that neither method alone could 
produce. Until the first phase was complete it was not apparent which aspects of risk 
and of the experience of ulceration by injectors should be explored in the second phase. 
The first phase therefore provided the basis for the subsequent interviews to allow the 
exploration of injecting habits and risks associated with leg ulceration in a more refined 
way than was revealed during the qualitative element of Phase 1. Hence the two phases 
were firmly connected (Creswell and Plano Clark, 2001, p234).  
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Each phase was analysed separately and independently of the other as is common for a 
sequential design (Creswell and Plano Clark, 2011, p232-4). The first phase was 
analysed using descriptive and inferential statistics and the second phase utilised 
framework analysis. Both methods of analysis are robust and widely accepted methods 
of analysis for the type of data collected (Creswell and Plano Clark, 2011, p203 - 50). 
The findings from both phases were brought together using a system of logical 
inference (Erzberger and Kelle, 2003) and whilst the qualitative findings helped to 
explain the quantitative results, they also added depth and another dimension to the 
study by exploring in more depth how the participants felt about have a leg ulceration 
and its’ impact (Creswell and Plano Clark, 2011, p221). The convergence of the Phase 
1 results and the Phase 2 findings allowed similarities, differences, and conflicts to be 
explored within the sequential explanatory design. Synthesising the two phases was 
challenging but the findings from the phases were integrated in such a way as to 
demonstrate the similarities between the findings of each phase, such as the presence of 
deep vein thrombosis in almost all participants with leg ulceration. Another example 
would be the lack of insight into the harms and risks associated with injecting in the 
groin for participants in each phase.   
 
A separate element to Phase 2 allowed the participant’s views about harm reduction, 
the third research question, to be explored in more depth than the direct questions raised 
in the first phase. In doing so, there was slightly more collegiality to the responses as all 
Phase 2 participants had leg ulceration, enabling themes to be identified more clearly.  
 
There was a time gap between the two studies caused by extenuating circumstances 
unrelated to the research. However, it is doubtful that this significantly affected the 
findings. The second phase sought to explain and explore the findings from the first 
phase and there was limited change in the evidence base, or knowledge around the 
development of leg ulceration in PWID. During the gap between the two study phases, 
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the literature continued to be searched and no new developments within the specific 
field of research were found that would influence the second phase.  
 
Undertaking a mixed methods approach was challenging, but developing two phases 
and linking them was worthwhile. The two phases allowed a deeper understanding 
around the research questions and for further exploration to be undertaken once the 
initial quantitative data were collected. However, given the opportunity to repeat the 
study again, it would be helpful to spend more time on creating, and piloting a specific 
questionnaire. The knowledge gained about risk, injecting sites and thrombosis, would 
enable a more exacting focus and for that to be explored robustly within another study. 
It would also be useful to incorporate some method of identifying changes in injecting 
practice and health outcomes over time.  
 
However, the development of the questionnaire and the semi-structured interview 
schedule was part of the evolutionary research process and if further research were to 
be undertaken then the evidence from this study would be useful to inform future 
research designs and tools, together with any new emerging evidence from other 
sources. 
 
Overall, the use of mixed methods with a sequential design was a good choice to allow 
the research questions to be explored, the two phases enhanced rigour, and the findings 
were more robust as a result of their integration. 
 
Application of framework analysis to analyse and interpret data 
Framework analysis is a now tested approach for analysing qualitative data (Ritchie and 
Spencer, 1994). This method appealed, because both the systematic and matrix 
approach was not aligned to any particular philosophical stance, so was suited for use 
with the critical realist approach.   
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As a novice qualitative researcher, framework analysis allowed a clear plan for 
organisation of a large amount of data derived from interview transcripts. The 
structured approach offered by the framework was a helpful learning tool to guide and 
manage a large amount of data using detailed summaries and proved effective for 
answering the research questions. 
 
In early literature, which was drawn upon when planning the study, the method was 
heralded as useful where timescales were short (Pope et al, 2000).  Yet later accounts of 
using framework analysis describe it as time-consuming and resource intensive (Smith 
and Firth, 2011; Gale et al, 2013). Indeed the method was time-consuming however, the 
approach allowed the efficient handling of quotes and ensured that checking and cross-
checking back and forth from the raw data within NVivo was simple to manage. It was 
particularly helpful to use framework within NVivo as some participants were known 
to the researcher and their data became anonymised within the charting process. 
Similarly NVivo was helpful in allowing the simplified management of large amounts 
of data and helped aid retrieval and refinement. 
 
Framework analysis allowed a transparent and rigorous approach to the analysis of the 
qualitative data. Using an inductive approach to the analysis worked well with the 
framework allowing themes to be generated from the data collected, and subsequent 
refining of those themes to form the basis of the narrative (Gale et al, 2013).It was a 
replicable method of analysis so transparency could be ensured if others wished to 
revisit the data, or indeed if further analysis or retrieval of data is required for future 
publications. Although the interpretation might have been viewed as rather individual, 
it could still be followed by others within the transparent frameworks or matrices 
created within NVivo.  This benefit of transparency also lent itself to easy retrieval and 
revisiting of the data during the writing up and revision process.  
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Links to the Recovery Strategy 
During the course of this study the Scottish Government published their strategy 
entitled ‘A Road to Recovery – a new approach to tackling Scotland’s drug problem’ 
(Scottish Government, 2008). Harm reduction may be seen to be set apart from 
Recovery per se but every small step that an individual takes towards health 
improvement forms part of their journey away from drug use harms. 
Whilst this study is rooted within harm reduction, preventing leg ulceration from 
occurring by early intervention with groin or leg injectors would also form part of the 
process of recovery. There needs to be consideration within policy frameworks for 
addressing the physical harms of injecting as part of Recovery. PWID would benefit 
from better information in order that their choices to inject in the femoral vein or the 
lower leg may be fully informed regarding the associated risks, and this information 
currently appears to be absent from harm reduction material. 
 
Reflexivity 
Across both phases some of the participants may have known me as a nurse within a 
wound clinic. A few mentioned this during interview. This may have had advantages in 
that they may have been more willing to participate or divulge information, but 
alternatively it may have inhibited them. It was important to be aware of the different 
roles as a nurse and researcher, and that the participants also may hold other views. 
Whilst previous experiences had led to the research questions and could not be 
disregarded in entirety, prior knowledge needed to be set aside with the participants 
whilst remaining professionally compassionate and empathetic to each participant’s 
situation (Berger, 2015). My entire approach needed to be reflexive and I 
acknowledged the impact my personal experiences and views may have had on the 
interactions. Depersonalisation of the ensuing data by the utilisation of the Framework 
Approach to analysis and through the coding process helped reduce the reliance on the 
personal experiences and improve rigour and credibility in the research. 
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Clinical practice 
Throughout the process of this PhD study, my own clinical practice has continued 
within a nurse-led wound clinic for PWID. The knowledge gained throughout the 
process has substantially influenced my own role. For example, when assessing patients 
with leg ulceration, or offering advice to groin injectors, the knowledge I have gained 
about risk factors and potential sequelae following DVT has resulted in improvements 
to my practice such as earlier prescribing of compression and more specific advice. 
This knowledge has also been passed to colleagues and others through publications and 
teaching (Coull et al, 2014; Coull, 2015). 
 
Chapter summary 
By using a mixed methods approach, all of the research questions have been addressed. 
Each phase contributed uniquely to the development of new knowledge about risk 
factors and harm reduction but it is clear that more work is required to raise awareness 
of venous disease amongst PWID and service providers.  The final chapter follows to 
conclude with recommendations for clinical practice, research and policy.  
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Chapter 7 
Conclusion and Recommendations 
Introduction 
The chapter summarises the findings of this applied health research study. 
Recommendations for practice, research and policy will be outlined and are sourced 
largely but not exclusively from the discussion within Chapter 6. The thesis closes by 
stating the study’s original contribution to knowledge. 
 
7.1 Prevalence 
Within this study, the prevalence of leg ulceration in young people who inject drugs 
was found to be very high at 15%.  This very high level of morbidity is notable and 
should be considered in planning services for PWID. 
 
7.2 Risk factors 
This study has shown empirically that leg ulceration is directly attributable to deep vein 
thrombosis with risk predominantly associated with leg injecting and groin injecting. 
This is new knowledge that services involved in preventing and reducing harm can 
utilise.  
 
7.3 Harm reduction 
The impact of leg ulceration on the lives of people who injected was substantial; pain, 
embarrassment, and reduced mobility were cited as particular problems. To date it 
seems that existing harm reduction is inadequate in relation to raising awareness about 
the sequelae of injecting below the waist in PWID. 
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7.4 Recommendations for practice 
Education for PWID 
It is clear that there is a lack of knowledge in relation to leg ulceration amongst PWID. 
Injectors need to be more aware of the risks of injecting below the waist, within the legs 
and the groin. Difficulties in accessing the femoral vein should not be regarded as 
standard but as a ‘red flag’ that the vein is damaged and that there will be consequences 
such as deep vein thrombosis, chronic venous insufficiency and ulceration. The 
presence of DVT should indicate to injectors that damage has occurred and that the 
likely sequela is post-thrombotic syndrome in up to half of all sufferers. 
Harm reduction services should consider providing education about the visible skin 
changes associated with venous disease and the wholly negative impact that the 
experience of living with a leg ulcer has on quality of life. Consideration should be 
given to the display of graphic images of venous insufficiency in the leg caused by 
injecting.  
 
Education for service providers 
Whilst the education and knowledge of service providers was not specifically explored 
as a research question in this study it is an important topic and worthy of further 
investigation.  
A third of participants in Phase 1 reported a lack of appropriate leg ulcer assessment. 
There was an overall lack of knowledge about the aetiology of leg ulceration in 
injectors, which could or perhaps should, have been considered by healthcare providers 
and discussed with service users. The findings from this study should be disseminated 
amongst service providers to help address this gap in knowledge.  
Consideration should be given to offering education to those working with PWID in 
any setting, including primary and secondary care encounters. Training should include 
raising awareness around groin injecting as this is often hidden, and may lead to venous 
insufficiency and ulceration.  Health professionals need to be better informed about 
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deep vein thrombosis and post-thrombotic syndrome and the potential use of 
compression therapy to prevent progressive disease.  
Service providers should consider improving injecting advice to prevent early transition 
to groin injecting. 
 
7.5 Recommendations for research 
Definitions 
The literature describing injecting harm often mentions skin-related damage but 
generally the definitions used have been unclear or absent. A desirable outcome would 
be the adoption of a clearer reporting system for skin breakdown, with defining and 
differentiating of terms such as ‘soft tissue infection’ and ‘ulceration’. Future studies 
would benefit from clearly articulating the signs and symptoms of injecting injury and 
defining terms unambiguously.  
 
Infections 
In this study, identification of true infection would have been difficult without clinical 
assessment and unlikely to be accurate however, given the emphasis on soft tissue 
infection in the literature and the apparent difficulty with definition, this would be 
useful to explore in future.  
 
It would be interesting to examine drug-related deaths and whether they relate to 
resistant organisms  and, if so, if this is due to availability of ‘street’ antibiotics, or the 
failure to properly complete a course of antibiotics when appropriately prescribed, or 
the over-prescribing of antibiotics to PWID. 
 
Many injectors had blood-borne viruses, and this was significantly linked to leg 
ulceration in Phase 1 but not explored in Phase 2. A useful study might investigate 
whether BBVs have an impact on skin breakdown and on healing. 
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Post-thrombotic syndrome 
Further exploration of limb changes following DVT would be valuable, seeking to 
confirm or deny the presence of post-thrombotic syndrome.  
It would also be useful to examine how and why a DVT forms so often in the thighs of 
PWID, and whether DVT in the thigh or the lower leg is most associated with leg 
ulceration, and whether ulceration occurs at the site of injection and if overlying the site 
of a DVT is of importance. 
 
Harm reduction 
The impact of harm reduction in relation to venous disease such as the use of images of 
the progressive disease of chronic venous insufficiency such as varicose veins, skin 
staining and ankle flare and the deterrent effect, if any, should be explored in a further 
study.  
 
Similarly, research into the prevention of DVT in PWID through educational initiatives 
around injecting below the waist would be useful.  
 
7.6 Recommendations for Policy 
Local service delivery which is person-centred and responsive to changing patterns of 
drug use, such as tackling the  increasing numbers of people groin injecting, forms part 
of the Recovery Strategy (Scottish Government, 2008). The Scottish Government 
recommends that treatment and rehabilitation services be available at local level  and 
that should include appropriate provision of services for PWID with physical health 
needs and wounds,  provided on a drop-in basis that are inclusive, welcoming, and non-
judgmental, and this may reduce crisis attendance at hospitals. 
Service providers need to have a better understanding of the situations that can lead to 
drug use. There could be better links between wound care / leg ulcer specialists and 
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addictions services in order to bridge gaps and focus on ensuring venous disease is 
detected early and treated appropriately.  
 
The increase in femoral injecting and rising concerns around long-term damage require 
to be addressed more formally within health policy. Physical examination of the lower 
leg should be included within harm reduction interventions and form part of practice 
recommendations for services providing injecting equipment. Service provision should 
encompass safer injecting advice, assessment of venous and arterial damage below the 
waist and the provision of compression therapy following DVT. 
 
Preventing drug use through school education 
The Recovery strategy (Scottish Government, 2008) discusses approaches to preventing 
and tackling substance misuse amongst children and families. The education of children 
falls outwith the parameters of this research. Other experts within the field of health 
promotion and harm reduction may wish to consider the findings from this study and its 
relevance to localities where there is significant and early injecting occurring. 
The study participants identified a need to tackle initiation into drug use early in life. 
Participants recommended that education regarding injecting of drugs should be 
delivered to primary school-age children before they are likely to come into contact 
with substance misuse. This intervention would be viewed by some as both 
controversial and very sensitive. Future educational initiatives might wish to consider 
the challenging participant views within this study and the issues involved in including 
information and discussion around physical harms caused by injecting within education 
programmes tackling substance misuse. Participants also felt that consideration might 
also be given to the use of images of injecting-related damage that may impact and be 
remembered.   
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7.7 Impact 
This thesis focused on the exploration of leg ulceration in PWID and in so doing, tales 
of personal tragedy associated with drug use were uncovered. Stories such as the 14 
year old girl who was given heroin by her mother as a reward for sitting an exam, and 
two years later was taught to inject by her mother; the 12 year old girl who was taught 
to inject by a babysitter as a reward for good behaviour; and the women who may have 
lost their homes, their children, and undertaken crimes that horrify them such as 
prostitution, assault, and theft, but who continue to be driven by their addiction.  
 
Drug addiction can lead to desperate situations and there appears to be an inability 
within the civil system to offer real solutions.  Frustration was repeatedly expressed by 
those on methadone - desperate to come off it, but held back by what they perceive as 
‘the system working against them’. Harm reduction services alone are not enough to 
improve the circumstances of drug users. Public health interventions must address 
social factors such as housing, imprisonment and low socio-economic status amongst 
drug users although these were areas not explored in this study. 
 
The true impact of ulceration on lives was not immediately apparent. Failure to address 
wounds early can result in crisis admission to hospital. One participant described being 
hospitalised because of infected ulcers, and due to non-attendance then lost her 
methadone prescription, her tenancy and subsequently her children were taken into 
care. The knock-on impact of non-healing ulceration may be underestimated. 
Prevention, or appropriate, and early, assessment and treatment are essential.  
 
7.8 Original contribution to knowledge 
This thesis sought to ensure that the definition of skin problems is sound and reasoned 
and to set a precedent for others to follow and develop.  
 
The original contribution to knowledge is three-fold: 
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1. Leg ulcers have been found to be highly prevalent in young people who inject 
drugs. 
2. Ulceration is predominantly caused by venous thrombosis due to injecting in the 
legs or groin.  
3. Harm reduction related to the development of venous disease has lacked impact 
and effect. 
 
Untreated ulceration is likely to become chronic and recurrent, and will become a 
critical problem for the health-service in the future as the drug injectors of the 1980’s 
and 1990’s reach middle age.  The impact of ulceration on people’s lives should not be 
underestimated, as Participant 6 summed up:   
 
‘Aye it’s torture the pain, when you see it you think how can there be so much pain 
coming off this wee thing. But it’s murder and you keep going on and on about it 
wherever you are staying but you get that sick of talking about it because it drives you 
pure crazy. It affects your sleep, it affects your mood you are constantly thinking about 
it, you know it affects you walking, it affects you taking part in any sports and all that 
stuff, so it really grinds you down. It’s on your mind constantly all the time.’ 
 
277 
 
References 
 
Abelson, J., Treloar, C., Crawford, J., Kippax, S., van Beek, I., & Howard, J. (2006) 
Some characteristics of early-onset injection drug users prior to and at the time of their 
first injection. Addiction  101, 4, pp. 548-555. 
Acquaro, J. (2012) Managing a chronic wound in a heroin user. Wounds International  
3, 94, pp. 24-25. 
Acton, C. (2008) Treatment of a venous leg ulcer found in an intravenous drug user. 
Wound Essentials  3, pp. 69-71. 
Aitken, C., Dwyer, R., Spelman, T., & Power, R. (2009) Is handedness associated  with 
health outcomes for people who inject drugs? Drugs: education, prevention and policy  
16, 5, pp. 471-477. 
Al Zahrani, H. A. (1997) Vascular complications following intravascular self-injection 
of addictive drugs. Journal of the Royal College of Surgeons of Edinburgh  42, 
February, pp. 50-55. 
Albini, T. A., Sun, R. L., Holz, E. R., Khurana, R. N., & Rao, N. A. (2007) Lemon 
juice and candida endophthalmitis in crack cocaine misuse. British Journal of 
Opthalmology  91, 5, pp. 702-703. 
Andresz, V., Marcantoni, N., Binder, F., Velten, M., Alt, M., Weber, J.-C., & Stephan, 
D. (2006) Puffy hand syndrome due to drug addiction: a case-control study of the 
pathogenesis. Addiction  101, pp. 1347-1351. 
Anema, A., Wood, E., Weiser, S. D., Qi, J., Montaner, J. S. G., & Kerr, T. (2010) 
Hunger and associated harms among injection drug users in an urban Canadian setting. 
Substance Abuse Treatment, Prevention, and Policy  5, 20. 
Anonymous (1993) Drug injectors in Glasgow: a community at risk? A report from a 
multi-disciplinary group: The Possilpark Group. Health Bulletin (Edinburgh)  51, pp. 
418-429. 
Anonymous (1997) Double Take. Nine cases of lifestyle-associated disorders. 
Consultant  37, 8, pp. 2199-2213. 
278 
 
Arbulu, A., Holmes, R. J., & Asfaw, I. (1993) Surgical treatment of intractable right-
sided infective endocarditis in drug addicts: 25 years experience. The Journal of Heart 
Valve Disease  2, pp. 129-137. 
Arumugaswamy, A. & Tran, H. (2014) Post-thrombotic syndrome: a potential cause of 
venous leg ulcer. Wound Practice and Research  22, 2, pp. 85-90. 
Atkinson, J. (2000) Nursing Homeless Men: A study of proactive intervention Whurr, 
London. 
Aveyard, H. & Hawley, G. (2007), "How to do ethical health care research," in Ethics 
in clinical practice, G. Hawley, ed., Pearson Education Limited, Harlow, pp. 348-365. 
Bachor, D. (2002) Increasing the believability of case study reports. The Alberta 
Journal of Educational Research  48, 1, pp. 20-29. 
Badiaga, S., Raoult, D., & Brouqui, P. (2008) Preventing and Controlling Emerging 
and Reemerging Transmissible Diseases in the Homeless. Emerging Infectious 
Diseases  14, 9, pp. 1353-1359. 
Baldeweg, S. E. (2000) Injecting drug use is a major risk factor for deep vein 
thrombosis. British Medical Journal  321, p. 1018. 
Ballotta, D. & Bergeron, H. (2006) What drug policies cost. Does Europe know how 
much it is spending to face the drugs phenomenon? Addiction  101, pp. 339-340. 
Bambra, C. (2011) Real world reviews: a beginner's guide to undertaking systematic 
reviews of public health policy interventions. Journal of Epidemiology and Community 
Health  65, pp. 14-19. 
Bannigan, K. & Watson, R. (2009) Reliability and validity in a nutshell. Journal of 
Clinical Nursing  18, pp. 3237-3243. 
Barg, N. L., Supena, R. B., & Fekety, R. (1986) Persistent staphylococcal bacteremia in 
an intravenous drug user. Antimicrobial Agents and Chemotherapy  29, 2, pp. 209-211. 
Barnard, M.A. (1993) Needle sharing in context: patterns of sharing among men and 
women injectors and HIV risks. Addiction 88, 6, pp. 805 – 812. 
Bartlett, S. (2002) Healthy respect. The Big Issue in Scotland May 23 - 29, pp. 14-15. 
Baumann, M., Spitz, E., Guillemin, F., Ravaud, J.-F., Choquet, M., Falissard, B., Chau, 
N., & Lorhandicap group (2007) Associations of social and material deprivation with 
279 
 
tobacco, alcohol and psychotropic drug use, and gender: a population-based study. 
International Journal of Health Geographics  6, 50. 
Baumgardner, D. J. (2012) Soil-related bacterial and fungal infections. The Journal of 
the American Board of Family Medicine   25, 5, pp. 734-744. 
Beeching, N. J. & Crowcroft, N. S. (2005) Tetanus in injecting drug users. British 
Medical Journal  330, pp. 208-209. 
Bell, K. & Salmon, A. (2012) Good intentions and dangerous assumptions: research 
ethics committees and illicit drug use research. Research Ethics  8, 4, pp. 191-199. 
Bellis, M. A., Beynon, C., Millar, T., Ashton, J. R., Thomson, R., Djuretic, T., & 
Taylor, A. (2001) Unexplained illness and deaths among injecting drug users in 
England: a case control study using Regional Drug Misuse Databases. Journal of 
Epidemiology and Community Health  55, pp. 843-844. 
Bennet, R. G., Leyden, J. J., & Decherd, J. W. (1973) The heroin ulcer. Archives of 
Dermatology  107, 1, pp. 121-122. 
Bergen, R. (2015) Now I see it, now I don't: researcher's position and reflexivity  in 
qualitative research. Qualitative Research  15, 2, pp. 219-234. 
Bergstein, J. M. & Baker IV, E. J. (1995) Soft tissue abscesses associated with 
parenteral drug abuse: presentation, microbiology and treatment. American Surgeon  
61, 12, pp. 1105-1108. 
Bernaldo de Quiros, J. C. L., Moreno, S., Cercenado, E., Diaz, D., Bereguer, J., 
Miralles, P., Catalan, P., & Bouza, E. (1997) Group A streptococcal bacteremia A 10-
year prospective study. Medicine  76, 4, pp. 238-248. 
Beynon, C., Stimson, G., & Lawson, E. (2010) Illegal drug use in the age of ageing. 
British Journal of General Practice  60, 576, pp. 481-482. 
Bickley, L. K., Schwartz, R. A., & Lambert, W. C. (1988) Localized cutaneous 
leukocytoclastic vasculitis in an intravenous drug abuser.  International Journal of 
Dermatology  27, 7, pp. 512-513. 
Biderman, P. & Hiatt, J. R. (1987) Management of soft-tissue infections of the upper 
extremity in parenteral drug abusers. The American Journal of Surgery  154, 5, pp. 526-
528. 
280 
 
Biller, J. A. & Murr, A. H. (2004) The importance of etiology on the clinical course of 
neck abscesses. Otolaryngology  131, 4, pp. 388-391. 
Binswanger, I. A., Kral, A. H., Blunthenal, R. N., Rybold, D., & Edlin, B. R. (2000) 
High Prevalence of Abscesses and Cellulitis among Community-Recruited Injection 
Drug users in San Francisco. Clinical Infectious Diseases  30, pp. 579-581. 
Blair, S. D., Wright, D. D., Backhouse, C. M., Riddle, E., & McCollum, C. M. (1988) 
Sustained compression and healing of chronic venous ulcers. British Medical Journal  
297, 6657, pp. 1159-1161. 
Bloor, M., McIntosh, J., McKeganey, N., & Robertson, M. (2008) 'Topping up' 
methadone: An analysis of patterns of heroin use among a treatment sample of Scottish 
drug users. Public Health  122, 10, pp. 1013-1019. 
Bowling, A. (1997) Research methods in health.  Open University Press, Buckingham. 
Bowling, A. (2005) "Quantitative social science: the survey," in Handbook of health 
research methods.  A. Bowling & S. Ebrahim, eds., Open University Press, 
Maidenhead, pp. 190-214. 
Boys, A., Farrell, M., Bebbington, P., Brugha, T., Coid, J., Jenkins, R., Lewis, G., 
Marsden, J., Meltzer, H., Singleton, N., & Taylor, C. (2002) Drug use and initiation in 
prison:results from a national prison survey in England and Wales. Addiction  97, pp. 
1551-1560. 
Brett, M. M., Hallas, G., & Mpamugo, O. (2004) Wound botulism in the UK and 
Ireland. Journal of Medical Microbiology  53, pp. 555-561. 
Brett, M. M., Hood, J., Brazier, J. S., Duerden, B. I., & Hahne, S. J. M. (2005) Soft 
tissue infections caused by spore-forming bacteria in injecting drug users in the United 
Kingdom. Epidemiology and Infection  133, pp. 575-582. 
Brettle, R. P. & Nelles, B. (1988) Special problems of injecting drug-misusers. British 
Medical Bulletin  44, 1, pp. 149-160. 
Briggs, M. & Flemming, K. (2007) Living with leg ulceration: a synthesis of qualitative 
research. Journal of Advanced Nursing  59, 4, pp. 319-328. 
Brust, J. C. M. (1997) Vasculitis owing to substance abuse. Neurological clinics  15, 4, 
pp. 945-957. 
281 
 
Burnard, K. G., Whimster, I., Naidoo.A., & Browse, N. L. (1982) Pericapillary fibrin in 
the ulcer-bearing skin of the leg: the cause of lipodermatoscelrosis and venous 
ulceration. British Medical Journal  285, 16 Oct, pp. 1069-1072. 
Burns, N. & Grove, S. K. (2005) The Practice of Nursing Research Conduct Critique 
and Utilization, Fifth edition, Elsevier Saunders, St Louis. 
Burton, C. S. (1993) Treatment of leg ulcers. Dermatologic Clinics  11, 2, pp. 315-323. 
Burton, C. S. (1994) Venous ulcers. American Journal of Surgery  167, 1A supplement, 
pp. 37S-40S. 
Butcher, M. (2000) Treating mixed aetiology ulcers in a man undergoing drug 
rehabilitation. British Journal of Nursing (Supplement)  9, 6, p. S28-S31. 
Buttner, A., Mall, G., Penning, R., & Weis, S. (2000) The neuropathology of heroin 
abuse. Forsensic Science International  113, pp. 435-442. 
Buttner, A., Mall, G., Penning, R., Sachs, H., & Weis, S. (2003) The neuropathology of 
cocaine abuse. Legal Medicine  5, p. S240-S242. 
Callahan, T. E., Schecter, W. P., & Horn, J. K. (1998) Necrotizing soft tissue infection 
masquerading as cutaneous abscess following illicit drug injection. Archives of Surgery  
133, pp. 812-819. 
Callam, M. J., Harper, D. R., Dale, J. J., & Ruckley, C. V. (1987) Chronic ulcer of the 
leg: the clinical history. British Medical Journal  294, 6584, pp. 1389-1391. 
Callam, M. J. (1992) Prevalence of chronic leg ulceration and severe chronic venous 
disease in western countries.  Phlebology  7, Suppl, pp. 6-12. 
Carroll, J. (1996) Attitudes to drug users according to age of staff. Professional Nurse  
11, 6, pp. 401-404. 
Carter, A. & Henderson, L. (2005), "Approaches to qualitative data collection in social 
sciences," in Handbook of health research methods, A. Bowling & S. Ebrahim, eds., 
Open University Press, Maidenhead, pp. 215-229. 
Chandler, A., Whittaker, A., Cunningham-Burley, S., Williams, N., McGorm, K., & 
Mathews, G. (2013) Substance, structure and stigma:Parents in the UK accounting for 
opioid substitution therapy during the antenatal and postnatal periods. International 
Journal of Drug Policy  24, p. e35-e42. 
282 
 
Charney, M. A. & Stern, P. J. (1991) Digital ischaemia in clandestine intravenous drug 
users. The Journal of Hand Surgery  16, 2, pp. 308-310. 
Chen, J. C., Hsiang, Y. N., Morris, C., & Benny, W. B. (1996) Cocaine-induced 
multiple vascular occlusions: a case report. Journal of Vascular Surgery  23, April, pp. 
719-723. 
Cheng, S. W. K., Fok, M., & Wong, J. (1992) Infected femoral pseudoaneurysm in 
intravenous drug abusers. British Journal of Surgery  79, June, pp. 510-512. 
Cherry, S., Williams, H., Oyefeso, A., & Bennett, J. (2009) Injecting other users: a pilot 
study in an area of high prevalence of drug-related deaths. Journal of Substance Use  
14, 5, pp. 289-294. 
Chiang, K., Schanzer, H., & Peirce, E. C. (1990) Chronic venous stasis as a 
consequence of intravenous drug abuse. Current Surgery  47, 6, pp. 454-456. 
Clark, A. (1998) The qualitative-quantitative debate: moving from positivism and 
confrontation to post-positivism and reconciliation. Journal of Advanced Nursing  27, 
pp. 1242-1249. 
Cohen, J. (1992) A Power Primer. Psychological Bulletin  112, 1, pp. 155-159. 
Condon, L., Hek, G., Harris, F., Powell, J., Kemple, T., & Price, S. (2007) Users' views 
of prison health services: a qualitative study. Journal of Advanced Nursing  58, 3, pp. 
216-226. 
Cook, L. & Jordan, K. (2010) Leg ulceration in drug users: development of a 
multidisciplinary pathway. Wounds UK  6, 4, pp. 74-82. 
Coomber, R. (1997) The adulteration of drugs: what dealers do to illicit drugs, and 
what they think is done to them. Addiction Research  5, 4, pp. 297-306. 
Coomber, R. (1997) Dangerous drug adulteration - an international survey of drug 
dealers using the internet and the world wide web (www). The International Journal of 
Drug Policy  8, 2, pp. 71-81. 
Coomber, R. (1997) Vim in the veins- fantasy or fact: the adulteration of illicit drugs. 
Addiction Research  5, 3, pp. 195-212. 
283 
 
Cooper, C. L. & Mills, E. J. (2006) Therapeutic challenges in hepatitis C-infected 
injection drug using patients. Harm Reduction Journal  3, 31. Doi:10.1186/1477-7517-
3-31 Accessed 14.11.07 
Cooper, R. A. (1990) Mondor's disease secondary to intravenous drug abuse. Archives 
of Surgery  125, June, pp. 807-808. 
Cornwall, J. V., Dore, C. J., & Lewis, J. D. (1986) Leg ulcers: epidemiology and 
aetiology. British Journal of Surgery  73, pp. 693-696. 
Cortimiglia-Bish, L. & Brazinsky, B. (1998) Use of a Four-Layer Bandage System in 
the Treatment of an I.V. Drug Abuser with Chronic Upper Extremity Ulcerations: A 
case Study. Ostomy / Wound Management  44, 3, pp. 48-55. 
Coull, A. (2015) The role of intravenous drug use in venous leg ulceration. British 
Journal of Nursing  24, 20, p. S17. 
Coull, A. F. & Pieper, B. (2006) Personal communication. Email. 25-4-2006.  
Coull, A. F., Atherton, I., Taylor, A., & Watterson, A. E. (2014) Prevalence of skin 
problems and leg ulceration in a sample of young injecting drug users.  Harm 
Reduction Journal  11, 22.  DOI: 10.1186/1477-7517-11-22 Accessed  2.12.14 
Craine, N., Walker, M., Carwath, T., & Klee, H. (2004) Hepatitis C testing and 
injecting risk behaviour: the results of a UK based pilot study. International Journal of 
Drug Policy  15, pp. 115-122. 
Creswell, J. W. (2003) Research design: Qualitative, quantitative, and mixed method 
approaches. Second edition, Sage, London. 
Creswell, J. W. & Plano Clark, V. L. (2011) Designing and Conducting Mixed Methods 
Research. Second edition, Sage, London. 
Creswell, J. W. (2014) Research Design. Qualitative, Quantitative and Mixed Methods 
Approaches.  Fourth edition, Sage, London. 
Cronin, P., Ryan, F., & Coughlan, M. (2008) Undertaking a literature review: a step-
by-step approach. British Journal of Nursing  17, 1, pp. 38-43. 
Cullen, W., Kelly, Y., Stanley, J., Langton, D., & Bury G. (2005) Experience of 
hepatitis C among current of former heroin users attending general practice. Irish 
Medical Journal  98, 3, pp. 73-74. 
284 
 
Cunningham, D. L. & Persky, L. (1989) Penile ecthyma gangrenosum. Complication of 
drug addiction. Urology  34, 2, pp. 109-110. 
Curran, G. M., Sullivan, G., Williams, K., Han, X., Allee, E., & Kotrla, K. J. (2008) 
The association of psychiatric comorbidity and use of the emergency department 
among persons with substance use disorders: an observational cohort study. BMC 
Emergency Medicine  8, 17. DOI:10.1186/1471-227X-8-17 Accessed 20.09.09 
Cutting, K. F. & Harding, K. G. (1994) Criteria for identifying wound infection. 
Journal of Wound Care  3, 4, pp. 198-201. 
Dale, J. J., Callam, M. J., Ruckley, C. V., Harper, D. R., & Berrey, P. N. (1983) 
Chronic ulcers of the leg: a study of prevalence in a Scottish Community. Health 
Bulletin (Edinburgh)  41, 6, pp. 310-314. 
Daniel, D. M. (1973) The acutely swollen hand in the drug user. Archives of Surgery  
107, 4, October, pp. 548-551. 
Darke, S., Ross, J., & Hall, W. (1996) Prevalence and correlates of the injection of 
methadone syrup in Sydney, Australia. Drug and Alcohol Dependence  43, 3, pp. 191-
198. 
Darke, S. (1998) Self-report among injection drug users: A review. Drug and Alcohol 
Dependence  51, pp. 253-263. 
Darke, S., Ross, J., & Kaye, S. (2001) Physical injecting sites  among injecting drug 
users in Sydney, Australia. Drug and Alcohol Dependence  62, 1, pp. 77-82. 
Darke, S., Duflou, J., & Torok, M. (2015) The health consequences of injecting tablet 
preparations: foreign body pulmonary embolism and pulmonary hypertension amongst 
deceased drug users. Addiction  110, 7, pp. 1144-1151. 
Davidson, P. J., Ochoa, K. C., Hahn, J. A., Evans, J. L., & Moss, A. R. (2002) 
Witnessing heroin-related overdoses: the experiences of young injectors in San 
Francisco. Addiction  97, pp. 1511-1516. 
Davis, M., Rhodes, T., & Martin, A. (2004) Preventing hepatitis C: 'Common sense', 
'the bug' and other perspectives from the risk narratives of people who inject drugs. 
Social Science and Medicine  59, pp. 1807-1818. 
285 
 
Day, C. A., Ross, J., Dietze, P., & Dolan, K. (2005) Initiation to heroin injecting among 
heroin users in Sydney, Australia: a cross sectional survey. Harm Reduction Journal  2, 
2.  DOI: 10.1186/1477-7517-2-2 Accessed 14.06.06 
Del Giudice, P., Vandenbos, F., Boissy, C., Cua, E., Marion, B., Bernard, E., & 
Dellamonica, P. (2005) Cutaneous complications of direct intra-arterial injections in 
drug addicts. Acta Dermato Vernereologica  85, 5, pp. 451-452. 
Derricott, J., Preston, A., & Hunt, N. (1999) The safer injecting briefing HIT, 
Liverpool. 
Deutscher, M. & Perlman, D. C. (2008) Why some injection drug users lick their 
needles: A preliminary study. The International Journal of Drug Policy  19, pp. 342-
345. 
Devey, T. (2007) Drug misuse and leg ulceration. Leg Ulcer Forum Journal  21, 
Autumn, pp. 18-20. 
Devey, T. (2010) Using an outreach service to meet the needs of users of intravenous 
drugs with leg ulceration. Nursing Times  106, 20, pp. 22-23. 
Dietze, P., Jolley, D., Fry, C., & Bammer, G. (2005) Transient changes in behaviour 
lead to heroin overdose: results from a case-crossover study of non-fatal overdose. 
Addiction  100, pp. 636-642. 
Dodd, T. J., Scott, R. N., Woodburn, K. R., & Going, J. J. (1994) Limb ischaemia after 
intra-arterial injection of Temazepam gel: Histology of nine cases. Journal of Clinical 
Pathology  47, pp. 512-514. 
Dolan, K. A. & Niven, H. (2005) A review of HIV prevention among young injecting 
drug users: A guide for researchers. Harm Reduction Journal  2, 5. DOI: 10.1186/1477-
7517-2-5  Accessed 14.06.06 
Donovan, J. & Sanders, C. (2005) "Key issues in the analysis of qualitative data in 
health services," in Handbook of health research methods. A. Bowling & S. Ebrahim, 
eds., Open University Press, Maidenhead, pp. 523-532. 
Dormandy, J. A. (1997) Pathophysiology of venous leg ulceration - an update. 
Angiology  48, 1, pp. 71-75. 
286 
 
Ducasse, E., Chevalier, J., Dasnoy, D., Speziale, F., Fiorani, P., & Puppinck, P. (2004) 
Popliteal artery entrapment associated with cannabis arteritis. European Journal of 
Vascular and Endovascular Surgery  27, pp. 327-332. 
Dunlop, M. G. & Steedman, D. J. (1985) Intravenous drug abuse and the accident and 
emergency department. Archives of Emergency Medicine  2, pp. 73-77. 
Dunne, J. H. & Johnson, W. C. (1972) Necrotizing skin lesions in heroin addicts. 
Archives of Dermatology  105, April, pp. 544-547. 
Dwyer, R. (2008) Privileging pleasure: Temazepam injection in a heroin marketplace. 
International Journal of Drug Policy  19, pp. 367-374. 
Dwyer, R., Topp, L., Maher, L., Power, R., Hellard, M., Walsh, N., Jauncey, M., 
Conroy, A., Lewis, J., & Aitken, C. (2009) Prevalences and correlates of non-viral 
injecting-related injuries and diseases in a convenience sample of Australian injecting 
drug users. Drug and Alcohol Dependence  100, pp. 9-16. 
Dyson, S. & Brown, B. (2006) Social Theory and Applied Health Research Open 
University Press, Maidenhead. 
ECDC European Centre for Disease Prevention and Control (2015) Wound botulism in 
people who inject heroin, Norway and the United Kingdom - 14 February 2015, ECDC, 
Stockholm. 
Eklof, B., Rutherford, R. B., Bergan, J. J., Carpentier, P. H., Glovicski, P., & Kistner, 
R. L. (2004) Revision of the CEAP classification for chronic venous disorders: 
consensus statement. Journal of Vascular Surgery  40, 6, pp. 1248-1252. 
Ensign, B. & Ammerman, S. (2008) Ethical issues in research with homeless youths. 
Journal of Advanced Nursing   62, 3, pp. 365-372. 
Ensign, B. J. (2006) Perspectives and experiences of homeless young people. Journal 
of Advanced Nursing  54, 6, pp. 647-652. 
Ensign, J. (2003) Ethical issues in qualitative health research with homeless youths. 
Journal of Advanced Nursing  43, 1, pp. 43-50. 
Erwin, M. B., Hoyle, J. R., Smith, C. S., & Deliargyris, E. N. (2004) Cocaine and 
accelerated atherosclerosis: insights from intravascular ultrasound. International 
Journal of Cardiology  93, pp. 301-303. 
287 
 
Erzberger, C. & Kelle, U. (2003) "Making inferences in mixed methods: the rules of 
integration," in Handbook of Mixed Methods in Social and Behavioural Research. A. 
Tashakkori & C. Teddlie, eds., Sage, Thousand Oaks, CA. 
Ettridge, L. (2011) Post-thrombotic syndrome: a case study. Nursing Standard  25, 33, 
pp. 60-68. 
Evans, C. J., Fowkes, F. G. R., Ruckley, C. V., & Lee, A. J. (1999) Prevelence of 
varicose veins and chronic venous insufficiency in men and women in the general 
population: Edinburgh Vein Study. Journal of Epidemiology and Community Health  
53, 3, pp. 149-153. 
EWMA (2005) Identifying criteria for wound infection. European Wound Management 
Association Position Document.  EWMA, London. 
EWMA (2006) Management of wound infection European Wound Management 
Association Position Document.  EWMA, London. 
EWMA (2013) European Wound Management Association Document: Antimicrobials 
and Non-healing Wounds Evidence, controversies and suggestions. EWMA, London. 
Exchange Supplies, National Needle Exchange Forum, & UK Harm Reduction 
Alliance (2007) Reducing injecting related harm: Consensus statement on best 
practice. Exchange Supplies, London. 
Fah, F., Zimmerli, W., Jordi, M., & Schoenenberger, R. A. (2002) Septic deep vein 
thrombosis in intravenous drug users. Swiss Medical Weekly  132, 27 - 28, pp. 386-392. 
Fakis, A., Hilliam, R., Stoneley, H., & Townend, M. (2014) Quantitative analysis of 
qualitative information from interviews: a systematic literature review. Journal of 
Mixed Methods Research  8, 139. 
Farrant, P., Creamer, D., & Fuller, C. (2005) Extensive cutaneous fibrosis and 
ulceration caused by methadone injection. Clinical and Experimental Dermatology  30, 
1, pp. 87-97. 
Farrell, M. & Marsden, J. (2007) Acute risk of drug-related death among newly 
released prisoners in England and Wales. Addiction  103, pp. 251-255. 
Fellner, M. J. & Ledesma, G. N. (1990) Leg ulcers secondary to drug reactions. Clinics 
in Dermatology  8, 3-4, pp. 144-149. 
288 
 
Field, A. (2009) Discovering statistics using SPSS. Third edition, Sage, London. 
Finelli, P. F. & Taylor, G. W. (1977) Unusual injection neuropathy in heroin addict: 
case report. Military Medicine  149, pp. 704-705. 
Finnie, A. & Nicolson, P. (2002a) Injecting drug use: developing a drop-in wound care 
clinic. British Journal of Nursing (Supplement)  11, 12, p. S8-S20. 
Finnie, A. & Nicolson, P. (2002b) Injecting drug use: implications for skin and wound 
management. British Journal of Nursing (Supplement)  11, 6, p. S17-S28. 
Finnie, A. (2003) Doppler ultrasound assessment and Ankle Brachial Pressure. In 
NM53 Research Project Work Book, (Paterson B ed.). University of Stirling, Stirling 
Finnie, A. & Nicolson, P. (2003) Homeless people and injecting drug users: 
implications for wound care. Leg Ulcer Forum Journal  17, Autumn, pp. 18-22. 
Firth, J., Nelson, E. A., Hale.C., Hill, J., & Helliwell, P. (2010) A review of design and 
reporting issues in self-reported prevalence studies of leg ulceration. Journal of Clinical 
Epidemiology  63, 8, pp. 907-913. 
Fitzgerald, J., Dovey, K., Dietze, P., & Rumbold, G. (2004) Health outcomes and 
quasi-supervised settings for street injecting drug use. The International Journal of 
Drug Policy  15, pp. 247-257. 
Ford, R., Bammer, G., & Becker, N. (2008) The determinants of nurses' therapeutic 
attitude to patients who use illicit drugs and implications for workforce development. 
Journal of Clinical Nursing  17, pp. 2452-2462. 
Formica, R. & Perazella, M. A. (1998) Leg pain and swelling in an HIV-infected drug 
abuser. Hospital Practice   33, 10, pp. 195-197. 
Forshaw, M. J. & Power, D. M. (2001) Bilateral septic lower limb ulceration following 
drug abuse. The Internet Journal of Surgery  2, 2. http://print.ispub.com/api/0/ispub-
article/3888 Accessed 08/03/06 
Forsyth, A. J. M., Farquhar, D., Gemmell, M., Shewan, D., & Davies, J. B. (1993) The 
dual use of opioids and temazepam by drug injectors in Glasgow (Scotland). Drug and 
Alcohol Dependence  32, pp. 277-280. 
289 
 
Fountain, J., Howes, S., Marsden, J., Taylor, C., & Strang, J. (2003) Drug and alcohol 
use and the link with homelessness: results from a survey of homeless people in 
London. Addiction Research and Theory  11, 4, pp. 245-256. 
Fowler, C., Reid, S., Minnis, J., & Day, C. (2014) Experiences of mothers with 
substance dependence: informing the development of parenting support. Journal of 
Clinical Nursing  23, 19 - 20, pp. 2835-2843. 
Franks, P. J., Moody, M., Moffatt, C. J., Patton, J., Bradley, L., Chaloner, D., Stevens, 
J., Stevens, J., & Lewis, C. (2004) Quality of life in a trial of short stretch versus four-
layer bandaging in the management of chronic venous ulceration. Phlebology  19, 2, pp. 
87-91. 
Franks, P. J., Moffatt, C. J., Doherty, D. C., Smithdale, R., & Martin, R. (2006) Longer-
term changes in quality of life in chronic leg ulceration. Wound Repair and 
Regeneration  14, pp. 536-541. 
Fred, H. L. & Hariharan, R. (1997) High fever and shaking chills in a heroin addict. 
Hospital Practice  32, 3, pp. 224-226. 
Frischer, M., Bloor, M., Finlay, A., Goldberg, D., Green, S., Haw, S., McKeganey, N., 
& Platt, S. (1991) A new method of estimating prevalence of injecting drug use in an 
urban population: results from a Scottish city. International Journal of Epidemiology  
20, 4, pp. 997-1000. 
Frischer, M., Goldberg, D., Rahman, M., & Berney, L. (1997) Mortality and survival 
among a cohort of drug injectors in Glasgow 1982 - 1994. Addiction  92, 4, pp. 419-
427. 
Fullarton, G. M. (1983) Soft tissue infections in drug abusers presenting to an accident 
and emergency department. Health Bulletin (Edinburgh)  39, 41/6, pp. 296-299. 
Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., & Strathdee, S. A. (2002) 
High-risk behaviours associated with transition from illicit non-injection to injection 
drug use among adolescent and young adult drug users: a case control study. Drug and 
Alcohol Dependence  66, 3, pp. 189-198. 
Furber, C. (2010) Framework analysis: a method of analysing qualitative data. African 
Journal of Midwifery and Women's Health  4, 2, pp. 97-100. 
290 
 
Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013) Using the 
framework method for the analysis of qualitative data in multi-disciplinary health 
research. BMC Research Methodology  13, 117. http://biomedcentral.com/1471-
2288/13/117 Accessed 06.12.13  
Galea, S. & Vlahov, D. (2002) Social determinants and the health of drug users: 
socioeconomic status, homelessness, and incarceration. Public Health Reports  117, 
Suppl 1, p. S135-S145. 
Gan, J. P., Leiberman, D. P., & Pollock, J. G. (2000) Outcome after ligation of infected 
false femoral aneurysms in intravenous drug abusers. European Journal of Vascular 
and Endovascular Surgery  19, pp. 158-161. 
Georgiadis, G. S., Lazarides, M. K., Polychronidis, A., & Simopoulos, C. (2005) 
Surgical treatment of femoral artery infected false aneurysms in drug abusers. ANZ 
Journal of Surgery  75, pp. 1005-1010. 
Gerrish, K. & Lacey, A. (2006) The research process in nursing. Fifth edition, 
Blackwell Publishing Ltd, Oxford. 
Gertner, E. & Hamlar, D. (2002) Necrotizing granulomatous vasculitis associated with 
cocaine use. Journal of Rheumatology  29, 8, pp. 1795-1797. 
Giddings, L. S. (2006) Mixed-methods research: Positivism dressed up in drag? 
Journal of Research in Nursing  11, 3, pp. 195-203. 
Gilchrist, G., Moskalewicz, J., Slezakova, S., Okruhlica, L., Torrens, M., Vajd, R., & 
Baldacchino, A. (2011) Staff regard towards working with substance users: a European 
multi-centre study. Addiction  106, pp. 1114-1125. 
Gill, O., Noone, A., & Heptonstall, J. (1995) Imprisonment, injecting drug use and 
bloodborne viruses. British Medical Journal  310, pp. 275-276. 
Giuliano, K. K. (2003) Expanding the use of empiricism in nursing: can we bridge the 
gap between knowledge and clinical practice? Nursing Philosophy  4, 1, pp. 44-52. 
Glenesk, A. (2008) The basics of deep vein thrombosis. Independent Nurse  February, 
4, p. 36. 
Godley, D. (2007) My wound helped me get clean. Touch  June, pp. 8-9. 
291 
 
Gonzalez, M. H., Garst, J., Nourbash, P., Pulvirenti, J., & Hall, R. F. (1993) Abscesses 
of the upper extremity from drug abuse by injection. Journal of Hand Surgery  18A, pp. 
868-870. 
Gonzalez, M. H., Kay, T., Weinzweig, N., Brown, A., & Pulvirenti, J. (1996) 
Necrotizing fasciitis of the upper extremity. The Journal of Hand Surgery  21A, pp. 
689-692. 
Goodall, C. (2010) Is there a correlation between injecting heroin into the groin and 
abscesses, leg ulcers, deep vein thrombosis and pulmonary emboli? 
http://www.ceebl.manchester.ac.uk/resources/ugreports/Chloe_Goodall.pdf 
Unpublished project. University of Manchester  Manchester. Accessed 25/11/2015 
Gorman, W. P., Davis, K. R., & Donnelly, R. (2000) Swollen lower limb-1: General 
assessment and deep vein thrombosis. British Medical Journal  320, pp. 1453-1456. 
Graham, C. A., McNaughton, G. W., & Crawford, R. (1999) 'Popping': a cause of soft 
tissue sepsis in chronic drug abusers. European Journal of Emergency Medicine  6, 3, 
pp. 259-261. 
Graham, I. D., Harrison, M. B., Nelson, E. A., Lorimer, K., & Fisher, A. (2003) 
Prevalence of lower-limb ulceration: a systematic review of prevalence studies. 
Advances in Skin and Wound Care  16, November, pp. 305-316. 
Greasley, P. (2008) Quantitative data analysis using SPSS. Open University Press, 
Maidenhead. 
Greene, D. (2010) Leg ulcers in addiction services. WIN  18, 8, p. 30. 
Greene, J. M. & Ringwalt, C. L. (1996) Youth and familial substance use's association 
with suicide attempts among runaway and homeless youth. Substance use and misuse  
31, 8, pp. 1041-1058. 
Grunow, R., Klee, S. R., Beyer, W., George, M., Grunow, D., Barduhn, A., Klar, S., 
Jacob, D., Elschner, M., Sandven, P., Kjerulf, A., Jensen, J. S., Cai, W., Zimmermann, 
R., & Schaade, L. (2013) Anthrax among heroin users in Europe possibly caused by 
same bacillus anthracis strain since 2000. Eurosurveillance  18, 13. 
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20437  Accessed  
05.12.13 
292 
 
Guild, A. (2008) Wound care, harm reduction and social impact. EWMA Journal  8, 1, 
pp. 5-9. 
Gursel, E., Medina, J., Wilson, N., & Binns, H. (1978) Drug injection injuries of the 
hands: evaluation and treatment. Journal of the American College of Emergency 
Physicians  7,  1, pp. 9-11. 
Hall, J., Buckley, H. L., Lamb, K. A., Stubbs, N., Saramago, P., Dumville, J. C., & 
Cullum, N. A. (2014) Point prevalence of complex wounds in a defined United 
Kingdom population. Wound Repair and Regeneration  22, pp. 694-700. 
Hall, W. (2015) What has research over the past two decades revealed about the 
adverse health effects of recreational cannabis use? Addiction  110, 1, pp. 19-35. 
Halliday, N. J., Dundee, J. W., Carlisle, R. J. T., Moore, J., McCafferty, D. F., & 
Woolfson, A. D. (1986) Experiences with I.V. temazepam. British Journal of 
Anaesthesia  58,  pp. 810-811. 
Hamilton, I. (2009) Substance use 2: nursing assessment, management and types of 
intervention. Nursing Times  105, 27, pp. 14-17. 
Hammersley, M. & Atkinson, P. (1995) Ethnography principles in practice. Second 
edition, Routledge, London. 
Hammersley, R., Cassidy, M. T., & Oliver, J. (1995) Drugs associated with drug-
related deaths in Edinburgh and Glasgow, November 1990 to October 1992. Addiction  
90, pp. 959-965. 
Hammersley, R. & Pearl, S. (1996) Drug use and other problems of residents in 
projects for the young single homeless. Health and Social Care in the Community  4, 4, 
pp. 193-199. 
Hardacre, P., Preston, A., & Derricott, J (2005) Preventing unnecessary vein damage. 
http://helpingaddicts.net. 2005. Accessed 29/11/2015.  
Harding K et al (2015) Simplifying venous leg ulcer management. Consensus 
recommendations, Wounds International, London. 
Harris, H. W. & Young, D. M. (2002) Care of injection drug users with soft tissue 
infections in San Francisco, California. Archives of Surgery  137, November, pp. 1217-
1222. 
293 
 
Harris, M. & Rhodes, T. (2012) Venous access and care: harnessing pragmatics in harm 
reduction for people who inject drugs. Addiction  107, 6, pp. 1090-1096. 
Haverkos, H. W. & Lange, W. R. (1990) Serious infections other than human 
immunodeficiency virus among intravenous drug abusers. The Journal of Infectious 
Diseases  161, pp. 894-902. 
Haw, S. (1985) Drug problems in Glasgow. SCODA, Glasgow. 
Hay, G. & Smit, F. (2003) Estimating the number of drug injectors from needle 
exchange data. Addiction Research and Theory  11, 4, pp. 235-243 
Hay, G. & Gannon, M. (2006) Capture-recapture estimates of the local and national 
prevalence of problem drug use in Scotland. International Journal of Drug Policy  17, 
pp. 203-210. 
Health Protection Scotland & University of the West of Scotland (2008)  The Needle 
Exchange Surveillance Initiative (NESI): Prevalence of HCV, HIV and injecting risk 
behaviours among injecting drug users attending needle exchanges in Scotland, 2007, 
Health Protection Scotland, Glasgow. 
Hecht, G., Barnsdale, L., & McAuley, A. (2014) The National Drug-Related Deaths 
Database (Scotland) Report: Analysis of Deaths occurring in 2012. Information 
Services Division.  NSS, Edinburgh. 
Heis, H. A., Bani-Hani, K. E., Elheis, M. A., Yaghan, R. J., & Bani-Hani, B. K. (2008) 
Postcatheterization femoral artery pseudoaneurysms: therapeutic options. A case-
controlled study. International Journal of Surgery  6, 3, pp. 214-219. 
Henriksen, B. M., Albrektsen, S. B., Simper, L. B., & Gutschik, E. (1994) Soft tissue 
infections from drug abuse. Acta Orthopaedica Scandinavica  65, 6, pp. 625-628. 
Hirsch, C. S. (1972) Dermatopathology of narcotic addiction. Human Pathology  3, 1, 
pp. 37-53. 
Hofbauer, G. F. L., Hafner, J., & Trueb, R. M. (1999) Urticarial vasculitis following 
cocaine use. British Journal of Dermatology  141, pp. 573-609. 
Holt, M. (2007) Agency and dependency within treatment: drug treatment clients 
negotiating methadone and antidepressants. Social Science and Medicine  64, 9, pp. 
1937-1947. 
294 
 
Holzman, R. S. & Bishko, F. (1971) Osteomyelitis in heroin addicts. Annals of Internal 
Medicine  75, pp. 693-696. 
Hope, V., Kimber, J., Vickerman, P., Hickman, M., & Ncube, F. (2008) Frequency, 
factors and costs associated with injection site infections: findings from a national 
multi-site survey of injecting drug users in England. BMC Infectious Diseases  8, 120. 
http://www.biomedcentral.com/1471-2334/8/120 Accessed 14.04.09 
Hope, V. D., Ncube, F., Parry, J. V., & Hickman, M. (2014) Healthcare seeking and 
hospital admissions by people who inject drugs in response to symptoms of injection 
site infections or injuries in three urban areas of England. Epidemiology and Infection. 
Epub Feb 24, doi: 10.1017/S0950268814000284.  Accessed 02.02.15 
Hope, V. D., Scott, J., Cullen, K. J., Parry, J. V., Ncube, F., & Hickman, M. (2015) 
Going into the groin: Injection into the femoral vein among people who inject drugs in 
three urban areas of England. Drug and Alcohol Dependence  152, pp. 239-245. 
Horn, E. H., Henderson, H. R., & Forrest, J. A. H. (1987) Admissions of drug addicts to 
a general hospital: a retrospective study in the northern district of Glasgow. Scottish 
Medical Journal  32, pp. 041-045. 
Howie, M. (2008) Worsening drug toll prompts huge study. The Scotsman 15/01/08. 
Hughes, R. (2001) Drug injecting and infection-related risk behavior. Journal of 
Addictions Nursing  13, 3/4, pp. 163-174. 
Human, P., Franz, T., Scherman, J., Moodley, L., & Zilla, P. (2009) Dimensional 
analysis of human saphenous vein grafts: Implications for external mesh support.  
Journal of Thoracic and Cardiovascular Surgery  137, pp. 1101-1108. 
Hussey, H. H. & Katz, S. (1950) Infections resulting from narcotic addiction. American 
Journal of Medicine  9, August, pp. 186-193. 
Hutchinson, S. J., Wadd, S., Taylor, A., Bird, S. M., Mitchell, A., Morrison, D. S., 
Ahmed, S., & Goldberg, D. J. (2004) Sudden rise in uptake of hepatitis B vaccination 
among injecting drug users associated with a universal vaccine programme in prisons. 
Vaccine  23, pp. 210-214. 
Hutchinson, S. J., Roy, K. M., Wadd, S., Bird, S. M., Taylor, A., Anderson, E., Shaw, 
L., Codere, G., & Goldberg, D. J. (2006) Hepatitis C Virus Infection in Scotland: 
295 
 
Epidemiological Review and Public Health Challenges. Scottish Medical Journal  51, 
2, pp. 8-15. 
Idler, E. & Benyamini, Y. (1997) Self-rated health and mortality: a review of twenty-
seven community studies. Journal of Health and Social Behavior  38, 1, pp. 21-37. 
Ingram, S. & Baxter, G. M. (1994) Colour doppler sonography of femoral vein 
stenosis: a report of three cases. Clinical Radiology  49, 4, pp. 268-269. 
ISD Information Services Division Scotland (2012) Drug Misuse Statistics Scotland 
2011.  NHS National Services Scotland, Edinburgh. 
ISD Information Services Division (2014) Estimating the National and Local 
Prevalence of Problem Drug Use in Scotland 2012/ 2013.  Information Services 
Division, NHS National Services Scotland, Edinburgh. 
ISD Information Services Division (2011) Estimating the National and Local 
prevalence of Problem Drug Use in Scotland 2009/10.  Information Services Division, 
NHS National Services Scotland, Edinburgh. 
Jawien, A., Grzela, T., & Ochwat, A. (2003) Prevalence of chronic venous 
insufficiency in men and women in Poland: multicenter cross sectional study in 40095 
patients. Phlebology  18, pp. 110-121. 
Jenkinson, R. A., Clark, N. C., Fry, C. L., & Dobbin, M. (2005) Buprenorphine 
diversion and injection in Melbourne, Australia: an emerging issue? Addiction  100, 2, 
pp. 197-205. 
Jensen, S. & Gregersen, M. (1991) Fatal poisoning with intravenously injected 
methadone and no fresh injection marks found. International Journal of Legal 
Medicine  104, pp. 299-301. 
Johnson, J. E., Lucas, C. E., Ledgerwood, A. M., & Jacobs, L. A. (1984) Infected 
venous pseudoaneurysm. Archives of Surgery  119, 9, pp. 1097-1098. 
Johnston, E. (2007) The role of nutrition in tissue viability. Wound Essentials  2, pp. 
10-21. 
Jones, R., Gruer, L., Gilchrist, G., Seymour, A., Black, M., & Oliver, J. (2002) Recent 
contact with health and social services by drug misusers in Glasgow who died of a fatal 
overdose in 1999. Addiction  97, pp. 1517-1522. 
296 
 
Joseph, W. L., Fletcher, H. S., Giordano, J. M., & Adkins, P. C. (1973) Pulmonary and 
cardiovascular complications of drug addiction. Annals of Thoracic Surgery  15, 3, pp. 
263-274. 
Kahn, S. R. & Ginsberg, J. S. (2004) Relationship between deep venous thrombosis and 
the postthrombotic syndrome. Archives of Internal Medicine  164, Jan 12, pp. 17-26. 
Karch, S. B. & Billingham, M. E. (1995) Coronary artery and peripheral vascular 
disease in cocaine users. Coronary Artery Disease.  6, 3, pp. 220-225. 
Kaye, S. & Darke, S. (2004) Injecting and non-injecting cocaine use in Sydney, 
Australia: physical and psychological morbidity. Drug and Alcohol Review  23, 
December, pp. 391-398. 
Keaney, F., Gossop, M., Dimech, A., Guerrini, I., Butterworth, M., Al-Hassani, H., & 
Morinan, A. (2011) Physical health problems among patients seeking treatment for 
substance use disorders: A comparison of drug dependent and alcohol dependent 
patients. Journal of Substance Use  16, 1, pp. 27-37. 
Kearns, A. M., Rathmann, I. R., Holmes, A., Pitt, T. L., & Cookson, B. D. (2004) An 
unusual clone of MRSA causing infection in injecting drug users. Journal of Infection  
49, 1, pp. 49-50. 
Kemm, J. (2006) The limitations of 'evidence-based' public health. Journal of 
Evaluation in Clinical Practice   12, 3, pp. 319-324. 
Kemp, P. A., Neale, J., & Robertson, M. (2006) Homelessness among problem drug 
users: prevalence, risk factors and trigger events. Health and Social Care in the 
Community  14, 4, pp. 319-328. 
Kemplay, R. (2015) Going in the groin.  Manchester, Lifeline.  
Khanna, D. & Drehmer, T. J. (2001) Intravenous drug abuse mimicking vasculitis. 
Southern Medical Journal  94, 5, pp. 505-507. 
Kippax, S. & Race, K. (2003) Sustaining safe practice: twenty years on. Social Science 
and Medicine  57, pp. 1-12. 
Kirchenbaum, S. E. & Midenberg, M. L. (1982) Pedal and lower extremity 
complications of substance abuse. Journal of the American Podiatry Association  72, 8, 
pp. 380-387. 
297 
 
Kolbach, D. N., Sandbrink, M. W. C., Prins, M. H., & Neumann, M. H. A. M. (2003) 
Compression therapy for treating stage 1 and 11(Widmer) post-thrombotic syndrome.  
J Wiley & Sons, Cochrane Library, Issue 4. 
Korthuis, P. T., Feaster, D. J., Gomez, Z. L., Das, M., Tross, S., Wiest, K., Douaihy, A., 
Mandler, R. N., Sorensen, J. L., Colfax, G., McCarty, D., Cohen, S. E., Penn, P. E., 
Lape, D., & Metsch, L. R. (2012) Injection behaviors among injection drug users in 
treatment: The role of hepatitis C awareness. Addictive Behaviours  37, pp. 552-555. 
Kwiatkowski, C. F., Corsi, K. F., & Booth, R. E. (2002) The association between 
knowledge of hepatitis C virus status and risk behaviours in injection drug users. 
Addiction  97, pp. 1289-1294. 
Lakon, C. M., Ennett, S. T., & Norton, E. C. (2006) Mechanisms through which drug, 
sex partner, and friendship network characteristics relate to risky needle use among 
high risk youth and young adults. Social Science and Medicine  63, pp. 2489-2499. 
Lankenau, S. E., Clatts, M. C., Goldsamt, L. A., & Welle, D. L. (2004) Crack cocaine 
injection practices and HIV risk: findings from New York and Bridgeport. Journal of 
Drug Issues  34, 2, pp. 319-332. 
Lathlean, J. (2006) "Qualitative analysis," in The research process in nursing, K. 
Gerrish & A. Lacey, eds., Blackwell, Oxford, pp. 417-433. 
Lawson, E. (2010) Geriaddicts - the older drug user. Northern Doctors Antidote 
http://northerndoctor.com/2010/07.09/geriaddicts Accessed 25/10/2015 
Leaper, D. J. (1998) Defining infection. Journal of Wound Care  7, 8, p. 373. 
Lees, T. A. & Lambert, D. (1992) Prevalence of lower limb ulceration in an urban 
health district. British Journal of Surgery   79, 10, pp. 1032-1034. 
Levine, D. P., Crane, L. R., & Zervos, M. J. (1986) Bacteremia in narcotic addicts at 
the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. 
Reviews of Infectious Diseases  8, 3, pp. 374-396. 
Lincoln, Y. S. & Guba, E. G. (1985) Naturalistic Inquiry. Sage Publications, 
California. 
Linton, R. R. (1953) The post-thrombotic ulceration of the lower extremity: its 
aetiology and surgical treatment. Annals of Surgery  138, 3, pp. 415-430. 
298 
 
Lloyd-Smith, E., Kerr, T., Hogg, R. S., Li, K., Montaner, J. S. G., & Wood, E. (2005) 
Prevalence and correlates of abscesses among a cohort of injection drug users. Harm 
Reduction Journal  2, 24. DOI: 10.1186/1477-7517-2-24 Accessed 06.06.06 
Lloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Montaner, J. S. G., & Kerr, T. 
(2008) Risk factors for developing a cutaneous injection-related infection among 
injection drug users: a cohort study. BMC Public Health  8, 405. 
http://www.biomedcentral.com/1471-2458/8/405   Accessed 04.05.09 
Lo, A. C., Vasiljevich, J. M., & Kerstein, M. D. (1990) Parenteral illegal drug use and 
limb loss. Journal of Cardiovascular Surgery  31, pp. 760-762. 
Long, J., Allwright, S., & Begley, C. (2004) Prisoners views of injecting drug use and 
harm reduction in Irish prisons. International Journal of Drug Policy  15, pp. 139-149. 
Louria, D. B., Hensle, T., & Rose, J. (1967) The major medical complications of heroin 
addiction. Annals of Internal Medicine  67, 1, p. 22. 
Lowry, S. (1990) Health and homelessness. British Medical Journal  300, 6th January, 
pp. 32-34. 
Lyer, S., Pabari, A., & Khoo, C. T. (2011) A well vascularised muscle flap- drug user's 
dream. Journal of Plastic, Reconstructive and Aesthetic Surgery  65, pp. 399-401. 
MacKenzie, A. R., Laing, R. B. S., Douglas, J. G., Greaves, M., & Smith, C. C. (2000) 
High prevalence of iliofemoral venous thrombosis with severe groin infection among 
injecting drug users in North East Scotland: successful use of low molecular weight 
heparin with antibiotics. Postgraduate Medical Journal  76, pp. 561-565. 
MacKenzie, R. K., Brown, D. A., Allan, P. L., Bradbury, A. W., & Ruckley, C. V. 
(2003) A comparison of patients who developed venous leg ulceration before and after 
their 50th birthday. European Journal of Vascular and Endovascular Surgery  26, pp. 
176-178. 
Mackesy-Amiti, M. E., Donenberg, G. R., & Ouellet, L. J. (2012) Prevalence of 
psychiatric disorders among young injection drug users. Drug and Alcohol Dependence  
124, pp. 70-78. 
299 
 
Mackridge, A. J., Beynon, C. M., McVeigh, J., Whitfield, M., & Chandler, M. (2010) 
Meeting the health needs of problematic drug users through community pharmacy: a 
qualitative study. Journal of Substance Use  15, 6, pp. 367-376. 
Macleod, J., Whittaker, A., & Robertson, J. R. (1998) Changes in opiate treatment 
during attendance at a community drug service - findings from a clinical audit. Drug 
and Alcohol Review  17, 1, pp. 19-25. 
Macleod, J., Copeland, L., Hickman, M., McKenzie, J., Kimber, J., De Angelis, A., & 
Robertson, J. R. (2010) The Edinburgh Addiction Cohort: recruitment and follow-up of 
a primary care based sample of injection drug users and non drug-injecting controls. 
BMC Public Health  10, 101. http://biomedcentral.com/1471-2458/10/101 Accessed  
14.12.12 
Macleod, J., Hickman, M., Jones, H. E., Copeland, L., McKenzie, J., De Angelis, A., 
Kimber, J., & Robertson, J. R. (2013) Early life influences on the risk of injecting drug 
use: case control study based on the Edinburgh Addiction Cohort. Addiction  108, 4, pp. 
743-750. 
Maggi, P., Fullone, M., Federico, M., Angarano, G., Pastore, G., & Regina, G. (1995) 
Drug injection in jugular veins: a new risk factor for vascular diseases in HIV-infected 
patients? Angiology  46, 11, pp. 1049-1052. 
Makower, R. M., Pennycook, A. G., & Moulton, C. (1992) Intravenous drug abusers 
attending an inner city accident and emergency department. Archives of Emergency 
Medicine  9, pp. 32-39. 
Male, S., Coull, A., & Murphy-Black, T. (2007) Preliminary study to investigate the 
normal range of Ankle Brachial Pressure Index in young adults. Journal of Clinical 
Nursing  16, 10, pp. 1878-1885. 
Maliphant, J. & Scott, J. (2005) Use of the femoral vein ('groin injecting') by a sample 
of needle exchange clients in Bristol, UK. Harm Reduction Journal  2, 6. 
DOI:10.1186/1477-7517-2-6 Last accessed 05.11.15 
Marks, M., Pollock, E., Armstrong, M., Morris-Jones, S., Kidd, M., Gothard, P., 
Noursadeghi, M., & Doherty, J. F. (2013) Needles and the damage done: reasons for 
300 
 
admission and financial costs associated with injecting drug use in a Central London 
Teaching Hospital. Journal of Infection  66, pp. 95-102. 
Martijn, C. & Sharpe, L. (2006) Pathways to youth homelessness. Social Science and 
Medicine  62, 1, p. 12. 
Martin, A. & Stenner, P. (2004) Talking about drug use: what are we (and our 
participants) doing in qualitative research? International Journal of Drug Policy  15, 
pp. 395-405. 
Martin, R. M. (2005) "Epidemiological study designs for health care research." in 
Handbook of health research methods, A. Bowling & S. Ebrahim, eds., Open 
University Press, Maidenhead, pp. 98-163. 
Matheson, C., Bond, C. M., & Pitcairn, J. (2002) Community pharmacy services for 
drug misusers in Scotland: what difference does 5 years make? Addiction  97, pp. 1405-
1411. 
May, E. (2002) Excellent idea: leg clinics for drug users. British Journal of Nursing  
11, 14, p. 934. 
McBride, A. J., Pates, R. M., Arnold, K., & Ball, N. (2001) Needle fixation, the drug 
user's perspective: a qualitative study. Addiction  96, 7, pp. 1049-1058. 
McClelland, G. (2006) Caring for problem drug users. Nursing Times  102, 20, pp. 26-
28. 
McColl, M. D., Tait, R. C., Greer, I. A., & Walker, I. D. (2001) Injecting drug use is a 
risk factor for deep vein thrombosis in women in Glasgow. British Journal of 
Haematology  112, pp. 641-643. 
McCreaddie, M., Lyons, I., Watt, D., Ewing, E., Croft, J., Smith, M., & Tocher, J. 
(2010) Routines and rituals: a grounded theory of the pain management of drug users in 
acute settings. Journal of Clinical Nursing  19, pp. 2730-2740. 
McElrath, K., Chitwood, D. D., Griffin, D. K., & Comerford, M. (1994) The 
consistency of self-reported HIV risk behavior among injection drug users. American 
Journal of Public Health  84, 12, pp. 1965-1970. 
McEvoy, P.& Richards, D. (2006) A critical realist rationale for using a combination of 
quantitative and qualitative methods. Journal of Research in Nursing 11, pp. 66 -78 
301 
 
McGrath, P. & Phillips, E. (2007) Making them more vulnerable: nursing insights on 
the irony of using questionnaires. Nursing Forum  42, 2, pp. 65-72. 
McGuigan, C. C., Penrice, G. M., Gruer, L., Ahmed, S., Goldberg, D., Black, M., 
Salmon, J. E., & Hood, J. (2002) Lethal outbreak of infection with clostridium novyi 
type A and other spore-forming organisms in Scottish injecting drug users. Journal of 
Medical Microbiology  51, 11, pp. 971-977. 
McIntosh, J. & McKeganey, N. (2000) Addicts' narratives of recovery from drug use: 
constructing a non-addict identity. Social Science and Medicine  50, pp. 1501-1510. 
McKee, M. (2005) Injecting crack cocaine is surprisingly common. New Scientist  13, 
33. 
McKeganey, N., Barnard, M., & Watson, H. (1989) HIV-related risk behaviour among 
a non-clinic sample of injecting drug users. British Journal of Addiction  84, pp. 1481-
1490. 
McKeganey, N., Bloor, M., Robertson, M., Neale, J., & MacDougall, J. (2006) 
Abstinence and drug abuse treatment: results from the drug outcome research in 
Scotland study. Drugs: education, prevention and policy  13, 6, pp. 537-550. 
McKeganey, N., Bloor, M., McIntosh, J., & Neale, J. (2008) Key findings from the 
Drug Outcome Research in Scotland (DORIS) study., University of Glasgow Centre for 
Drug Misuse Research, Glasgow. 
McLaughlin, D. & Long, A. (1996) An extended literature review of health 
professionals perceptions of illicit drugs and their clients who use them. Journal of 
Psychiatric and Mental Health Nursing  3, pp. 283-288. 
Meetoo, D. (2010) In too deep: understanding, detecting and managing DVT. British 
Journal of Nursing  19, 16, pp. 1021-1027. 
Mercure, S., Tetu, I., Lamonde, S., Cote, F., & Guides de Rue Working Group (2008) 
Seeing is believing: an educational outreach activity on disinfection practices. Harm 
Reduction Journal  5, 7. DOI: 10.1186/1477-7517-5-7 Accessed 14.04.09 
Millburn, J. & Brittenden, J. (2006) Pseudo-aneurysms in injecting drug abusers: a 
diagnosis not to be missed. Scottish Medical Journal  52, 1, pp. 55-58. 
302 
 
Miller, P. G., Lintzeris, N., & Forzisi, L. (2008) Is groin injecting an ethical boundary 
for harm reduction? International Journal of Drug Policy  19, pp. 486-491. 
Miller, P. G., Forzisi, L., Zador, D., Lintzeris, N., Metrebian, N., Van der waal, R., 
Mayet, S., & Strang, J. (2009) Groin injecting in injectable opiod treatment service 
users in South London. Addiction Research and Theory  17, 4, pp. 381-389. 
Miller, P. G. (2009) Safe using messages may not be enough to promote behaviour 
change amongst injecting drug users who are ambivalent or indifferent towards death. 
Harm Reduction Journal  6, 18. DOI: 10.1186/1477-7517-6-18 Accessed 14.12.14 
Miller, P. G. & Sonderlund, A. L. (2010) Using the internet to research hidden 
populations of illicit drug users: a review. Addiction  105, pp. 1557-1567. 
Mittal, R. R. & Pahuja, K. (2000) Chronic leg ulcers in drug abusers. Indian Journal of 
Dermatology, Venereology and Leprology  66, 4, pp. 213-221. 
Mockel, M., Kampf, D., Lobeck, H., & Frei, U. (1999) Severe panarteritis associated 
with drug abuse. Intensive Care Medicine   25, pp. 113-117. 
Moffatt, C. J. & Franks, P. J. (1994) A pre-requisite underlying the treatment 
programme. Risk factors associated with venous disease. Professional Nurse  9, June, 
pp. 637-642. 
Moffatt, C. J., Franks, P. J., Doherty, D. C., Martin, R., Blewett, R., & Ross, F. (2004) 
Prevalence of leg ulceration: a study in a London population. Quarterly Journal of 
Medicine  97, 7, pp. 431-437. 
Moffatt, C., Martin, R., & Smithdale, R. (2007) Leg Ulcer Management Blackwell, 
London. 
Moffatt, C. J., Franks, P. J., Oldroyd, M., Bosanquet, N., Greenhalgh, R. M., & 
McCollum, C. M. (1992) Community clinics for leg ulcers and impact on healing. 
British Medical Journal  305, 6866, pp. 1389-1392. 
Morrison, A., Elliott, L., & Gruer, L. (1997) Injecting-related harm and treatment-
seeking behaviour among injecting drug users. Addiction  92, 10, pp. 1349-1352. 
Morse, J. M., Barrett, M., Mayan, M., Olson, K., & Spiers, J. (2002) Verification 
strategies for establishing reliability and validity in qualitative research. International 
Journal of Qualitative Methods   1, 2, pp. 13-22. 
303 
 
Mossey, J. M. & Shapiro, E. (1982) Self Rated Health: A predictor of mortality among 
the elderly. American Journal of Public Health  72, pp. 800-808. 
Mottahedeh, M. & da Silva, A. F. (2003) Quality of evidence underlying the 
management of thrombophlebitis. Phlebology  18, 4, pp. 167-172. 
Murphy, E. L., DeVita, D., Liu, H., Vittinghof, E., Leung, P., Ciccarone, D. H., & 
Edlin, B. R. (2001) Risk factors for skin and soft-tissue abscesses among injection drug 
users: a case-control study. Clinical Infectious Diseases  33, pp. 35-40. 
Murtagh, L. (2007) Implementing a critically quasi-ethnographic approach. The 
Qualitative Report  12, 2, pp. 193-215. 
Musani, M. H., Matta, F., Yaekoub, A. Y., Liang, J., Hull, R. D., & Stein, P. D. (2010) 
Venous compression for prevention of postthrombotic syndrome: a meta-analysis. The 
American Journal of Medicine  123, pp. 735-740. 
Mutasa, H. C. F. (2001) Risk factors associated with noncompliance with methadone 
substitution therapy (MST) and relapse among chronic opiate users in Outer London. 
Journal of Advanced Nursing  35, 1, pp. 97-107. 
Myers, G. H., Hansen, T. H., & Jain, A. (1991) Left main coronary artery and femoral 
artery vasospasm associated with cocaine use. Chest  100, 1, pp. 257-258. 
Nambiar, D., Stoove, M., & Dietze, P. (2014) A cross-sectional Study describing 
factors associated with utilisation of GP services by a cohort of people who inject 
drugs. BMC Health Services Research  14, p. 308. 
http://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-308 
Accessed 02.03.15 
Nambiar, D., Weir, A., Aspinall, E., Stoove, M., Hutchinson, S., Dietze, P., Waugh, L., 
& Goldberg, D. J. (2015) Mortality and cause of death in a cohort of people who had 
ever injected drugs in Glasgow: 1982 - 2012. Drug and Alcohol Dependence  147, pp. 
215-221. 
Napper, L. E., Fisher, D. G., Johnson, M. E., & Wood, M. M. (2010) The reliability and 
validity of drug users' self reports of amphetamine use among primarily heroin and 
cocaine users. Addictive Behaviours  35, pp. 350-354. 
304 
 
Navarro, C. & Leonard, L. (2004) Prevalence and factors related to public injecting in 
Ottawa, Canada: implications for the development of a trial safer injecting facility. 
International Journal of Drug Policy  15, pp. 275-284. 
Neal, M. (1999) Necrotising fasciitis. Journal of Wound Care  8, 1, pp. 18-19. 
Neale, J. (2001) Homelessness amongst drug users: a double jeopardy explored. 
International Journal of Drug Policy  12, pp. 353-369. 
Neale, J. & Robertson, M. (2003) Comparison of self-report data and oral fluid testing 
in detecting drug use amongst new treatment clients. Drug and Alcohol Dependence  
71, pp. 57-64. 
Neale, J. (2004a) Measuring the health of Scottish drug users. Health and Social Care 
in the Community  12, 3, pp. 202-211. 
Neale, J. (2004b) Gender and illicit drug use. British Journal of Social Work  34, 6, pp. 
851-870. 
Neale, J., Nettleton, S., Pickering, L., & Fischer, J. (2011) Eating patterns among 
heroin users: a qualitative study with implications for nutritional interventions. 
Addiction  107, 3, pp. 635-641. 
Needle, R., Weatherby, N., Chitwood, D., Booth, R., Watters, J., Fisher, D. G., Brown, 
B., Cesari, H., Williams, M. L., Andersen, M., & Braunstein, M. (1995) Reliability of 
self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors  9, 4, 
pp. 242-250. 
Neglen, P. (2006) Invasive treatment of post-thrombotic symptoms. Phlebolymphology  
13, 3, pp. 163-171. 
Neiman, J., Haapaniemi, H. M., & Hillbom, M. (2000) Neurological complications of 
drug abuse: pathophysiological mechanisms. European Journal of Neurology  7, pp. 
595-606. 
Nelson, E. A. (1996) Compression bandaging in the treatment of venous leg ulcers.  
Journal of Wound Care   5, 9, pp. 415-418. 
Nelzen, O., Bergqvist, D., Lindhagen, A., & Hallbook, T. (1991) Chronic leg ulcers: an 
underestimated problem in primary health care among elderly patients. Journal of 
Epidemiology and Community Health  45, pp. 184-187. 
305 
 
Niblo, J. & Coull, A. (2013)  Ankle brachial pressure index of normal healthy younger 
adults.  British Journal of Nursing  22, 12, p. S16-S21. 
NICE (2004) Thrombin injections for pseudoaneurysms. NICE interventional 
procedural guidance (IPG 60). NICE. London.  
Nicolaides, A., Fernandes, E., Fernandes, J., & Pollock, A. V. (1980) Intermittent 
sequential pneumatic compression of the legs in the prevention of venous stasis and 
postoperative deep venous thrombosis. Surgery  87, 1, pp. 69-75. 
Novick, D. M. & Ness, G. L. (1984) Abuse of antibiotics by abusers of parenteral 
heroin or cocaine. Southern Medical Journal   77, 3, pp. 302-303. 
O'Brien, R. J. & Schroedl, B. L. (1991) Talc Retinopathy. Optometry and Vision 
Science  68, 1, pp. 54-57. 
O'Hare, L. (1995) Venous leg ulceration: treatment by high compression bandaging.  
Ostomy / Wound Management  41, 4, pp. 16-25. 
Onwuegbuzie, A.J. and Teddlie, C. (2003) ‘A framework for analysing data in mixed 
methods research’  in Tashakkori, A. & Teddlie, C. (2003) Handbook of mixed 
methods in social and behavioural research. Sage, California. 
 
Orangio, G. R., Pitlick, S. D., Latta, P. D., Mandel, L. J., Marino, C., Guarneri, J. J., 
Giron, J. A., & Margolis, I. B. (1984) Soft tissue infections in parenteral drug abusers. 
Annals of Surgery  199, 1, pp. 97-100. 
Paley, J. (2001) Positivism and qualitative nursing research. Scholarly Inquiry for 
Nursing Practice: An International Journal  15, 4, pp. 371-387. 
Palfreyman, S., Tod, A. M., King, B., Tomlinson, D., Brazier, J. E., & Michaels, J. A. 
(2007) Impact of intravenous drug use on quality of life for patients with venous ulcers. 
Journal of Advanced Nursing   58, 5, pp. 458-467. 
Palfreyman, S. (2008) Assessing the impact of venous ulceration on quality of life. 
Nursing Times  104, 41, pp. 34-37. 
Palfreyman, S. & Fenwick, N. (2011) Misusers who inject need a specialist wounds 
service. Nursing Standard  25, 48, pp. 32-33. 
306 
 
Pallant, J. (2007) SPSS Survival Manual. Third edition, McGraw Hill, Maidenhead, 
England. 
Parahoo, K. (2006) Nursing Research. Second edition, Palgrave MacMillan, 
Hampshire. 
Pardes, J. B., Falanga, V., & Kerdel, F. A. (1993) Delayed cutaneous ulcerations 
arising at sites of prior parenteral drug abuse. Journal of the American Academy of 
Dermatology  29, December, pp. 1052-1054. 
Parkin, S. & Coomber, R. (2011) Public injecting drug use and the social production of 
harmful practice in high-rise tower blocks (London, UK): A Lefebvrian analysis. 
Health and Place  17, pp. 717-726. 
Passaro, D. J., Werner, S. B., McGee, J., Mackenzie, W. R., & Vugia, D. J. (1998) 
Wound botulism associated with black tar heroin among injecting drug users. JAMA  
279, 11, pp. 859-863. 
Pawson, R., Greenhalgh, T., Harvey, G., & Walshe, K. (2005) Realist review - a new 
method of systematic review designed for complex policy interventions. Journal of 
Health Sciences Research and Policy  10, suppl 1, pp. 21-34. 
Peretti-Watel, P. & Moatti, J. P. (2006) Understanding risk behaviours: how the 
sociology may contribute? The case of drug-taking. Social Science and Medicine  63, 
pp. 675-679. 
Phillips, K. T., Altman, J. K., Corsi, K. F., & Stein, M. D. (2013) Development of a risk 
reduction intervention to reduce bacterial and viral infections for injection drug users. 
Substance use and misuse   48, 1/2, pp. 54-64. 
Pieper, B. (1996a) A retrospective analysis of venous ulcer healing in current and 
former users of injected drugs. Journal of Wound, Ostomy and Continence Nursing  23, 
pp. 291-296. 
Pieper, B. (1996b) Physical effects of heroin and cocaine: considerations for a wound 
care service. Journal of Wound, Ostomy and Continence Nursing  23, pp. 248-256. 
Pieper, B., Rossi, R., & Templin, T. (1998) Pain associated with venous ulcers in 
injecting drug users. Ostomy / Wound Management  44, 44, pp. 54-67. 
307 
 
Pieper, B. & DiNardo, E. (1998) Reasons for nonattendance for the treatment of venous 
ulcers in an inner-city clinic. Journal of Wound, Ostomy and Continence Nursing  25, 
4, pp. 180-186. 
Pieper, B., Szczepaniak, K., & Templin, T. (2000) Psychosocial adjustment, coping, 
and quality of life in persons with venous ulcers and a history of intravenous drug use. 
Journal of Wound, Ostomy and Continence Nursing  27, pp. 227-239. 
Pieper, B. & Templin, T. (2001) Chronic venous insufficiency in persons with a history 
of injecting drug use. Research in Nursing and Health  24, pp. 423-432. 
Pieper, B. & Templin, T. (2003) Lower extremity changes, pain, and function in 
injection drug users. Journal of Substance Abuse Treatment  25, pp. 91-97. 
Pieper, B. (2005) Wound management in vulnerable populations. Rehabilitation 
Nursing  30, 3, pp. 100-105. 
Pieper, B., Templin, T., & Ebright, J. R. (2006a) Chronic venous insufficiency in HIV-
positive persons with and without a history of injection drug use. Advances in Skin and 
Wound Care  19, 1, pp. 37-42. 
Pieper, B., Templin, T. N., & Ebright, J. R. (2006b) The impact of chronic venous 
insufficiency and leg function on the quality of life of HIV-positive persons. Ostomy / 
Wound Management  52, 4, pp. 43-58. 
Pieper, B., Templin, T. N., Birk, T. J., & Kirsner, R. S. (2008) Chronic venous 
disorders and injection drug use. Impact on balance, gait, and walk speed. Journal of 
Wound, Ostomy and Continence Nursing  35, 3, pp. 301-310. 
Pieper, B., Kirsner, R. S., Templin, T. N., & Birk, T. J. (2009a) Peripheral arterial 
disease among substance abusers in drug treatment.  Advances in Skin and Wound Care  
22, 6, pp. 265-272. 
Pieper, B., Templin, T. N., Kirsner, R. S., & Birk, T. J. (2009b) Impact of injection 
drug use on distribution and severity of chronic venous disorders. Wound Repair and 
Regeneration  17, 4, pp. 485-491. 
Pieper, B., Templin, T. N., Kirsner, R. S., & Birk, T. J. (2010a) Injection-related 
venous disease and walking mobility. Journal of Addictive Diseases  29, 4, pp. 481-
492. 
308 
 
Pieper, B., Templin, T. N., Kirsner, R. S., & Birk, T. J. (2010b) The impact of vascular 
leg disorders on physical activity in methadone maintained adults. Research in Nursing 
and Health  33, pp. 426-440. 
Pieper, B., DiNardo, E., & Nordstrom, C. (2013) A cross-sectional, comparative study 
of pain and activity in persons with and without injection-related venous ulcers. Ostomy 
/ Wound Management  59, 5, pp. 14-24. 
Pieper, B., Templin, T. N., Birk, T. J., & Kirsner, R. S. (2015) Reliability and clinical 
validity of a technique to assess lifetime illicit injection drug use. Ostomy / Wound 
Management  54, 2, pp. 16-34. 
Pirard, D., Bellens, B., & Vereecken, P. (2008) The post-thrombotic syndrome - a 
condition to prevent. Dermatology Online Journal  14, 3, pp. 13-14. 
http://www.ncbi.nlm.nih.gov/pubmed/18627714  Accessed 04.0309 
Pirozzi, K., Van, J. C., Pontious, J., & Meyr, A. J. (2014) Demographic description of 
the presentation and treatment of lower extremity skin and soft tissue infections 
secondary to skin popping in intravenous drug abusers. The Journal of Foot and Ankle 
Surgery  53, pp. 156-159. 
Ponton, R. & Scott, J. (2004) Injection preparation processes used by heroin and crack 
cocaine injectors. Journal of Substance Use  9, 1, pp. 7-19. 
Pope, C., Ziebland, S., & Mays, N. (2000) Analysing qualitative data. British Medical 
Journal  320, 7227, pp. 114-116. 
Pope, C., Ziebland, S., & Mays, N. (2007) "Analysing Qualitative Data," in Qualitative 
Research in Healthcare Third edition, C. Pope & N. Mays, eds., Blackwell, London. 
pp. 63-81. 
Porter, S. (1993) Nursing research conventions: objectivity or obfuscation. Journal of 
Advanced Nursing  18, pp. 137-143. 
Porter, S. (1998) Social Theory and Nursing Practice MacMillan Press Ltd, 
Basingstoke. 
Powell, A. G. M. T., Crozier, J. E. M., Hodgson, H., & Galloway, D. J. (2011) A case 
of septicaemic anthrax in an intravenous drug users. BMC Infectious Diseases  11, 21. 
http://dx.doi.org/10.1186/1471-2334-11-21  Accessed 02.12.14 
309 
 
Powell, G. (2011a) Wound care for injecting drug users: part 1. Nursing Standard  25, 
46, pp. 51-58. 
Powell, G. (2011b) Wound care for injecting drug users: part 2. Nursing Standard  25, 
47, pp. 41-45. 
Powers, B. A. & Knapp, T. R. (1995) A dictionary of nursing theory and research. 
Second edition, Sage, California. 
Prandoni, P., Lensing, A. W. A., Prins, M. H., Frulla, M., Marchiori, A., Bernardi, E., 
Tormene, D., Mosena, L., Pagnan, A., & Girolami, A. (2004) Below-knee elastic 
compression stockings to prevent the post-thrombotic syndrome. Annals of Internal 
Medicine  141, pp. 249-256. 
Prendergast, H., Jerrard, D., & O'Connell, J. (1997) Atypical presentations of epidural 
abscess in intravenous drug abusers. American Journal of Emergency Medicine  15, 2, 
pp. 158-160. 
Preston, A. & Derricott, J. (2007) In the groin femoral injecting. Third edition, 
Exchange Supplies, Dorset. 
Preston, A. (2008) The methadone handbook. Eighth edition, Exchange Supplies, 
Dorset. 
Preston, A. & Derricott, J. (2013) The safer injecting handbook. Seventh edition, 
Exchange Supplies, Dorset. 
Prevost, T. C., Presanis, A. M., Taylor, A., Goldberg, D. J., Hutchinson, S. J., & De 
Angelis, D. (2015) Estimating the number of people with hepatitis C virus who have 
ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for 
Scotland. Addiction  110, pp. 1287-1300. 
'Public Health Groups' : Public Health England, Health Protection Scotland, Public 
Health Wales, & and Public Health Agency Northern Ireland (2014), Shooting Up: 
Infections among people who inject drugs in the United Kingdom, 2013, Public Health 
England, London. 
'Public Health Groups' : Public Health England, Health Protection Scotland, Public 
Health Wales, & and Public Health Agency Northern Ireland (2015), Shooting Up: 
310 
 
Infections among people who inject drugs in the UK, 2014, Public Health England, 
London. 
Raeside, L. (2003) Attitudes of staff towards mothers affected by substance abuse. 
British Journal of Nursing   12, 5, pp. 302-310. 
Rattray, J. & Jones, M. C. (2007) Essential elements of questionnaire design and 
development. Journal of Clinical Nursing  16, pp. 234-243. 
Rawson, R. A. & Condon, T. P. (2007) Why do we need an Addiction supplement 
focused on methamphetamine? Addiction  102, Supplement 1, pp. 1-4. 
Reddy, D. J., Smith, R. F., Elliott, J. P., Haddad, G. K., & Wanek, E. A. (1986) Infected 
femoral artery false aneurysms in drug addicts: evolution of selective vascular 
reconstruction. Journal of Vascular Surgery  3, 5, pp. 718-724. 
Redondo, P., Molano, E., Lloret, P., & Bauza, A. (2002) 'Skin popping' ulceration in an 
HIV patient. Successful treatment with antiretroviral drugs and stanozolol. 
International Journal of STD and AIDS  13, pp. 508-509. 
Reed, A. & Jefferson, B. (2003) Cases from the Osler Medical service at John Hopkins 
University. The American Journal of Medicine  115, September, pp. 326-328. 
Reese, W. G. & Sullivan, L. M. (1997) Tc-99m labeled WBC imaging of lower 
extremity abscesses and skin necrosis due to skin popping. Clinical Nuclear Medicine  
22, 12, pp. 865-866. 
Reid, P. & Klee, H. (1999) Young homeless people and service provision. Health and 
Social Care in the Community  7, pp. 17-24. 
Reuter, P. 2006, "What drug policies cost. Estimating government drug policy 
expenditures".  Addiction  101, pp. 315-322. 
Rhodes, T., Stoneman, A., Hope, V., Hunt, N., Martin, A., & Judd, A. (2006a) Groin 
injecting in the context of crack cocaine and homelessness: From 'risk boundary' to 
'acceptable risk'? International Journal of Drug Policy  17, pp. 164-170. 
Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., & Holloway, 
G. (2006b) Public injecting and the need for 'safer environment interventions' in the 
reduction of drug-related harm. Addiction  101, 10, pp. 1384-1393. 
311 
 
Ritchie, J. & Spencer, L. (1994) "Qualitative data analysis for applied policy research," 
in Analyzing qualitative data. A. Bryman & R. G. Burgess, eds., Routledge, London, 
pp. 173-194. 
Ritland, D. & Butterfield, W. (1973) Extremity complications of drug abuse. American 
Journal of Surgery  126, November, pp. 639-648. 
Ritson, E. (1999) Alcohol, drugs and stigma. International Journal of Clinical Practice  
53, 7, pp. 549-551. 
Roberts, K. & Hunter, C. (2004) A comprehensive system of pharmaceutical care for 
drug misusers. Harm Reduction Journal  1, 6. 
Robertson, J. R., Ronald, P. J. M., Raab, G. M., Ross, A. J., & Parpia, T. (1994) 
Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug 
users followed up for 10 years. British Medical Journal  309, 6 August, pp. 369-370. 
Robertson, R. & Richardson, A. (2007) Heroin injecting and the introduction of HIV/ 
AIDS into a Scottish city. Journal of the Royal Society of Medicine  100, 11, pp. 491-
494. 
Robinson, W. T., Risser, J. M. H., McGoy, S., Becker, A. B., Rehman, H., Jefferson, 
M., Griffin, V., Wolverton, M., & Tortu, S. (2006) Recruiting injection drug users: a 
three -site comparison of results and experiences with respondent driven and targeted 
sampling procedures. Journal of Urban Health  83, 7, p. i29-i38. 
Rocha, S. M. M., Lima, R. A. G., & Peduzzi, M. (2000) Understanding nursing: the 
usefulness of a philosophical perspective. Nursing Philosophy  1, 1, pp. 50-56. 
Roe, B., Beynon, C., Pickering, L., & Duffy, P. (2010) Experiences of drug use and 
ageing: health, quality of life, relationship and service implications. Journal of 
Advanced Nursing  66, 9, pp. 1968-1979. 
Roose, R. J., Hayashi, A. S., & Cunningham, C. O. (2009) Self-management of 
injection-related wounds among injecting drug users. Journal of Addictive Diseases  
28, 1, pp. 74-80. 
Roszler, M. H., Rashid, T., McCarroll, K. A., Kling, G. A., & Donovan, K. R. (1989) 
The groin hit: complications of intravenous drug abuse. RadioGraphics  9, 3, pp. 487-
508. 
312 
 
Routledge, F. (2007) Exploring the use of feminist philosophy within nursing research 
to enhance post-positivist methodologies in the study of cardiovascular health. Nursing 
Philosophy  8, 4, pp. 278-290. 
Rowe, J. (2005) Laying the foundations: addressing heroin use among the 'street 
homeless'. Drugs: education, prevention and policy  12, 1, pp. 47-59. 
Roxburgh, A., Degenhardt, L., & Breen, C. (2005) Drug use and risk behaviours among 
injecting drug users: a comparison between sex workers and non-sex workers in 
Sydney, Australia. Harm Reduction Journal  2, 7. DOI: 10.1186/1477-7517-2-7 
Accessed 06.06.06 
Roy, K., Howie, H., Sweeney, C., Parry, J., Molyneux, P., Goldberg, D., & Taylor, A. 
(2004) Hepatitis A virus and injecting drug misuse in Aberdeen, Scotland: a case-
control study. Journal of Viral Hepatitis  11, pp. 277-282. 
Roy, K. M., Goldberg, D., Taylor, A., & Mills, P. (2003) Investigating the source of 
hepatitis C virus infection among individuals whose route of infection is undefined: a 
study of ten cases. Scandinavian Journal of Infectious Diseases  35, pp. 326-328. 
Saunders, S. A., Democratis, J., Martin, J., & Macfarlane, I. A. (2004) Intravenous drug 
abuse and Type 1 diabetes: financial and healthcare implications. Diabetic Medicine  
21, 12, pp. 1269-1273. 
Schiller, C. (2016) Critical realism in nursing: an emerging approach. Nursing 
Philosophy 17,  2,  pp. 88 - 102 
Schmidt, J. & Williams, E. (1999) When all else fails try harm reduction. American 
Journal of Nursing  99, 10, pp. 67-70. 
Schnall, S. B., Holtom, P. D., & Lilley, J. C. (1994) Abscesses secondary to parenteral 
abuse of drugs. A study of demographic and bacteriological characteristics. The Journal 
of Bone and Joint Surgery  76, 10, pp. 1526-1530. 
Schofield, J. W. (2000) " Increasing the generalizability of the case study.," in Case 
Study Method: Key Issues, Key Texts.  R. Gomm, M. Hammersley, & P. Foster, eds., 
Sage, Thousand Oaks CA. 
313 
 
Schwartz, A. C., Bradley, R., Penza, K. M., Sexton, M., Jay, D., Haggard, P. J., 
Garlow, S. J., & Ressler, K. J. (2006) Pain medication use among patients with 
posttraumatic stress disorder. Psychosomatics  47, pp. 136-142. 
Scott, J., Winfield, A., Kennedy, E., & Bond, C. (2000) Laboratory study of the effects 
of citric and ascorbic acids on injections prepared with brown heroin. The International 
Journal of Drug Policy  11, 6, pp. 417-422. 
Scott, J. (2005) Laboratory study of the effectiveness of filters used by heroin injectors. 
Journal of Substance Use  10, 5, pp. 293-301. 
Scott, J. (2008) Safety, risks and outcomes from the use of injecting paraphernalia, 
Scottish Government, Edinburgh. 
Scott, J. & Mackridge, A. J. (2009) Pharmacy support staff involvement in, and 
attitudes towards, pharmacy-based services for drug misusers. International Journal of 
Pharmacy Practice  17, pp. 325-332. 
Scott, T. E., LaMorte, W. W., Gorin, D. R., & Menzoian, J. O. (1995) Risk factors for 
chronic venous insufficiency: a dual case-control study. Journal of Vascular Surgery  
22, pp. 622-628. 
Scottish Government (2008) A Road to Recovery – a new approach to tackling 
Scotland’s drug problem. The Scottish Government, Edinburgh. 
Scottish Government. (2010) Guidelines for services providing injecting equipment: 
Best practice recommendations for commissioners and injecting equipment provision 
(IEP) services in Scotland.  The Scottish Government. Edinburgh. 
Scottish Leg Ulcer Trial participants (2002) Effect of a National Community 
Intervention Programme on Healing Rates of Chronic Leg Ulcer: Randomised 
Controlled Trial. Phlebology  17, 2, pp. 47-53. 
Senbanjo, R., Hunt, N., & Strang, J. (2010) Cessation of groin injecting behaviour 
among patients on oral opioid substitution treatment. Addiction  106, pp. 376-382. 
Senbanjo, R., Tipping, T., Hunt, N., & Strang, J. (2012) Injecting drug use via femoral 
vein puncture: Preliminary findings of a point-of-care ultrasound service for opioid-
dependent groin injectors. Harm Reduction Journal  9, 6. DOI: 10.1186/1477-7517-9-6 
Accessed 14.12.14 
314 
 
Seymour, A., Black, M., Jay, J., Cooper, G., Weir, C., & Oliver, J. (2003) The role of 
methadone in drug-related deaths in the west of Scotland. Addiction  98, pp. 995-1002. 
Shand, F. L., Degenhardt, L., Slade, T., & Nelson, E. C. (2011) Sex differences 
amongst dependent heroin users: Histories, clinical characteristics and predictors of 
other substance dependence. Addictive Behaviours  36, 1-2, pp. 27-36. 
Shewan, D. (1992) Illegal drug use in Greater Glasgow.  A survey of current service 
responses. The International Journal of Drug Policy  3, 1, pp. 39-43. 
Shewan, D., Dalgarno, P., Marshall, A., Lowe, E., Campbell, M., Nicholson, S., Reith, 
G., McLafferty, V., & Thomson, K. (1998) Patterns of heroin use among a non-
treatment sample in Glasgow (Scotland). Addiction Research  6, 3, pp. 215-234. 
Shewan, D. & Dalgarno, P. (2005) Evidence for controlled heroin use? Low levels of 
negative health and social outcomes among non-treatment heroin users in Glasgow. 
British Journal of Health Psychology  10, 1, pp. 33-48. 
Shiman, M. I., Pieper, B., Templin, T. N., Birk, T. J., Patel, A. R., & Kirsner, R. S. 
(2009) Venous ulcers: A reappraisal analyzing the effects of neuropathy, muscle 
involvement, and range of motion upon gait and calf muscle function. Wound Repair 
and Regeneration  17, 2, pp. 147-152. 
Shin, S. S., Moreno, P. G., Rao, S., Garfein, R. S., Novotny, T. E., & Strathdee, S. A. 
(2013) Cigarette smoking and quit attempts among injection drug users in Tijuana, 
Mexico. Nicotine and Tobacco Research  15, 12, pp. 2060-2068. 
Sieber, J. E. (1992) Planning ethically responsible research. A guide for students and 
internal review boards. Sage, California. 
SIGN Scottish Intercollegiate Guidelines Network. (2006)  Diagnosis and management 
of peripheral arterial disease. A national clinical guideline No 89.  SIGN, Edinburgh. 
SIGN Scottish Intercollegiate Guidelines Network. (1998) The care of patients with 
chronic leg ulcer A national clinical guideline No 26.  SIGN, Edinburgh. 
SIGN Scottish Intercollegiate Guidelines Network. (2010) Management of chronic 
venous leg ulcers. A national clinical guideline No 120. SIGN, Edinburgh. 
Sillars, J. (2013) Guidance on drug and alcohol use and oral nutritional supplement 
drinks (ONS) on prescription. NHS Forth Valley, Falkirk . NHS Forth Valley.  
315 
 
Silverman, D. (1993) Interpreting qualitative data. Methods for analysing talk, text and 
interaction. Sage, London. 
Sim, M. G., Hulse, G., & Khong, E. (2004) Injecting drug use and skin lesions. 
Australian Family Physician  33, 7, pp. 519-522. 
Simmonds, L. & Coomber, R. (2009) Injecting drug users: A stigmatised and 
stigmatising population. International Journal of Drug Policy  20, pp. 121-130. 
Simmons, J., Rajan, S., & McMahon, J. M. (2012) Retrospective accounts of injection 
initiation in intimate partnerships. International Journal of Drug Policy  23, pp. 303-
311. 
Smith, D. J., Busuito, M. J., Venavich, V., Spotts, J., Heggers, J. P., & Robson, M. C. 
(1989) Drug injection injuries of the upper extremity. Annals of Plastic Surgery  22, 1, 
pp. 19-24. 
Smith, J. & Firth, J. (2011) Qualitative data analysis: the framework approach. Nurse 
Researcher  18, 2, pp. 52-62. 
Smith, M. E., Robinowitz, N., Chaulk, P., & Johnson, K. E. (2014) Self-care and risk 
reduction habits in older injection drug users with chronic wounds: a cross-sectional 
study. Harm Reduction Journal  11, 28. DOI: 10.1186/1477-7517-11-28 Accessed 
02.02 15 
Spencer, L., Ritchie, J., O'Connor, W., Morrell, G., & Ormston, R. (2014) "Analysis in 
practice," in Qualitative Research Practice. Second edition, J. Ritchie et al., eds., Sage, 
London, pp. 295-345. 
Spijkerman, I. J. B., van Ameijden E.J.C., Meintjes, G. H. C., Coutinho, R. A., & van 
den Hoek, A. (1996) Human immunodeficiency virus infection and other risk factors 
for skin abscess and endocarditis among injection drug users. Journal of Clinical 
Epidemiology  49, 10, pp. 1149-1154. 
Stead, M., MacKintosh, A. M., McDermott, L., Eadie, D., Macneil, M., Stradling, R., & 
Minty, S. (2007) Evaluation of the effectiveness of drug education in Scottish schools. 
Scottish Executive, Edinburgh. 
316 
 
Steel, R. (2004) Involving marginalised and vulnerable people in research: a 
consultation document. INVOLVE: Promoting public involvement in NHS, public 
health, and social care research. Department of Health, Hampshire. 
Stewart, S. H., Pihl, R. O., Conrod, P., & Dongier, M. (1998) Functional association 
among trauma PTSD and substance-related disorders.  Addictive Behaviours  23, pp. 
797-812. 
Stone, M. H., Stone, D. H., & MacGregor, H. A. R. (1990) Anatomical distribution  of 
soft tissue sepsis sites in intravenous drug misusers attending an accident and 
emergency department. British Journal of Addiction  85, pp. 1495-1496. 
Strang, J., Griffiths, P., Abbey, J., & Gossop, M. (1994) Survey of use of injected 
benzodiazepines among drug users in Britain. British Medical Journal  308, 6936, p. 
1082. 
Strang, J., Gossop, M., Heuston, J., Green, J., Whiteley, C., & Maden, A. (2006) 
Persistence of drug use during imprisonment: relationship of drug type, recency of use 
and severity of dependence to use of heroin, cocaine and amphetamine in prison. 
Addiction  101, pp. 1125-1132. 
Stratigos, A. J., Stern, R., Gonzalez, E., Johnson, R. A., O'Connell, J., & Dover, J. S. 
(1999) Prevalence of skin disease in a cohort of shelter-based homeless men. Journal of 
the American Academy of Dermatology  41, pp. 197-202. 
Strike, C., Buchman, D. Z., Callaghan, R. C., Wender, C., Anstice, S., Lester, B., 
Scrivo, N., Luce, J., & Millson, M. (2010) Giving away used injection equipment: 
missed prevention message? Harm Reduction Journal  7, 2. DOI:10.1186/1477-7517-7-
2 Accessed 14.12.12 
Stuck, R. M. & Doyle, D. (1987) Superficial thrombophlebitis following parenteral 
cocaine abuse. Journal of the American Podiatric Medical Association  77, 7, pp. 351-
353. 
Sudhindran, S. (1997) Vascular complications of injecting drug use. British Journal of 
Surgery  84, 4, pp. 582-583. 
Summanen, P. H., Talan, D. A., Strong, C., McTeague, M., Bennion, R., Thompson, J. 
E., Vaisanen, M.-L., Moran, G., Winer, M., & Finegold, S. M. (1995) Bacteriology of 
317 
 
skin and soft-tissue infections: comparison of infections in intravenous drug users and 
individuals with no history of intravenous drug use. Clinical Infectious Diseases  20, 
Suppl 2, p. S279-S282. 
Syed, F. F. & Beeching, N. J. (2005) Lower-limb deep-vein thrombosis in a general 
hospital: risk factors, outcomes and the contribution of intravenous. QJM: An 
International Journal of Medicine 98, 2, pp. 139-145. 
Tabachnick, B. G. & Fidell, L. S. (1996) Using multivariate statistics. Third edition, 
HarperCollins, New York. 
Takahashi, T. A., Merril, J. O., Boyko, E. J., & Bradley, K. A. (2003) Type and 
location of injection drug use-related soft tissue infections predict hospitalisation. 
Journal of Urban Health  80, 1, pp. 127-136. 
Tashakkori, A. & Teddlie, C. (2003) Handbook of mixed methods in social and 
behavioural research. Sage, California. 
Taylor, A. (1993) Women Drug Users. An ethnography of a female injecting 
community Oxford University Press, Oxford. 
Taylor, A., Goldberg, D., Hutchinson, S., Cameron, S., & Fox, R. (2001) High risk 
injecting behaviour among injectors from Glasgow: cross sectional community wide 
surveys 1990 - 1999. Journal of Epidemiology and Community Health  55, 10, pp. 766-
767. 
Taylor, A., Fleming, A., Rutherford, J., & Goldberg, D. (2004a) Examining the 
injecting practices of injecting drug users in Scotland, Effective Interventions Unit; 
Scottish Executive Drug Misuse Research Programme, Edinburgh. 
Taylor, A., Fleming, A., Rutherford, J., & Goldberg, D. (2004b) Scottish report on 
hepatitis C and injecting practices has implications for policy and harm reduction 
strategies. Eurosurveillance  9, 4-6, p. 50. 
Taylor, A., Hutchinson, S., Lingappa, J., Wadd, S., Ahmed, S., Gruer, L., Taylor, T. H., 
Roy, K., Gilchrist, G., McGuigan, G., Penrice, G., & Goldberg, D. (2005) Severe 
illness and death among injecting drug users in Scotland: a case control study. 
Epidemiology and Infection  133, 2, pp. 193-204. 
318 
 
Taylor, A., Munro, A., Allen, E., Dunleavy, K., Cameron, S., Miller, L., & Hickman, 
M. (2013) Low incidence of HCV amongst prisoners in Scotland. Addiction  108, 7 pp. 
1296 - 304.  doi: 10.1111/add.12107 
Taylor, N. J. & Kearney, J. (2005) Researching hard-to reach populations: privileged 
access interviewers and drug using parents. Sociological Research Online  10, 2. 
Thakor, A. S. & Wijenaike, N. (2009) Infective endocarditis from injecting heroin into 
a leg ulcer. British Medical Journal Case Reports 17 March 
doi:10.1136/bcr.07.2008.0493 
The Alexander House Group (1992) Consensus Statement Consensus Paper on Venous 
Leg Ulcers.  Phlebology  7, pp. 48-58. 
Thiede, H., Hagan, H., Campbell, J. V., Strathdee, S. A., Bailey, S. L., Hudson, S. M., 
Kapadia, F., & Garfein, R. S. (2007) Prevalence and correlates of indirect sharing 
practices among young adult injection drug users in five U.S. cities. Drug and Alcohol 
Dependence  91S, p. S39-S47. 
Thomson, E. C. & Lynn, W. A. (2003) Septic thrombophlebitis with multiple 
pulmonary abscesses. The Lancet  3, February, p.86. 
Ti, L., Hayashi, K., Kaplan, K., Suwannawong, P., Wood, E., & Kerr, T. (2014) Groin 
injecting among a community-recruited sample of people who inject drugs in Thailand. 
Substance Abuse Treatment, Prevention, and Policy  9, 4. 
Tice, A. D. (2002) An unusual nonhealing ulcer on the forearm. The New England 
Journal of Medicine  347, 21, pp. 1725-1726. 
Ting, A. C. W. & Cheng, S. W. K. (1997) Femoral pseudoaneurysms in drug addicts. 
World Journal of Surgery  21, pp. 783-787. 
Tolat, R. D., O'Dell, M. W., Golamco-Estrella, S. P., & Avella, H. (2000) Cocaine-
associated stroke: three cases and rehabilitation considerations. Brain Injury  14, 4, pp. 
383-391. 
Topp, L., Iversen, J., Conroy, A., Salmon, A. M., & Maher, L. (2008) Prevalence and 
predictors of injecting-related injury and disease among clients of Australia's needle 
and syringe programs. Australian and New Zealand Journal of Public Health  32, 1, pp. 
34-37. 
319 
 
Treloar, C., Hull, P., Bryant, J., Hopwood, M., Grebely, J., & Lavis, Y. (2011) Factors 
associated with hepatitis C knowledge among a sample of treatment naive people who 
inject drugs. Drug and Alcohol Dependence  116, pp. 52-56. 
Tuazon, C. U., Hill, R., & Sheagren, J. N. (1974) Microbiologic study of street heroin 
and injection paraphernalia. The Journal of Infectious Diseases  129, 3, pp. 327-329. 
Tuchsen, F., Krause, N., Burr, H., & Kristensen, T. S. (2000) Standing at work and 
varicose veins. Scandinavian Journal of Work and Environmental Health  26, 5, pp. 
414-420. 
University of the West of Scotland, Health Protection Scotland, University of 
Strathclyde, and the West of Scotland Specialist Virology Centre. (2012) The Needle 
Exchange Surveillance Initiative (NESI) : Prevalence of HCV and injecting risk 
behaviours among people who inject drugs attending injecting equipment provision 
services in Scotland, 2008/ 2009 & 2010, University of the West of Scotland, Glasgow. 
UNODC (2012) World Drug Report 2012, United Nations, Austria. 
UNODC (2014) World Drug Report 2014, United Nations, Austria. 
van Beek, I., Dwyer, R., & Malcolm, A. (2001) Cocaine injecting: the sharp end of 
drug-related harm. Drug and Alcohol Review   20, pp. 333-342. 
Vlahov, D., Sullivan, M., Astemborski, J., & Nelson, K. E. (1992) Bacterial infections 
and skin cleaning prior to injection among intravenous drug users. Public Health 
Reports  107, 5, pp. 595-598. 
Ward, D. J., Furber, C., Tierney, S., & Swallow, V. (2013) Using framework analysis 
in nursing research: a worked example. Journal of Advanced Nursing  69, 11, pp. 2423-
31 
Watson, R., Atkinson, I., & Egerton, P. (2006) Successful statistics for nursing and 
healthcare. Palgrave, Basingstoke. 
Watt, D. (2007) On becoming a qualitative researcher: the value of reflexivity. The 
Qualitative Report  12, 1, pp. 82-101. 
Weaver, K. & Olson, J. K. (2006) Understanding paradigms used for nursing research. 
Journal of Advanced Nursing  53, 4, pp. 459-469. 
320 
 
Weidman, A. L. & Fellner, M. J. (1971) Cutaneous manifestations of heroin and other 
addictive drugs. Study and analysis. New York State Journal of Medicine  71, 22, pp. 
2643-2646. 
Welch, G. H., Reid, D. B., & Pollock, J. G. (1990) Infected false femoral aneurysms in 
the groin of intravenous drug abusers. British Journal of Surgery  77, pp. 330-333. 
Whittaker, A., Williams, N., Chandler, A., Cunningham-Burley, S., McGorm, K., & 
Mathews, G. (2015) The burden of care: a focus group study of healthcare practitioners 
in Scotland talking about parental drug misuse. Health and Social Care in the 
Community. DOI: 10.1111/hsc.12249 
WHO. (2007) Lexicon of alcohol and drug terms published by World Health 
Organisation. World Health Organisation, Geneva 
Wilce, H. (2004) Temazepam capsules: what was the problem? Australian Prescriber  
27, 3, pp. 58-59. 
Williams, A. M. & Southern, A. J. (2005) Conflicts in the treatment of chronic ulcers in 
drug addicts - case series and discussion. British Journal of Plastic Surgery  58, pp. 
997-999. 
Williams, K. & Abbey, E. (2006) Knowledge of deep vein thrombosis among 
intravenous drug misusers. The Psychiatrist  30, 7, pp. 263-265. 
Wilson, V. & McCormack, B. (2006) Critical realism as emancipatory action: the case 
for realistic evaluation in practice development. Nursing Philosophy  7, 1, pp. 45-57. 
Woodburn, K. R. & Murie, J. A. (1996) Vascular complications of injecting drug 
misuse. British Journal of Surgery  83, 10, pp. 1329-1334. 
Yates, P. R. (2006) Bad mouthing, bad habits and bad, bad boys. An exploration of the 
relationship between dyslexia and drug dependence, Unpublished MSc thesis, 
University of Stirling, Stirling. 
Yin, R. K. (2003) Case Study Research Design and Methods. Third edition, Sage 
Publications, California. 
Zador, D., Lintzeris, N., Van der waal, R., Miller, P., Metrebian, N., & Strang, J. (2008) 
The fine line between harm reduction and harm production - development of a clinical 
policy on femoral (groin) injecting. European Addiction Research  14, pp. 213-218. 
321 
 
Zador, D. A. (2007) Facilitating groin injecting behaviour: harm reduction or 
production? Addiction  102, pp. 1791-1792. 
Zerell, U., Ahrens, B., & Gerz, P. (2005) Documentation of a heroin manufacturing 
process in Afghanistan. Bulletin on Narcotics  57, 1-2, pp. 11-31. 
Zucker, D. M. (2001) Using case study methodology in nursing research. The 
Qualitative Report  6, 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
322 
 
List of Appendices  
 
Appendix 1  Glossary of terms ……………………………………………….323 
Appendix 2  Questionnaire Phase 1………………………………………….325 
Appendix 3  Information sheet: Health and Social Care Services……...335   
Appendix 4  Patient information leaflet Phase 1…………………………...336 
Appendix 5  Poster Phase 1……………………………………………………338 
Appendix 6  Patient information sheet Phase 1…………………………..   339 
Appendix 7  Consent form Phase 1…………………………………………...343 
Appendix 8  Semi-structured interview schedule Phase 2………………344 
Appendix 9  Poster Phase 2……………………………………………………346 
Appendix 10 Patient information sheet Phase 2……………………………347 
Appendix 11 Consent form Phase 2…………………………………………..351 
 
 
 
 
 
 
 
 
323 
 
Appendix 1 Glossary of terms and abbreviations 
Abscess: pus-filled swelling 
Abdine: An indigestion remedy used as an acid dissolver 
ABPI: Ankle Brachial Pressure Index – a test undertaken using Doppler to assess 
arterial deficit within the legs 
Ankle flare: dilatation of the arterioles around the ankle 
BBV: Blood-borne virus 
Benzos: slang for benzodiazepines the drug group includes diazepam and temazepam 
Cannabis:  marijuana (‘dope’, ‘hash’, ‘joint’, ‘skunk’) 
Cellulitis: Infection of the soft tissue characterised by a spreading redness, with 
tenderness 
Claudication: pain in the calf on walking due to ischaemia 
Coke: cocaine 
Cooker: container or receptacle used for heating drugs 
Crack:  also called freebase or rock 
CVI: Chronic venous insufficiency 
DVT: Deep vein thrombosis 
Eggs: Temazepam in gel form capsules 
Hit: injection 
IEP: Injecting equipment provision 
Induration: The hardening of a normally soft tissue or organ, especially the skin 
Jellies:  Temazepam usually in gel capsule format 
Kit: heroin 
Lipodermatosclerosis: a skin change of the lower legs usually appearing as a brown 
stain 
Mainlining: injecting in a large vein such as the brachial 
Methadone: Opiate substitute 
Missed hit: injecting into subcutaneous tissues or extravascular space usually in error 
Osteomyelitis: Infection of the bone 
Pins: needles 
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PTS: post-thrombotic syndrome 
PWID: people who inject drugs 
Rattled: withdrawing characterised by sweating, shaking and malaise 
Shooting galleries: areas where drug users will congregate to inject 
Smack - heroin 
Speedballing or snowballing the injection of mixed drugs commonly cocaine and 
heroin together but may include other drugs 
Tensosynovitis: inflammatory injury to the sheath surrounding tendon  
Thrombosis: clot 
Tools: injecting equipment 
Varicose veins: swollen and enlarged veins 
Works:  injecting equipment 
 
(Source WHO, 2007) 
 
 
 
 
 
325 
 
 
326 
 
327 
 
328 
 
329 
 
330 
 
331 
 
332 
 
333 
 
334 
 
335 
 
 
 
336 
 
 
 
337 
 
 
 
338 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
339 
 
340 
 
341 
 
342 
 
343 
 
344 
 
345 
 
346 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
347 
 
348 
 
349 
 
350 
 
351 
 
352 
 
 
